aspirin has been researched along with warfarin in 2036 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 214 (10.51) | 18.7374 |
| 1990's | 388 (19.06) | 18.2507 |
| 2000's | 677 (33.25) | 29.6817 |
| 2010's | 651 (31.97) | 24.3611 |
| 2020's | 106 (5.21) | 2.80 |
| Authors | Studies |
|---|---|
| Gubernator, K; Kansy, M; Senner, F | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Dikshit, M; Jain, M; Kumar, A; Kumar, M; Sashidhara, KV; Singh, S | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Fretz, H; Gnerre, C; Leroy, X; Peter, O; Pothier, J; Riederer, MA; Valdenaire, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Fretz, H; Gnerre, C; Hilpert, K; Leroy, X; Peter, O; Pothier, J; Riederer, MA; Valdenaire, A | 1 |
| Giridhar, R; Kanhed, A; Modh, P; Sinha, A; Verma, A; Yadav, MR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Hou, M; Lv, M; Peng, S; Wang, Y; Wu, J; Zhang, X; Zhao, M; Zhao, S | 1 |
| Bai, T; Feng, Q; Guo, T; Jia, J; Li, X; Liu, Y; Pei, J; Song, Y; Wu, L; Wu, S; Zhang, Y; Zheng, X | 1 |
| Romankiewicz, JA | 1 |
| Jick, H; Porter, J | 1 |
| Wiggins, CE | 1 |
| Brown, JM; Carmel, RJ | 1 |
| Schmähl, D | 1 |
| Robinson, DS | 1 |
| Cameron, JS; Clark, WF; George, CR | 1 |
| MacVaugh, H; Michelson, EL; Morganroth, J; Torosian, M | 1 |
| Vinazzer, H | 1 |
| Fisher, M | 2 |
| Loeliger, EA | 2 |
| Gitel, SN; Wessler, S | 1 |
| Weissbach, G | 1 |
| Huguier, M; Uhl, JF | 1 |
| Calvin, L; DeMots, H; Goodnight, SH; Harlan, BJ; Pantely, GA; Rahimtoola, SH; Rösch, J | 1 |
| Rose, SD | 1 |
| Heidrich, H | 1 |
| Larsson, S; Roberts, D; Südow, G; Swedberg, J | 1 |
| Kato, H; Koike, S; Yokoyama, T | 1 |
| Bruhn, HD | 2 |
| Adappa, MG; Ansbro, J; Gerbode, F; Hetzer, R; Hill, JD; Kamm, B; Kerth, WJ; Rodvien, R | 1 |
| Watson, RT | 1 |
| Hladovec, J | 1 |
| Glaves, D; Weiss, L | 2 |
| Glenn, WW; Hammond, GL; Moggio, RA; Stansel, HC | 1 |
| Harrison, MJ; Jestico, J; Marshall, J | 1 |
| Salzman, EW; Skillman, JJ; Yett, HS | 1 |
| Dulp-Gollasch, I; Fernández B de Quirós, J; Hess, H | 1 |
| Deykin, D | 1 |
| Bucher, HJ | 1 |
| O'Reilly, RA | 2 |
| Gavrilov, OK; Kaveshnikova, BF; Rachinskaia, NA | 1 |
| Hilgard, P; Thornes, RD | 1 |
| Breddin, K | 2 |
| Mason, RG; Shinoda, BA; Wolf, RH; Zucker, WH | 1 |
| Brady, LP | 1 |
| Sindermann, F | 1 |
| Feinstein, PA; Habermann, ET | 1 |
| Frank, HA; Friedman, EW; Ponn, R | 1 |
| Gruber, UF; Pfenninger, M | 1 |
| Gotshall, RA; Harker, LA | 1 |
| Assandri, A; Perazzi, A | 1 |
| Melzer, G; Nitz, RE; Resag, K | 1 |
| Arfors, KE; Bergqvist, D | 1 |
| Flemming, F; Thomas, E; Widera, R | 1 |
| Reuter, H | 1 |
| Heitland, W; Rahmer, H | 1 |
| Lachiewicz, P; Salvati, EA | 1 |
| Ahr, DJ; Andersen, CA; Collins, GJ; Rich, NM | 1 |
| Cervantes, FD; Schneiderman, LJ | 1 |
| Boost, G | 1 |
| Gent, M; Genton, E; Harker, LA; Hirsh, J | 1 |
| Dale, J; Myhre, E; Stormorken, H; Storstein, O | 1 |
| Davies, H; Genton, E; Ppppas, G; Steele, P; Weily, H | 1 |
| Austin, J; Kalendovsky, Z; Steele, P | 1 |
| Eiseman, B; Kelly, GL | 1 |
| Mason, RG; Shinoda, BA; Zucker, WH | 2 |
| Hosokawa, T; Ikematsu, S; Itoh, O; Samori, T | 1 |
| Bandinelli, C; Bellini, PG; De Mauro, G; Provvedi, D; Rubegni, M | 2 |
| Lavelle, SM; MacIomhair, M | 1 |
| De Clerck, F; Reneman, R; Vermylen, J | 1 |
| Hach, W; Siefer, H | 1 |
| Barth, P; Lange, D; Zieboll, J; Zimmermann, R | 1 |
| Karch, FE; Lasagna, L | 1 |
| Ardelt, W; Bolze, H; Dittrich, A | 1 |
| Johnsson, H; Olsson, P | 1 |
| Harris, WH; Paiement, GD; Schutzer, SF; Wessinger, SJ | 1 |
| Andres, F; Cosín, J; Hernandiz, A; Olagüe, J; Solaz, J | 1 |
| Sawaya, JI | 1 |
| Porath, A; Rubowitz, AH | 1 |
| Fouchard, J; Guérin, F; Le, F; Py, A | 1 |
| Dalen, JE; Hirsh, J | 1 |
| Albers, G; Dunn, M; Feinberg, W; Laupacis, A | 1 |
| Airaksinen, KE; Huikuri, HV; Ikäheimo, MJ; Korhonen, UR; Linnaluoto, MK; Takkunen, JT; Yli-Mäyry, S | 1 |
| Blackburn, T; Dunn, M | 1 |
| Asakura, H; Hifumi, S; Jokaji, H; Kumabashiri, I; Mizuhashi, K; Morishita, E; Saito, M; Shibata, K; Uotani, C; Yamazaki, M | 1 |
| Heit, JA; Ilstrup, DM; Mohr, DN; Morrey, BF; Silverstein, MD | 1 |
| Biller, J; Love, BB | 1 |
| Blewett, DR; Gress, DR; Hughes, RA; Kistler, JP; Maraventano, SW; Oertel, LB; Rosner, B; Sheehan, MA; Singer, DE | 2 |
| Bloomfield, P; Nolan, J | 1 |
| Hach-Wunderle, V | 1 |
| Kelleher, CC | 1 |
| Brennan, PJ; Kelleher, CC; Meade, TW; Roderick, PJ; Wilkes, HC | 1 |
| Kahn, JK | 1 |
| Himbert, D; Juliard, JM; Steg, PG | 1 |
| Clagett, GP | 1 |
| Andersen, P; Ovrebø, J; Smith, P | 1 |
| Bär, FW; de Swart, JB; van der Veen, FH; van Ommen, V; van Oppen, J; Wellens, HJ | 1 |
| Donnan, GA | 1 |
| Brewer, PM; Rosove, MH | 1 |
| Ernerudh, J; Lindström, F; Olsson, JE; Vrethem, M | 1 |
| Healy, B | 1 |
| Alter, M; Friday, GH; Lai, SM; Sobel, E; Toedter, LJ | 1 |
| Dunbabin, D; Sandercock, P | 1 |
| Kaufman, EE; O'Meara, PM | 1 |
| Grant, KF; Mahmood, NF; McDonald, CL | 1 |
| Tanabe, A; Toshima, H | 1 |
| Davis, S | 1 |
| Jafri, SM | 1 |
| Inoue, M; Iwane, Y; Kobune, K; Kudo, T; Morikawa, M; Takanami, Y; Tsuboi, M | 1 |
| Cairns, J; Connolly, SJ; Gent, M; Joyner, C; Laupacis, A; Roberts, RS | 1 |
| Albers, GW; Atwood, JE; Connolly, SJ; Hirsh, J; Hughes, RA; Sherman, DG | 1 |
| Altmann, E; Hoffmann, A; Schmidt, PK; Schweizer, J; Spranger, C | 1 |
| Cairns, JA | 1 |
| Takahashi, O | 1 |
| Oster, ZH; Som, P; Wang, GJ; Zamora, PO | 1 |
| Dalen, JE | 1 |
| Kutner, M; Nixon, G; Silverstone, F | 1 |
| Ma, X | 1 |
| Amlie, JP; Aursnes, I; Osnes, JB; Platou, ES; Smiseth, OA | 1 |
| Baim, DS; Cabin, HS; Cleman, MW; Ellis, SG; Goldberg, S; Hirshfeld, JW; Leon, M; Schatz, RA; Stagg, J; Walker, C | 1 |
| Kessler, CM | 1 |
| Watt, JM; Woolson, ST | 1 |
| Brassard, JA; Meyers, KM | 1 |
| Ferrario, A; Gomer, CJ | 1 |
| Boysen, G; Godtfredsen, J; Helweg-Larsen, S; Kastrup, J; Petersen, P | 1 |
| Chesebro, JH; Fuster, V; Halperin, JL | 1 |
| Anderson, DC | 1 |
| Adams, PC; Bach, M; Cohen, M; Fuster, V; Hawkins, L | 1 |
| McNulty, A; Miller, DH; Schreiber, TL; Silvasi, D; Zola, BE | 1 |
| Divino, CM; Schussler, GC | 1 |
| Cochrane, RH; Cogbill, TH; Hutter, RD; Landercasper, J; Merz, BJ; Olson, RA; Strutt, PJ | 1 |
| Meade, TW | 1 |
| Coffman, JD | 1 |
| Daneshmend, TK; Hawkey, CJ; Kitchingman, GK; Prichard, PJ; Walt, RP | 1 |
| Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
| Andersen, B; Andersen, ED; Boysen, G; Godtfredsen, J; Petersen, P | 1 |
| Meuwissen, OJ | 1 |
| Donadio, JV; Offord, KP | 1 |
| Lapinski, RH; Levy, DE; Slivka, A | 1 |
| Gent, M; Hirsh, J; Jay, RM; Julian, DH; Levine, M; Powers, PJ; Turpie, AG | 1 |
| Komatsu, Y; Miura, M; Miyazaki, Y; Miyazawa, Y; Shibata, N; Ueda, M | 1 |
| Miller, GJ | 1 |
| Abildgaard, U; Dahl, T; Sandset, PM | 1 |
| Hauser, WA; Mohr, JP; Petty, GW; Sacco, RL; Tatemichi, TK | 1 |
| D'Andrea, G; Joseph, R; Oster, SB; Welch, KM | 1 |
| Dejana, E; Prosdocimi, M; Zanetti, A; Zatta, A | 1 |
| Lorenz, RL; Schramm, W; Theisen, K; Weber, MA | 1 |
| Black, AJ; Brown, JE; Douglas, JS; Gianturco, C; King, SB; Robinson, KA; Roubin, GS; Siegel, RJ | 1 |
| Bollinger, A | 1 |
| Kitchens, CS; Mehta, JL | 1 |
| Costantini, V; Goracci, G; Nenci, GG; Pistolesi, R; Porcellati, S; Porrovecchio, P; Prosdocimi, M | 1 |
| Bianciardi, G; Massari, P; Orlando, P; Toti, P; Weber, G | 1 |
| Chesebro, JH; Fuster, V; Steele, PM | 1 |
| Furukawa, K; Hino, H; Kawachi, K; Konagai, N; Kudo, T; Shimizu, T | 1 |
| Burkel, WE; Graham, LM; Köveker, GB; Stanley, JC; Wakefield, TW | 1 |
| Hatsuoka, M; Kashii, A; Sasaki, K; Seiki, M | 1 |
| Freeman, JW | 1 |
| Estes, JW; Jones, DH; Lamis, PA; Mittenthal, MJ; Rosenthal, D; Ruben, DM; Stanton, PE | 1 |
| Holm, K; Kasuya, A | 1 |
| Deans, KW; Hartshorn, JC | 1 |
| Barnett, HJ; Buchan, A; Fox, AJ; Pelz, DM; Vinuela, F | 1 |
| Connor, FO; Gil Aguado, M; Larrea, JL; Nuñez, L; Pinto, AG | 1 |
| Sautter, RD | 1 |
| DeBoer, A; Hartz, RS; Kucich, V; LoCicero, J; Meyers, SN; Michaelis, LL; O'Mara, S | 1 |
| Burns, JC; Glodé, MP; Leung, DY; Newburger, JW; Toews, WH; Wiggins, JW; Wilson, H | 1 |
| Kasuya, Y; Urushidani, T; Yano, S | 1 |
| Adelman, B; Smith, T; Viverette, F | 1 |
| Weiner, CP | 1 |
| Boey, J; Chan, TK; Cheung, KL; Chow, J; Lee, PK; Mok, CK; Ng, RP; Tse, TF; Wang, R | 1 |
| Al Fagih, M; Al Kasab, S; Al Zaibag, M; Davies, G; Idris, M; Mashat, E; Ribeiro, PA; Wareham, E | 1 |
| Kline, OR; Sklar, C; Stone, LS | 1 |
| Bradley, LM; Getson, PR; Midgley, FM; Scott, LP; Watson, DC | 1 |
| Christakis, GT; David, TE; Ho, WI | 1 |
| Bollinger, A; Brunner, U | 1 |
| Aggeler, PM; O'Reilly, RA; Sahud, MA | 1 |
| van Aken, WG; Vreeken, J | 1 |
| Flynn, A; Kolenich, JJ; Mansour, EG | 1 |
| Hucker, HB; Stauffer, SC; White, SE | 1 |
| Coldwell, BB; Grice, HC; Zawidzka, ZZ | 1 |
| Fiedler, H; Thiele, G | 2 |
| Kingdon, HS | 1 |
| Cepelák, V; Grimová, J; Nĕmecek, O; Roubal, Z | 1 |
| Fontaine, L; Grand, M; Merle, S; Quentin, Y | 1 |
| Loew, D | 1 |
| Aglietti, P; Mendes, DG; Salvati, EA; Wilson, PD | 1 |
| Chuang, HY; Clark, HG; Kingdon, HS; Mason, RG; Shinoda, BA; Zucker, WH | 1 |
| Douglas, AS | 1 |
| Eriksson, M | 1 |
| Athanasoulis, C; Baum, S; DeSanctis, RW; Harris, WH; Salzman, EW; Waltman, AC | 1 |
| Barth, P; Masche, R; Zimmermann, R | 1 |
| Sherman, LA; Wessler, S | 1 |
| Barth, P; Walter, E; Weber, E; Zimmermann, R | 1 |
| Lyon, LJ; Nevins, MA | 1 |
| Johnson, G; Mandel, SR | 1 |
| Ahuja, SP; Coles, JC; McDonald, JW; Stuart, RK | 1 |
| George, CR; Harker, LA; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
| Bove, LG | 1 |
| Forbes, CD; Prentice, CR | 1 |
| Burkhardt, H; Loew, D; Röll, G | 1 |
| Nelson, DA; Perrin, JH | 1 |
| Eiden, W; Hahn, KJ; Hahn, M; Schettle, M; Walter, E; Weber, E | 1 |
| Cepelák, V; Cepeláková, H; Nĕmecek, O; Roubal, Z | 1 |
| Airaksinen, M; Julkunen, R; Jussila, J; Kekki, M; Mustala, O; Pyörälä, K; Salmi, H; Siurala, M | 1 |
| Perrier, CV; Sitavanc, L | 1 |
| Attar, S; Masaitis, C; McLaughlin, JS | 1 |
| Barth, P | 1 |
| Falk, EA; Glassman, E; Isom, OW; Spencer, FC; Williams, CD | 1 |
| Athanasoulis, C; DeSanctis, RW; Harris, WH; Salzman, EW; Sara, SM; Waltman, AC | 1 |
| Lüllmann, H; Schaefer, J | 1 |
| Schürer-Waldheim, H; Spängler, P; Staffen, A | 1 |
| Barth, P; Lindner, R; Zimmermann, R | 1 |
| Skillman, JJ | 1 |
| Jackson, RA; Smith, MC | 1 |
| Soloway, HB | 1 |
| Harker, LA; Slichter, SJ | 1 |
| Holmes, EL | 1 |
| Moll, F | 1 |
| DeSanctis, RW; Harris, WH; Salzman, EW | 1 |
| Sherry, S | 1 |
| Didisheim, P | 1 |
| Bailey, KR; Gallo, DG; Sheffner, AL | 1 |
| Marco, LA; Randels, PM | 1 |
| Bolte, HD | 1 |
| Hinton, RC | 1 |
| Hetherington, V; Petrantoni, C; Pilla, P | 1 |
| Wille, P | 1 |
| Ebert, PA; Mavroudis, C; Weinstein, GS | 1 |
| Catron, PW; Flynn, ET | 1 |
| Bettmann, MA; Garnic, JD; Murray, PD | 1 |
| Russell, JC | 1 |
| Azolov, VV; Ladygin, MS | 1 |
| Thiele, R | 1 |
| Douglas, JS; Gruentzig, AR; Hollman, J; King, SB; Thornton, MA | 1 |
| Royer, GL; Seckman, CE; Welshman, IR | 1 |
| Bazzan, M; Della Dora, N; Pannocchia, A; Schinco, PC; Tamponi, G | 1 |
| Brücke, P; Herbinger, W; Leisch, F | 1 |
| Chesebro, JH; Danielson, GK; Elveback, LR; Fuster, V; McGoon, DC; Orszulak, TA; Piehler, JM; Pluth, JR; Puga, FJ; Schaff, HV; Wallace, RB | 1 |
| Barnett, HJ | 1 |
| Furst, DE | 1 |
| Alho, A; Røttingen, J; Stangeland, L; Wiig, JN | 1 |
| Burke, W; DePace, NL; Glazier, EE; Kotler, MN | 1 |
| Berkowitz, HD; Freiman, DB; Gatenby, R; Gertner, M; Oleaga, JA; Ring, EJ; Roberts, B; Spence, R | 1 |
| Tilsner, V | 1 |
| Quick, D; Trowbridge, AA | 1 |
| Makita, T; Otsu, A; Sagara, K; Takesue, Y; Wada, H | 1 |
| Nair, CK; Pagano, T; Sketch, MH | 1 |
| Copeland, JG; Goldman, S | 1 |
| Friedman, EW; Hamilton, AJ | 1 |
| Baele, G; Barbier, F; Rasquin, K | 1 |
| Ritchie, JL; Stratton, JR | 1 |
| Furlan, AJ | 2 |
| O'Brien, JR | 1 |
| D'Arcy, PF | 1 |
| Crow, MJ; Donaldson, DR; Rajah, SM; Sreeharan, N | 1 |
| Avery, GJ; Gerbode, F; Hill, JD; Kerth, WJ; LaFollette, L; Rodvien, R; Szarnicki, RJ; Wilson, RM | 1 |
| Soyka, D | 1 |
| Limonova, SG; Makatsariia, AD | 1 |
| Wessler, S | 1 |
| Austen, WG; DeSanctis, RW; Gates, S; Harthorne, JW; McEnany, MT; Mundth, ED; Salzman, EW; Weintraub, RM | 1 |
| Chesebro, JH; Fuster, V | 1 |
| Alba, A; Damiano, A; Higes, A; Ruíz, M; Zulaíca, D | 1 |
| Aguado, MG; Celemín, D; Iglesias, A; Larrea, JL; Nuñez, L | 1 |
| Friedman, C; Romem, M; Singer, L | 1 |
| Booth, RE; Guyer, RD; Rothman, RH | 1 |
| Kosaka, H; Nagata, S; Sadamoto, H | 1 |
| Bowen, TE; Brott, WH; Davia, J; Green, DC; Zajtchuk, R | 1 |
| Davis, GL; Mutnick, AH | 1 |
| Nohara, Y; Yamasawa, I | 1 |
| RuDusky, BM | 1 |
| Barre, J; Campos, H; d'Athis, P; Prandota, J; Tillement, JP | 1 |
| Meier, B | 2 |
| Albers, GW; Cardinalli, AB; Gage, BF; Owens, DK | 1 |
| Imperiale, TF; Speroff, T | 1 |
| Forni, A; Giannopoulos, N; Kendall, SW; Mediratta, N; O'Regan, DJ; Pillai, R; Westaby, S | 1 |
| Kibel, AS; Loughlin, KR | 1 |
| Bulpitt, CJ; Cleland, JG; Falk, RH; Findlay, IN; Murray, G; Oakley, CM; Poole-Wilson, PA; Prentice, CR; Sutton, GC | 1 |
| Kariyazono, H; Moriyama, Y; Nakamura, K; Saigenji, H; Shimokawa, S; Taira, A; Toyohira, H; Yamada, K | 1 |
| Badimon, JJ; Chesebro, JH; Fallon, JT; Fuster, V; Gallo, R; Lettino, M; Toschi, V | 1 |
| Stratton, JR | 1 |
| Ganiats, T | 1 |
| Brown, MB; Chimowitz, MI; Furlan, AJ; Kokkinos, J; Levine, SR; Pessin, MS; Sila, CA; Silliman, S; Strong, J; Weichel, E | 1 |
| Bayazit, K; Gol, K; Kiziltepes, U; Mavitas, B; Sener, E; Tarcan, O; Tasdemir, O; Yamak, B | 1 |
| Akin, DR; Bonito, AJ; DeFriese, GH; Duncan, PW; Goldstein, LB; Matchar, DB; Oddone, EZ; Paul, JE; Samsa, GP | 1 |
| Kobayashi, H; Liu, JH; Xu, SX; Yao, XS | 1 |
| Gorelick, PB | 2 |
| Gulløv, AL; Koefoed, BG; Petersen, P | 3 |
| Reeder, GS | 1 |
| Halinen, MO; Koskinen, P; Kupari, M | 1 |
| Fowles, RE | 1 |
| Comp, PC; Durica, SS; Morrissey, JH; Owen, WL; Raskob, GE | 1 |
| Corson, JD; Hoballah, JJ; Kresowik, TF; Mohan, CR; Schueppert, MT; Sharp, WJ | 1 |
| Hastie, IR; Tozer, R | 1 |
| Stuart, AG; Wilson, DG; Wisheart, JD | 1 |
| Fiane, AE; Geiran, O; Lindberg, HL; Seem, E | 1 |
| Arnesen, H; Eritsland, J; Kierulf, P; Seljeflot, I | 1 |
| Chaithiraphan, S; Opartkiattikul, N; Poungvarin, N; Viriyavejakul, A | 1 |
| Horne, M | 1 |
| Beer, JH; Rihs, F; Sturzenegger, M | 1 |
| Brown, G; Leung, M; Webb, J | 1 |
| Meade, TW; Miller, GJ | 1 |
| Farkas, A; Sámóczi, M; Sipos, E; Tarján, J | 1 |
| Habib, GB | 1 |
| Galea, J; Goiti, JJ; Locke, TJ; Manché, A; Smith, GH; Wilkinson, GA | 1 |
| Barnett, HJ; Feussner, JR; Matchar, DB; McCrory, DC | 1 |
| Cuadrado, MJ; Hughes, GR; Hunt, BJ; Khamashta, MA; Mujic, F; Taub, NA | 1 |
| Bailey, KR; Chesebro, JH; Danielson, GK; Fuster, V; Grill, DE; Heras, M; Orszulak, TA; Penny, WJ; Pluth, JR; Puga, FJ | 1 |
| Adams, PC; Chamberlain, D; Chesebro, JH; Cohen, M; Fox, KA; Fuster, V; McBride, R; Parry, G; Wieczorek, I; Xiong, J | 1 |
| Loscalzo, J; Rabbani, LE | 1 |
| Coccheri, S; Morocutti, C | 1 |
| White, HD | 1 |
| Ezekowitz, MD; James, KE | 1 |
| Herranz, MT; Hughes, GR; Khamashta, MA; Rivier, G | 1 |
| Chalevelakis, G; Moutsopoulos, HM; Raptis, SA; Tsiakou, E; Vlachoyiannopoulos, PG | 1 |
| Barron, WM; Ginsberg, JS | 1 |
| Menke, J | 1 |
| Comp, PC; Durica, SS; Goodman, SG; Gray, RJ; Hall, JH; Hua, TA; Kelley, RP; Langer, A; Lee, RJ; Raskob, GE | 1 |
| Brack, MJ; Gershlick, AH; Hubner, PJ | 1 |
| Blair, KL; Douglas, JM; Glower, DD; Hatton, AC; Lowe, JE; Oldham, HN; Smith, LR; White, WD; Wolfe, WG; Young, WG | 1 |
| Lloyd, JV; Rodgers, SE | 1 |
| Adams, PC; Chamberlain, D; Cohen, M; Fox, KA; Fuster, V; Kronmal, R; Parry, G; Wieczorek, I; Xiong, J | 1 |
| Asakura, H; Matsuda, T; Yamazaki, M | 1 |
| Albers, GW | 2 |
| Brennan, PJ; Howarth, DJ; Meade, TW | 1 |
| Nelson, KM; Talbert, RL | 1 |
| Gershlick, AH | 2 |
| Connolly, SJ | 3 |
| Arnesen, H; Erikssen, J; Hurlen, M; Rollag, A; Smith, P | 1 |
| Bunk, A; Florek, HJ; Schweizer, J | 1 |
| Ramsay, LE | 1 |
| Gray, H; MacMahon, S; Rodgers, A | 1 |
| Fitzgerald, DJ; Keimowitz, RM | 1 |
| Kahle, B | 1 |
| Legerton, CW; Puett, DW; Sergent, JS | 1 |
| Furlan, AJ; Hanna, JP; Sila, CA; Stewart, WJ; Sun, JP; Tan, M | 1 |
| Cleves, M; Golden, WE | 1 |
| Alberts, MJ; Dawson, DV; Massey, EW | 1 |
| Bath, PM; Brown, MM; MacGregor, GA; Prasad, A | 1 |
| Algra, A | 2 |
| Falk, RH | 2 |
| Ansell, J; Chaturvedi, S; Recht, L | 1 |
| Halperin, JL; Rothlauf, EB | 1 |
| Farver, D | 1 |
| Walker, JE | 1 |
| de Swart, H; Lie, KI; Meyer, A; Michels, HR; van der Pol, JM; van Eenige, MJ; Veen, G; Verheugt, FW; Werter, CJ | 1 |
| Amano, T | 1 |
| Cheng, TO | 2 |
| Lip, GY | 6 |
| Gray, CS; O'Connell, JE | 2 |
| Lancaster, T | 1 |
| Mueller, RL; Scheidt, S | 1 |
| Adams, PC; Chamberlain, D; Chesebro, JH; Cohen, M; Fox, KA; Keller, C; Parry, G; Strain, J; Wieczorek, I; Xiong, J | 1 |
| Briët, E; Cannegieter, SC; Rosendaal, FR; van der Meer, FJ | 1 |
| Gardiner, RA; Lavin, MF; P'ng, KB; Seymour, GJ; Walsh, MD | 1 |
| Dunn, FG; Lip, GY; Tean, KN | 1 |
| Alam, S; Gharzeddine, W; Malouf, JF; Stefadouros, MA | 1 |
| Durham, SK; Heran, CL; Megill, JR; Schumacher, WA; Steinbacher, TE | 1 |
| Greenlee, RG; Unwin, DH | 1 |
| Basile, F; Gent, M; Gunstensen, J; Hirsh, J; Klimek, M; Latour, Y; Laupacis, A; Turpie, AG | 1 |
| Conti, CR | 1 |
| Barzegar, S; Bauer, KA; Gress, DR; Hughes, RA; Kistler, JP; Maraventano, SW; Millenson, MM; Oertel, LB; Sheehan, MA; Singer, DE | 1 |
| Bayazit, K; Eralp, A; Karagöz, HY; Tasdemir, O; Yamak, B; Zorlutuna, Y | 1 |
| Brace, LD; Helgason, CM; Hoff, JA; Kondos, GT | 1 |
| Langer, A | 1 |
| Abildgaard, U; Dale, J; Hegrenaes, L; Kontny, F; Lem, P; Morstøl, T | 1 |
| Ben-Baruch, G; Carp, HJ; Greenspoon, JS; Many, A; Mashiach, S; Menashe, Y; Rosen, DJ | 1 |
| Grossman, RS | 1 |
| Anderson, DC; Feinberg, WM; Hart, RG; Miller, VT; Pearce, LA; Rothrock, JF | 2 |
| Cleland, JG; Krikler, DM | 1 |
| Bower, S; Sandercock, P | 1 |
| Bruno, A | 1 |
| Besley, ME; Nuezca, LA; Salter, S; Thomas, A; Uldall, R; Vas, M | 1 |
| Chen, E; Christakis, GT; Fremes, SE; Goldman, BS; Levinton, C; Naylor, CD | 1 |
| LeBlanc, JG; Sett, SS; Vince, DJ | 1 |
| Lie, KI; Meijer, A; van der Pol, JM; van Eenige, MJ; Verheugt, FW; Werter, CJ | 1 |
| Sproat, TT; Yedinak, KC | 1 |
| Debruyne, FM; Doesburg, W; vd Meijden, AP; Witjes, JA | 1 |
| Gershen, B | 1 |
| Alonso, JJ; de la Fuente, L; Durán, JM; Fernández-Avilés, F; Gimeno, F; Muñoz, JC; San Román, JA | 1 |
| Hjertén, S; Lundahl, P; Zhang, R; Zhang, Y | 1 |
| Casazza, F; Cimminiello, C; Soncini, M | 1 |
| Jarvik, RK; Kaplon, RJ; Kwiatkowski, PA; Levin, HR; Oz, MC; Rose, EA; Shah, AS | 1 |
| Lip, GY; Lowe, GD | 2 |
| Belardi, J; Bonnier, H; Colombo, A; de Jaegere, P; Emanuelsson, H; Fajadet, J; Garcia, E; Goy, JJ; Heyndrickx, G; Kiemeney, F; Legrand, V; Lunn, AC; Macaya, C; Materne, P; Morel, MA; Morice, MC; Rutsch, W; Ruygrok, P; Serruys, PW; Suryapranata, H; van der Giessen, W | 1 |
| Abe, S; Shibuya, Y; Tanaka, H | 1 |
| Blackshear, JL; Hammill, SC; Kopecky, SL; Litin, SC; Safford, RE | 1 |
| Goodnight, SH | 1 |
| Ecker, ML; Keenan, AM; Kelley, MA; Lotke, PA; Meranze, S; Palevsky, H; Steinberg, ME | 1 |
| Matchar, DB; McCrory, DC | 1 |
| Kan, BD; Katz, DA | 1 |
| Gonzalez-Reimers, E; Martinez-Riera, A; Santolaria-Fernandez, F | 1 |
| Whisnant, JP; Yanagihara, T | 1 |
| Frey, JL | 1 |
| Kowey, P; Marinchak, R; Morley, J; Rials, SJ | 1 |
| Izawa, M; Kagawa, M; Kawamata, T; Kubo, O; Takakura, K; Takeshita, M | 1 |
| Fewkes, JL; Frank, W; Olbricht, SM; Otley, CC | 1 |
| Ahlquist, DA; Baker, VS; Blackshear, JL; Ellefson, R; Hart, RG; Holland, A; Koehler, J; Litin, SC | 1 |
| Gray, NJ; Hankey, GJ | 1 |
| Howell, J; Wahl, MJ | 1 |
| Fiore, LD | 1 |
| Gold, JA | 1 |
| Codinach Huix, P | 1 |
| Dahlqvist, A; Olofsson, K | 1 |
| Zuckerman, GR | 1 |
| Jolobe, OM | 3 |
| Cello, JP; Greenberg, PD; Rockey, DC | 1 |
| Aroney, CN; Bett, JH; McEniery, PT; Sankardas, MA | 1 |
| Hutter, AM | 1 |
| Cleland, JG; Cowburn, PJ; Falk, RH | 1 |
| Hosokawa, FG; Kim, K; Miyake, S; Saito, S; Tanaka, S | 1 |
| Connolly, SJ; Turpie, AG | 1 |
| Chauhan, A; More, RS | 1 |
| Bareford, D; Beevers, DG; Lip, GY; Lip, PL; Lowe, GD; Watson, RD; Zarifis, J | 1 |
| Ammash, N; Warnes, CA | 1 |
| Cardinalli, AB; Gage, BF; Owens, DK | 2 |
| Diederich, KW; Garbe, M; Mitusch, R; Sheikhzadeh, A; Siemens, HJ; Wagner, T | 1 |
| Noguchi, Y; Sugishita, Y; Yamaguchi, I | 1 |
| Bogousslavsky, J; Donati, F; Regli, F; Regli, L | 1 |
| Angueira, CE; Kadakia, SC; Moore, M; Ward, JA | 1 |
| Engler, E; Montgomery, ER; Sebastian, D; Segretario, J; Taylor, S | 1 |
| Albers, GW; Belew, KM; Bittar, N; Hall, EA; Hattemer, CR; Kemp, S; Morton, DJ; Phillips, BG; Vlasses, PH; Yim, JM | 1 |
| Cohen, IS; Ezekowitz, MD | 1 |
| Disch, DL; Greenberg, ML; Malenka, DJ | 1 |
| Chamberlain, DA; Julian, DG; Pocock, SJ | 1 |
| Badimon, J; Chesebro, JH; Fallon, JT; Fuster, V | 1 |
| Freiberg, AA | 1 |
| Cloutier, DA; Schatz, RA; Spinks, TJ; Strum, WB; Teirstein, PS; Younossi, ZM | 1 |
| De Caterina, R; Gensini, G; Gianetti, J; Simonetti, I | 1 |
| Chan, AW; Drobac, M; Sternberg, L | 1 |
| Brennan, PJ; Mann, AH; Meade, TW; Peart, S; Richards, M | 1 |
| Turpie, AG | 1 |
| Biller, J | 1 |
| Dick, B; Jacobi, FK | 1 |
| Chalon, S; Lechat, P | 1 |
| Cho, SY; Hong, MK; Jang, YS; Kang, JC; Kim, JJ; Kim, KB; Kim, KS; Oh, BH; Oh, DJ; Park, SJ; Park, SW | 1 |
| Buller, CE; Chauhan, A; Moscovich, MD; Penn, IM; Ricci, DR; Zubaid, M | 1 |
| Fondevila, CG; Frontroth, J; Lazzari, MA; Meschengieser, SS; Santarelli, MT | 1 |
| Boda, Z; Bódi, A; Csapó, K; Hegedús, I; Medgyesi, F; Pfliegler, G; Voith, L | 1 |
| Billingsley, EM; Maloney, ME | 1 |
| Bovill, EG; Cornell, ES; Feinberg, WM; Hart, RG; Nightingale, SD; Pearce, LA; Tracy, RP | 1 |
| Feddersen, C; Gulløv, AL; Koefoed, BG; Petersen, P | 1 |
| Albers, GW; Bittar, N; Gandhi, AJ; Hall, EA; Hattemer, CR; Kemp, SM; Morton, DJ; Vlasses, PH; Yim, J; Young, L | 1 |
| Richardson, J; Truman, C | 1 |
| Bradley, SM; Crawford, FA; Sade, RM; Stroud, MR | 1 |
| Colombo, A; Di Francesco, L; Di Mario, C; Martini, G; Moses, J; Moussa, I; Reimers, B; Tobis, J | 1 |
| Laperche, T; Laurian, C; Roudaut, R; Steg, PG | 1 |
| Morison, IM; Parker, JH; Stewart, RA; Williams, MJ | 1 |
| Anderson, LM; Jones, AB; Liao, AM; Liu, Y; Smith, TJ; Yang, CS | 1 |
| Diana, FJ; Gibson, AB; McCormick, TJ | 1 |
| Manning, WJ | 1 |
| Hattori, Y; Iriyama, T; Ozawa, K; Sai, N; Sugimura, S; Watanabe, K | 1 |
| Harper, RW; Peverill, RE; Smolich, JJ | 1 |
| Anzuini, A; Bonnier, H; Chierchia, SL; Coppi, R; Kulbertus, HE; Legrand, V; Marazzi, G; Montorfano, M; Pagnotta, P; Rosanio, S; Sheiban, I; Tocchi, M; Vicedomini, G | 1 |
| Harris, EN; Krnic-Barrie, S; Looney, SW; O'Connor, CR; Pierangeli, SS | 1 |
| Wheeldon, NM | 1 |
| Ray, JG; Turpie, AG | 1 |
| Verheugt, FW | 6 |
| Anzuini, A; Bonnier, H; Chierchia, SL; Coppi, R; Kulbertus, HE; Legrand, V; Rosanio, S; Sheiban, I; Tocchi, M | 1 |
| Busch, M; Einhäupl, KM; Masuhr, F | 1 |
| Almeida, JI; Coats, R; Liem, TK; Silver, D | 1 |
| Bush, D; Tayback, M | 1 |
| Bove, AA; Davis, MJ; Sorrell, VL | 1 |
| Gibaldi, M | 1 |
| Tijssen, JG | 1 |
| Calvey, TA; Gough, MJ | 1 |
| Kariyazono, H; Moriyama, Y; Nakamura, K; Taira, A; Toyohira, H | 1 |
| Pellegrino, TR | 1 |
| Zamorski, MA | 1 |
| Godtfredsen, J; Petersen, P | 1 |
| Schipper, JP | 1 |
| Gin, K; Loewen, P; Sunderji, R | 1 |
| Grigg, LE; Jayaprakash, S; Kalman, JM; Lewis, MA; Mond, HG; Sparks, PB | 1 |
| Vaidya, JS | 1 |
| Fahey, T; Peters, TJ | 1 |
| Donati, MB; Iacoviello, L | 1 |
| Cleland, JG; Ford, I | 1 |
| Charman, WN; FitzGerald, GA | 1 |
| Stiffman, MN | 1 |
| Andersen, ED; Boysen, G; Godtfredsen, J; Gulløv, AL; Koefoed, BG; Pedersen, TS; Petersen, P | 1 |
| Brown, A; Cullinane, M; Markus, HS; Monaghan, M; Wainwright, R | 1 |
| Aoshima, K; Asakura, H; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Triplett, DA; Uotani, C; Yamazaki, M | 1 |
| Anand, SS; Flather, M; Pogue, J; Weitz, JI; Yusuf, S | 1 |
| Back, MR; Carlton, LM; Flynn, TC; Huber, TS; Ozaki, CK; Sarac, TP; Seeger, JM | 1 |
| Cairns, JA; Easton, JD; Hart, RG; Sherman, DG | 1 |
| Nelson-Piercy, C | 1 |
| de May, MR; Higginson, LA; Jelley, J; Johansen, H; Labinaz, M; Laramee, LA; Leddy, D; Madan, M; Marquis, JF; O'Brien, E; Reid, F; Williams, WL | 1 |
| Carter, K; Miller, KM | 1 |
| Arnesen, H; Hurlen, M; Seljeflot, I | 3 |
| Kosar, EM; Nademanee, K | 1 |
| Khamashta, MA | 1 |
| Cook, T; Faergeman, O; Kjekshus, J; Pedersen, TR; Pyörälä, K; Thorgeirsson, G; Wilhelmsen, L | 1 |
| Ginsberg, JS; Hirsh, J | 1 |
| Albers, G; Dalen, J; Dunn, MI; Jacobson, AK; Laupacis, A; Singer, DE | 1 |
| Clagett, GP; Jackson, MR | 1 |
| Baim, DS; Cutlip, DE; Diver, DJ; Giambartolomei, A; Gordon, PC; Ho, KK; Kuntz, RE; Lasorda, DM; Leon, MB; Pocock, SJ; Popma, JJ; Williams, DO | 1 |
| Sharif, MN; Wyse, DG | 1 |
| De Caterina, R; Gensini, G; Gianetti, J | 1 |
| Andrew, M; Leaker, M; Monagle, P; South, M; Streif, W | 1 |
| Brown, RD; O'Fallon, WM; Petty, GW; Sicks, JD; Whisnant, JP; Wiebers, DO | 1 |
| Boechler, M; Flaker, GC; Fortune, G; Gage, B; McGowan, DJ | 1 |
| Atwood, JE; Marcus, RR | 1 |
| Gibbs, NM; Mahon, BD; Newman, MA; Sheminant, MR; Weightman, WM; Whitford, EG | 1 |
| Asinger, R; Blackshear, JL; Fenster, P; Halperin, J; Pearce, LA; Pennock, G; Strauss, R; Zabalgoitia, M | 1 |
| Ahn, C; Aronow, WS; Gutstein, H; Kronzon, I | 2 |
| Hartmann, A; Mohr, JP | 1 |
| Bell, MR; Berger, PB; Holmes, DR; Rihal, CS; Velianou, JL; Wilson, SH | 1 |
| Braatvedt, GD; Gamble, GD; Persson, S; Singh, Y; Stewart, FM | 1 |
| Hachiya, T; Hashimoto, K; Nagahori, R; Onoguchi, K; Sasaki, T; Takakura, H; Takeuchi, S | 1 |
| Buehler, KO; Colwell, CW; D'Lima, DD; Petersilge, WJ; Walker, RH | 1 |
| Beuhler, KO; Colwell, CW; D'Lima, DD; Otis, SM; Walker, RH | 1 |
| Birkmeyer, JD; Catherwood, E; Fitzpatrick, WD; Gerling, BR; Greenberg, ML; Holzberger, PT; Malenka, DJ | 1 |
| Eckman, MH; Pauker, SG | 1 |
| Bloom, JM | 1 |
| Branzi, A; Cervi, V; Descovich, B; Melandri, G; Nanni, S; Semprini, F | 1 |
| Koefoed, BG; Petersen, P | 1 |
| Ezekowitz, MD; Levine, JA | 1 |
| Fukunami, M | 1 |
| Li-Saw-Hee, FL; Lip, GY | 1 |
| Labovitz, AJ | 1 |
| Asinger, RW; Hart, RG; McBride, R; Pearce, LA; Rothbart, RM | 1 |
| Stewart, RA; Williams, MJ | 1 |
| Ghali, JK | 1 |
| Desmond, DW; Mohr, JP; Moroney, JT; Paik, MC; Tseng, CL | 1 |
| Furberg, CD; Lima, JA; Manolio, TA; Newman, AB; Psaty, BM; Smith, NL; White, R | 1 |
| Martin, AC; Wellman, M | 1 |
| Barbisoni, P; Bellelli, G; Gusmeri, A; Rozzini, R; Sabatini, T; Trabucchi, M | 1 |
| Scheen, AJ | 1 |
| Caine, S; Keir, S; Mac Mahon, M; Wensley, S | 1 |
| Biggs, J; Drake, E; Hart, RG; Laupacis, A; Man-Son-Hing, M; O'Connor, AM; Yetisir, E | 1 |
| Kausar, SA | 2 |
| Grobbee, DE; Kardinaal, AF; Kruijssen, DA; Princen, HM; van de Vijver, LP; van Duyvenvoorde, W; van Poppel, G | 1 |
| Bennett, G; Gompertz, P; Gupta, I | 1 |
| Davis, KB; Egan, DA; Garg, R; Griffin, B; Pettinger, MB; Thomason, T; Waclawiw, MA | 1 |
| Kong, DF; Tcheng, JE | 1 |
| Barmeyer, J; Germing, A; Jäger, D; Lange, S; Lemke, B; Machraoui, A; von Dryander, S | 1 |
| Anand, SS | 1 |
| Connor, SE; Wingate, JP | 1 |
| Benavente, O; Hart, RG; McBride, R; Pearce, LA | 1 |
| Ezekowitz, MD | 3 |
| Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F | 1 |
| Califf, RM; Fisher, M; Fuster, V; Goodman, S; Harrington, RA; Langer, A; O'Connor, CM | 1 |
| Vandenbossche, JL | 1 |
| Hart, RG | 3 |
| Kalra, L; Melbourn, A; Perez, I | 1 |
| Born, G | 1 |
| Futterman, LG; Lemberg, L | 1 |
| Peverill, RE | 1 |
| Halperin, JL; Hart, RG | 2 |
| Bovill, EG; Cornell, ES; Cushman, M; Feinberg, WM; Hart, RG; Lip, GY; Pearce, LA | 1 |
| Berntorp, E; Erhardt, L; Hillarp, A; Holm, J | 1 |
| Asinger, RW; Goldman, ME; Halperin, JL; Hart, RG; Pearce, LA; Safford, R; Zabalgoitia, M | 1 |
| Asinger, RW; Blackshear, JL; Fenster, PE; Halperin, JL; Hess, D; Koehler, J; Pearce, LA; Pennock, GD; Rothbart, RM; Strauss, R; Zabalgoitia, M | 1 |
| Jouhikainen, T; Julkunen, H; Kaaja, R | 1 |
| De Curtis, A; Donati, MB; Iacoviello, L; Krekora, K; Polishchuck, R | 1 |
| Bayazit, K; Iscan, Z; Katircioglu, SF; Mavitas, B; Tasdemir, O; Ulus, AT; Yamak, B | 1 |
| Bass, EB; Goodman, SN; Kim, N; McNamara, RL; Miller, MR; Powe, NR; Robinson, KA; Segal, JB | 1 |
| Asinger, RW; Halperin, JL; Hart, RG; McAnulty, JH; Pearce, LA; Rothbart, RM | 1 |
| Avidor, Y; Matzkin, H; Nadu, A | 1 |
| Ezekowitz, MD; Jagasia, DH; Williams, B | 1 |
| Morimoto, Y; Mukai, T; Okada, M; Sugimoto, T | 1 |
| Katayama, Y; Komada, T; Onoda, K; Pagoada-Cruz, B; Shimono, T; Shimpo, H; Yada, I; Yasuda, F | 1 |
| Douglas, M; Strelnick, A | 1 |
| Edds, W; Newton, W | 1 |
| Teo, KK; Tsuyuki, RT; Walters, B; Yim, R | 1 |
| Fabris, F; Girolami, A; Randi, ML; Rossi, C | 1 |
| Hemphill, JC | 1 |
| Fahey, T; Godfrey, P; Rimmer, J | 1 |
| Adhiyaman, V; Kamalakannan, D; Oke, A; Shah, IU; White, AD | 1 |
| Blann, AD; Li-Saw-Hee, FL; Lip, GY | 1 |
| Bousser, MG; Crassard, I; Niclot, P | 1 |
| Blétry, O; Hachulla, E; Hatron, PY; Piette, AM | 1 |
| MacKinlay, N; Renisson, F; Rickard, K; Taper, J | 1 |
| Barr, JD; Furlan, AJ; Katzan, I; Krieger, D; Markarian, GZ; Masaryk, TJ; Perl, J; Rasmussen, PA; Sila, C | 1 |
| Franke, A | 1 |
| Almoznino-Sarafian, D; Alon, I; Chachashvily, S; Cohen, N; Gorelik, O; Koopfer, M; Litvinjuk, V; Modai, D; Shteinshnaider, M | 1 |
| Altkorn, D; Levinson, W; Stern, S | 1 |
| Tonkin, A | 1 |
| Arnesen, H; Hurlen, M; Smith, P | 1 |
| Kitabatake, A; Kohya, T; Tomita, F | 1 |
| Borowsky, LH; Chang, Y; Go, AS; Henault, LE; Hylek, EM; Phillips, KA; Selby, JV; Singer, DE | 1 |
| Bhagat, K; Tisocki, K | 1 |
| Brookenthal, KR; Fitzgerald, RH; Freedman, KB; Lonner, JH; Williams, S | 1 |
| Bal, E; Ernst, SM; Kelder, JC; Mast, EG; Plokker, HW; Suttorp, MJ; ten Berg, JM; Verheugt, FW | 1 |
| Bailey, SR; Baim, DS; Cleman, MW; Deutsch, E; Diver, DJ; Fitzgerald, PJ; Hayase, M; Kuntz, RE; Leon, MB; Metz, JA; Moses, JW; Oesterle, SN; Oshima, A; Overlie, PA; Pepine, CJ; Safian, RD; Shani, J; Simonton, CA; Smalling, RW; Teirstein, PS; Yeung, AC; Yock, PG; Zidar, JP | 1 |
| Boki, KA; Ioannidis, JP; Moutsopoulos, HM; Tektonidou, MG; Vlachoyiannopoulos, PG | 1 |
| Austin, PC; Holroyd-Leduc, JM; Kapral, MK; Tu, JV | 1 |
| Halperin, JL; Hart, RG; Pearce, LA | 1 |
| Cokkinos, DV; Toutouzas, PK | 1 |
| Cuypers, MH; Hoyng, CB; Tilanus, MA; Vaandrager, W; Verbeek, AM | 1 |
| Albers, GW; Thijs, VN | 1 |
| Brennan, PJ; MacCallum, PK; Meade, TW | 1 |
| Haas, SB; Mosca, P; Peterson, M; Westrich, GH | 1 |
| Applegate, WB; Crouse, JR; Davis, KB; Egan, D; Elam, MB; Garg, R; Herd, JA; Hunninghake, DB; Johnson, WC; Kennedy, JW; Kostis, JB; Sheps, DS | 1 |
| Craig, J; Goudie, BM; MacWalter, RS | 1 |
| Hardy, KJ; Hutchinson, D; McNulty, SJ | 1 |
| Anderson, DC; Blackshear, JL; Feldman, G; Hart, RG; Laupacis, A; Man-Son-Hing, M; O'Connor, AM | 1 |
| Manners, R; Parkin, B | 1 |
| Kallio, H; Maunuksela, EL; Paloheimo, M | 1 |
| Petri, M | 3 |
| Basu, S; O'Brien, DF; O'Donnell, JR; Phillips, J; Roberts, GA | 1 |
| McAnulty, JH | 1 |
| Graham, SP | 1 |
| Cohen, H; Ebrahim, S; Taylor, FC | 1 |
| Little, SH; Massel, D | 1 |
| Arnesen, H; Hole, T; Hurlen, M; Seljeflot, I | 2 |
| Konstantatos, A | 1 |
| Chillotti, FM; Matteoli, S; Trappolini, M | 1 |
| Maxim, R | 2 |
| Arya, R; Blott, M; Flint, SK; Roberts, N; Ross, D | 1 |
| Iwado, Y; Kohno, M; Matsuo, H; Mizushige, K; Ohmori, K; Wada, Y | 1 |
| Castellino, G; Cuadrado, MJ; Godfrey, T; Hughes, GR; Khamashta, MA | 1 |
| Ornato, JP | 2 |
| Brookenthal, KR; Fitzgerald, RH; Freedman, KB; Lonner, JH; Lotke, PA | 1 |
| Hara, K; Ikari, Y; Kuroda, Y; Nakajima, H | 1 |
| Hutten, BA; Kelder, JC; Plokker, HW; ten Berg, JM; Verheugt, FW | 1 |
| Lee, TH | 2 |
| Ali, SN; Hardman, SM | 1 |
| Lapane, KL; Quilliam, BJ | 1 |
| Campeau, L; Forman, S; Fox, NL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hoppensteadt, D; Hunninghake, DB; Pifarré, R; Probstfield, JL; Terrin, ML; Walenga, JM | 1 |
| Bogaty, P; Huynh, T; Nasmith, J; Solymoss, S; Théroux, P | 1 |
| Tanahashi, N | 1 |
| Finazzi, G | 1 |
| Van de Werf, F | 1 |
| Fitzmaurice, D; Hobbs, FD; Lip, GY; Mant, J; Murray, E | 1 |
| Cleland, JG; Kaye, GC | 1 |
| Boysen, G; Godtfredsen, J; Peterson, P | 1 |
| Cates, C | 1 |
| Carroll, K; Majeed, A; Moser, K | 1 |
| Berkowitz, SD; Califf, RM; Daly, R; Fuster, V; Gattis, WA; Gheorghiade, M; Harrington, RA; Hellkamp, AS; Kopecky, SL; Langer, A; Larsen, RL; O'Connor, CM; O'Gara, PT | 1 |
| Ang, SY; Daud, R; Jackson, SL; Peterson, GM; Vial, JH | 1 |
| Dudley, N | 1 |
| Brand, RA; Gradisar, I; Heekin, R; Iorio, R; Leighton, R; Mesko, JW; Thornberry, R | 1 |
| Waugh, RJ | 1 |
| Buist, NN; Despotis, GJ; Kanter, KR; Levy, JH; Morris, CD; Smith, AL; Vega, JD | 1 |
| Buurma, H; Egberts, AC; Leufkens, HG; Rahimtoola, H; Tijssen, CC | 1 |
| Eaton, CB; Lapane, KL; Mor, V; Quilliam, BJ | 1 |
| Beerman, B; Frykman, V; Rosenqvist, M; Rydén, L | 1 |
| Harrison, P; Isenberg, DA; Joseph, JE; Machin, SJ; Mackie, IJ | 1 |
| Gottlieb, S | 1 |
| Anderson, DR; Brownell, BF; Cox, JL; Devereaux, PJ; Flowerdew, GJ; Gardner, MJ; Nagpal, S; Putnam, W | 1 |
| Blann, AD; Kamath, S; Lip, GY | 1 |
| Cleland, JG; Coletta, AP | 1 |
| Ikeda, U; Shimada, K | 1 |
| Evans, A; Kalra, L; Perez, I; Yu, G | 1 |
| Prisco, D | 1 |
| Pengo, V | 1 |
| Rollins, G | 1 |
| Dulitzki, M; Kenett, R; Langevitz, P; Livneh, A; Many, A; Pauzner, R | 1 |
| Adams, HP; Albers, GW; Furie, KL; Jackson, CM; Kistler, JP; Lazar, RM; Levin, B; Mohr, JP; Pettigrew, LC; Pullicino, P; Sacco, RL; Thompson, JL | 1 |
| Powers, WJ | 1 |
| Brown, JB; Delea, TE; Edelsberg, J; Elmer, PJ; Nichols, GA; Oster, G | 1 |
| Della Valle, CJ; Koval, KJ; Mirzabeigi, E; Zuckerman, JD | 1 |
| Brophy, MT; Ezekowitz, MD; Fiore, LD; Lu, D; Peduzzi, P; Sacco, J | 1 |
| Geary, EM; Jacobs, ML; Madan, N; McGrath, LB; Moore, JW; Pourmoghadam, KK; Reyes, AT | 1 |
| Bahit, MC; Granger, CB; Wallentin, L | 1 |
| Brorson, J; Cao, QL; Du, ZD; Heischmidt, M; Hijazi, ZM; Joseph, A; Koenig, P; Rhodes, J; Waight, DJ | 1 |
| Cerbone, AM; Di Minno, G; Tufano, A | 1 |
| Graatsma, HH; Stricker, BH; Visser, LE | 1 |
| Clagett, GP; Jackson, MR; Johnson, WC; Valentine, RJ; Williford, WO | 1 |
| Geraci, SA; Miller, AB; Sirajuddin, RA | 1 |
| Donnelly, R; Yeung, JM | 1 |
| Altorjay, I; Palatka, K; Tornai, I; Udvardy, M | 1 |
| Fleisch, M; Garachemani, AR; Meier, B; Pfiffner, D; Windecker, S | 1 |
| Laupacis, A; Man-Son-Hing, M | 1 |
| Johnson, WC; Williford, WO | 1 |
| Brouwer, MA; Verheugt, FW | 1 |
| Brunner, HI; Chan, WS; Feldman, BM; Ginsberg, JS | 1 |
| Amaral, CF; Carvalho, MG; Dusse, LM; Esteves, WA; Fenelon, LM; Ferreira, CN; Reis, CV; Vieira, LM | 1 |
| Lewis, SC; Sandercock, PA | 1 |
| Alaimo, DJ; Hsi, DH | 1 |
| Butera, G; Carminati, M; Chessa, M | 1 |
| Brennan, PJ; Knottenbelt, C; Meade, TW | 1 |
| Fukuda, N; Nakamori, Y; Oeda, E; Sato, Y; Shimohakamada, Y; Shinohara, K; Takahashi, T; Tominaga, T | 1 |
| Blann, AD; Caine, GJ; Chin, BS; Gurney, D; Kamath, S; Lip, GY | 1 |
| Iwata, M; Uchiyama, S; Yamazaki, M | 1 |
| Bounameaux, H; Sarasin, FP | 1 |
| Gray, H; Rodgers, A; Walker, N | 1 |
| Brennan, PJ; Fasey, N; Meade, TW | 1 |
| Fuster, V; Halperin, JL | 1 |
| Di Tullio, MR; Homma, S; Mohr, JP; Sacco, RL; Sciacca, RR | 3 |
| Allen, LC; Redman, AR | 1 |
| Hankey, GJ | 2 |
| Henry, RG; Little, JW; McIntosh, BA; Miller, CS | 1 |
| Kovich, O; Otley, CC | 2 |
| Norrving, B | 1 |
| Asp, E; Byrd, DR; Nguyen, TH; Otley, CC; Phillips, PK; Roenigk, RK; Weaver, AL; West, SW | 1 |
| Campbell, Do; Davis, S; Evans, A; Gerraty, R; Greenberg, P; Kilpatrick, C | 1 |
| Gibbs, CR; Lip, GY | 1 |
| Foster, E; Naqvi, TZ | 1 |
| Deckers, JW; Grobbee, DE; Jonker, JJ; van Es, RF; Verheugt, FW | 1 |
| Blann, AD; Chin, BS; Kamath, S; Lip, GY | 1 |
| Dickerson, LM; King, DE; Sack, JL | 1 |
| Aengevaeren, WR; Brouwer, MA; Hertzberger, DP; Luijten, HE; Uijen, GJ; van Boven, AJ; van den Bergh, PJ; Veen, G; Verheugt, FW; Vromans, RP | 1 |
| Lew, SJ; Lim, JK | 1 |
| Scully, C; Wolff, A | 1 |
| Cuadrado, MJ | 1 |
| Avegliano, G; Elorz, C; Evangelista, A; García del Castillo, H; González-Alujas, T; Soler-Soler, J | 1 |
| Elliott, RA; Oborne, CA; Woodward, MC | 1 |
| Dlugos, D; Hunter, JV; Kao, A; Mamula, P; Thorarensen, O | 1 |
| Abdelnoor, M; Arnesen, H; Erikssen, J; Hurlen, M; Smith, P | 1 |
| Becker, RC | 1 |
| Kristensen, SR | 1 |
| Lawrence, CM; Stables, G | 1 |
| Blann, AD; Fitzmaurice, DA; Lip, GY | 1 |
| MacWalter, RS; Shirley, CP | 1 |
| de Jesús, NR; Levy, RA; Vilela, VS | 1 |
| Gohh, RY; Kestin, A; Madras, PN; Monaco, AP; Morrissey, PE; Ramirez, PJ; Yango, AY | 1 |
| Bickel, C; Buerke, M; Hauroeder, B; Hundt, F; Meyer, J; Peetz, D; Rupprecht, HJ; Schlitt, A; Victor, A | 1 |
| Aleil, B; Blann, AD; Cazenave, JP; Chin, BS; Kamath, S; Lanza, F; Lip, GY | 1 |
| Tilly-Gentric, A | 1 |
| Ishikawa, K; Nakai, S | 1 |
| Amaral, CF; das Graças Carvalho, M; de Magalhães Esteves, WA; Dusse, LM; Fenelon, LM; Ferreira, CN; Vieira, LM | 1 |
| Barrios Alonso, V; Campuzano Ruiz, R | 1 |
| Dykstra, DM; Gillespie, B; Held, PJ; Saran, R; Wolfe, RA; Young, EW | 1 |
| Fujita, T; Ono, A | 1 |
| Arvieux, J; Hachulla, E | 1 |
| Baumgarten, A; Levy, J; Lifshitz, T; Rabinowitz, R; Rosenthal, G | 1 |
| Hak, E; Hoes, AW; Rutten, FH; Stalman, WA; Verheij, TJ | 1 |
| Kelder, JC; Plokker, HW; Suttorp, MJ; ten Berg, JM; Verheugt, FW | 1 |
| Diner, BM | 1 |
| Pullicino, P; Thompson, JL | 1 |
| Aronow, WS | 1 |
| Amit, G; Ilia, R; Zahger, D | 1 |
| Radley, DC; Stafford, RS | 1 |
| Buchan, AM; Kennedy, J | 1 |
| Andersen, K; Arnesen, H; Hurlen, M; Seljeflot, I | 1 |
| Abe, Y; Asakura, T; Gotou, J; Ishikawa, S; Iwai, M; Maehara, K; Maruyama, Y; Muroi, S; Nagata, K; Ono, M; Saitoh, F; Sakabe, A; Sakamoto, N; Sando, M; Satoh, M; Suzuki, S; Watanabe, Y | 1 |
| Feloney, CD; Malacaria, B | 1 |
| Narendran, N; Williamson, TH | 1 |
| Loewen, P; Sprague, D | 1 |
| Arnold, M; Mattle, HP; Nedeltchev, K | 1 |
| Biasiutti, FD; Strebel, JK | 1 |
| Anand, SS; Yusuf, S | 1 |
| Doggrell, SA | 1 |
| Ghate, M; Kattimani, SY; Kulkarni, V; Manohar, D; Shobha, R | 1 |
| Dawn, B; Longaker, RA; Singh, P; Stoddard, MF | 1 |
| Aursnes, I; Kvan, E; Landmark, K; Reikvam, A | 1 |
| Kanmatsuse, K; Tani, S | 1 |
| Ishikawa, K | 1 |
| Conner, AC; Lebon, LF; Obialo, CI | 1 |
| Hennerici, MG | 1 |
| Anderson, DC; Halperin, JL; Hart, RG; Kronmal, RA; Marler, JR; McBride, R; Nasco, E; Pearce, LA; Sherman, DG; Talbert, RL | 1 |
| Davis, M; Fisher, A | 1 |
| Mohr, JP | 2 |
| Kumana, CR | 1 |
| Leung, CS; Tam, KM | 1 |
| Bain, BJ | 1 |
| Berger, P; Steinhubl, S | 1 |
| Eckman, MH; Greenberg, SM; Knudsen, KA; Rosand, J; Singer, DE | 1 |
| Yamaguchi, T | 1 |
| Edvardsson, N; Juul-Möller, S; Omblus, R; Pehrsson, K | 1 |
| Ashby, D; Brennan, P; Meade, T; Rudnicka, AR | 1 |
| Landmark, K; Madsen, S; Reikvam, A | 1 |
| Nasonov, EL | 1 |
| Berger, PB; Charnoff, NE; Fasseas, P; Horlocker, T; Lennon, RJ; Melby, S; Orford, JL; Wilson, SH | 1 |
| Martin, DO | 1 |
| Collart, F; Derouck, D; Feier, H; Kerbaul, F; Mesana, TG | 1 |
| Lüleci, E; Sindel, T; Yegin, A; Yilmaz, S | 1 |
| Allan, T; Banting, M; Bryan, S; Fitzmaurice, D; Fletcher, K; Hobbs, FD; Lip, GY; Mant, JW; Murray, E; Raftery, J; Rahman, J; Richards, SH | 1 |
| Christ, G; Huber, K; Kopp, CW; Maurer, G; Minar, E; Priglinger, U; Probst, P; Steiner, S | 1 |
| Aversa, M; Betocchi, S; Chiariello, M; Golino, P; Losi, MA; Ragni, M | 1 |
| Natarajan, M | 3 |
| McKelvie, R | 3 |
| Chang, Y; Go, AS; Henault, LE; Hylek, EM; Jensvold, NG; Selby, JV; Singer, DE | 1 |
| Mooe, T | 1 |
| Algra, A; Eikelboom, BC; Lawson, J; Tangelder, MJ; van Urk, H | 1 |
| Bass, EB; Feldman, MA; Fleisher, LA; Katz, J; Lubomski, LH; Petty, BG; Schein, OD; Tielsch, JM | 1 |
| Couvreur, G; Gere, J; Giroud, M; Minier, D; Moreau, T; Osseby, GV | 1 |
| Arnesen, H; Eikvar, L; Hurlen, M; Seljeflot, I; Solheim, S | 1 |
| Gleason, BL; Jeddy, AS | 1 |
| Christian, JB; Lapane, KL; Toppa, RS | 1 |
| Jin, JL; Lee, S; Lee, YY; Yun-Choi, HS | 1 |
| D'Angelo, A; Mol, B; Oates-Whitehead, RM | 2 |
| Cook, TD | 1 |
| Otley, CC | 1 |
| Han, A; Katoh, S; Kurata, H; Morimoto, S; Nemoto, M; Tajima, N; Utsunomiya, K | 1 |
| Mounsey, A | 1 |
| Kearon, C | 1 |
| Nicholson, NS; Parlow, JJ; Salyers, AK; South, MS; Suleymanov, OD; Szalony, JA; Wood, RS | 1 |
| Crome, P; Epstein, EF | 1 |
| Anderson, D; Cox, J; Flowerdew, G; Gardner, M; Nagpal, S; Putnam, W | 1 |
| Khairy, P; Landzberg, MJ | 1 |
| Cooper, HA | 1 |
| Elkind, MS | 1 |
| Brey, RL; Costigan, TM; Levin, B; Levine, SR; Lu, Y; Mohr, JP; Murphy, A; Rhine, C; Sacco, RL; Sciacca, RR; Thompson, JL; Tilley, BC; Triplett, DA | 1 |
| Bungard, TJ; Lau, E; Tsuyuki, RT | 1 |
| Erhardt, L; Haglid Evander, M; Herlitz, J; Holm, J; Karlson, BW; Peterson, M | 1 |
| Fang, MC; Singer, DE | 1 |
| Becker, RC; Spencer, FA | 1 |
| Berger, PB; Burger, K; Fasseas, P; Holmes, DR; Melby, S; Orford, JL; Steinhubl, SR | 1 |
| Finsterer, J; Stöllberger, C | 2 |
| Casas, JP; Hingorani, AD; MacAllister, R | 1 |
| Johnson, W | 1 |
| Feely, J; O'Neill, D; White, S | 1 |
| Carman, TL; Farray, D; Fernandez, BB | 1 |
| Crotty, M; Esterman, A; Finucane, P; Halbert, J; Rowett, D; Weller, D; Whitehead, C | 1 |
| Lip, GY; Tan, KT | 1 |
| Angelini, G; Jayaprakash, A; McCullagh, E; McGrath, C; Probert, C; Smith, F | 1 |
| Barer, D; Chatterjee, K; Fall, S | 1 |
| Chambers, BR; Dewey, HM; Donnan, GA | 1 |
| Ammon, SE; Armstrong, PW; Cleland, JG; Collins, JF; Ezekowitz, M; Jafri, SM; Krol, WF; Massie, BM; O'Connor, CM; Packer, M; Schulman, KA; Teo, K; Warren, S | 1 |
| Califf, RM | 1 |
| Faulkner, MA; Lenz, NJ; Lenz, TL | 1 |
| Hegbom, K; Vik-Mo, H | 1 |
| Dawson, D; Flaker, GC; Goldman, L; Greenspon, AJ; Hart, RG; Hellkamp, AS; Lamas, GA; Lee, KL; Schron, E; Silver, M | 1 |
| Arjomand, H; Cohen, M; Ezekowitz, MD | 1 |
| Uchiyama, S | 1 |
| Chang, HW; Chang, YY; Chen, MC; Chen, SS; Chen, WH; Kao, YF; Lai, SL; Lan, MY; Liu, JS; Yip, HK | 1 |
| Dan, VN; Kharazov, AF; Perisaev, GA; Pokrovskiĭ, AV; Sapelkin, SV | 1 |
| Anderson, M; Kirk, M | 1 |
| Mueller, RL | 1 |
| Eikelboom, JW; Hankey, GJ | 1 |
| Browning, DJ; Fraser, CM | 1 |
| Ferro, JM | 1 |
| Economides Muñoz, C; Singh, BN | 1 |
| Blich, M; Gross, B | 1 |
| Vadivelu, MK | 1 |
| Batyraliev, TA; Kiktev, VG; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA | 2 |
| Bulpitt, C; Cleland, JG; Falk, R; Findlay, I; Ford, I; Jafri, S; Poole-Wilson, PA; Prentice, C; Sutton, G; Trainer, A | 1 |
| Cocci, F; De Caterina, R; Lazzerini, G; Lorenzoni, R | 1 |
| Bédard, PJ; Goldstein, WG; Hendry, PJ; Masters, RG; Mesana, TG; Pipe, AL; Rubens, FD; Ruel, M | 1 |
| Colli, A; Gherli, T; Nicolini, F | 1 |
| DiTullio, MR; Homma, S; Mohr, JP; Sacco, RL; Sciacca, RR | 1 |
| Fisher, ES; Larson, RJ | 1 |
| Gomyo, Y; Inoue, R; Nakanishi, T; Ohashi, N; Sumii, K | 1 |
| Guthmann, R; Mayer, JB; Robertson, SL | 1 |
| Hofer, JM; Hollier, LH; Panneton, JM | 1 |
| Felmeden, DC; Lip, GY | 2 |
| Buchalter, M; Burr, ML; Ho, SF; O'Mahony, MS; Steward, JA | 1 |
| Alcalay, J; Alkalay, R | 1 |
| Beghi, C; Borrello, B; Colli, A; D'Amico, R; Fragnito, C; Gherli, T; Nicolini, F; Saccani, S | 1 |
| Barlas, S; Tansel, T | 1 |
| Calder, NJ; MacDonald, D | 1 |
| Asai, A; Bito, S; Fukui, T; Hayano, K; Hira, K; Maeda, K; Matsumura, S; Sakai, T; Sato, TS; Yamashiro, S | 1 |
| Anderson, DR; Bates, SM; Desjardins, L; Douketis, J; Kahn, SR; Kearon, C; Kovacs, MJ; Rodger, M; Solymoss, S; Turpie, AG; Wells, PS | 1 |
| Barzegar, S; Bauer, K; Costigan, T; Furie, KL; Kistler, JP; Mohr, JP; Rosenberg, R; Rosner, B; Sciacca, R; Thompson, JL; Thornell, B | 1 |
| Lee, RT | 1 |
| Jackson, SL; Peterson, GM; Vial, JH | 1 |
| Chesebro, JH; Grill, DE; Hassinger, NL; McBane, RD | 1 |
| Benjamin, EJ; D'Agostino, RB; Lambert, JW; Levy, D; Massaro, JM; Sam, C; Wolf, PA | 1 |
| Fuller, R | 1 |
| Brouwer, MA; Karreman, AJ; Kievit, PC; Veen, G; Verheugt, FW | 1 |
| Chang, Y; Fang, MC; Go, AS; Greenberg, SM; Hylek, EM; Rosand, J; Singer, DE | 1 |
| Crowther, MA; Wisloff, F | 1 |
| Chelly, JE; Despotis, GJ; Hantler, C; Sinha, R | 1 |
| Lane, D; Lip, GY | 1 |
| Manios, E; Peppes, V; Spengos, K; Tsivgoulis, G; Vemmos, K; Zakopoulos, N | 1 |
| Waldo, AL | 1 |
| Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K | 1 |
| Shinohara, Y | 1 |
| Heidenreich, PA; Olkin, I; Schleinitz, MD | 1 |
| Hori, M | 2 |
| Erhardt, L; Evander, MH; Herlitz, J; Holm, J; Karlson, BW; Peterson, M | 1 |
| Bereznicki, LR; Jackson, SL; Peterson, GM | 1 |
| Fukui, T; Hosoda, Y; Takanashi, S | 1 |
| Brouwer, A; Verheugt, FW; Waskowsky, WM | 1 |
| Gage, BF; O'Brien, CL | 1 |
| Hamaoka, K; Itoi, T; Kiyosawa, N; Onouchi, Z; Ozawa, S; Sakata, K; Shiraishi, I | 1 |
| Baumgartner, RW; Gandjour, J; Georgiadis, D; Zeindler, J | 1 |
| Weinberger, J | 1 |
| Burgess, L; Dewbury, KC; Ihezue, CU; Mehta, R; Smart, J | 1 |
| Benesch, CG; Chaturvedi, S; Chimowitz, MI; Frankel, MR; Hertzberg, VS; Howlett-Smith, H; Jovin, TG; Kasner, SE; Levine, SR; Lynn, MJ; Romano, JG; Sila, CA; Stern, BJ | 2 |
| Koroshetz, WJ | 1 |
| Aghaji, MA; Anisiuba, BC; Eze, JC; Ezemba, N; Ezike, HA; Onah, HE | 1 |
| Buresly, K; Eisenberg, MJ; Pilote, L; Zhang, X | 1 |
| Burkhardt, JD; Chung, MK; Klein, AL | 1 |
| Block, PC; El-Chami, MF; Hanna, IR; Helmy, T | 1 |
| Scully, MF | 1 |
| Hunt, BJ; Khamashta, MA | 1 |
| Anderson, DR | 1 |
| Barbui, T; Baudo, F; Berrettini, M; Brancaccio, V; D'Angelo, A; Finazzi, G; Marchioli, R; Musial, J; Schinco, P; Testa, S; Tognoni, G; Wisloff, F | 1 |
| Barber, PA; Gommans, J; McNaughton, H; Nowitz, M | 1 |
| Chin, BS; Conway, DS; Hart, RG; Lip, GY; Pearce, LA | 1 |
| Manios, E; Moulopoulos, SD; Spengos, K; Toumanidis, S; Tsivgoulis, G; Vemmos, KN; Zakopoulos, N | 1 |
| Costanza, S; Cotrufo, M; De Feo, M; De Santo, LS; Della Corte, A; Scardone, M | 1 |
| Di Pasquale, G; Rubboli, A | 2 |
| Chauhan, A; Katira, R; More, RS | 1 |
| Hart, RG; Pearce, LA; Tonarelli, SB | 1 |
| Gatzoulis, MA; Walker, HA | 1 |
| Joyce, JJ; Lilje, C | 1 |
| Hart-Mitchell, RD; Ong-Tone, L; Paluck, EC | 1 |
| Corley, SD; DiMarco, JP; Flaker, G; Greene, HL; Mitrani, G; Nemeth, M; Rosenfeld, LE; Safford, RE; Waldo, AL | 1 |
| Benli, K; Bulut, S; Gökkaya, S; Memiş, A; Ozdal, OL; Ozden, C | 1 |
| Ebell, MH | 1 |
| Espitalier, F; Garnier, LF; Rouesnel, P | 1 |
| Ballard, DJ; Becker, RC; Caprini, JA; Colgan, KJ; Hyers, TM; Khetan, R; Shillington, AC; Tapson, VF; Waldo, AL; Wittkowsky, AK | 1 |
| Indredavik, B; Lydersen, S; Rohweder, G | 1 |
| Li, G; Shih, WJ; Wang, Y | 1 |
| Chung, I; Lip, GY | 1 |
| Crowther, MA; Ng, HJ | 1 |
| Celestin, C; Cook, JR; Fiore, LD; Lawler, E; Rothberg, MB | 1 |
| Cieślik, T; Cieślik-Bielewska, A; Pelc, R | 1 |
| Averbuch, L; Dotan, G; Ehrlich, R; Hirsh, R; Mutzmacher, L | 1 |
| Arnesen, H; Eikvar, L; Hurlen, M; Seljeflot, I | 1 |
| Andreotti, F; Biondi-Zoccai, GG; Crea, F; Testa, L | 1 |
| Løkken, P; Skjelbred, P | 1 |
| Edwards, SJ; Lip, GY | 1 |
| Arab, D; Cho, L; Joyal, D; Lewis, B; Leya, F; Steen, L | 1 |
| Brey, RL | 1 |
| Burkiewicz, JS | 1 |
| Chen, CM; Goddard, AF; Goddard, WP; James, MW; Scott, BB | 1 |
| Bailey, KR; Barnes, ME; Cha, SS; Gersh, BJ; Iwasaka, T; Miyasaka, Y; Seward, JB; Tsang, TS | 1 |
| Vaughan, P; Waterworth, PD | 1 |
| Lengyel, M | 1 |
| Cohen, AT; Wolozinsky, M; Yavin, YY | 1 |
| Boccara, F; Cohen, A; Ederhy, S; Hammoudi, N; Janower, S; Meuleman, C | 1 |
| Bajorek, BV; Duguid, MJ; Krass, I; Ogle, SJ; Shenfield, GM | 1 |
| Lip, GY; Varma, C | 1 |
| Tjønnfjord, GE | 1 |
| Behar, S; Gottlieb, S; Hammerman, H; Hasdai, D; Hod, H; Iakobishvili, Z; Konstantino, Y; Porter, A; Sandach, A; Zahger, D | 1 |
| Gill, SS | 1 |
| Szapáry, L | 1 |
| Ahonen, M; Hillbom, M; Juvela, S; Pyhtinen, J; Saloheimo, P; Savolainen, ER | 1 |
| Climent, V; García-Honrubia, A; Marín, F; Roldán, V; Sogorb, F | 1 |
| Kim, BC; Kim, S; Kim, TI; Kim, WH; Park, S; Shin, SJ | 1 |
| Murata, M; Yokoyama, K | 1 |
| Benesch, CG; Chaturvedi, S; Chimowitz, MI; Cloft, HJ; Frankel, MR; Hertzberg, VS; Howlett-Smith, H; Jovin, TG; Kasner, SE; Levine, SR; Lynn, MJ; Romano, JG; Sila, CA; Stern, BJ | 1 |
| Angerson, WJ; Blatchford, O; Knill-Jones, RP; Taha, AS | 1 |
| Berend, KR; Lombardi, AV | 1 |
| Lip, GY; Watson, T | 1 |
| Barton, B; Freudenberger, RS; Graham, S; Levin, B; Pullicino, P; Thompson, JL | 1 |
| Barutcu, I; Boztosun, B; Gunes, Y; Kirma, C | 1 |
| Akova, YA; Gedik, S; Gür, S; Yilmaz, G | 1 |
| Chadha, V; Chakrabarti, S; Cobb, CJ; Sanders, R | 1 |
| Levin, B; Mohr, JP; Murphy, A; Prabhakaran, S; Sacco, RL; Sciacca, RR; Thompson, JL | 1 |
| Choi, L; Crowell, MD; Jones, MP; Kaplan, M; Keshavarzian, A; Lau, C; Sharp, L; Wessinger, S; Williams, M | 1 |
| Gulba, DC; Klutmann, M; Tillmanns, C | 1 |
| Brenna, E; Hatlen-Rebhan, P; Qvigstad, G; Waldum, HL | 1 |
| Chimowitz, M; Lynn, MJ; Ovbiagele, B; Saver, JL | 1 |
| Carey, FA; Clarke, P; Jack, F; Steele, RJ | 1 |
| Belvís, R; Bravo, Y; Castellanos, M; Cocho, D; Egido, J; Geffner, D; Gich, I; Gil-Núñez, A; Marta, J; Martí-Fàbregas, J; Martí-Vilalta, JL; Millán, M; Navarro, R; Obach, V; Palomeras, E; Rodríguez-Campello, A | 1 |
| Bergman, G; Chou, E; Hong, MK; Khurram, Z; Minutello, R; Naidu, S; Parikh, M; Wong, SC | 1 |
| Hussein, MA | 1 |
| Kallergis, EM; Vardas, PE | 1 |
| Cokkinos, DV; Haralabopoulos, GC; Kostis, JB; Toutouzas, PK | 1 |
| Heffline, MS | 1 |
| Casella, G; Di Pasquale, G; Greco, C; Pallotti, MG; Pavesi, PC; Perugini, E | 1 |
| Merli, GJ | 1 |
| Battler, A; Hasdai, D; Iakobishvili, Z; Konstantino, Y; Porter, A; Shachar, L | 1 |
| Hu, DY; Jiang, LQ; Sun, YH; Zhang, HP | 1 |
| Han, W; Shen, DT; Wang, YM | 1 |
| Cooper, NJ; Khunti, K; Lu, G; Sutton, AJ | 1 |
| Jivan, S; Kumar, N; McLure, H; Thomas, P | 1 |
| Eggers, AE | 1 |
| Carberry, KE; Chang, AC; Dreyer, WJ; Kennedy, CE; McKenzie, ED; Moffett, BS; Morales, DL; Price, JF; Studer, MA; Teitel, ER | 1 |
| Cullen, G; Kelly, E; Murray, FE | 1 |
| Chaiyakunapruk, N; Jampachaisri, K; Kotirum, S; Rojnuckarin, P; Wattanasombat, S | 1 |
| Fletcher, K; Hobbs, FD; Hurley, V; Ireson, R; Lip, GY; Mant, J | 1 |
| Baird, D; Kearon, C; Kulik, A; Lam, BK; Mesana, TG; Rubens, FD; Wells, PS | 1 |
| Akashi, H; Aoyagi, S; Arinaga, K; Fukunaga, S; Kosuga, T; Tayama, E | 1 |
| Laine, L | 1 |
| Thompson, CA | 1 |
| Grant, PJ; Jaffer, AK | 1 |
| Erasmus, A; Kiemer, N; Rust, T | 1 |
| Cordonnier, C; Leys, D | 1 |
| Galor, A; Hoffman, GS; Lee, MS; Smith, SD | 1 |
| Khalifeh, MR; Redett, RJ | 1 |
| Cohen, A; Ederhy, S | 1 |
| Dotsenko, O; Kakkar, VV | 1 |
| Chaparro, S; Connolly, SJ; Flaker, GC; Goldman, S; Gruber, M; Halinen, MO; Halperin, JL; Horrow, J; Vahanian, A | 1 |
| Kakar, P; Lip, GY | 1 |
| Gilard, M; Helft, G; Le Feuvre, C; Zaman, AG | 1 |
| Fukui, D; Ibayashi, S; Inoue, T; Makihara, N; Minematsu, K; Okada, Y; Toyoda, K; Uwatoko, T; Yasumori, K | 1 |
| Berneman, Z; Koudstaal, PJ; Lindemans, J; Michiels, JJ; Neumann, HA; Schroyens, W; van Vliet, HH | 1 |
| Shichita, T; Yasaka, M | 1 |
| Hashimoto, S; Iwata, M; Miyazaki, K; Terashi, H; Tsutsumi, Y; Uchiyama, S | 1 |
| Karpha, M; Lip, GY | 1 |
| Channer, KS; Downes, T; Morgan, N; Portner, R; Rash, A; Yeo, WW | 1 |
| McClaskey, EM; Michalets, EL | 1 |
| DeWal, H; Di Cesare, PE; Patel, VP; Preston, C; Sehgal, B; Walsh, M | 1 |
| Graham, DY | 1 |
| Wu, QH | 1 |
| Blann, A; Choudhury, A; Chung, I; Lip, GY | 1 |
| Gainsborough, N; Morrison, CM; Rajkumar, C | 1 |
| Akins, PT; Albers, GW; Diener, HC; Feldman, HA; Newman, D; Spitzer, SG; Zoble, RG | 1 |
| Barreales Tolosa, L; García Rodríguez, LA | 1 |
| Airaksinen, KE; Airaksinen, TJ; Karjalainen, PP; Niemelä, M; Nyman, K; Porela, P; Vahlberg, T; Vaittinen, MA; Vikman, S; Ylitalo, A | 1 |
| Dublin, S; French, B; Glazer, NL; Heckbert, SR; Hrachovec, JB; Jackson, LA; Psaty, BM; Siscovick, DS; Smith, NL | 1 |
| Colli, A; Gherli, T; Leguerrier, A; Verhoye, JP | 1 |
| Rath, W; Richter, ON | 1 |
| Halperin, JL; Strong, SH | 1 |
| Blann, AD; Choudhury, A; Chung, I; Lip, GYH | 1 |
| Arndt, CA; Jensen, AW; Tefferi, A | 1 |
| Aframian, DJ; Lalla, RV; Peterson, DE | 1 |
| Kanorskiĭ, SG; Shevelev, VI; Zafiraki, VK; Zingilevskiĭ, KB | 1 |
| Andrel, J; Chervoneva, I; DeCaro, M; DeEugenio, D; Duong, P; Greenspon, A; Kolman, L; Lam, L; Lee, G; McGowan, C; Ruggiero, N; Singhal, S | 1 |
| Enlund, H; Hartikainen, SA; Hiitola, PK; Sulkava, RO | 1 |
| Blann, AD; Choudhury, A; Chung, I; Lip, GY | 1 |
| Chimowitz, MI; Cotsonis, GA; Lynn, MJ; Waddy, SP; Williams, JE | 1 |
| Ammar, AD; Woolard, JD | 1 |
| Eccles, MP; Greenaway, J; May, CR; Murtagh, MJ; Steen, IN; Stobbart, L; Thomson, RG | 1 |
| Bennett, K; Feely, J; Mahmud, A; Okechukwu, I | 1 |
| Agostoni, P; Andreotti, F; Crea, F; Porto, I; Testa, L; Trotta, G; Zoccai, GB | 1 |
| Agnelli, G; Allegrone, J; Brieger, D; Budaj, A; Goodman, SG; Gulba, DC; Lefkovits, J; Lim, YL; Nguyen, MC; Walton, A | 1 |
| Hamada, H; Higashi, K; Honda, T; Kanazawa, M; Kohno, Y; Terai, M | 1 |
| Anand, S; Budaj, A; Cina, C; Crowell, R; Eikelboom, J; Gosselin, G; Guzman, R; Keltai, M; Liu, L; Pogue, J; Sussex, B; Xie, C; Yusuf, S | 1 |
| Baudo, F; Cucchini, U; Del Bono, R; Ghirarduzzi, A; Iliceto, S; Molinatti, M; Palareti, G; Pegoraro, C; Pengo, V | 1 |
| Banerjee, A; Modi, P; Niwariya, Y; Sahi, S; Singh, H; Srivastava, AR | 1 |
| Chimowitz, MI; Lynn, MJ; Ovbiagele, B; Saver, JL | 1 |
| Dixon, AJ; Dixon, JB; Dixon, MP | 1 |
| Marshall, G; Rankin, AC | 1 |
| Dudley, N; Fuller, R | 1 |
| Kondrat'eva, LV; Patrushev, LI; Patrusheva, NL; Reshetniak, TM | 1 |
| Garcia, D; Hylek, E | 1 |
| Fitzmaurice, D; Fletcher, K; Hobbs, FD; Lip, GY; Mant, J; Murray, E; Roalfe, A | 1 |
| Brophy, JM; Delaney, JA; Opatrny, L; Suissa, S | 1 |
| Bayoumi, AM; Naimark, DM; Oliver, MJ; Quinn, RR | 1 |
| Reilly, JT | 1 |
| Dayani, PN; Holekamp, NM; Siddiqi, OK | 1 |
| Abe, Y; Di Tullio, MR; Homma, S; Jin, Z; Mohr, JP; Okajima, K; Sacco, RL; Salameh, MJ; Suzuki, K | 1 |
| Papasteriadis, E; Skafidas, D; Stefanidis, A | 1 |
| Odutola, A; Palan, J; White, SP | 1 |
| Abrahams, S; Louw, VJ; Smedema, JP | 1 |
| Cağdaş, DN; Paç, FA | 1 |
| Kirkorian, AY; Marmur, ES; Moore, BL; Siskind, J | 1 |
| Alonso Santor, JE; Inglada Galiana, L; Pérez Paredes, G | 1 |
| De Caterina, R; Renda, G; Zimarino, M | 1 |
| Bruè, C; Ferrara, DC; Koizumi, H; Spaide, RF | 1 |
| Bergeron, S; Brulotte, S; Lemieux, A; Magne, J; Nguyen, CM; Poirier, P; Sénéchal, M | 1 |
| Aguilar, MI; Hart, RG; Pearce, LA | 1 |
| Lim, HS; Lip, GY | 1 |
| Ezekowitz, MD; Lionetti, DA; Nagarakanti, R; Nehmiz, G; Parcham-Azad, K; Pedersen, KE; Reilly, PA; Simmers, TA; Stangier, J; Wallentin, L | 1 |
| Anderson, J; Beksaç, B; González Della Valle, A; Salvato, EA; Sculco, TP; Sharrock, NE | 1 |
| Cai, YY; Hu, Y; Luo, M; Quan, HB; Xie, RM | 1 |
| Ewigman, B; Schumann, SA | 1 |
| Diug, B; Evans, S; Lowthian, J | 1 |
| Day, AG; Harman, GJ; Holden, RM; Holland, D; Wang, M | 1 |
| Hashimoto, Y; Hirano, T; Ito, Y; Mori, A; Uchino, M; Yonemura, K | 1 |
| Su, JL; Yao, CH; Yuan, BH; Zeng, H; Zuo, HJ | 1 |
| Hylek, EM; Magnani, JW | 1 |
| Kouperberg, E; Sprecher, E; Telman, G; Yarnitsky, D | 1 |
| Hunt, BJ; Khamashta, MA; Ruiz-Irastorza, G | 1 |
| Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z | 1 |
| Cannon, CP; Laine, L; Murphy, SA; Schreiner, GC | 1 |
| Dufresne, RG; Lewis, KG | 1 |
| Anderson, KC; Attal, M; Barlogie, B; Belch, A; Bladé, J; Boccadoro, M; Bringhen, S; Cavo, M; Dimopoulos, MA; Durie, BG; Harousseau, J; Hussein, MA; Joshua, D; Knop, S; Kyle, R; Lonial, S; Ludwig, H; Morgan, GJ; Niesvizky, R; Orlowski, RZ; Palumbo, A; Rajkumar, SV; Richardson, PG; San Miguel, J; Sezer, O; Shimizu, K; Sonneveld, P; Vesole, D; von Lilienfeld-Toal, M; Waage, A; Weber, D; Westin, J; Zangari, M; Zonder, JA | 1 |
| Castella, M; Colli, A; Gherli, T; Mestres, CA | 1 |
| Algra, A; Gorter, JW; Kappelle, LJ; Koudstaal, PJ; van Gijn, J; van Wijk, I | 1 |
| Hersh, EV; Moore, PA; Pinto, A | 1 |
| Delate, T; Johnson, SG; Rogers, K; Witt, DM | 1 |
| Andersen, LV; Deichgraeber, P; Frost, L; Lindholt, JS; Mortensen, LS; Vestergaard, P | 1 |
| Eter, N; Meyer, CH | 1 |
| Good, DE | 1 |
| Benzimra, JD; Chung, AK; Eke, T; Galloway, PH; Jaycock, P; Johnston, RL; Lambert, G; Sparrow, JM | 1 |
| Liakishev, AA | 1 |
| Go, G; Gonzalez Della Valle, A; Lyman, S; Salvati, EA; Sharrock, NE | 1 |
| Ishii, M; Kudo, Y; Matsuishi, T; Suda, K; Sugawara, Y | 1 |
| Camporota, L; Wyncoll, D | 1 |
| Hegbom, K; Slette, M; Vik-Mo, H | 1 |
| Banning, AP; Ryding, AD | 1 |
| Asbury, W; Chester, C; Chimowitz, M; Cotsonis, G; Hertzberg, V; Lynn, M | 1 |
| Francescone, S; Halperin, JL | 1 |
| Brown, AJ; Fletcher, VJ; Frampton, CM; Hanger, HC; Sainsbury, R; Wilkinson, TJ | 1 |
| Carroll, TJ; Famuboni, A; Patel, MD; Starke, ID; Umasankar, U | 1 |
| Anker, SD; Farmakis, D; Filippatos, G; Kremastinos, DT; Lainscak, M; Parissis, JT | 1 |
| Smoot, EC | 1 |
| Connolly, SJ; De Caterina, R; Flaker, G; Hart, RG; Healey, JS; Hohnloser, SH; Pfeffer, MA; Pogue, J; Yusuf, S | 1 |
| Corbett, TL; Garwood, CL | 1 |
| Eshtehardi, P; Eslami, M; Moayed, DA | 1 |
| Salonia, J | 1 |
| Dunning, J; Fabbri, A; Kolh, P; Lockowandt, U; Nashef, SA; Pavie, A; Versteegh, M | 1 |
| Ahnert, AM; Freudenberger, RS | 1 |
| Lincoff, AM; Madhwal, S; Rolston, DD | 1 |
| Alwitry, A; King, AJ; Vernon, SA | 1 |
| Adiguzel, C; Bick, R; Clarke, M; Demir, M; Fareed, D; Fareed, J; Hoppensteadt, DA; Wahi, R | 1 |
| Al-Khatib, SM; Allen Lapointe, NM; d'Almada, P; Kaplan, S; Sun, JL | 1 |
| Srivastava, SD | 1 |
| Billett, HH | 1 |
| Ezekowitz, M; Lee, R; Nagarakanti, R; Sodhi, S | 1 |
| Cockbain, AJ; El Masry, MA; Katonis, P; Lindner, T; Schizas, C; Tsiridis, E | 1 |
| Smith, DA | 1 |
| Abdelnoor, M; Arnesen, H; Hurlen, M; Smith, PJ | 1 |
| Friedman, T; Klein, D; Shalom, A; Westreich, M | 1 |
| Appelbom, H; Arnesen, H; Brodin, E; Hansen, JB; Hurlen, M; Seljeflot, I | 1 |
| Hermosillo, AJ; Spinler, SA | 1 |
| Adiguzel, C; Bick, R; Clarke, M; Cunanan, J; Demir, M; Fareed, J; Iqbal, O; Wahi, R | 1 |
| Boos, CJ; Lip, GY | 1 |
| Aribaş, A; Aygül, N; Can, I; Ozdemir, K | 1 |
| Bek, D; Beksaç, B; Della Valle, AG; Salvati, EA; Sculco, TP | 1 |
| Boshoff, D; Eyskens, B; Gewillig, M; Mertens, L | 1 |
| Gallagher, AM; Plumb, J; Rietbrock, S; van Staa, TP | 1 |
| Albers, GW; Dalen, JE; Fang, MC; Go, AS; Halperin, JL; Lip, GYH; Manning, WJ; Singer, DE | 1 |
| Neundörfer, B | 1 |
| Airaksinen, KE; Buerke, M; Eeckhout, E; Freedman, SB; Gershlick, AH; Halperin, JL; Lip, GY; Rubboli, A; Schlitt, A; Tse, HF; Verheugt, FW | 1 |
| García Rodríguez, LA; Massó González, EL | 1 |
| Cambronero, F; Caro, C; Garrido, IP; Lip, GYH; Manzano-Fernández, S; Marín, F; Pascual-Figal, DA; Pastor, FJ; Pinar, E; Valdés, M | 1 |
| Boyd, HS | 1 |
| Cucchiara, B; Ross, M | 1 |
| Dembo, L; Lovett, M; O'Driscoll, G; Thomas, MD; Wood, C | 1 |
| Hipp, R; Matsumura, ME; Miller, MM | 1 |
| Khoo, CW; Lip, GY | 1 |
| Goldstein, L; Marmagkiolis, K; Nikolaidis, IG; Politis, T | 1 |
| Acharjee, S; Bridges, JS; Kumar, K; Raphael, JA; Ruan, Y; Welty, FK | 1 |
| Hu, D; Sun, Y | 2 |
| Friesen, M | 1 |
| Chaturvedi, S; Chimowitz, M; Cotsonis, G; Frankel, MR; Lynn, MJ; Waddy, SP; Williams, JE | 1 |
| Cheng, CL; Cheng, MH; Kao Yang, YH; Lee, CH; Lin, LJ; Wung, DC | 1 |
| Butler, KL; Fortuna, GR; James, LE; Mueller, EW; Shutter, LA | 1 |
| Ellis, TC; George, JF; Holman, WL; Kirklin, JK; Nielsen, VG; Steenwyk, BL | 1 |
| Lockshin, MD | 1 |
| Alonso, R; Alonso-Coello, P; Charles, C; Coll-Vinent, B; Devereaux, P; Díaz, MG; Diez, AI; Gich, I; Guyatt, G; Montori, VM; Oliver, S; Roura, M; Ruiz, R; Schünemann, HJ; Solà, I; Souto, JC | 1 |
| Kitagawa, Y; Ohkuma, H; Tokuoka, K | 1 |
| Halperin, JL; Rubboli, A | 1 |
| Marín, F; Roldán, V | 1 |
| Gatt, A; Martlew, V; Thachil, J | 1 |
| Boyle, A; Colvin-Adams, M; John, R; Joyce, L; Kamdar, F; Liao, K; Miller, L | 1 |
| Bockeria, LA; Kuts, EV; Skopin, II | 1 |
| Di Pasquale, G; Palareti, G | 1 |
| Lurie, F; Wong, DK; Wong, LL | 1 |
| Chimowitz, MI; Cotsonis, G; Levine, SR; Lynn, MJ; Maidan, L; Romano, JG; Turan, TN | 1 |
| Lane, DA; Lip, GY; Tay, KH | 2 |
| de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC | 1 |
| Freitas, GR; Hasslocher-Moreno, A; Sousa, AS; Xavier, SS | 1 |
| Fang, MC | 1 |
| Coory, M; Eckermann, S; Willan, AR | 1 |
| Kirsch, ME; Loisance, D; Nakashima, K; Rosanval, O; Vermes, E | 1 |
| Julka, M; Paruchuri, R; Rao, S | 1 |
| Aydog, ST; Demirel, H; Dönmez, G; Doral, MN; Ozçakar, L; Pasaoglu, I; Yörübulut, M | 1 |
| Aengevaeren, WR; Brouwer, MA; Kievit, PC; van den Bergh, PJ; Veen, G; Verheugt, FW | 1 |
| Hussein, A; Irani, F; Kasmani, R; Mohan, G | 1 |
| Haralson, RH; Johanson, NA; Lachiewicz, PF; Lieberman, JR; Lotke, PA; Parvizi, J; Pellegrini, V; Stringer, TA; Tornetta, P; Watters, WC | 1 |
| Baiamonte, V; Coppola, G; Corrado, E; Fazio, G; Muratori, I; Novo, G; Novo, S; Nuccio, A; Puccio, D; Vernuccio, L | 1 |
| Gallagher, AM; Plumb, JM; Rietbrock, S; van Staa, TP | 1 |
| Chang, YJ; Chen, JR; Chiu, TF; Hu, HH; Ryu, SJ; Yip, PK | 1 |
| Ammon, SE; Armstrong, PW; Cleland, JG; Collins, JF; Ezekowitz, M; Jafri, SM; Krol, WF; Massie, BM; O'Connor, CM; Schulman, KA; Teo, K; Warren, SR | 1 |
| Davis, SM; Donnan, GA | 1 |
| Baudhuin, LM; Chen, D; Rumilla, K | 1 |
| Griffith, KE; Pye, M | 1 |
| Di Tullio, MR; Homma, S; Jin, Z; Mohr, JP; Russo, C; Sacco, RL | 1 |
| Alberts, MJ; Bassin, SL; Batjer, HH; Bernstein, RA; Bleck, TP; Lindholm, PF; Naidech, AM | 1 |
| Chimowitz, MI; Famakin, BM; George, MG; Lynn, MJ; Stern, BJ | 1 |
| Beverland, DE; Cusick, LA | 1 |
| Christensen, TD; Christiansen, K; Jensen, C; Larsen, TB; Sørensen, B | 1 |
| Ayusawa, M; Higaki, T; Kudo, Y; Matsuishi, T; Matsumura, M; Miura, M; Nomura, Y; Ogawa, S; Suda, K | 1 |
| Dewilde, S; Goldhaber, SZ; Monz, BU; Plumb, JM; Singer, DE; Sorensen, SV | 1 |
| DeLeon, D; Mold, JW; Schwiebert, LP; Shah, N | 1 |
| Ferman, MT; Rasool, SI; Saghir, T; Sial, JA | 1 |
| Acet, H; Duygu, H; Eren, NK; Ergene, AO; Ertaş, F; Nazli, C | 1 |
| Abrams, AP; Gangavati, AS; Kelly, SP; Kiely, DK; Kulchycki, LK; Lipsitz, LA; Mottley, JL; Nathanson, LA; Wolfe, RE | 1 |
| Khamashta, MA; Tuthill, JI | 1 |
| Giles, I; Rahman, A | 1 |
| Billett, HH; Dinglas, C; Freeman, K; Jacobs, LG; Jumaquio, L | 1 |
| Barnes, CL; Clarke, HD; Hanssen, AD; Lachiewicz, PF; Lieberman, JR; Pellegrini, VD | 1 |
| Brotman, DJ; Grant, PJ; Jaffer, AK | 1 |
| Auerbach, AD; Bozic, KJ; Lindenauer, PK; Maselli, JH; Pekow, PS; Vail, TP | 1 |
| Berglund, RK; Boorjian, SA; Herr, HW; Maschino, AC; Savage, CJ | 1 |
| Gonzalgo, ML | 1 |
| Galletly, DC; Harding, SA; Hermiz, S; Larsen, P | 1 |
| Boyle, AJ; Farrar, DJ; Frazier, OH; Heatley, G; John, R; Moazami, N; Pagani, FD; Russell, SD; Slaughter, MS; Teuteberg, JJ | 1 |
| Lim, TC; Loke, KY; Quek, SC; Yeo, WS | 1 |
| Farhang, S; Javadzadegan, H; Mehdizadeh Baghbani, J | 1 |
| Büller, HR; de Peuter, OR; Kamphuisen, PW; Kok, WE; Torp-Pedersen, C | 1 |
| Adekoya-Cole, TO; Enweluzo, GO; Giwa, SO; Obalum, DC; Ogo, CN | 1 |
| Fujishiro, M; Goto, O; Hirano, K; Kodashima, S; Koike, K; Niimi, K; Ono, S; Yamamichi, N | 1 |
| Crijns, HJ; Dinh, T; Pisters, R | 1 |
| Butaffuoco, F; Richard, T; Vanhaeverbeek, M | 1 |
| Di Matteo, A; Iuliano, L; Straface, G | 1 |
| Bhatt, DL; Cannon, CP; Depta, JP; Fonarow, GC; Peacock, WF; Zhao, X | 1 |
| Healey, JS | 1 |
| Apostolakis, S; Lane, DA; Lip, GY; Shantsila, E | 1 |
| Atsumi, T | 1 |
| Donadini, MP; Douketis, JD | 1 |
| Chu, KM; Kan, LP; Lin, GM | 1 |
| Major, J; Reed, MJ | 1 |
| Lim, W | 1 |
| Caldas, CA; de Carvalho, JF | 1 |
| Pendleton, RC; Vinik, R; Wanner, N | 1 |
| Choi, DH; Hwang, ES; Kim, SK; Kim, YH; Kwak, JJ; Lee, BH; Pak, HN; Park, JH; Park, JS | 1 |
| Bauer, T; Bestehorn, K; Gitt, A; Jünger, C; Koeth, O; Senges, J; Towae, F; Zahn, R; Zeymer, U | 1 |
| Anjum, N; Child, N; Cooper, HL; Keohane, SG | 1 |
| Extramiana, F; Lafuente-Lafuente, C; Mahé, I | 1 |
| Grzywna, E; Krupa, M; Moskała, M; Składzień, T | 1 |
| Kitagawa, Y; Okuma, H; Takagi, S; Tokuoka, K; Yasuda, T | 1 |
| Tomoda, H | 1 |
| Mannucci, PM; Moia, M | 1 |
| Boyella, R; Goldman, S; Moukabary, T; Pierce, MK; Shanmugasundaram, M; Thai, H; Thal, S | 1 |
| Owen, A | 2 |
| Lane, DA; Lip, GY | 1 |
| Bhindi, R; Ormerod, OJ | 1 |
| Trynda-Lemiesz, L; Wiglusz, K | 1 |
| Hopps, S; Marcy, TR | 1 |
| Homma, S; Pullicino, P | 1 |
| Akhter, M; Baber, U; Kini, A; Kothari, S; Sharma, SK | 1 |
| Ageno, W; Bozzato, S; Dentali, F; Manfredi, E; Squizzato, A | 1 |
| Hadad, E; Kramer, E; Shalom, A; Westreich, M | 1 |
| Brennan, MT; Furney, SL; Hong, CH; Lockhart, PB; Napeñas, JJ | 1 |
| Ashwal, S; Askalan, R; deVeber, G; Jordan, LC; Rafay, MF; Smith, SE; Zamel, KM | 1 |
| Ahmad, M; Eikelboom, JW; Natarajan, MK; Salehian, O; Schwalm, JD | 1 |
| Garg, A | 1 |
| Goto, S; Hasegawa, T; Hirabayashi, T; Hirai, T; Ikeda, Y; Inoue, H; Kaneko, Y; Koretsune, Y; Nozawa, T; Ono, S; Origasa, H; Sasagawa, Y; Shimada, K; Uchiyama, S | 1 |
| Böhm, M; Dichgans, M; Diener, HC; Endres, M; Grond, M; Hacke, W; Hoppe, UC; Kirchhof, P; Laufs, U; Meinertz, T; Ringelstein, EB; Rosenkranz, S; Röther, J | 1 |
| Bond, JH; McDougall, H; Nelson, DB; Sawhney, MS | 1 |
| Butwick, AJ; Carvalho, B | 1 |
| Lee, SY; Savides, TJ | 1 |
| Gao, F; Jia, de A; Liu, XL; Nie, B; Shen, H; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhou, YJ | 1 |
| Egami, S; Fujiwara, T; Hayashida, M; Hydo, M; Kawano, Y; Kawarasaki, H; Mizuta, K; Nakata, M; Sakuma, Y; Sanada, Y; Wakiya, T; Yasuda, Y | 1 |
| Connolly, SJ; Diaz, R; Eikelboom, JW; Flaker, G; Hart, R; Hohnloser, S; Joyner, C; Lawrence, J; O'Donnell, M; Pais, P; Pogue, J; Synhorst, D; Yusuf, S | 1 |
| Chen, FY; Cohn, LH; DiBardino, DJ; ElBardissi, AW; Yamashita, MH | 1 |
| Cordonnier, C | 1 |
| Bello, RA; D'Alessandro, DA; Edwards, P; Goldstein, DJ; Kazam, J; Maybaum, S; Stern, DR | 1 |
| Hagiwara, N; Mori, F; Ogawa, H; Takagi, A; Uchida, Y | 1 |
| Kowey, PR; Myerburg, R; Naccarelli, GV; Packer, DL; Pratt, CM; Reiffel, JA; Reiter, MJ; Waldo, AL | 1 |
| Della Valle, CJ; Lieberman, JR; Sheth, NP | 1 |
| Aaronson, KD; Boyle, A; Conte, JV; Farrar, DJ; John, R; Naka, Y; Pagani, FD; Russell, SD; Slaughter, MS; Sundareswaran, KS | 1 |
| McCarthy, DM | 1 |
| Cohen, AT; Nandini, B; Ota, S; Wills, JO | 1 |
| Eikelboom, JW; Mehta, SR; Paikin, JS | 1 |
| Bacà, M; Crea, F; Dato, I; Niccoli, G; Pontecorvo, ML | 1 |
| Arora, R; Bhuriya, R; Chaudhari, D | 1 |
| Dager, WE | 1 |
| Berger, RD; Brinker, JA; Calkins, H; Cheng, A; Dalal, D; Halperin, H; Henrikson, CA; Leng, CT; Marine, JE; Nazarian, S; Sinha, S; Spragg, DD; Tomaselli, GF; Tompkins, C | 1 |
| Carkman, S; Ergüney, S; Korman, U; Ozben, V; Pekmezci, S; Saribeyoğlu, K; Somuncu, E | 1 |
| Ganigara, M; Nair, RS; Pavithran, S; Prabhu, A; Valliatu, J; Varghese, R | 1 |
| Cairns, JA; Eikelboom, JW; Hirsh, J; Paikin, JS | 1 |
| Aleksandrova, EN; Kondrat'eva, LV; Kovalenko, TF; Ostriakova, EV; Patrushev, LI; Patrusheva, NL; Reshetniak, TM | 1 |
| Burton, P; Cheng, M; Griffin, G; Lee, MS; Oppenheimer, L; Plotnikov, AN; Weinstein, R; Yuan, Z; Zhang, J; Zolynas, R | 1 |
| Kobayashi, H | 1 |
| Hwang, DY; Pless, ML | 1 |
| Al-Khatib, SM; Blazing, MA; Califf, RM; Kong, MH; O'Connor, C; Shaw, LK | 1 |
| Åhsberg, K; Höglund, P; Staël von Holstein, C | 1 |
| Avakian, Z; Edmunds, I | 1 |
| Ahsberg, K; Höglund, P; Kim, WH; von Holstein, CS | 1 |
| Biffi, A; Busl, K; Gilson, A; Greenberg, MS; Halpin, A; Rosand, J; Rost, N; Smith, EE; Towfighi, A; Viswanathan, A | 1 |
| Abildstrøm, SZ; Andersen, SS; Clausen, MT; Fog-Petersen, ML; Folke, F; Gadsbøll, N; Gislason, GH; Hansen, ML; Køber, L; Poulsen, HE; Raunsø, J; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
| Pellegrini, VD | 1 |
| Dyer, C; Kim, D; Rainsbury, J; Siddiq, S; Smith, J | 1 |
| Aronow, WS; Bakerywala, S; Desai, HV; Gandhi, K; Laimuanpuii, J; Peterson, SJ; Sharma, M | 1 |
| Al-Hussain, F; Alexandrov, AV; Demchuk, AM; Hussain, M; Ibrahim, MM; Khan, K; Molina, C; Saqqur, M; Sebastian, J; Uchino, K | 1 |
| Bay, C; Emrani, F; Mehdipour, M; Sharifi, J; Sharifi, M | 1 |
| Gajra, A; Singh, A | 1 |
| Alden, PB; Goldman, JA; Graber, JN; Rizvi, AZ; Rosenbaum, A; Sullivan, TM; Tretinyak, AS | 1 |
| Albert, MA; Feist, RM; Frederick, PA; Mason, JO; Neimkin, MG; Thomley, ML; White, MF | 1 |
| Akdemir, R; Balcı, MM; Biçer Yeşilay, A; Doğan, M; Karakurt, O; Kılıç, H; Orçan, S | 1 |
| Ergene, O; Oran, I; Sarıtaş, T; Saylan Çevik, B; Tavlı, V | 1 |
| Bôer, BN; Grinberg, M; Lavitola, Pde L; Oliveira, WA; Sampaio, RO; Spina, GS; Tarasoutchi, F | 1 |
| Budnitz, DS; Kegler, SR; Shehab, N; Sperling, LS | 1 |
| Morimoto, Y; Nakatani, T; Niwa, H | 1 |
| Gendlin, GE; Storozhakov, GI; Tronina, OA | 1 |
| Goodyear-Smith, F | 1 |
| Lu, N; Salvati, EA | 1 |
| Bergmann, JF; Emery, C; Fagnani, F; Lafuente-Lafuente, C; Laurendeau, C | 1 |
| Hughes, GR | 1 |
| Fujita, M; Haruma, K; Honda, K; Ishii, M; Kamada, T; Matsumoto, H; Murao, T; Sakakibara, T; Shiotani, A; Tarumi, K | 1 |
| Minarelli, M; Valgimigli, M | 1 |
| Goldhaber, SZ | 1 |
| Cohn, RM; Cornell, CN; Della Valle, AG | 1 |
| Arora, R; Bedi, U; Khosla, S; Molnar, J; Singh, M; Singh, PP | 1 |
| Gao, F; Jia, de A; Liu, XL; Nie, B; Wang, ZJ; Yan, ZX; Yang, SW; Zhou, YJ | 1 |
| Etuwewe, B; Ladusans, E; Mangat, J | 1 |
| Brost, BC; DeStephano, CC; Meena, M; Watson, WJ | 1 |
| McLintock, C | 1 |
| Baldini, L; Benevolo, G; Boccadoro, M; Bringhen, S; Callea, V; Caravita, T; Carella, AM; Cavo, M; Cellini, C; Crippa, C; Elice, F; Evangelista, A; Galli, M; Gentilini, F; Magarotto, V; Marasca, R; Montefusco, V; Morabito, F; Nozzoli, C; Offidani, M; Palumbo, A; Patriarca, F; Pescosta, N; Polloni, C; Pulini, S; Ria, R; Romano, A; Rossi, D; Tacchetti, P; Tosi, P; Zamagni, E; Zambello, R | 1 |
| Lane, DA; Lip, GYH; Tapp, LD | 1 |
| Li, SH; Wang, ZH; Zhang, W; Zhang, Y; Zhao, HJ; Zheng, ZT; Zhong, M | 1 |
| Charles, J; Miller, G; Pan, Y | 1 |
| Vik-Mo, H | 1 |
| Cacciapuoti, F | 1 |
| Garg, RK; Glazer, NL; Heckbert, SR; Newton, KM; Psaty, BM; Siscovick, DS; Smith, NL; Thacker, EL; Wiggins, KL | 1 |
| Smetana, GW; Srour, JF | 1 |
| Kamal, AK; Khan, M | 2 |
| Rubboli, A | 2 |
| Kim, SS; Oh, J; Smiddy, WE | 1 |
| Heyrosa, MG; Khubchandani, IT; Thekkeurumbil, SV | 1 |
| Brioli, A; Cavo, M; Pantani, L; Tacchetti, P; Zamagni, E; Zannetti, B | 1 |
| Douketis, JD | 2 |
| Carangelo, B; Palma, L; Peri, G | 1 |
| Atarashi, H; Inoue, H; Kumagai, N; Okumura, K; Origasa, H; Yamashita, T | 1 |
| Baty, SR; Griffith, CB; Phillippe, HM | 1 |
| Saliba, W | 1 |
| Chimowitz, M; Cloft, HJ; Feldmann, E; Lynn, MJ | 1 |
| Bryan, S; Fitzmaurice, D; Fletcher, K; Hobbs, FD; Jowett, S; Lip, GY; Mant, J; Roalfe, A | 1 |
| Brewer, JD; Cook-Norris, RH; Michaels, JD; Otley, CC; Phillips, PK; Roenigk, RK; Weaver, AL | 1 |
| Bell, PR; Khadim, MF; Lewis, HG; Rashid, A | 1 |
| Stecker, EC | 1 |
| Fendrick, AM | 1 |
| Allison, PM; Bayat, M; Bracey, AW; Chen, AJ; Reyes, MA | 1 |
| Green, A; Sauder, M; Ziegelstein, RC | 1 |
| Chan, NY; Choy, CC; Chu, PS; Lau, CL; Lau, ST; Lo, YK; Mok, NS; Tsui, PT; Yuen, HC | 1 |
| Ding, X; Kaminsky, LS; Li, L; Zhang, X | 1 |
| Sillence, D; Tchan, M | 1 |
| Bini, SA; Inacio, MC; Khatod, M; Paxton, EW | 1 |
| Chinnakotla, S; Davis, GL; Goldstein, RM; Kim, P; Klintmalm, E; Klintmalm, GB; Landaverde, C; Levy, MF; Saad, R; Stone, MJ; Tomiyama, K; Trotter, JF | 1 |
| Alonzo, MJ; Hahn, D; Kim, S; Patel, NH; Schneider, JR; Verta, MJ | 1 |
| Mantha, S; Pianka, AM; Tsapatsaris, N | 1 |
| Barequet, IS; Budnik, I; Moisseiev, J; Priel, A; Sachs, D; Salomon, O; Shenkman, B; Wasserzug, Y | 1 |
| Hayreh, SS; Podhajsky, PA; Zimmerman, MB | 1 |
| Kukin, M; Messerli, FH | 1 |
| Graham, JD; Koenig, SC; Pappas, PS; Slaughter, MS; Sobieski, MA; Tatooles, AJ | 1 |
| Campbell, D; Harris, IA; Jenkin, DE; Millar, MJ; Molnar, RB | 1 |
| Andrew, M; Cochrane, A; Hughes, M; Manlhiot, C; McCrindle, BW; Monagle, P; Roberts, R; Szechtman, B; Weintraub, R | 2 |
| Amano, Y; Fukuba, N; Ishihara, S; Kinoshita, Y; Kusunoki, R; Mishima, Y; Moriyama, I; Murakawa, Y; Oka, A; Okada, M; Oshima, N; Sato, M; Sato, S; Sumita, Y; Tada, Y; Yuki, T | 1 |
| Chai, SD; Dong, MF; Ma, SJ; Ma, ZS; Tang, PZ; Wang, LX; Yao, DK | 1 |
| Brown, JS; Mahmoud, TH | 1 |
| Bojic, D; Drmic, D; Franjic, S; Hrelec, M; Kolenc, D; Radic, B; Seiwerth, S; Sikiric, P; Stupnisek, M; Vcev, A | 1 |
| Abu-Yousef, MM; Kuehn, DM; Laroia, AT; Larson, JH; Wu, AS | 1 |
| Bariol, SV; Brooks, AJ; Drummond, M; Lau, HM; McDonald, C; Patel, MI; Raj, MD; Wang, AC; Woo, HH | 1 |
| Bushnell, CD; Lopes, RD; Olson, DM; Pan, W; Peterson, ED; Shah, BR; Zhao, X | 1 |
| Asinger, RW; Hart, RG; Herzog, CA; Pearce, LA | 1 |
| Celikyurt, U; Ertaş, G; Kılıç, T; Kozdağ, G; Sahin, T; Ural, D; Yaymacı, M | 1 |
| Haaga, JR; Nakamoto, DA; Wilkins, LR | 1 |
| Engel, G; Kong, MH; Mead, RH; Patrawala, RA; Winkle, RA | 2 |
| Asil, T; Balci, K; Celik, Y; Ir, N; Tekinaslan, I; Unlu, E; Utku, U | 1 |
| Fraenkel, L; Fried, TR; Street, RL | 1 |
| Fiorella, D; Kelly, ME; Moskowitz, SI; Obuchowski, N | 1 |
| Arnold-Lloyd, T; Ata, A; Bonville, DJ; Jahraus, CB; Rosati, C; Salem, L; Stain, SC | 1 |
| Anderson, FA; Friedman, RJ; Huang, W; Kwong, LM; Lieberman, JR; Pellegrini, VD | 1 |
| Almadi, MA; Barkun, A; Brophy, J | 1 |
| Filgate, R; Guo, DY; Macneil, F; Taylor, K | 1 |
| Woo, HH | 1 |
| Blackburn, D; Eurich, DT; Evans, CD; Remillard, AJ; Shevchuk, YM | 1 |
| O'Shea, D; Romero-Ortuno, R | 1 |
| Dwivedi, G; Felmeden, DC; Lip, GY | 1 |
| Lane, DA; Lip, GY; Tse, HF | 1 |
| Bajorek, BV; Ren, S | 1 |
| Fiorella, D | 1 |
| Farney, AC; Rogers, J; Stratta, RJ | 1 |
| Anglade, MW; Coleman, CI; Kluger, J; Sobieraj, DM; Straznitskas, AD | 1 |
| Ghaswalla, PK; Harpe, SE; Slattum, PW | 1 |
| Crowther, M; Donadini, MP; Lim, W; Spencer, FA; Warkentin, AE | 1 |
| Jaff, MR; Margey, R; Rogers, RK; Rosenfield, K; Sakhuja, R; Stone, JH | 1 |
| Flaker, G; Littrell, R | 1 |
| Correa, ZM; Foster, RE; Malik, AI; Miller, DM; Petersen, MR; Riemann, CD | 1 |
| Hirose, Y; Inamasu, J; Miyatake, S; Nakatsukasa, M | 1 |
| Kristinsson, SY; Landgren, O | 1 |
| Broder, A; Putterman, C; Tobin, JN | 1 |
| Eikelboom, JW; Paikin, JS | 1 |
| Adams, H; Albers, GW; Felberg, R; Furlan, AJ; Herrmann, H; Kar, S; Landzberg, M; Massaro, J; Mauri, L; Raizner, A; Reisman, M; Wechsler, L | 1 |
| Alison, JF; Lockwood, S; Mottram, P; Obeyesekere, MN | 1 |
| Krittalak, K; Sawanyawisuth, K; Tiamkao, S | 1 |
| Collinge, CA; Kelly, KC; Little, B; Schuster, RD; Weaver, T | 1 |
| Agarwal, S; Hachamovitch, R; Menon, V | 1 |
| Airaksinen, KE; Biancari, F; Karjalainen, P; Kiviniemi, T; Niemelä, M; Pietilä, M; Puurunen, M; Vikman, S; Ylitalo, A | 1 |
| Kano, T; Matsuzaki, K; Mine, H; Okudaira, Y; Sakai, F; Sanefuji, K; Shioshita, K; Suehiro, N; Suehiro, T; Suetsugu, F; Suetsugu, K; Sugie, Y; Suhiro, K; Toyokawa, T; Yakeishi, Y | 1 |
| Athanasiou, T; Dimitrakakis, G; Kourliouros, A; Mydin, MI; Nowell, J; Younis, J | 1 |
| Bron, AM; Creuzot-Garcher, C; Juniot, A; Koehrer, P; Passemard, M | 1 |
| Alexander, KP; Fosbol, EL; Klaskala, W; Li, S; Lopes, RD; Mills, RM; Peterson, ED; Piccini, JP; Roe, MT; Shah, B; Thomas, L; Wang, TY | 1 |
| Amin, AG; Hsu, W; Lim, M; Ng, J; Pradilla, G; Quinones-Hinojosa, A; Raza, S | 1 |
| Di Pierro, F; Lucarelli, M; Rinaldi, F; Rossoni, G | 1 |
| Connolly, SJ; Eikelboom, JW | 1 |
| Ammon, SE; Anker, SD; Buchsbaum, R; del Valle, ML; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Gabriel, AP; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Massie, BM; Mejia, V; Mohr, JP; Ponikowski, P; Pullicino, PM; Sacco, RL; Sanford, AR; Teerlink, JR; Thompson, JL | 1 |
| Di Tommaso, L; Lillo, S; Monaco, M; Pinna, GB; Schiavone, V; Stassano, P | 1 |
| Altan, I; Aytac, S; Cetin, M; Gokce, M; Gumruk, F; Gurgey, A; Kuskonmaz, B; Tuncer, M; Unal, S | 1 |
| Andreotti, F; Anker, SD; Filippatos, G; Homma, S; Lane, DA; Lip, GY; Marin, F; Morais, J; Ponikowski, P; Pullicino, P; Rasmussen, LH | 1 |
| Halperin, JL; Varughese, CJ | 1 |
| Esposito, A; Gesell, M; Gonzalez Della Valle, A; Ma, Y; Memtsoudis, SG; Vulcano, E | 1 |
| Dworzynski, K; Higgins, B; Kelsey, A; Palmer, K; Pollit, V | 1 |
| Lip, GY; Pisters, R; Wrigley, BJ | 1 |
| Badellino, M; Moore, MM; Pasquale, MD | 1 |
| Bhatt, DL; Kar, S | 1 |
| Callahan, S; Goldsberry, A; Kim, G; Yoo, S | 1 |
| Azoulay, L; Dell'Aniello, S; Langleben, D; Renoux, C; Simon, TA; Suissa, S | 1 |
| Anglade, MW; Coleman, CI; Hagstrom, K; Kluger, J; Lee, S; Meng, J | 1 |
| Alexander, KP; Foody, JM; Funk, M; Granger, CB; Li, L; Lopes, RD; Peterson, ED; Wang, TY | 1 |
| DeSimone, LJ; Gillette, BP; Pagnano, MW; Sierra, RJ; Trousdale, RT | 1 |
| Kanorskiĭ, SG; Shevelev, VI | 1 |
| Kadoyama, K; Okuno, Y; Sakaeda, T; Tamura, T | 1 |
| Fung, KP; Lau, BS; Leung, PC; Wang, S; Zhang, Z; Zhou, L; Zuo, Z | 1 |
| Giannubilo, SR; Tranquilli, AL | 1 |
| Gislason, GH; Hommel, K; Kamper, AL; Køber, L; Lane, DA; Lindhardsen, J; Lip, GY; Olesen, JB; Torp-Pedersen, C | 1 |
| Alexander, M; Kirsa, S; Mellor, JD | 1 |
| Parra, D; Rosenstein, R; Shah, S | 1 |
| Chua, D; Ignaszewski, A; Nishi, C | 1 |
| Jamil, HA; Witte, KK | 1 |
| Booth, ME; Brennan, JM; Dokholyan, RS; Douglas, PS; Edwards, FH; O'Brien, S; Peterson, ED; Zhao, Y | 1 |
| Eikelboom, JW; Whitlock, RP | 1 |
| Carroll, PR; Chan, JM; Choe, KS; Cowan, JE; D'Amico, AV; Liauw, SL | 1 |
| Abbas, A; Chowdhury, R; Hoy, A; Idriz, S; Rutherford, EE; Smart, JM | 1 |
| Al-Atassi, T; Bedard, P; Boodhwani, M; Forgie, M; Goldstein, W; Hendry, P; Lam, K; Masters, R; Mesana, T; Rubens, F; Ruel, M | 1 |
| Allemang, MT; Hingorani, A; Kashyap, VS; Nelson, PR; Rajani, RR | 1 |
| Filipský, T; Hrdina, R; Jahodář, L; Karlíčková, J; Macáková, K; Mladěnka, P; Parmar, VS; Pávek, P; Prasad, AK; Řeháková, Z; Říha, M; Saso, L | 1 |
| Brown, RD; Christianson, TJ; Flemming, KD; Link, MJ | 1 |
| Alexander, M; Kirsa, S; Lingaratnam, S; Mellor, JD; Teoh, KC | 1 |
| Smith, SA | 1 |
| Budaj, A; Connolly, SJ; Eikelboom, JW; Flaker, GC; Hart, RG; Husted, S; Kaatz, S; Lip, GY; Shestakovska, O; Yusuf, S | 1 |
| Foster, CS; Kruh, JN; Yang, P | 1 |
| Dovjak, P; Püllen, R | 1 |
| Kimura, T; Kitao, T; Nagaoka, E; Sakota, D; Takakuda, K; Takatani, S; Yokoyama, Y | 1 |
| Chicoine, MR; Cross, DT; Dacey, RG; Derdeyn, CP; Kadkhodayan, Y; Lee, JM; Moran, CJ; Rich, KM; Vellimana, AK; Zazulia, AR; Zipfel, GJ | 1 |
| Alexander, JH; Alexander, KP; Broderick, S; Granger, CB; Hess, CN; Lopes, RD; Mahaffey, KW; Newby, LK; Peterson, ED; Piccini, JP; Shaw, LK | 1 |
| Celenza, A; Chen, W; Falzon, CM; Lee, G | 1 |
| Braun, OÖ; Koul, S; Lumsden, J; Ohman, J; Rydell, E; Scherstén, F; Smith, JG; Svensson, PJ; van der Pals, J; Wieloch, M | 1 |
| Andreotti, F; Anker, SD; Filippatos, G; Homma, S; Lane, DA; Lip, GY; Marín, F; Morais, J; Piotrponikowski, P; Pullicino, P; Rasmussen, LH | 1 |
| Cohen, SM; Witmer, MT | 1 |
| Habich, S | 1 |
| Bartolomé García, S; Gesell, MW; González Della Valle, A; Haas, SB; Ma, Y; Memtsoudis, SG; Salvati, EA | 1 |
| Berrone, S; Boffano, P; Fasolis, M; Guglielmi, V; Palumbo, C; Viterbo, S | 1 |
| Delluc, A; Lacut, K; Mottier, D | 1 |
| Kozan, Ö | 1 |
| Goyal, MK; Kumar, G | 1 |
| Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A | 1 |
| Floege, J; Krüger, T; Schlieper, G | 1 |
| Baumann, M; Poppert, H; Seifert, CL | 1 |
| Sood, MM; Tangri, N | 1 |
| Araki, H; Suemaru, K; Tanaka, A; Tanaka, M | 1 |
| Hattori, K; Ichikawa, A; Igarashi, A; Kato, A; Koshino, M; Nagata, K; Takano, H | 1 |
| Kiss, RG | 2 |
| Cao, KJ; Chen, KP; Huang, CX; Huang, DJ; Ma, CS; Wang, FZ; Zhang, S | 1 |
| Hong, KS; Lee, M; Ovbiagele, B; Saver, JL; Wu, HC | 1 |
| de Lucia, C; Femminella, GD; Ferrara, N; Komici, K; Leosco, D; Moja, L; Pagano, G; Parisi, V; Perrone-Filardi, P; Rengo, G; Savarese, G; Squizzato, A | 1 |
| Buchbinder, M; Doshi, SK; Halperin, JL; Holmes, D; Huber, K; Neuzil, P; Reddy, VY; Sievert, H | 1 |
| Brey, RL; Buchsbaum, R; Christenson, RH; deFilippi, CR; Elkind, MS; Gross, R; Kronmal, RA; Levine, SR; Longstreth, WT; Mohr, JP; Seliger, SL; Thompson, JL; Tirschwell, DL | 1 |
| Kamath, AF; Levack, A; Lonner, JH | 1 |
| Komarova, IB; Zykov, VP | 1 |
| Abe, M; Akao, M; Chun, YH; Esato, M; Furuke, K; Hasegawa, K; Hashimoto, T; Tsuji, H; Wada, H | 1 |
| Huang, CL; Matthews, GD; Sabir, IN | 1 |
| Di Luozzo, M; Di Roma, M; Lanzillo, C; Lioy, E; Maresca, L; Minati, M; Patrizi, R; Pendenza, G; Preziosi, P; Romagnoli, E; Romeo, F; Sciahbasi, A; Summaria, F | 1 |
| Agewall, S; Andreotti, F; Atar, D; Cattaneo, M; Collet, JP; Grove, EL; Huber, K; Husted, S; Kjeldsen, K; Lip, GY; Morais, J; Pathak, A; Rosano, G; Storey, RF; Verheugt, FW; Wassmann, S | 1 |
| Chan, AK; Chen, K; Mondal, TK; Williams, S | 1 |
| Devlin, HL; Hosman, AE; Shovlin, CL | 1 |
| Chang, JP; Chen, HC; Chen, MC; Chen, YL; Guo, BF; Lin, YS; Pan, KL; Tsai, TH | 1 |
| Farkouh, ME; Gandhi, S; Marshall, JK; Narula, N | 1 |
| Badalato, GM; Hruby, GW; Lipsky, MJ; McKiernan, JM; Motamedinia, P | 1 |
| Golan, S; Kurtz, S; Levkovitch-Verbin, H; Shemesh, G | 1 |
| Beckmann, Y; Ciftçi, Y; Seçil, Y; Tokuçoğlu, F | 1 |
| Calafiore, AM; Iacò, AL; Marullo, AG | 1 |
| Attia, JR; Pearce, R | 1 |
| Al Habib, HF; Chu, MW; Diamantorous, P; Tarola, C | 1 |
| Alexopoulou, M; Balbarini, A; Bortolotti, U; De Carlo, M; Faggioni, L; Santini, C; Violo, C | 1 |
| Acet, H; Akil, MA; Alan, S; Bilik, MZ; Celepkolu, T; Ertas, F; Kaya, H; Oylumlu, M; Ozhan, H; Yildiz, A | 1 |
| Gao, YX; Li, L; Li, Y; Sun, TW; Yu, XZ; Yuan, YQ; Zhao, XY | 1 |
| Acar, G; Akıl, MA; Arıbaş, A; Aydın, M; Bilik, MZ; Bulur, S; Cağlıyan, CE; Ergene, O; Ertaş, F; Gedik, S; Gül, M; Kahya Eren, N; Kanadaşı, M; Kaya, H; Kaya, Z; Köroğlu, B; Köse, N; Oylumlu, M; Ozhan, H; Simşek, Z; Ulgen, MS; Vatan, B; Yeter, E; Yıldız, A; Yılmaz, R; Yüksel, M | 1 |
| Keating, GM | 1 |
| Avidan, B; Bardan, E; Beer-Gabel, M; Carter, D; Eliakim, R; Novis, B | 1 |
| Brennan, JM; Gammie, JS; He, X; O'Brien, SM; Rankin, JS; Schaff, HV; Suri, RM; Thourani, VH | 1 |
| Birocchi, S; Ferrari, L; Podda, GM; Scannella, E | 1 |
| Diener, HC | 1 |
| Bates, P; Culpan, P; El-Daly, I; Reidy, J | 1 |
| Hozack, WJ; Huang, R; Parvizi, J; Raphael, IJ; Rothman, RH; Tischler, EH | 1 |
| Cookson, C; Gaist, D; García-Rodríguez, LA; González-Pérez, A; Morton, J | 1 |
| Al-Majzoub, O; Assiri, A; Donovan, JL; Kanaan, AO; Silva, M | 1 |
| Feifer, A; Fernandes, SM; Khairy, P; Landzberg, MJ; Leong-Sit, P; Mayer, JE; Potter, BJ; Triedman, JK; Walsh, EP | 1 |
| Deng, X; Ma, Z; Peng, S; Yan, H | 1 |
| Baylor, K; Berger, PB; Henry, Y; Simmons, J; Toepfer, NJ | 1 |
| Anker, SD; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Gabriel, AP; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Massie, BM; Mohr, JP; Ponikowski, P; Pullicino, PM; Sacco, RL; Sanford, AR; Teerlink, JR; Thompson, JL | 1 |
| Ando, T; Inagaki, T; Kato, H; Kawakami, O; Sugiura, M; Suzuki, M | 1 |
| Bartlett, MJ; Gadzhanova, SV; Roughead, EE | 1 |
| D'Souza, MD; Gangemi, JJ; Hoyer, AW; Jayakumar, KA; Seckeler, MD | 1 |
| Anker, SD; Di Tullio, MR; Diek, M; Freudenberger, RS; Graham, S; Haddad, H; Homma, S; Labovitz, AJ; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Sanford, AR; Teerlink, JR; Thompson, JL | 1 |
| Kansal, AR; Pokora, T; Sorensen, SV; Zheng, Y | 1 |
| Ahn, T; Choi, H; Choi, IS; Han, SH; Kang, WC; Lee, K; Moon, CI; Oh, PC; Shin, EK; Suh, SY | 1 |
| Toyoda, K | 1 |
| Efthymiou, CA; Mills, RJ; O'Regan, DJ | 1 |
| Edogawa, S; Harada, S; Higuchi, K; Kojima, Y; Ota, K; Takeuchi, T; Tokioka, S; Umegaki, E | 1 |
| He, X; Jin, X; Kong, Q; Liu, Y; Sun, Y; Wu, J; Zhang, Y | 1 |
| Fiaccadori, E; Maggiore, U; Regolisti, G | 1 |
| Kalita, J; Kumar, P; Misra, UK | 1 |
| He, B; Kun, L; Liu, X; Wu, B | 1 |
| Dugdale, M; Fabian, TC; Gordon, JL; Lee, MD | 1 |
| Holm, L; Loikas, D; Malmström, RE; Mejyr, S; Rydberg, DM; Schenck-Gustafsson, K; von Euler, M; Wettermark, B | 1 |
| Aguirre, A; Akil, M; Amigo, MC; Bertolaccini, ML; Cuadrado, MJ; Egurbide, MV; Espinosa, G; Galindo, M; Gil, A; Gordon, C; Houssiau, F; Khamashta, MA; Martin, H; McHugh, N; Mico, L; Murru, V; Rahman, A; Ruiz-Irastorza, G; Seed, PT; Tektonidou, MG | 1 |
| Chimowitz, MI; Smock, A; Turan, TN | 1 |
| Amin, A; Deitelzweig, S; Graham, J; Jing, Y; Lin, J; Makenbaeva, D; Wiederkehr, D | 1 |
| Bjornsson, ES; Hreinsson, JP; Jonasson, JG | 1 |
| Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V | 1 |
| Allan, GM; Banh, HL; Ference, J | 1 |
| Becker, RC; Breithardt, G; Califf, RM; Fox, KA; Goodman, SG; Hacke, W; Halperin, JL; Hankey, GJ; Mahaffey, KW; Nessel, CC; Patel, MR; Piccini, JP; Singer, DE; Stevens, SR; White, HD | 1 |
| Alexander, JH; Alings, M; Atar, D; Aylward, P; Goto, S; Granger, CB; Hanna, M; Huber, K; Husted, S; Lewis, BS; Lopes, RD; McMurray, JJ; Pais, P; Pouleur, H; Steg, PG; Thomas, L; Verheugt, FW; Wallentin, L; Wojdyla, DM | 1 |
| Ahn, JE; Chang, J; Chun, L; Landsman, N; Patel, KK; Rhee, K | 1 |
| Aronow, WS; Harikrishnan, P; Palaniswamy, C | 1 |
| Forslund, T; Hasselström, J; Hjemdahl, P; von Euler, M; Wändell, P; Wettermark, B | 2 |
| Dull, RB; Prom, R; Usedom, JE | 1 |
| Arnold, WV; Huang, R; Parvizi, J; Raphael, IJ; Rothman, RH | 2 |
| Andreoli, L; Shoenfeld, Y; Tincani, A | 1 |
| Januel, JM | 1 |
| Cairns, T; Condon, M; Galliford, J; Griffith, M; Levy, J; Medjeral-Thomas, N; Ziaj, S | 1 |
| Carlson, K; Chapin, J; Christos, PJ; DeSancho, MT | 1 |
| Araki, T; Enomoto, Y; Hara, H; Hori, M; Iijima, R; Itaya, H; Ito, N; Nagashima, Y; Nakamura, M; Shiba, M; Sugi, K; Tokue, M; Utsunomiya, M; Yamazaki, K | 1 |
| Jankauskas, A; Jurkienė, N; Kėvalas, R; Kudzytė, J; Labanauskas, L; Rakauskienė, V; Šileikienė, R | 1 |
| Aziz, H; Friese, RS; Joseph, B; Kulvatunyou, N; O'Keeffe, T; Pandit, V; Rhee, P; Sadoun, M; Tang, A; Wynne, JL | 1 |
| Guo, X; Hao, X; Li, J; Ma, H; Wang, J; Wang, Y | 1 |
| Eckman, P; John, R; Kamdar, F | 1 |
| Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Lassen, JF; Lip, GY; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C | 1 |
| Fujita, H; Ide, T; Ishihama, Y; Nishimura, S; Tosa, M | 1 |
| Gilchrist, IC; Kunselman, AR; Lippe, CM; Reineck, EA | 1 |
| Gupta, K; Singh, D; Vacek, JL | 1 |
| Anderson, C; Fermin, L; Gerdisch, M; Graeve, A; Hughes, C; Kong, B; Martin, T; McGrath, M; Nichols, D; Puskas, J; Quinn, R; Rhenman, B; Sethi, G; Wait, M | 1 |
| Dorian, P; Hernandez, L; Iloeje, U; Kongnakorn, T; Kuznik, A; Lanitis, T; Lip, GY; Liu, LZ; Phatak, H; Rublee, DA | 1 |
| Chimowitz, MI; Cotsonis, G; Derdeyn, CP; Fiorella, D; Lynn, MJ; Stern, BJ; Swanson, S; Turan, TN; Williams, JE; Wooley, RH | 1 |
| Chaturvedi, S; Culebras, A; Gronseth, G; Kase, CS; Messé, SR | 1 |
| Alpert, JS; Asencio, LA; Huang, JJ | 1 |
| Lavie, O; Leviov, M; Rennert, G; Rennert, HS; Sagi, S; Shai, A | 1 |
| Brandao, LR; Kayssi, A; Roche-Nagle, G; Rubin, BB; Shaikh, F; Williams, SA | 1 |
| Choe, KS; Chun, SG; Hannan, R; Jacobs, CD; Kim, DW; Lotan, Y; Pistenmaa, DA; Roehrborn, CG; Xie, XJ; Yan, J | 1 |
| Lip, GY; Shantsila, E | 1 |
| Fitzmaurice, D; Fletcher, K; Hobbs, FD; Lip, GY; Mant, J; Mavaddat, N; Roalfe, A | 2 |
| Amarenco, P; Cohen, AA; Davis, S; Donnan, GA; Heiss, WD; Jones, EF; Kaste, M; Laouénan, C; Macleod, M; Young, D | 1 |
| Albers, GW; George, PM | 1 |
| Kimber-Trojnar, Z; Leszczynska-Gorzelak, B; Mierzynski, R; Oleszczuk, J; Poniedzialek-Czajkowska, E | 1 |
| Izumi, T | 1 |
| Cao, G; Feng, L; Huang, H; Li, Y; Liu, X; Xu, Q; Yu, J; Zhang, S; Zhou, M | 1 |
| Corrada, E; Ferri, M; Savonitto, S | 1 |
| Alonso-Coello, P; Coll-Vinent, B; Devereaux, PJ; Díaz, MG; Diez, AI; Gich, I; Guyatt, G; Mas, G; Montori, VM; Oliver, S; Roura, M; Ruiz, R; Schünemann, HJ; Solà, I; Souto, JC | 1 |
| Erastov, AA; Kostanyan, AE; Shishilov, ON | 1 |
| Cotté, FE; Durand-Zaleski, I; Gaudin, AF; Kachaner, I; Kongnakorn, T; Lanitis, T | 1 |
| Crijns, HJ; Iorio, A; Lip, GY; Marcucci, M; Nieuwlaat, R; Pisters, R | 1 |
| Eroglu, M; Gunay, E; Senturk, I | 1 |
| Lümmen, G | 1 |
| De Geer, A; Jacobson, L; Kongnakorn, T; Lanitis, T | 1 |
| Akiyama, J; Aoki, T; Kishida, Y; Mizokami, M; Nagata, N; Niikura, R; Sakurai, T; Sekine, K; Shimbo, T; Tanaka, S; Uemura, N; Watanabe, K; Yanase, M; Yokoi, C | 1 |
| Choi, KJ; Joung, B; Kim, YH; Lee, MH; Nam, GB; Pak, HN; Uhm, JS; Won, H | 1 |
| Di Nisio, M; Lattanzio, F; Zito, S | 1 |
| Pang, Y; Qin, S; Su, D; Wang, K | 2 |
| Guo, X; Li, L; Tang, B; Xu, G; Zhang, Y; Zhou, X | 1 |
| Daels, FP; de la Rosette, JJ; Erkan, E; Gaizauskas, A; Melekos, M; Ozgok, Y; Rioja, J; Varshney, AK | 1 |
| Agnelli, G; Becattini, C; Brighton, TA; Eikelboom, JW; Kirby, AC; Mister, R; Prandoni, P; Simes, J | 1 |
| Henke, PK; Obi, AT; Wakefield, TW | 1 |
| Goto, S | 1 |
| Connors, JM | 1 |
| Frank, J; Podszun, M | 1 |
| Thompson, PL; Verheugt, FW | 1 |
| Aguiar, C; Chatzitheofilou, I; Fonseca Santos, I; McLeod, E; Morais, J; Pereira, S | 1 |
| Jeong, HJ; Jun, JE; Kim, JH; Kim, JS; Lee, JE; Lee, SY; Ryu, DH | 1 |
| Ferrigno, L; Grotts, J; Kaminski, S; Reddy, S; Sharma, R | 1 |
| Coban, G; Horasanlı, B; Karalezli, A; Yeşilırmak, N | 1 |
| Bauer, DC; Boudreau, R; Donohue, JM; Hanlon, JT; Marcum, ZA; Newman, AB; Perera, S; Shorr, RI; Simonsick, EM; Strotmeyer, ES | 1 |
| Burns, JC; Gordon, JB; Levin, M | 1 |
| Anker, SD; Di Tullio, MR; Estol, CJ; Freudenberger, R; Graham, S; Homma, S; Levin, B; Lip, GY; Lok, DJ; Mann, D; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JL | 1 |
| Bacchi-Reggiani, ML; Bolognese, L; Briguori, C; Calabrò, P; Carosio, G; Di Pasquale, G; Galvani, M; Imperadore, F; La Vecchia, L; Maggioni, AP; Palmieri, C; Rizzi, A; Rubboli, A; Saia, F; Sangiorgi, GM; Sciahbasi, A; Steffanon, L; Steffenino, G; Valgimigli, M | 1 |
| Atsumi, T; Horita, T; Noguchi, A; Watanabe, K; Yasuda, S | 1 |
| Eikelboom, JW; Hart, RG | 1 |
| Chan, KH; Chan, PH; Cheung, E; Hai, JJ; Ho, CW; Ho, MH; Lau, CP; Lau, KK; Leung, GK; Lip, GY; Siu, CW; Tse, HF; Yeung, CY | 1 |
| BinBrek, AS; Mahmoud, WE; Murugesan, V; Rajani, AR | 1 |
| Anker, SD; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Sanford, AR; Teerlink, JR; Thompson, JL; Ye, S | 1 |
| García-Rinaldi, R | 1 |
| Ahn, H; Hwang, HY | 1 |
| Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L | 1 |
| Barrack, RL; Johnson, SR; Keeney, JA; Nam, D; Nunley, RM | 1 |
| Anker, SD; Cheng, B; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Sacco, RL; Shaffer, JA; Thompson, JL; Ye, S | 1 |
| Bruno, M; Caronna, S; De Angelis, C; Debernardi-Venon, W; Elia, C; Manfrè, SF; Marengo, A; Musso, A; Puglisi, F; Rizzetto, M; Sguazzini, C | 1 |
| Bico, B; Braun, OÖ; Chaudhry, U; Gustav Smith, J; Jovinge, S; Koul, S; Scherstén, F; Svensson, PJ; Tydén, P; van der Pals, J; Wagner, H | 1 |
| Dong, MF; Ma, SJ; Ma, ZS; Song, GM; Wang, JT | 1 |
| Alotaibi, GS; Alsaleh, K; Linkins, LA; McMurtry, MS; Wu, C | 1 |
| Boroja, T; Katanić, J; Matić, S; Mihailović, M; Mihailović, V; Mladenović, M; Stanić, S; Stanković, N; Stanković, V; Sukdolak, S; Vuković, N | 1 |
| Bonde, AN; Gislason, GH; Hansen, ML; Hansen, PR; Hommel, K; Kamper, AL; Lamberts, M; Lip, GY; Olesen, JB; Torp-Pedersen, C | 1 |
| Guo, Y; Lip, GYH; Tian, Y; Wang, H; Wang, Y | 1 |
| Chen, SC; Rineer, J; Schreiber, D; Schwartz, D; Telivala, T; Worth, M | 1 |
| Azumi, M; Hashizume, K; Hori, J; Iwata, T; Kakizaki, H; Kita, M; Kobayashi, S; Matsumoto, S; Okazaki, S; Wada, N | 1 |
| Chen, L; Fu, C; Lu, W; Ma, G; Wang, Y; Yao, Y; Zuo, P | 1 |
| Suda, K | 1 |
| Maltenfort, MG; Mostafavi Tabatabaee, R; Parvizi, J; Rasouli, MR | 1 |
| Forslund, T; Hjemdahl, P; Holmström, M; Johnsson, H; von Euler, M; Wettermark, B | 1 |
| Chen, KP; Zhang, JT; Zhang, S | 1 |
| Chen, G; Serenko, M; Zhang, W | 1 |
| Feng, X; Huan, Y; Lv, Y | 1 |
| Chan, PH; Hai, JJ; Siu, CW | 1 |
| Loomba, RS | 1 |
| Dunn, A | 1 |
| Bultas, J | 1 |
| Akiyama, J; Aoki, T; Moriyasu, S; Nagata, N; Niikura, R; Okubo, H; Sakurai, T; Sekine, K; Shimbo, T; Uemura, N; Watanabe, K; Yanase, M; Yokoi, C | 1 |
| Alarcon, LH; Bauer, J; Chen, SH; Grandhi, R; Harrison, G; Nicholas, D; Okonkwo, DO; Voronovich, Z | 1 |
| Cho, JY; Choi, RK; Hong, SJ; Joo, HJ; Kang, DO; Kim, HD; Kim, JS; Lee, HJ; Lim, DS; Park, JH; Park, JS; Yu, CW | 1 |
| Angoulvant, D; Bejan-Angoulvant, T; Fauchier, L; Ivanes, F; Lip, GYH; Saint Etienne, C; Villejoubert, O | 1 |
| Jarmak, A; Jończyk-Skórka, K; Kowalski, J; Śliwczyńska-Rodziewicz, D | 1 |
| DiSalvo, T; Lindenfeld, J; Zalawadiya, SK | 1 |
| Anker, SD; Buchsbaum, R; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JL; Ye, S | 1 |
| Carlsson, AC; Gasevic, D; Sundquist, J; Sundquist, K; Wändell, P | 1 |
| Gao, C; Jiang, S; Ren, C; Zhang, L | 1 |
| Bell, JJ; Crawford, RW; Ginsel, BL; Pulle, CR; Taher, A; Whitehouse, SL | 1 |
| García-Dorado, D; Sambola, A | 1 |
| Garbacz, M; Kaczmarski, J; Kuliczkowski, W; Pacholewicz, J; Serebruany, V; Zakliczyński, M; Zembala, M | 1 |
| Calabrò, P; Rubboli, A; Saia, F; Sciahbasi, A | 1 |
| Gao, F; Liu, XL; Shen, H; Wang, ZJ; Yang, SW; Zhou, YJ | 1 |
| Gutowski, CJ; Lonner, JH; Parvizi, J; Purtill, JJ; Zmistowski, BM | 1 |
| Connor, C; Harrison, CN; Keohane, C; McLornan, DP; Radia, D; Sanchez, K | 1 |
| Agewall, S; Huber, K; Lip, GY; Rubboli, A | 1 |
| Chan, PH; Hai, JJ; Li, WH; Siu, CW; Tse, HF | 1 |
| Fletcher, J; Gruen, R; Koh, TL; Ong, WL; Royce, P | 1 |
| Barrack, RL; Clohisy, JC; Johnson, SR; Keeney, JA; Nam, D; Nunley, RM | 2 |
| Buckley, PS; Huang, R; Parvizi, J; Purtill, JJ; Scott, B | 1 |
| An, J; Aranda, G; Bruno, A; Dills, DG; Jazdzewski, KP; Lang, DT; Le, PT; Meissner, B; Mendes, R; Niu, F; Rashid, N | 1 |
| Anker, SD; Buchsbaum, R; Cheng, B; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JL; Ye, S | 1 |
| Kozikowski, A; Lolis, J; Makaryus, AN; Oo, W; Pekmezaris, R; Stein, J; Wolf-Klein, G | 1 |
| Larsen, TB; Lip, GY; Nielsen, PB; Rasmussen, LH; Skjøth, F | 1 |
| Larsen, TB; Lip, GY; Nielsen, PB; Skjøth, F | 1 |
| Bhatt, DL; de Lemos, JA; Fosbol, EL; Hess, CN; Peng, SA; Peterson, ED; Saucedo, JF; Thomas, L; Wang, TY | 1 |
| Ken, J; Khangura, D; Stickles, SP | 1 |
| Gerson, LB; Shalman, D | 1 |
| Ahluwalia, S; Mani, H | 1 |
| Allen, CC; Alsaied, T; Alsidawi, S; Faircloth, J; Palumbo, JS; Veldtman, GR | 1 |
| Friberg, L; Rosenqvist, M | 1 |
| Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP | 1 |
| Arellano, AR; Bare, LA; Devlin, JJ; Louie, JZ; Perez, MV; Shiffman, D | 1 |
| Abe, T; Tokuda, Y; Watanabe, Y | 1 |
| Cao, J; Cui, X; Han, Z; Song, W; Wen, H; Xu, Y | 1 |
| Daşlı, T; Demir, H; Erden, İ; Erkol, A; Mutlu, A; Turan, B | 1 |
| Abadi, U; Ellis, MH | 1 |
| Lane, DA; Lip, GY; Proietti, M; Senoo, K | 1 |
| Chan, PH; Chan, TM; Hai, J; Huang, D; Lip, GY; Lo, WK; Siu, CW; Tse, HF; Yip, PS | 1 |
| Ahmed, O; Daniel, E; Grunwald, JE; Maguire, MG; Martin, DF; Ying, GS | 1 |
| Hu, T; Huang, J; Huang, X; Li, J; Li, L; Pappoe, F; Shen, C; Tang, H; Zhang, P; Zhang, W | 1 |
| Anker, SD; Buchsbaum, R; Cheng, B; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Sacco, RL; Sanford, A; Teerlink, JR; Thompson, JL | 1 |
| Gándara, E; Gonzalez, JP; Vazquez, FJ | 1 |
| Cavallazzi, R; Marik, PE | 1 |
| Ghaffari, S; Hobika, GH; Khaki, N; Masnadi-Shirazi, K; Nader, ND; Pourafkari, L | 1 |
| Forslund, T; Hjemdahl, P; Wettermark, B | 1 |
| Carlson, ML; Driscoll, CL; Haynes, DS; Hunter, JB; Sweeney, AD; Tombers, NM; Wanna, GB | 1 |
| Hussein, A; Saliba, W; Wazni, OM | 1 |
| Assali, A; Codner, P; Eisen, A; Kornowski, R; Lev, EI; Orvin, K; Perl, L; Vaknin-Assa, H; Zemer-Wassercug, N | 1 |
| Bor-Seng-Shu, E; Garrard, JW; Nogueira, RC; Simm, RF | 1 |
| Boost, KA; Gandorfer, A; Haritoglou, C; Heinicke, N; Hintschich, C; Huebert, I; Kampik, A; Kook, D; Mayer, WJ; Miller, CV; Wolf, A | 1 |
| D'Alessandro, D; Goldstein, DJ; Guerrero, C; Jermyn, R; Jorde, UP; Kargoli, F; Levin, AP; Madan, S; Nguyen, J; Patel, SR; Saeed, O; Shah, A; Shin, J; Sims, DB | 1 |
| Chu, C; He, L; Huang, G; Liang, X; Liu, F; Wu, L; Zhao, L | 1 |
| Ako, J; Fukaya, H | 1 |
| Ansell, J; Chang, P; Fonarow, GC; Gersh, BJ; Go, AS; Hylek, EM; Kowey, P; Lopes, RD; Mahaffey, KW; Peterson, ED; Piccini, JP; Rao, M; Simon, DN; Singer, DE; Thomas, L | 1 |
| Akiyoshi, D; Esaki, M; Kameda, M; Maehata, Y | 1 |
| Anker, SD; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Kato, TS; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JL; Wu, M | 1 |
| Coughlan, CA; Gutkin, M; Kinsella, J; Lonergan, R; McCabe, DJ; Murphy, SJ; Tobin, O | 1 |
| Higuchi, T; Koyamada, R; Mizuno, A; Okada, S; Son, R; Yamashiro, Y | 1 |
| Sternik, L | 1 |
| Akehurst, RL; Amorosi, SL; Armstrong, SO; Brereton, N; Hertz, DS; Holmes, DR; Reddy, VY | 1 |
| Bell, AD; Deschaintre, Y; Gross, P; Heffernan, M; Purdham, DM; Roux, JF; Shuaib, A | 1 |
| Chen, H; Wang, H; Wu, XY; Zheng, LF; Zhou, XK | 1 |
| Carlsson, M; Jöud, A; Juhlin, T; Mochalina, N; Sandberg, MEC; Själander, A; Svensson, PJ | 1 |
| Blann, AD; Lau, YC; Lip, GY; Ranjit, P; Xiong, Q | 1 |
| Lee, RT; Lee, TH | 1 |
| Awad, BF; El-Hamamsy, MH; Eldessouki, R; Elmansy, H; Elmazar, MM; Elsisi, GH; Taha, AS | 1 |
| Baker, D; Narasimhan, S; Wilsmore, B | 1 |
| Kataoka, Y; Nakagawa, A; Otoshi, T; Otsuka, K; Tomii, K | 1 |
| Apitz, C; Hansmann, G | 1 |
| Atarashi, H; Chishaki, A; Inoue, H; Kiyono, K; Kodama, I; Kodani, E; Lip, GY; Okumura, K; Okuyama, Y; Origasa, H; Watanabe, E; Yamamoto, M; Yamashita, T | 1 |
| Bai, DS; Chen, P; Jiang, GQ; Jin, SJ; Qian, JJ; Xia, BL; Zuo, SQ | 1 |
| Bhatt, DL; Qamar, A | 1 |
| Leebeek, FW | 1 |
| Austin, MS; Chen, AF; Hozack, WJ; Huang, RC; Parvizi, J | 1 |
| Briere, JB; Evers, T; Hori, M; Ikeda, S; Koretsune, Y; Matsuda, S; Montouchet, C; Okumura, K; Rossi, B; Ruff, L; Watanabe-Fujinuma, E | 1 |
| Chen, AF; Deirmengian, GK; Heller, S; Maltenfort, M; Parvizi, J; Smith, EB | 1 |
| Amengual, O; Atsumi, T; Bohgaki, T; Horita, T; Kaneko, K; Murashima, A; Nakanishi, I; Nozawa, K; Oku, K; Oomura, K; Sugiura-Ogasawara, M; Yasuda, S | 1 |
| Bayley, E; Bhamber, NS; Brown, S; Howard, PW | 1 |
| Fauchier, L; Freedman, SB; Gianni, C; Lane, DA; Lip, GY; Natale, A; Nattel, S; Potpara, T; Rienstra, M; Tse, HF; Van Gelder, I | 1 |
| Alansari, SA; Khan, AR; Khan, MS; Krasuski, RA; Luni, FK; Raza, S; Riaz, H; Riaz, IB; Riaz, T | 1 |
| Fushimi, K; Hirata, Y; Koike, K; Matsui, H; Niikura, R; Yamada, A; Yasunaga, H | 1 |
| Agarwal, S; Barakat, AF; Chaudhury, P; Ellis, SG; Faza, NN; Kapadia, SR; Mentias, A; Murat Tuzcu, E; Parashar, A; Wayangankar, S | 1 |
| Attard, C; Bullock, A; Celermajer, DS; d'Udekem, Y; Galati, JC; Gentles, TL; Grigg, LE; Iyengar, AJ; Justo, RN; Radford, DJ; Sholler, GS; Weintraub, RG; Wheaton, GR; Winlaw, DS | 1 |
| Kitagawa, K | 2 |
| Gehi, AK; Hsu, JC; Katz, DF; Kennedy, K; Lubitz, SA; Maddox, TM; Marcus, GM; Marzec, LN; Turakhia, MP | 1 |
| Deshpande, S; Wann, LS | 1 |
| Anker, SD; Buchsbaum, R; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JL | 1 |
| Camargo, HP; Girotto, E; Guidoni, CM; Obreli-Neto, PR; Pereira, LR | 1 |
| Ambrosio, G; Maiello, M; Palmiero, P; Pelliccia, F; Savino, K | 1 |
| Björck, F; Lip, GY; Renlund, H; Själander, A; Svensson, PJ; Wester, P | 1 |
| Anker, SD; Buchsbaum, R; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GY; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JL; Ye, S; Zhao, B | 1 |
| Hamaguchi, T; Inagaki, Y; Inoue, S; Iwakawa, S; Okada, M; Tatsumi, A | 1 |
| Chauhan, SK; Poole, WE; Rogers, BA; Wilson, DG | 1 |
| Erastov, AA; Kostanyan, AE | 1 |
| Fahed, E; Ghauche, J; Maarrawi, J; Menassa-Moussa, L; Moussa, R; Nohra, G; Okais, N; Rahme, R; Rizk, T; Samaha, E | 1 |
| Benedetti, R; Fenoglio, L; Imberti, D; Pomero, F | 1 |
| Musgrave, KM; Powell, J | 1 |
| Laurence, TN; Raheemullah, A | 1 |
| Becker, RC; Berkowitz, SD; Breithardt, G; Fox, KA; Hacke, W; Halperin, JL; Hankey, GJ; Hellkamp, A; Lokhnygina, Y; Mahaffey, KW; Nessel, CC; Patel, MR; Piccini, JP; Shah, R; Singer, DE | 1 |
| Eckman, MH; So, CH | 1 |
| Cushman, M; Dawood, FZ; Herrington, DM; Howard, G; Howard, VJ; Judd, S; Limdi, NA; Meschia, JF; Soliman, EZ | 1 |
| El Amri, H; Zaiou, M | 1 |
| Tu, I; Zhao, YT | 1 |
| Fenstad, ER; Janish, CD; Liang, JJ; Sinak, LJ | 1 |
| Barbieri, L; De Luca, G; Schaffer, A; Suryapranata, H; Verdoia, M | 1 |
| Huang, X; Li, J; Li, L; Shen, C; Wu, C; Zhang, P; Zhang, W | 1 |
| Chen, C; Deng, L; Li, D | 1 |
| Di Tullio, MR; Homma, S; Thompson, JL | 1 |
| Ärnlöv, J; Carlsson, AC; Holzmann, M; Johansson, SE; Sundquist, J; Sundquist, K; Wändell, P | 1 |
| Cheng, V; Cote, MP; Lieberman, JR | 1 |
| Athanasakis, K; Bilitou, A; Boubouchairopoulou, N; Karampli, E; Kyriopoulos, J; Savvari, P; Tarantilis, F | 1 |
| Cai, HX; Cao, JJ; Chen, BY; Gao, CY; Qin, YH; Wang, XP; Zhao, HW; Zhao, SJ | 1 |
| Køber, L; Lilleør, NB; Lund, JT; Møller, CH; Olsen, PS; Rafiq, S; Steinbrüchel, DA; Thiis, JJ | 1 |
| Wong, CW | 1 |
| Breuer, M; Fuchs, J; Hüter, L; Kuntze, T; Lauer, B; Owais, T; Rouman, M | 1 |
| Jolly, SS; Natarajan, MK | 1 |
| Doty, JR; Stevens, SM | 1 |
| Barrack, RL; Haynes, J; Nam, D | 1 |
| Gu, HW; Hu, Y; Liu, Z; Sun, XD; Wang, T; Wu, HL; Xiao, R; Yin, XL; Yu, RQ | 1 |
| Li, YH; Wu, HM; Xu, Y; Yang, J; Yang, LH; Yue-Meng, W | 1 |
| Davidson, M; Nilsson, C; Offman, E | 1 |
| Artemiou, P; Bena, M; Gasparovic, I; Hudec, V; Hulman, M | 1 |
| Coons, JC; Iasella, CJ; Kane-Gill, SL; Verlinden, NJ | 1 |
| Al-Khatib, SM; Alexander, JH; Bushnell, CD; Diener, HC; Easton, JD; Gabriel Melo de Barros E Silva, P; Granger, CB; Guimarães, PO; Hanna, M; Held, C; Kolls, BJ; Lopes, RD; Thomas, L; Wallentin, L; Wojdyla, DM | 1 |
| Choo, SJ; Chung, CH; Jung, SH; Kim, JB; Lee, JW; Lee, KS; Lee, SI | 1 |
| d'Udekem, Y; Dalziel, K; Iyengar, AJ; Schilling, C | 1 |
| Belmin, J; Jarzebowski, W; Lafuente-Lafuente, C; Melkonian, M; Pautas, E; Siguret, V | 1 |
| Barmparas, G; Bosarge, P; Brown, CV; Bukur, M; Carrick, MM; Catalano, RD; Coimbra, R; Holly-Nicolas, J; Inaba, K; Kaminski, S; Klein, AL; Kobayashi, L; Kopelman, T; Ley, EJ; Martinez, EM; Moore, FO; Murry, J; Nirula, R; Paul, D; Quick, J; Rivera, O; Schreiber, M | 1 |
| Chen, WC; Chuah, SK; Hsu, PI; Huang, YT; Lin, KH; Sun, WC; Tsai, TJ; Wu, DC | 1 |
| Abdul-Rahim, AH; Alexander, JH; Connolly, SJ; Flaker, GC; Granger, CB; Guimarães, PO; Hanna, M; Lees, KR; Lopes, RD; McMurray, JJV; Wallentin, L; Wang, J; Wojdyla, DM | 1 |
| Churilov, L; Hardidge, AJ; Suen, K; Westh, RN | 1 |
| Ahn, JM; Choi, HI; Kang, SH; Kang, SJ; Kim, YH; Lee, CW; Lee, PH; Lee, SW; Park, DW; Park, SJ; Park, SW | 1 |
| Amanatullah, DF; Bala, A; Goodman, SB; Huddleston, JI; Maloney, WJ | 1 |
| Barutçu, I; Çakal, B; Demir, GG; Guler, E; Guler, GB; Güneş, H; Ibisoglu, E; Karaca, İO; Kiliçaslan, F; Kizilirmak, F; Olgun, E; Omaygenç, MO; Savur, U | 1 |
| Bartlett, M; Bierle, DM; Daniels, PR; Mauck, KF; Saadiq, RA | 1 |
| Chang, S; Chang, Y; Lu, S; Sun, Q; Zhang, Y | 1 |
| Bini, SA; Cafri, G; Cheetham, CT; Chen, Y; Gould, MK; Khatod, M; Paxton, EW; Sluggett, J | 1 |
| Huang, RC; Yuan, C; Zhong, L | 1 |
| Whiting, DR | 1 |
| Amano, H; Ikeda, T; Okubo, R; Saito, D; Toda, M; Yabe, T | 1 |
| Jolobe, OMP | 1 |
| Anker, SD; Bello, NA; Di Tullio, MR; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Lee, SC; Levin, B; Lip, GYH; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JLP | 1 |
| Atakli, HD; Erdogan, M; Ince Yasinoglu, KN; Selcuk, HH; Senadim, S | 1 |
| Mahajan, K; Merwaha, R; Negi, P; Sharma, M | 1 |
| Han, FS; He, H; Ke, BB; Li, X; Li, Y; Zeng, YJ | 1 |
| Bhatt, DL; Cannon, CP; Ellis, SG; Gropper, S; Harper, R; Hohnloser, SH; Januzzi, JL; Kimura, T; Kleine, E; Lip, GYH; Maeng, M; Manassie, J; Merkely, B; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM; Zeymer, U | 1 |
| Ball, J; Kido, K | 1 |
| Bliden, KP; Gurbel, PA; Tantry, US; Venkataraman, G | 1 |
| Li, YH; Wan, YM; Wu, HM; Wu, XN; Xu, Y; Xu, ZY; Yang, JH; Yang, LH | 1 |
| Brodie, MM; Newman, JC; Rockey, DC; Smith, T | 1 |
| Hamaguchi, T; Inoue, S; Iwakawa, S; Tatsumi, A | 1 |
| Doan, G; Kaltenbach, T; Lin, D; McQuaid, K; Mou, S; Pham, C; Rouse, RV; Shergill, AK; Soetikno, RM; Somsouk, M | 1 |
| Ramli, A; Robertson, L; Yeoh, SE | 1 |
| Gaglia, MA | 1 |
| Lip, GYH; Proietti, M | 1 |
| Fleischman, AN; Goel, R; Higuera, C; Huang, R; Parvizi, J; Rothman, RH; Sterbis, E; Tan, T | 1 |
| Ding, Y; Lv, H; Sun, L; Tang, Y; Xu, Q; Yan, W | 1 |
| Consolo, F; D'Angelo, A; Della Valle, P; Pappalardo, F; Pozzi, L; Sferrazza, G; Slepian, MJ | 1 |
| Narayan, SW; Nishtala, PS | 1 |
| Camm, AJ; Correa, A; de Lusignan, S; Gatenby, P; Goldsmith, D; Hriskova, M; Jones, S; Kumar, S; McGovern, A | 1 |
| Alexander, JH; Bahit, MC; Granger, CB; Halvorsen, S; Huber, K; Jones, WS; Kopin, D; Lewis, BS; Lopes, RD; Parkhomenko, A; Sherwood, MW; Verheugt, FWA; Vinereanu, D; Wallentin, L; Wojdyla, DM | 1 |
| Battistella, M; Cameron, K; Farrell, A; Feldberg, J; Ma, J; Patel, P; Sivarajahkumar, S | 1 |
| Box, HN; Huo, MH; Shahrestani, S | 1 |
| James, S | 1 |
| Gibb, GJ; Laghari, FJ; Phinney, TA | 1 |
| Liu, X; Zhang, JJ | 1 |
| Balouch, MA; Chi, G; Jafarizade, M; Jamil, A; Jamil, U; Kalayci, A; Karimi, Z; Kumar, S; Marszalek, J; Pahlavani, S; Radulovic, M; Shaukat, H | 1 |
| Ahmed, FS; Akbik, F; Feske, SK; Givertz, MM; Izzy, S; Renault, S; Rubin, DB; Smallwood, JA; Sylvester, KW; Vaitkevicius, H | 1 |
| Atkins, D; Berenbom, LD; Cunnane, R; Dendi, R; Emert, MP; Lakkireddy, DR; Lavu, M; Parikh, V; Pimentel, R; Reddy, YM; Sheldon, SH | 1 |
| Attard, C; Huang, J; Ignjatovic, V; Monagle, P | 1 |
| Chen, HC; Liu, CY | 1 |
| Anoopkumar-Dukie, S; Badrick, T; Bernaitis, N; Boyce, ML; Davis, A; Zayac, A | 1 |
| Gibler, WB | 1 |
| Crowther, MA; Eikelboom, JW | 1 |
| Alexander, JH; Darius, H; Goodman, SG; Granger, CB; Liaw, D; Lopes, RD; Mehran, R; Vora, AN; Windecker, S | 1 |
| Accola, K; Armitage, J; Askew, J; Azar, H; Copeland, J; Douville, EC; Duncan, D; Ely, J; Fermin, L; Gerdisch, M; Graeve, A; Hagberg, R; Hughes, GC; Jamieson, WRE; Kapoor, D; Kong, B; Landvater, L; Levy, P; Martin, T; McGrath, M; Meyer, S; Nichols, D; Puskas, JD; Quinn, R; Rhenman, B; Trotter, T; Wait, M; Yanagawa, B; Ye, J | 1 |
| Huang, J; Liu, L; Tang, X; Zhang, X | 1 |
| Anker, SD; Buchsbaum, R; Di Tullio, MR; Estol, CJ; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Levin, B; Lip, GYH; Lok, DJ; Mann, DL; Mohr, JP; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JLP | 1 |
| Azboy, I; Groff, H; Parvizi, J | 1 |
| Anker, SD; Buchsbaum, R; Di Tullio, MR; Estol, C; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Lee, TC; Levin, B; Lip, GYH; Lok, DJ; Mann, DL; Mohr, JP; Nakanishi, K; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JLP; Ye, S | 1 |
| Belcaro, G; Cotellese, R; Dugall, M; Eggenhoffner, R; Giacomelli, L; Hosoi, M; Hu, S; Ledda, A; Peterzan, P; Riva, A; Togni, S | 1 |
| Akboğa, MK; Altay, S; Çekirdekçi, E; Çelik, A; Durukan, M; Elçik, D; Kılıç, S; Yayla, Ç; Zoghi, M | 1 |
| Gleason, TG; Kilic, A; Navid, F; Seese, L; Sultan, I | 1 |
| Chen, S; Chun, KRJ; Schmidt, B; Weise, FK | 1 |
| Kahlenberg, CA; Richardson, SS; Schairer, WW; Sculco, PK | 1 |
| Angelini, F; Cornara, S; Crimi, G; De Ferrari, GM; De Servi, S; Ferlini, M; Fortuni, F; Leonardi, S; Oltrona Visconti, L; Potenza, A; Somaschini, A | 1 |
| Carlsen, SM; Giannadakis, C; Gulati, AM; Gulati, S; Jakola, AS; Jensberg, H; Madsbu, MA; Salvesen, Ø; Solheim, O; Øie, LR | 1 |
| Ahn, JY; Choi, KD; Jung, HY; Jung, KW; Kim, DH; Kim, N; Lee, GH; Lee, JH; Na, HK; So, S; Song, HJ | 1 |
| Bawa, H; Dirschl, DR; Luu, HH; Weick, JW | 1 |
| Ekström, M; Hasselgren, M; Janson, P; Runer, T | 1 |
| Ben-Dor, I; Buchanan, KD; Gajanana, D; Iantorno, M; Okubagzi, PG; Pichard, AD; Rogers, T; Satler, LF; Thourani, VH; Torguson, R; Waksman, R; Weintraub, WS | 1 |
| Hsue, SS; Lin, LH; Lu, SY | 1 |
| Bassano, C; Greci, M; Nardi, P; Pellegrino, A; Russo, M; Ruvolo, G | 1 |
| Palareti, G; Poli, D | 1 |
| Fujimura, H; Hasuike, Y; Matsumura, T; Saito, T; Sakoda, S | 1 |
| Al-Akchar, M; Bhattarai, M; Chami, Y; Hudali, T; Robinson, R; Vogler, C | 1 |
| Berger, JS; Gislason, GH; Lamberts, M; Lock Hansen, M; Nissen Bonde, A; Olesen, JB; Pallisgaard, JL; Sindet-Pedersen, C; Staerk, L; Torp-Pedersen, C | 1 |
| Sugimoto, K | 1 |
| Fujimoto, K; Fujishiro, M; Haruma, K; Horimatsu, T; Hoteya, S; Iwakiri, R; Kaminishi, M; Katada, C; Kato, M; Kida, M; Kobayashi, K; Kodashima, S; Koike, K; Kutsumi, H; Matsuda, K; Matsuda, T; Miyata, H; Muto, M; Niikura, R; Oda, I; Ohtsuka, K; Ryozawa, S; Saito, Y; Shinozaki, T; Tajiri, H; Tanaka, K; Uemura, N; Yamada, A; Yamamoto, H | 1 |
| Chang, TY; Fan, PY; Hsieh, MY; Kuo, CF; Lee, CC; Li, IJ; Liu, SH; Tian, YC; Tu, KH; Weng, CH; Wu, HH; Yang, CW | 1 |
| Englund, E; Jensen, J; Själander, A; Wadell, D | 1 |
| Bravata, DM; Coffing, JM; Homoya, BJ; Kansagara, D; Murphy, L; Myers, J; Myers, LJ; Perkins, AJ; Quin, JA; Snow, K; Zhang, Y | 1 |
| Cipparrone, NE; Goldstein, JM; Goldstein, WM; Pardi, BM; Schwartz, BE; Shah, RR; Woon, CYL | 1 |
| Spence, JD | 1 |
| Gottschalk, MB; Pour, AE; Roberson, JR; Runner, RP; Staley, CA | 1 |
| Botteri, E; Bretthauer, M; de Lange, T; Frigstad, SO; Hoff, G; Holme, Ø; Randel, KR; Romstad, KMK | 1 |
| Bostrom, MP; Richardson, SS; Schairer, WW; Sculco, PK | 1 |
| Ahmad, A; Al-Khatib, SM; Blank, M; Coylewright, M; DiBattiste, P; Gersh, BJ; Granger, CB; Healey, JS; Hedrich, O; Hylek, EM; Kline-Rogers, E; Mendys, P; Mirro, MJ; Naccarelli, G; Patel, P; Peterson, ED; Pokorney, SD; Ruff, CT; Rutman, H; Stockbridge, N; Temple, R | 1 |
| Hiraoka, E; Miyagaki, A; Motomura, Y; Sato, J; Yamada, T | 1 |
| Al Alshaykh, HA; Al-Jazairi, AS; Alhalees, ZY; De Vol, EB; Di Salvo, G | 1 |
| Bhatt, DL; Brueckmann, M; Cannon, CP; Hohnloser, SH; Kimura, T; Kleine, E; Lip, GYH; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
| Fradkov, E; Goldowsky, A; Quiles, K; Williams, R | 1 |
| King, A; Levi, C; Madigan, J; Markus, HS; Norris, J | 1 |
| Fay, M; Medlinskiene, K; Petty, D | 1 |
| Anker, SD; Buchsbaum, R; Di Tullio, MR; Estol, C; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Lee, TC; Levin, B; Lip, GYH; Lok, DJ; Mann, DL; Mohr, JP; Mu, L; Nakanishi, K; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JLP; Ye, S | 1 |
| Almany, SL; Barnes, GD; Froehlich, JB; Gu, X; Haymart, B; Kaatz, S; Kline-Rogers, E; Kozlowski, JH; Krol, GD; Li, Y; Schaefer, JK; Sood, SL; Souphis, NM | 1 |
| Bai, DS; Jiang, GQ; Jin, SJ; Qian, JJ; Xia, BL; Ye, J; Zhang, C | 1 |
| Bertoletti, L; Cucherat, M; Grange, C; Jardel, S; Lega, JC; Mai, V; Provencher, S | 1 |
| Chen, AF; Foltz, C; Hansen, EN; Higuera, C; Huang, R; Parvizi, J; Sing, DC; Siqueira, M; Tan, TL | 1 |
| Amanatullah, DF; Bala, A; Burk, DR; Goodman, SB; Huddleston, JI; Maloney, WJ; Murasko, MJ | 1 |
| Cho, DJ; Jeong, SK; Jung, KH; Lee, CH | 1 |
| Dimmitt, SB; Ferner, RE; Floyd, CN | 1 |
| Ahmad, K; AlTurki, A; Ayala-Paredes, F; Birnie, D; Coutu, B; Crystal, E; Essebag, V; Healey, JS; Kavanagh, K; Krahn, AD; Leather, R; Leiria, TLL; Proietti, R; Rinne, C; Sapp, J; Seifer, C; Simpson, CS; Sturmer, M; Toal, S; Verma, A; Wells, GA | 1 |
| Burgin, WS; Di Tullio, MR; Dong, C; García-Rivera, EJ; Gardener, H; Goldberger, JJ; Gutierrez, CM; Koch, S; Romano, JG; Rose, DZ; Rundek, T; Sacco, RL; Sur, NB; Wang, K; Zevallos, JC | 1 |
| Agnelli, G; Becattini, C; Franco, L; Giustozzi, M; Vedovati, MC | 1 |
| Keskin, M; Orhan, AL | 1 |
| Attard, C; d'Udekem, Y; Huang, J; Ignjatovic, V; Monagle, P; Newall, F | 1 |
| Gremmel, T; Niessner, A; Sulzgruber, P | 1 |
| Çelik, A; Kılıç, S; Zoghi, M | 1 |
| Lundin, MS; Messenger, GG | 1 |
| Dahlen, JR; Hosokawa, K; Kaikita, K; Tsujita, K | 1 |
| Duggal, B; Khanra, D; Shrivastava, Y; Tiwari, P | 1 |
| Kowacs, PA; Macuco, ALB; Nascimento, MTMS; Rizelio, V; Sato, HK; Souza, RKM | 1 |
| Batko, BD; Courtney, PM; Edmiston, TA; Hannon, CP; Levine, BR; Manista, GC; Sexton, AC | 1 |
| Arachchillage, DRJ; Farag, M; Gorog, DA; Gue, Y; Lip, GYH; Spinthakis, N; Srinivasan, M; Wellsted, D | 1 |
| Asleh, R; Dawit, S; Freeman, WD; Li, Z; Matos, NL; O'Carroll, CB; Rabinstein, AA; Santos, CD | 1 |
| Dhingra, R; Fiedler, AG; Hermsen, JL; Smith, JW | 1 |
| Anker, SD; Buchsbaum, R; Di Tullio, MR; Estol, C; Freudenberger, RS; Graham, S; Homma, S; Labovitz, AJ; Lee, TC; Levin, B; Lip, GYH; Liu, Y; Lok, DJ; Mann, DL; Matsumoto, K; Mohr, JP; Nakanishi, K; Ponikowski, P; Pullicino, PM; Qian, M; Sacco, RL; Teerlink, JR; Thompson, JLP | 1 |
| Bungard, TJ; Butcher, K; Hodgson, M; Schultz, K; Wan, A | 1 |
| Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Jansky, P; Kleine, E; Lip, GYH; Nordaby, M; Oldgren, J; Seung, KB; Steg, PG; Ten Berg, JM; Zateyshchikov, DA | 1 |
| Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Maeng, M; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
| Ansari, M; Balaei, F; Farhadian, N; Moradi, S; Shahlaei, M | 1 |
| Liao, YWB; Wang, TKM | 1 |
| Kim, U; Lee, CH | 1 |
| Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Kimura, T; Lip, GYH; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
| Gupta, M; Hendey, GW; Loo, GT; Mower, WR; Probst, MA; Rodriguez, RM; Winkel, G | 1 |
| Bocchino, PP; D'Ascenzo, F; De Ferrari, GM; De Filippo, O; Imazio, M; Piroli, F; Scacciatella, P | 1 |
| Cheemalavagu, S; Knight, JS; McCoy, SS | 1 |
| Mastel, MS; van der Merwe, JM | 1 |
| Andrew, P; Farrington, B; Lawes, CM; Merriman, E; Millar, JS; Misur, P; Walker, M | 1 |
| Bhatt, DL; Peterson, BE | 1 |
| Barry, F; Brown, A; Bryg, RJ; Cheng, EM; Jackson, NJ; Li, N; Richards, A; Sanossian, N; Towfighi, A; Vickrey, BG | 1 |
| Berry, NC; Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Mauri, L; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
| Afzal, M; Davidson, E; Li, J; Nagaraj, TA; Snider, MJ; Weiss, R | 1 |
| Gustafsson, F | 1 |
| Blattnig, SR; Huff, JL; Norman, RB; Slaba, TC; Werneth, CM | 1 |
| Curtis, BR; Erdil, RM; Gilyard, SN; Knelson, EH; Leaf, RK; Malhotra, R; Puram, RV; Ranganathan, R; Van Beuningen, AM; Wallwork, R; Weber, BN | 1 |
| Gonzalez Della Valle, A; Liu, J; Memtsoudis, S; Nguyen, J; Salvati, EA; Shanaghan, KA; Sharrock, NE | 1 |
| Abdelbaky, M; Elefteriades, JA; Gryaznov, AA; Imran, M; Li, Y; Papanikolaou, D; Saeyeldin, A; Tanweer, M; Zafar, MA; Ziganshin, BA | 1 |
| Amarenco, P; Cabrejo, L; Charles, H; Guidoux, C; Hobeanu, C; Labreuche, J; Lavallée, PC; Martin-Bechet, A; Meseguer, E; Nighoghossian, N; Ong, E; Rigual, R | 1 |
| Hamada, K; Hori, S; Inoue, M; Ishikawa, H; Ishiyama, S; Kanzaki, H; Kawahara, Y; Kobayashi, S; Matsubara, M; Miyahara, K; Miyaike, J; Nishimura, M; Okada, H; Takahashi, S; Takenaka, R; Toyokawa, T; Tsuzuki, T; Yamasaki, Y; Yamauchi, K; Yunoki, N | 1 |
| Edward, JA; Gopal, RK | 1 |
| Zimmer, V | 1 |
| Fung, KP; Ge, B; Ho, NJ; Lau, CBS; Lee, VHL; Leung, PC; Lin, Z; Mok, RY; Wong, RSM; Yang, M; Zhang, Y; Zhang, Z; Zuo, Z | 1 |
| Oliashirazi, A; Saleh, U; Shahi, A; Singh, V; Tarabichi, S | 1 |
| Alexander, JH; Alings, M; De Caterina, R; Eikelboom, JW; Ezekowitz, MD; Granger, CB; Held, C; Hijazi, Z; Huber, K; Hylek, EM; Lindbäck, J; Lopes, RD; Oldgren, J; Siegbahn, A; Vinereanu, D; Wallentin, L | 1 |
| Ao, X; Dong, L; Dong, Y; Fu, B; Zhang, H | 1 |
| Almeida, AP; Ardito, RV; Atik, FA; Barreto, DO; Berwanger, O; Campos, VB; Cavalcante, MA; Cavalcanti, AB; D'Oliveira Vieira, R; Damiani, L; de Barros E Silva, PGM; de Lima, CEB; de Souza Neto, JD; Dos Santos, JRY; Farias, FR; Ferreira, JFM; Figueira, FAMS; Fonseca, FH; Guimarães, HP; Hoffmann-Filho, CR; Junior, RA; Kalil, PSA; Kojima, F; Lamprea, D; Laranjeira, L; Leiria, TLL; Liporace, IL; Lopes, RD; Magalhães, CC; Maldonado, JGA; Mesas, CE; Moisés, VA; Nakagawa, RH; Paiva, MSMO; Paixão, M; Patriota, R; Pavanello, R; Pinto, IM; Precoma, DB; Sampaio, BS; Sampaio, RO; Saraiva, JFK; Silveira, FS; Tarasoutchi, F; Zilli, AC | 1 |
| Kwon, O; Masic, D; Rech, MA | 1 |
| Abe, Y; Hagimoto, H; Inoue, K; Kawakita, M; Kokubun, H; Kubota, M; Makita, N; Matsuoka, T; Murata, S; Suzuki, I; Tohi, Y; Tsutsumi, N; Yamasaki, T | 1 |
| Ahlsson, A; Bergfeldt, L; Björck, S; Franzén, S; Friberg, L; Jeppsson, A; Nielsen, SJ; Taha, A | 1 |
| Alexander, JH; Carnicelli, AP; Connolly, SJ; Eikelboom, J; Giugliano, RP; Granger, CB; Hohnloser, SH; Hong, H; Hua, K; Lopes, RD; Morrow, DA; Oldgren, J; Patel, MR; Piccini, JP; Ruff, CT; Wallentin, L; Wojdyla, D | 1 |
| Anand, A; Charalambous, CP; Hughes, LD; Lum, J; Mahfoud, Z; Malik, RA | 1 |
| Greason, KL; Nei, SD; Scott, R; Wieruszewski, PM | 1 |
| Asch, FM; Ben-Dor, I; Bilfinger, T; Brizzio, ME; Buchbinder, M; Cocke, T; Comas, G; Craig, P; Garcia-Garcia, HM; Hahn, C; Hanna, N; Levitt, R; Mahoney, P; Moreno, R; Newton, J; Parikh, P; Rogers, T; Satler, LF; Shea, C; Shults, C; Torguson, R; Waksman, R; Weissman, G; Zhang, C | 1 |
| Burns, JC; Choueiter, NF; Crean, A; Dahdah, N; Dallaire, F; Friedman, K; Giglia, TM; Harahsheh, AS; Jain, S; Low, T; Mackie, AS; Mathew, M; McCrindle, BW; Mondal, T; Newburger, JW; Norozi, K; Osborne, J; Portman, MA; Raghuveer, G; Runeckles, K; Szmuszkovicz, JR; Yetman, AT | 1 |
| Gao, J; Huang, L; Wang, J | 1 |
| Bi, LJ; Jiang, W; Li, W; Song, CG; Wang, X; Yang, F; Zhao, JJ | 1 |
| Attard, C; Briody, J; Cordina, R; d'Udekem, Y; Hassan, EB; Ignjatovic, V; Mackay, MT; Monagle, PT; Rice, K; Simm, P | 1 |
| Lubert, AM; Redington, AN | 1 |
| Bhangoo, NS; Borton, ZM; Howard, PW; Quah, CS; Stephen, AB | 1 |
| Hanley, J; Hoather, TJ; Surianarayanan, V; Thompson, ER; Tingle, SJ; Wilson, CH | 1 |
| Jiang, T; Liu, C; Ma, T; Qin, H; Wu, R; Zhou, P | 1 |
| Arnold, M; Bonati, LH; Brehm, A; Bruni, N; Christensen, H; De Marchis, GM; Engelter, ST; Feil, K; Fischer, U; Gensicke, H; Gralla, J; Hamann, J; Jung, S; Kägi, G; Kahles, T; Kellert, L; Leib, SL; Luft, AR; Lyrer, P; Michel, P; Nedeltchev, K; Nolte, CH; Peters, N; Polymeris, AA; Psychogios, MN; Rosenbaum, S; Schaedelin, SA; Seiffge, D; Simonetti, BG; Sirimarco, G; Steiner, L; Stippich, C; Sztajzel, R; Traenka, C; Vehoff, J; von Rennenberg, R; Wegener, S | 1 |
| Bhatt, DL; Cannon, CP; Gabriel Steg, P; Halvorsen, S; Hohnloser, SH; Kimura, T; Kleine, E; Lip, GYH; Maeng, M; Miede, C; Nordaby, M; Oldgren, J; Peterson, BE; Ten Berg, JM; Zeymer, U | 1 |
| Asahina, Y; Fujisaki, J; Fujishiro, M; Hasatani, K; Hatta, W; Hayashi, Y; Hikichi, T; Hoteya, S; Iguchi, M; Inoue, T; Kiyotoki, S; Kobayashi, M; Kuribayashi, S; Mabe, K; Masamune, A; Matsumura, T; Michida, T; Mikami, T; Morita, Y; Nagami, Y; Nakamatsu, D; Narasaka, T; Nebiki, H; Nishikawa, J; Ohnita, K; Shiroma, S; Sugimoto, M; Sumiyoshi, T; Suzuki, H; Tomida, H; Tsuji, S; Tsuji, Y; Ueyama, H; Yabuuchi, Y; Yada, T; Yamaguchi, S; Yoshio, T | 1 |
| Kozieł, M; Lip, GY; Shantsila, E | 1 |
| Biyani, K; Guttendorf, R; Klaerner, G; Lee, A; Li, E; Mathur, V; Parsell, D; Shao, J; Stasiv, Y; Tabakman, S; Tsao, L; Wu, YS | 1 |
| Anwer, F; Chakraborty, R; Faiman, BM; Garcia, AVM; Khorana, AA; Khouri, J; Rybicki, L; Samaras, CJ; Valent, J | 1 |
| Ifuku, T; Nishiguchi, T | 1 |
| Baetz, B; Bennett, A; Campbell, PT; Desai, S; Eiswirth, C; Krim, SR; Pfeffer, M; Thai, S; Ventura, HO; Wever-Pinzon, J | 1 |
| Fleming, RP; Jennings, C; Johnson, SA; Jones, AE; Simon, K; Witt, DM; Young, E | 1 |
| Amano, T; Ikari, Y; Inohara, T; Ishii, H; Kohsaka, S; Nishida, H; Noma, S; Shimoji, K; Tanaka, N; Ueno, K; Yamaji, K; Yashima, F | 1 |
| Chacón-Aponte, AA; Durán-Vargas, EA; Janjua, T; Lozada-Martínez, ID; Moscote-Salazar, LR; Picón-Jaimes, YA | 1 |
| Bellora, M; Berne, JD; Borrego, R; Bugaev, N; Carrick, MM; Crandall, M; Cullinane, DC; Haan, JM; Hayward, TZ; Kerwin, AJ; Lightwine, KL; Lottenberg, L; Mukherjee, K; Noorbakhsh, MR; Nordham, KD; Ong, AW; Philps, FH; Ratnasekera, A; Rodriguez Mederos, D; Schroeppel, TJ; Taghavi, S; Tatum, DM; Yorkgitis, BK | 1 |
| Alonso-Escalante, JC; Machado, L; Tabar, KR; Thai, N; Tindall, R; Uemura, T | 1 |
| Craig, CM; Louie, PK; Manzur, MK; Qureshi, SA; Urakawa, H | 1 |
| Bonora, M; Consolo, F; D'Angelo, A; Della Valle, P; Marasi, A; Pappalardo, F; Pieri, M; Redaelli, A; Scandroglio, AM; Zangrillo, A | 1 |
| Mone, P; Santulli, G; Trimarco, B | 1 |
| Bree, KK; Dinney, CP; Hensley, PJ; Kamat, AM; Lobo, N; Navai, N; Nogueras-Gonzalez, GM | 1 |
| Bobba, PS; Brott, BC; Garner, JN; Hou, D; Hwang, PTJ; Jun, HW; Lynd, TO; Millican, RC; Sherwood, JA | 1 |
| Chisari, E; Ludwick, L; Parvizi, J; Shohat, N; Sutton, R | 1 |
| Arai, H; Tasaki, D; Yokoyama, K; Yoshizaki, T | 1 |
| Goel, R; Ludwick, L; Parvizi, J; Shohat, N | 1 |
| Iwai, S; Miwa, K; Nagashima, T | 1 |
| Balceniuk, MD; Doyle, AJ; Ellis, JL; Glocker, RJ; Kong, DS; Mix, D; Stoner, MC | 1 |
| Venketasubramanian, N | 1 |
| Curtis, JP; Daimee, UA; Doshi, SK; Du, C; Freeman, JV; Friedman, DJ; Gibson, D; Goldsweig, AM; Higgins, AY; Masoudi, FA; Minges, KE; Pereira, L; Price, MJ; Reddy, VY; Varosy, PD; Wang, Y | 1 |
| Alexander, JH; Aronson, R; Bahit, MC; Berwanger, O; Dombrowski, KE; Goodman, SG; Granger, CB; Halvorsen, S; Jordan, JD; Kolls, BJ; Li, Z; Lopes, RD; Mehran, R; Thomas, L; Vinereanu, D; Vora, AN; Windecker, S; Wojdyla, DM | 1 |
| Fu, X; Li, Y; Liu, P; Liu, S; Pan, Y | 1 |
| Dreyfuss, I; Frech, FS; Hernandez, L; Nouri, K; Shah, H | 1 |
| Fujisaki, J; Hirasawa, T; Horie, Y; Horiuchi, Y; Ishiyama, A; Maetani, I; Tsuchida, T; Yoshimizu, S; Yoshio, T | 1 |
| Aynardi, MC; Bonaddio, V; Kirchner, GJ; Koroneos, Z; Lorenz, FJ; Manto, KM; Martinazzi, BJ; Stauch, CM | 1 |
| Kozieł-Siołkowska, M; Lip, GY; Shantsila, E | 1 |
| Li, X; Shao, H; Wang, G; Xie, X; Zhang, X; Zhao, Y | 1 |
| Arghami, A; Crestanello, JA; Daly, RC; Dearani, JA; King, KS; Macielak, SA; Mazur, PK; Nei, SD; Schaff, HV; Viehman, JK | 1 |
| Alexandris-Souphis, T; Ali, MA; Barnes, GD; Errickson, J; Froehlich, JB; Gu, X; Haymart, B; Kaatz, S; Kline-Rogers, E; Kozlowski, JH; Krol, GD; Schaefer, JK; Shah, V; Sood, SL | 1 |
| Li, C; Liu, T; Shen, Q; Zhang, C; Zhang, Z; Zhu, H | 1 |
| Ge, T; Song, EJ; Tang, S; Wang, J; Zhou, W; Zhu, Z | 1 |
| Bagozzi, L; Bottigliengo, D; Bottio, T; Fabozzo, A; Fagan, D; Gerosa, G; Gregori, D; Mastro, FR; Pagnin, C; Tarzia, V; Tessari, C | 1 |
| Chu, Y; Ma, Q; Wang, C; Wang, H; Xu, Y; Yu, X | 1 |
| Ishii, M; Kaikita, K; Matsumoto, S; Matsuo, O; Miyamura, F; Morinaga, J; Nakamura, K; Tsujita, K | 1 |
| Alahdab, F; Alsaied, T; Feingold, B; Goldstein, BH; Hoskoppal, AK; Possner, M; Rathod, RH; Saraf, A; Van den Eynde, J; Veldtman, G | 1 |
| Lin, J; Lluri, G | 1 |
| Kroger, EW; Prentice, HA; Singh, G; Winston, BA | 1 |
| Christ, AB; Heckmann, ND; Lieberman, JR; Mayfield, CK; Oakes, DA; Piple, AS; Richardson, MK; Wang, JC | 1 |
| Alsbrook, DL; Bhatia, K; Carr, KH; Di Napoli, M; Divani, AA; Hinduja, A; Hosseini Farahabadi, M; Jafarli, A; Ladd, LM; McCullough, LD; Ortiz Garcia, JG; Sabbagh, SY; Saver, JL | 1 |
| Ahn, J; Hake, ME; Maturana, C; Perdue, AM; Schaffer, NE; Singh, M | 1 |
| Manunga, J; Pai, A; Pedersen, C; Skeik, N; Stanberry, L; Sullivan, TM | 1 |
| Ito, Y; Kimata, M; Koseki, T; Sekido, K; Tanaka, J; Yamada, S | 1 |
| Alizai, Q; Berndtson, AE; Bhogadi, SK; Black, G; Burruss, S; Campbell, M; Castanon, L; Colosimo, C; Costantini, T; Cullinane, D; Delgado, L; Ditillo, M; Dultz, L; Gomez, M; Hosseinpour, H; Joseph, B; Kerwin, A; Magnotti, LJ; Mederos, DR; Nelson, A; Skarupa, D; Spencer, AL; Stewart, C; Winfield, R | 1 |
| Barham, L; Chikumbanje, MM; Raza, S | 1 |
| Elkind, MSV; Kamel, H | 1 |
| Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF | 1 |
| Ben-Dor, I; Bhogal, S; Case, BC; Merdler, I; Reddy, PK; Rogers, T; Satler, LF; Waksman, R; Weissman, G; Zhang, C | 1 |
| Mills, RM | 1 |
| Bakos, I; Eiskjær, H; Gustafsson, F; Horváth-Puhó, E; Kristensen, SL; Larsson, JE; Løgstrup, BB; Mols, RE; Schjødt, I | 1 |
| Allocco, DJ; Coylewright, M; Freeman, JV; Gibson, DN; Holmes, DR; Hsu, JC; Kapadia, SR; Nair, DG; Piccini, JP; Price, MJ; Yeh, RW | 1 |
| Xu, ZH; Xu, ZQ; Zhang, N | 1 |
452 review(s) available for aspirin and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
Topics: Fibrinolytic Agents; Humans; Molecular Structure; Thrombosis | 2022 |
The role of platelets in glomerulonephritis.
Topics: Adenosine; Antidepressive Agents; Aspirin; Blood Platelets; Complement System Proteins; Endothelium; Glomerulonephritis; Hemostasis; Heparin; Histamine H1 Antagonists; Humans; Immunity; Immunoglobulins; Indomethacin; Kidney Diseases; Meclofenamic Acid; Mopidamol; Phagocytosis; Phenylbutazone; Platelet Aggregation; Prostaglandins; Pyrimidines; Sulfinpyrazone; Tranquilizing Agents; Warfarin | 1975 |
[Prevention of postoperative thrombosis].
Topics: Adult; Aspirin; Collagen; Coumarins; Dextrans; Epinephrine; Heparin; Humans; Platelet Aggregation; Postoperative Complications; Thrombosis | 1977 |
[Possibilities of drug-induced prevention of thrombosis with special reference to pre-, per- and postoperative time of treatment].
Topics: Aspirin; Coumarins; Dextrans; Heparin; Humans; Phlebography; Postoperative Complications; Thromboembolism; Time Factors | 1977 |
[Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
Topics: Aspirin; Coumarins; Dextrans; Dipyridamole; Heart Valve Prosthesis; Heparin; Humans; Lipids; Platelet Aggregation; Postoperative Care; Preoperative Care; Sulfinpyrazone; Thrombosis; Xanthinol Niacinate | 1977 |
Coagulation for cardiologists.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Aspirin; Blood Circulation; Blood Coagulation; Coumarins; Dextrans; Endothelium; Fibrinolysis; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Thrombosis; Venoms | 1978 |
[Thrombosis prevention and treatment in pediatrics].
Topics: Adolescent; Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Child; Child, Preschool; Coumarins; Dipyridamole; Disseminated Intravascular Coagulation; Heart Valve Prosthesis; Hemolytic-Uremic Syndrome; Heparin; Humans; Infant; Infant, Newborn; Intracranial Embolism and Thrombosis; Renal Veins; Shock, Septic; Streptokinase; Thrombosis | 1979 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; Heparin; Humans; Hydroxychloroquine; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Random Allocation; Thromboembolism; Thrombophlebitis | 1979 |
[Anticoagulation therapy in myocardial infarction (author's transl)].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; Leg; Myocardial Infarction; Platelet Aggregation; Recurrence; Thromboembolism; Thrombophlebitis | 1975 |
Vitamin K and the oral anticoagulant drugs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anticoagulants; Aspirin; Barbiturates; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Chemical Phenomena; Chemistry; Cholestyramine Resin; Disulfiram; Diuretics; Drug Interactions; Ethanol; Female; Humans; Infant, Newborn; Male; Phenylbutazone; Prothrombin; Receptors, Drug; Vitamin K; Warfarin | 1976 |
[Current trends in anticoagulant and thrombolytic therapy of thrombosis].
Topics: Anticoagulants; Aspergillus; Aspirin; Brinolase; Coumarins; Dipyridamole; Disseminated Intravascular Coagulation; Drug Evaluation; Fibrinolytic Agents; Heparin; Humans; Peptide Hydrolases; Streptokinase; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator | 1975 |
Anticoagulants in the treatment of cancer.
Topics: Ancrod; Animals; Anticoagulants; Aspirin; Coumarins; Factor XIII; Fibrinolytic Agents; Heparin; Humans; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Platelet Aggregation; Rabbits; Rats | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Sick sinus syndrome: strategies for reducing mortality.
Topics: Aspirin; Atrial Fibrillation; Combined Modality Therapy; Humans; Pacemaker, Artificial; Risk Factors; Sick Sinus Syndrome; Warfarin | 1992 |
[Isolated atrial fibrillation. The risk of embolism and its prevention].
Topics: 4-Hydroxycoumarins; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Indenes; Intracranial Embolism and Thrombosis; Male; Middle Aged; Recurrence; Risk Factors; Vitamin K; Warfarin | 1992 |
Antithrombotic therapy. Introduction.
Topics: Aspirin; Cerebrovascular Disorders; Humans; Myocardial Infarction; Thrombosis; Warfarin | 1992 |
Antithrombotic therapy in atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Embolism; Heart Diseases; Humans; Thrombolytic Therapy; Warfarin | 1992 |
Consultation section. Attitudes regarding the concomitant use of anti-coagulants with elective cataract surgery.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Cataract Extraction; Contraindications; Dipyridamole; Eye Hemorrhage; Humans; Platelet Aggregation; Thrombosis; Warfarin | 1992 |
Anticoagulant treatment of atrial fibrillation in the elderly.
Topics: Aged; Aspirin; Atrial Fibrillation; Contraindications; Humans; Risk Factors; Thromboembolism; Warfarin | 1992 |
Controversies in the management of cerebrovascular disease in older patients.
Topics: Adult; Aged; Angiography; Aspirin; Cerebrovascular Disorders; Endarterectomy; Evaluation Studies as Topic; Female; Geriatrics; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Risk Factors; Thrombolytic Therapy; Tomography, X-Ray Computed; Warfarin | 1992 |
Non-rheumatic atrial fibrillation: warfarin or aspirin for all?
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Warfarin | 1992 |
Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
Topics: Aged; Aspirin; Blood Coagulation; Coronary Thrombosis; Dietary Fats; Drug Therapy, Combination; Factor VII; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Risk Factors; Smoking; Warfarin | 1992 |
Anticoagulant therapy for atrial fibrillation. Recommendations from major studies.
Topics: Acute Disease; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chronic Disease; Electric Countershock; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Research Design; Rheumatic Heart Disease; Risk Factors; Warfarin | 1992 |
[Can coronary "restenosis" after percutaneous angioplasty be prevented?].
Topics: Adrenal Cortex Hormones; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Coronary Vasospasm; Fish Oils; Heparin; Humans; Platelet-Derived Growth Factor; Recurrence; Risk Factors; Warfarin | 1992 |
Prophylaxis for venous thromboembolism in total hip arthroplasty: a review.
Topics: Aspirin; Bandages; Dextrans; Dihydroergotamine; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Male; Postoperative Complications; Risk Factors; Thromboembolism; Warfarin | 1990 |
Management of transient ischaemic attacks.
Topics: Aspirin; Diagnosis, Differential; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; Warfarin | 1991 |
Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Topics: Aspirin; Dipyridamole; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone; Warfarin | 1991 |
How should results from completed studies influence ongoing clinical trials? The CAFA Study experience.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Therapy, Combination; Embolism; Humans; Meta-Analysis as Topic; Research Design; Warfarin | 1991 |
Stroke prevention in nonvalvular atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1991 |
[Drug therapy of acute coronary syndrome. Summary of a hearing arranged by the Norwegian Cardiologic Society and the Institute of pharmacotherapy].
Topics: Adrenergic beta-Antagonists; Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Heparin; Humans; Myocardial Infarction; Norway; Warfarin | 1990 |
The pharmacology of aspirin, heparin, coumarin, and thrombolytic agents. Implications for therapeutic use in cardiopulmonary disease.
Topics: Aspirin; Coumarins; Fibrinolytic Agents; Heparin; Humans; Thromboembolism; Thrombolytic Therapy; Thrombosis | 1991 |
Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease.
Topics: Aspirin; Coronary Disease; Drug Therapy, Combination; Humans; Incidence; Randomized Controlled Trials as Topic; Warfarin | 1990 |
Deep venous thrombosis and pulmonary emboli: etiology, medical treatment, and prophylaxis.
Topics: Ancrod; Aspirin; Dextrans; Fibrinolytic Agents; Heparin; Humans; Pulmonary Embolism; Risk Factors; Thrombophlebitis; Warfarin | 1989 |
Pharmacology of platelet-inhibitory drugs, anticoagulants, and thrombolytic agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Platelets; Calcium Channel Blockers; Epoprostenol; Fibrinolytic Agents; Hemostasis; Heparin; Humans; Phosphodiesterase Inhibitors; Streptokinase; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Warfarin | 1987 |
Warfarin metabolism and drug-drug interactions.
Topics: Anti-Bacterial Agents; Aspirin; Barbiturates; Cholestyramine Resin; Clofibrate; Diuretics; Drug Interactions; Ethanol; Humans; Rifampin; Vitamin K; Warfarin | 1987 |
The management of TIAs in 1986.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyridamole; Endarterectomy; Female; Heparin; Humans; Ischemic Attack, Transient; Male; Risk; Warfarin | 1986 |
Diagnosis and management of thromboembolic disease during pregnancy.
Topics: Acute Disease; Aspirin; Bacterial Infections; Female; Heparin; Humans; Ovary; Phlebography; Plethysmography, Impedance; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Renal Veins; Thromboembolism; Thrombophlebitis; Ultrasonography; Vena Cava, Inferior; Warfarin | 1985 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Cold Temperature; Dextrans; Dipyridamole; Disease Models, Animal; Dogs; Heparin; Humans; Placebos; Platelet Adhesiveness; Postoperative Care; Rabbits; Rats; Thromboembolism; Thrombosis; Warfarin | 1974 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status.
Topics: Anticoagulants; Aspirin; Blood Coagulation Factors; Coumarins; Dextrans; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Adhesiveness; Prostaglandins; Streptokinase; Thromboembolism | 1972 |
Prevention of thromboembolism after hip fracture.
Topics: Aged; Anticoagulants; Aspirin; Bandages; Coumarins; Dextrans; Exercise Therapy; Femoral Neck Fractures; Fibrinogen; Fractures, Bone; Hemorrhage; Hip Injuries; Humans; Iodine Isotopes; Physical Exertion; Postoperative Care; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Warfarin | 1973 |
Prevention and management of venous thrombosis and pulmonary embolism.
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Dipyridamole; Female; Heparin; Humans; Male; Methods; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1973 |
The prevention of thrombosis.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Coumarins; Dipyridamole; Heparin; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1974 |
Anticoagulants.
Topics: Anticoagulants; Aspirin; Blood Platelet Disorders; Dipyridamole; Enzyme Therapy; Factor IX; Factor VII; Factor X; Hemolysin Proteins; Hemorrhage; Heparin; Heparin Antagonists; Humans; Infusions, Parenteral; Phenindione; Protamines; Prothrombin; Streptokinase; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Venoms; Warfarin | 1974 |
[Mass spectrophotometric analysis of natural and medicinal materials].
Topics: Alkaloids; Amides; Amines; Amino Acids; Anti-Bacterial Agents; Aspirin; Barbiturates; Chlorophyll; Coumarins; Cresols; Flavonoids; Formaldehyde; Gases; Glycerol; Glycosides; Hydrocarbons; Methods; Molecular Weight; Peptides; Pesticides; Pharmaceutical Preparations; Phenols; Purines; Spectrophotometry; Steroids; Sulfonamides; Terpenes; Vitamins | 1969 |
Adjuvant drug therapy for decompression sickness: a review.
Topics: Adrenal Cortex Hormones; Animals; Anti-Arrhythmia Agents; Aspirin; Bronchodilator Agents; Coumarins; Cyproheptadine; Decompression Sickness; Dextrans; Diazepam; Dipyridamole; Fluid Therapy; Heparin; Humans; Indomethacin; Levodopa; Niacin; Vasoconstrictor Agents; Vasodilator Agents | 1982 |
Prophylaxis of postoperative deep vein thrombosis and pulmonary embolism.
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Clothing; Dextrans; Early Ambulation; Heparin; Hip Joint; Humans; Knee Joint; Physical Exertion; Postoperative Complications; Posture; Pulmonary Embolism; Risk; Thrombophlebitis; Warfarin | 1983 |
Cancer cell damage at the vascular endothelium.
Topics: Animals; Aspirin; Blood Vessels; Capillaries; Endothelium; Fibrin; Heparin; Lung Neoplasms; Microcirculation; Neoplasm Metastasis; Neoplasms; Platelet Aggregation; Warfarin | 1983 |
Hypothesis: polypharmacy. The treatment of thrombotic risk.
Topics: Aspirin; Blood Coagulation Tests; Clofibrate; Hemorrhage; Heparin; Humans; Thrombosis; Warfarin | 1980 |
[Specific measures in drug therapy in stroke. Anticoagulants, inhibitors of thrombocyte aggregation, initial barbiturate therapy].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Barbiturates; Carotid Arteries; Cerebral Infarction; Cerebrovascular Disorders; Coumarins; Heparin; Humans; Ischemic Attack, Transient; Platelet Aggregation | 1980 |
[Anticoagulants and pregnancy].
Topics: Anticoagulants; Aspirin; Blood Platelets; Coumarins; Disseminated Intravascular Coagulation; Female; Hemostasis; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Risk; Thromboembolism; Vitamin K | 1981 |
[Mucocutaneous lymph node syndrome or Kawasaki disease].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aspirin; Child; Child, Preschool; Female; Heart Diseases; Humans; Infant; Infant, Newborn; Japan; Lymphatic Diseases; Male; Middle Aged; Mucocutaneous Lymph Node Syndrome; Prednisone; United States; Warfarin | 1981 |
[Blood thinning in heart patients].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Coronary Disease; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Warfarin | 1995 |
A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
Topics: Aspirin; Bandages; Dextrans; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Postoperative Complications; Randomized Controlled Trials as Topic; Research Design; Thromboembolism; Warfarin | 1994 |
Pathogenesis and prophylaxis of postoperative thromboembolic disease in urological pelvic surgery.
Topics: Aspirin; Bandages; Dextrans; Heparin; Humans; Pelvis; Postoperative Complications; Thromboembolism; Time Factors; Urologic Diseases; Warfarin | 1995 |
Is aspirin safe for patients with heart failure?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Coronary Disease; Drug Interactions; Heart Failure; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 1995 |
Evolving concepts in the pathogenesis and treatment of arterial thrombosis.
Topics: Adult; Angioplasty; Animals; Anticoagulants; Antithrombin III; Aspirin; Blood Coagulation Tests; Coronary Thrombosis; Fibrinolysis; Heart Diseases; Humans; Middle Aged; Platelet Aggregation Inhibitors; Rabbits; Swine; Thrombin; Thrombolytic Therapy; Thrombosis; Time Factors; Warfarin | 1995 |
Warfarin or aspirin for non-rheumatic atrial fibrillation?
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Randomized Controlled Trials as Topic; Risk Factors; Warfarin | 1994 |
Stroke prevention.
Topics: Alcohol Drinking; Aspirin; Carotid Stenosis; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetes Complications; Exercise; Female; Heart Diseases; Humans; Hypertension; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Warfarin | 1995 |
[Bleeding complications in oral anticoagulant treatment].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Heart Valve Prosthesis; Hemorrhage; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; Thromboembolism; Warfarin | 1995 |
Adjunctive therapy in the management of patients with acute myocardial infarction.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Chemotherapy, Adjuvant; Heparin; Humans; Hypolipidemic Agents; Magnesium Sulfate; Morphine; Myocardial Infarction; Nitrates; Warfarin | 1995 |
[Antithrombotic treatment in chronic nonrheumatic atrial fibrillation].
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebral Infarction; Chronic Disease; Clinical Trials as Topic; Embolism; Fibrinolytic Agents; Humans; Middle Aged; Warfarin | 1993 |
Myocardial infarction in the 1990s. The importance of early thrombolytic therapy.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Heparin; Humans; Middle Aged; Myocardial Infarction; Nitroglycerin; Risk Factors; Streptokinase; Time Factors; Urokinase-Type Plasminogen Activator; Warfarin | 1995 |
Current status of thrombolysis in acute myocardial infarction. Part III. Optimalization of adjunctive therapy after thrombolytic therapy.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Chemotherapy, Adjuvant; Heparin; Humans; Myocardial Infarction; Thrombolytic Therapy; Warfarin | 1995 |
Medical treatment for stroke prevention.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Ischemic Attack, Transient; Myocardial Infarction; Recurrence; Risk Factors; Ticlopidine; Warfarin | 1994 |
Atherothrombotic insights into secondary prevention after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Combined Modality Therapy; Coronary Artery Disease; Coronary Circulation; Humans; Hyperlipidemias; Hypolipidemic Agents; Myocardial Infarction; Thrombolytic Therapy; Warfarin | 1993 |
Anticoagulation and the GP patient.
Topics: Algorithms; Aspirin; Blood Coagulation; Dose-Response Relationship, Drug; Drug Overdose; Family Practice; Hemostasis, Surgical; Heparin; Humans; Preoperative Care; Tooth Extraction; Warfarin | 1994 |
Atrial fibrillation and stroke. Three new studies, three remaining questions.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Risk Factors; Warfarin | 1994 |
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Topics: Aged; Analysis of Variance; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Warfarin | 1994 |
Preventing stroke in patients with nonrheumatic atrial fibrillation.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Male; Randomized Controlled Trials as Topic; Risk Factors; Warfarin | 1994 |
Role of antithrombotic therapy in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Humans; Thrombolytic Therapy; Warfarin | 1994 |
Arkansas Foundation for Medical Care report: preventing stroke in atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Middle Aged; Primary Prevention; Risk Factors; Societies, Medical; Warfarin | 1994 |
Current management of atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Electric Countershock; Electrocardiography; Heart Atria; Humans; Sinoatrial Node; Warfarin | 1994 |
Stroke prevention in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Humans; Randomized Controlled Trials as Topic; Warfarin | 1993 |
[The prevention of stroke in atrial fibrillation].
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Prospective Studies; Risk Factors; Warfarin | 1993 |
Prophylactic drug therapy in cerebrovascular disease.
Topics: Aspirin; Cerebrovascular Disorders; Humans; Ticlopidine; Warfarin | 1993 |
Modification of atherosclerosis by agents that do not lower cholesterol.
Topics: Animals; Antioxidants; Arteriosclerosis; Aspirin; Calcium Channel Blockers; Fibrinolytic Agents; Heparin; Humans; Probucol; Rabbits; Vitamins; Warfarin | 1993 |
Antiplatelet and anticoagulant therapy.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Transient; Male; Warfarin | 1993 |
Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Logistic Models; Postoperative Complications; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Warfarin | 1993 |
Heparin and warfarin therapy after acute myocardial infarction.
Topics: Aspirin; Cerebrovascular Disorders; Drug Therapy, Combination; Heparin; Humans; Injections, Intravenous; Myocardial Infarction; Thrombolytic Therapy; Warfarin | 1993 |
[The new frontier of antithrombotic therapy: ASA + warfarin, the ideal solution?].
Topics: Angina, Unstable; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Warfarin | 1995 |
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Fibrinolytic Agents; Humans; Risk Factors; Thromboembolism; Warfarin | 1996 |
[Emergency drug therapy of pulmonary thromboembolism].
Topics: Anticoagulants; Aspirin; Emergencies; Heparin; Humans; Plasminogen Activators; Platelet Aggregation Inhibitors; Pulmonary Embolism; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Warfarin | 1995 |
Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Catheter Ablation; Cerebrovascular Disorders; Diabetes Complications; Digoxin; Diltiazem; Embolism; Humans; Hypertension; Thromboembolism; Verapamil; Warfarin | 1996 |
Antiplatelet therapy with aspirin: from clinical trials to practice.
Topics: Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Endothelium, Vascular; Epoprostenol; Female; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 1995 |
Stroke prevention: the emerging strategies.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Decision Trees; Humans; Ischemic Attack, Transient; Public Health; Risk Factors; Warfarin | 1996 |
Asymptomatic carotid stenosis: surgery's the answer, but that's not the question.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arteriosclerosis; Aspirin; Brain Ischemia; Carotid Stenosis; Endarterectomy, Carotid; Humans; Warfarin | 1996 |
Atrial fibrillation, anticoagulation, and stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Warfarin | 1996 |
The risks and benefits of antithrombotic therapy in chronic atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Utilization; Humans; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Thromboembolism; Thrombolytic Therapy; Warfarin | 1996 |
Anticoagulation: risks and benefits in atrial fibrillation.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Embolism; Heart; Humans; Middle Aged; Risk Factors; Warfarin | 1996 |
[Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Embolism; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1996 |
An ounce of prevention. Toward preventing gastrointestinal endoscopic complications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Aspirin; Diagnostic Tests, Routine; Dipyridamole; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Humans; Hypoglycemic Agents; Insulin; Medical History Taking; Physical Examination; Platelet Aggregation Inhibitors; Ticlopidine; Vasodilator Agents; Warfarin | 1996 |
The role of coumadin and aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Echocardiography; Electric Countershock; Humans; Intracranial Embolism and Thrombosis; Warfarin | 1996 |
Warfarin and aspirin as thromboprophylaxis in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism; Thrombolytic Therapy; Warfarin | 1996 |
Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials.
Topics: Aspirin; Atrial Fibrillation; Humans; Randomized Controlled Trials as Topic; Risk Factors; Warfarin | 1996 |
Antithrombotic therapy in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Treatment Outcome; Warfarin | 1996 |
Anti-thrombotic therapy for non-rheumatic atrial fibrillation.
Topics: Aged; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Thromboembolism; Thrombolytic Therapy; Warfarin | 1996 |
[Anticoagulation in cardiology].
Topics: 4-Hydroxycoumarins; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cyclooxygenase Inhibitors; Heparin; Humans; Indenes; Myocardial Infarction; Postoperative Care; Vitamin K | 1995 |
Prevention of thromboembolism in patients with atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Echocardiography, Transesophageal; Electric Countershock; Humans; Platelet Aggregation Inhibitors; Risk; Thromboembolism; Warfarin | 1996 |
Therapeutic strategies for atrial fibrillation. The value of decision analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Decision Support Techniques; Electric Countershock; Humans; Markov Chains; Quinidine; Randomized Controlled Trials as Topic; Warfarin | 1996 |
Plaque rupture, thrombosis, and therapeutic implications.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Coronary Thrombosis; Disease Progression; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Lipids; Models, Biological; Platelet Aggregation Inhibitors; Rupture, Spontaneous; Thromboembolism; Thromboplastin; Warfarin | 1996 |
[Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cost-Benefit Analysis; Costs and Cost Analysis; Humans; Italy; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 1996 |
Safer anticoagulant therapy after heart valve replacement. Recommendations for less intense regimens.
Topics: Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Warfarin | 1997 |
[Treatment protocol of cerebral vascular accident].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Carotid Stenosis; Clinical Protocols; Endarterectomy; Humans; Platelet Aggregation Inhibitors; Warfarin | 1997 |
[Antithrombotic therapy of atrial fibrillation].
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Treatment Outcome; Vitamin K; Warfarin | 1996 |
Treating the non-electrical risks of atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Warfarin | 1997 |
Role of transesophageal echocardiography in the management of thromboembolic stroke.
Topics: Anticoagulants; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Echocardiography, Transesophageal; Heart Atria; Heart Diseases; Heart Septal Defects, Atrial; Heart Valve Diseases; Humans; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Medical History Taking; Physical Examination; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Referral and Consultation; Reproducibility of Results; Thrombosis; Treatment Outcome; Warfarin | 1997 |
Atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Electrocardiography; Humans; Warfarin | 1998 |
Current knowledge and significance of coronary artery ectasia: a chronologic review of the literature, recommendations for treatment, possible etiologies, and future considerations.
Topics: Anticoagulants; Aspirin; Calcium Channel Blockers; Coronary Disease; Coronary Vessels; Dilatation, Pathologic; Diltiazem; Humans; Incidence; Nitric Oxide; Platelet Aggregation Inhibitors; Warfarin | 1998 |
Prevention and treatment of stroke: where do we stand?
Topics: Aspirin; Cerebrovascular Disorders; Humans; Risk Factors; Warfarin | 1997 |
[Consensus antithrombotic prophylaxis of vascular incidents in patients with manifest atherosclerotic vascular diseases. Central Guidance Organization for Peer Review].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Coronary Disease; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 1998 |
Anticoagulants and antiplatelet agents in acute ischemic stroke.
Topics: Acute Disease; Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Platelet Aggregation Inhibitors; Prognosis; Ticlopidine; Warfarin | 1998 |
The efficacy and safety of combination warfarin and ASA therapy: a systematic review of the literature and update of guidelines.
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Safety; Thromboembolism; Treatment Outcome; Warfarin | 1998 |
Choice of antithrombotic therapy for stroke prevention in atrial fibrillation: warfarin, aspirin, or both?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Humans; Patient Selection; Risk; Warfarin | 1998 |
Prevention of stroke in patients with nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Male; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vitamin K; Warfarin | 1998 |
Prevention of thromboembolism in pregnancy.
Topics: Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism; Warfarin | 1998 |
Long-term antithrombotic treatment for atrial fibrillation.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Europe; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism; United States; Warfarin | 1998 |
Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Contraindications; Drug Therapy, Combination; Female; Heparin; Humans; Iloprost; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Recurrence; Thrombophilia; Thrombosis; Warfarin | 1998 |
Use of antithrombotic agents during pregnancy.
Topics: Administration, Oral; Antibodies, Antiphospholipid; Aspirin; Female; Fetus; Fibrinolytic Agents; Heart Valve Prosthesis Implantation; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism; Warfarin | 1998 |
Antithrombotic therapy in atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Cerebrovascular Disorders; Electric Countershock; Fibrinolytic Agents; Humans; Risk Factors; Warfarin | 1998 |
Antithrombotic therapy in peripheral arterial occlusive disease.
Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Endarterectomy, Carotid; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 1998 |
Atrial fibrillation: overview of therapeutic trials.
Topics: Age Factors; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Cardiac Pacing, Artificial; Clinical Trials as Topic; Electric Countershock; Female; Fibrinolytic Agents; Heart Rate; Humans; Male; Thrombolytic Therapy; Warfarin | 1998 |
Atrial fibrillation and anticoagulation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chemoprevention; Drug Combinations; Echocardiography, Transesophageal; Electric Countershock; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Warfarin | 1999 |
Long-term arterial patency after coronary reperfusion.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Humans; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Vascular Patency; Warfarin | 1999 |
Very low-intensity antithrombotic therapy in atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Warfarin | 1999 |
Preventing stroke in patients with atrial fibrillation.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Echocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Warfarin | 1999 |
[Frontiers in prevention of thromboembolism in nonvalvular atrial fibrillation].
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Female; Humans; Male; Thromboembolism; Warfarin | 1999 |
Atrial fibrillation, thromboembolism and antithrombotic therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Middle Aged; Thromboembolism; Warfarin | 1999 |
Contemporary issues in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Anticoagulants; Aspirin; Community Health Services; Coumarins; Heart Failure; Humans; Hypertension; Myocardial Ischemia; Stroke Volume; United States; Ventricular Dysfunction, Left | 1999 |
[Clinical study of the month. Prevention of cerebral vascular accidents in patients with atrial fibrillation].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Warfarin | 1999 |
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Hemorrhage; Humans; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Warfarin | 1999 |
Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Male; Risk Factors; Stroke; Thromboembolism; Warfarin | 1999 |
[Phospholipid antigens, thrombosis and repeated fetal death].
Topics: Abortion, Habitual; Adult; Antigens; Aspirin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Fetal Death; Heparin; Humans; Male; Middle Aged; Phospholipids; Pregnancy; Risk Assessment; Sensitivity and Specificity; Venous Thrombosis; Warfarin | 1996 |
Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Treatment Outcome; Warfarin | 2000 |
Clinical implication of antiembolic trials in atrial fibrillation and role of transesophageal echocardiography in atrial fibrillation.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Echocardiography, Transesophageal; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Warfarin | 2000 |
Ischemic stroke. Clinical strategies based on mechanisms and risk factors.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Fibrillation; Brain Ischemia; Endarterectomy, Carotid; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Recurrence; Risk Factors; Tissue Plasminogen Activator; Warfarin | 2000 |
[Aspirin and cerebral ischemic accidents].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Placebos; Platelet Aggregation Inhibitors; Primary Prevention; Recurrence; Risk Factors; Stroke; Ticlopidine; Vasodilator Agents; Warfarin | 2000 |
[Aspirin and antiphospholipid syndrome].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndrome; Arteriosclerosis; Aspirin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Fetal Death; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Primary Prevention; Recurrence; Risk Factors; Thrombosis; Warfarin | 2000 |
Anticoagulation therapy for atrial fibrillation and coronary disease.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Echocardiography; Humans; Stroke; Thromboembolism; Warfarin | 2000 |
[Antithrombotic therapy for stroke prevention in patients with atrial fibrillation].
Topics: Age Factors; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Diabetes Complications; Humans; Hypertension; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thromboembolism; Warfarin | 2000 |
A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Chemoprevention; Confidence Intervals; Female; Heparin, Low-Molecular-Weight; Humans; Linear Models; Male; Middle Aged; Placebos; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Pressure; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Safety; Survival Rate; Thromboembolism; Treatment Outcome; Venous Thrombosis; Warfarin | 2000 |
Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Bandages; Combined Modality Therapy; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Odds Ratio; Phlebography; Platelet Aggregation Inhibitors; Research Design; Thromboembolism; Treatment Outcome; Warfarin | 2000 |
Treatment of the antiphospholipid antibody syndrome: progress in the last five years?
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Aspirin; B-Lymphocytes; Hematopoietic Stem Cell Transplantation; Heparin; Humans; Immunization, Passive; Injections, Intravenous; Plasmapheresis; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2000 |
[Acetylsalicylic acid versus coumarin derivatives in atrial fibrillation].
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Coumarins; Dose-Response Relationship, Drug; Hemorrhage; Humans; International Normalized Ratio; Practice Guidelines as Topic; Risk Factors; Stroke | 2000 |
Anticoagulation and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Heart Failure; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Ventricular Dysfunction, Left; Warfarin | 2001 |
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Hemorrhage; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Warfarin | 2001 |
Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin | 2001 |
Atrial fibrillation and stroke : concepts and controversies.
Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Humans; Intracranial Embolism; Prevalence; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Thrombosis; Vitamin K; Warfarin | 2001 |
Anticoagulation and cataract surgery: a review of the current literature.
Topics: Aged; Anesthesia, Local; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cataract Extraction; Humans; Male; Middle Aged; Retrobulbar Hemorrhage; Warfarin | 2001 |
[Atrial fibrillation and thromboembolic events prevention. State of the art].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Controlled Clinical Trials as Topic; Electric Countershock; Fibrinolytic Agents; Humans; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Randomized Controlled Trials as Topic; Rheumatic Heart Disease; Risk Factors; Stroke; Thromboembolism; Warfarin | 2001 |
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; Postoperative Complications; Randomized Controlled Trials as Topic; Venous Thrombosis; Warfarin | 2001 |
[Antithrombotic therapy in cerebral infarction].
Topics: Acute-Phase Reaction; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Infarction; Heparin; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Warfarin | 2000 |
The epidemiology of the antiphospholipid syndrome: who is at risk?
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Blood Coagulation Tests; Case-Control Studies; Child; Child, Preschool; Clinical Trials as Topic; Cohort Studies; Female; Glycoproteins; Humans; Lupus Coagulation Inhibitor; Male; Mice; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Pregnancy; Prospective Studies; Prothrombin; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Thrombosis; Time Factors; Warfarin | 2001 |
New data in treatment of acute coronary syndromes.
Topics: Anticoagulants; Antithrombin III; Aspirin; Clinical Trials as Topic; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Oligosaccharides; Syndrome; Warfarin | 2001 |
Management of thrombosis in antiphospholipid antibody syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Hemorrhage; Heparin; Humans; Lupus Erythematosus, Systemic; Risk Factors; Thrombosis; Warfarin | 2001 |
Platelets and atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Blood Platelets; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Thromboembolism; Warfarin | 2001 |
[Thromboembolism in non-rheumatic atrial fibrillation].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Consensus Development Conferences as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electric Countershock; Female; Hemorrhage; Humans; Incidence; International Normalized Ratio; Isoenzymes; Isoindoles; Male; Membrane Proteins; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2001 |
Thromboembolic prophylaxis for patients with a fracture of the proximal femur.
Topics: Anticoagulants; Aspirin; Bandages; Dextrans; Femoral Fractures; Fibrinolytic Agents; Fracture Fixation, Internal; Heparin; Humans; Platelet Aggregation Inhibitors; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin | 2002 |
Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment.
Topics: Angina, Unstable; Aspirin; Clopidogrel; Coronary Thrombosis; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Ticlopidine; Time Factors; Warfarin | 2002 |
The use of antithrombotic drugs in older people.
Topics: Aged; Aspirin; Clopidogrel; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pulmonary Embolism; Secondary Prevention; Stroke; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin | 2002 |
Anticoagulation in patients with dilated cardiomyopathy and sinus rhythm: a critical literature review.
Topics: Anticoagulants; Aspirin; Cardiomyopathy, Dilated; Heart Failure; Humans; Incidence; Thromboembolism; Warfarin | 2002 |
Management of intermittent claudication: the importance of secondary prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Blood Pressure; Coronary Disease; Forecasting; Humans; Hypolipidemic Agents; Intermittent Claudication; Peripheral Vascular Diseases; Risk Factors; Smoking; Warfarin | 2002 |
[Acute gastrointestinal bleeding in patients with antithrombotic therapy].
Topics: Acute Disease; Anticoagulants; Aspirin; Coumarins; Deamino Arginine Vasopressin; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Hemostatics; Heparin; Humans; Thrombolytic Therapy; Ticlopidine | 2002 |
[Prevention of recurrence in cerebral infarction].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebral Infarction; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Warfarin | 2002 |
Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
Topics: Anticoagulants; Aspirin; Double-Blind Method; Humans; International Normalized Ratio; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Treatment Outcome; Warfarin | 2002 |
Antithrombotic agents: implications in dentistry.
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Dental Care; Drug Interactions; Embolism; Fibrinolytic Agents; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Venous Thrombosis; Warfarin | 2002 |
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
Topics: Adult; Anticoagulants; Aspirin; Heart Failure; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Treatment Outcome; Warfarin | 2002 |
Anticoagulation during pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Female; Heart Valve Prosthesis; Heparin; Humans; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Thromboembolism; Warfarin | 2002 |
Oral surgery in patients on anticoagulant therapy.
Topics: Analgesics; Anti-Infective Agents; Anticoagulants; Aspirin; Dental Care for Chronically Ill; Drug Interactions; Heparin; Humans; International Normalized Ratio; Oral Hemorrhage; Oral Surgical Procedures; Postoperative Hemorrhage; Warfarin | 2002 |
Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).
Topics: Acute Disease; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Monitoring; Heparin, Low-Molecular-Weight; Humans; Immunosuppressive Agents; Recurrence; Stroke; Thromboembolism; Warfarin | 2002 |
Management of patients taking anticoagulant, aspirin, non-steroidal anti-inflammatory and other anti-platelet drugs undergoing dermatological surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Loss, Surgical; Dermatologic Surgical Procedures; Humans; Platelet Aggregation Inhibitors; Warfarin | 2002 |
Bleeding risks of antithrombotic therapy.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Thrombosis; Warfarin | 2002 |
A benefit-risk assessment of agents used in the secondary prevention of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Aspirin; Clinical Trials as Topic; Clopidogrel; Coumarins; Dipyridamole; Humans; Hypertension; Hypoglycemic Agents; Insulin; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Smoking Cessation; Stroke; Ticlopidine; Warfarin | 2002 |
Prevention of thrombosis during pregnancy.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation Tests; Bone Diseases, Metabolic; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fetus; Fibrinolytic Agents; Gestational Age; Heart Valve Prosthesis; Heparin; Heparin, Low-Molecular-Weight; Humans; Injections, Subcutaneous; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Pulmonary Embolism; Risk Factors; Thrombocytopenia; Thrombophilia; Thrombophlebitis; Thrombosis; Time Factors; Warfarin | 2002 |
[Anticoagulants and antiplatelets].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 1994 |
[Aspirin in the primary prevention of the hypertensive patient].
Topics: Aspirin; Female; Humans; Hypertension; Male; Primary Prevention; Warfarin | 2002 |
[Antiphospholipid syndrome].
Topics: Adult; Aged; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans; Lupus Erythematosus, Systemic; Middle Aged; Platelet Aggregation Inhibitors; Pregnancy; Recurrence; Risk Factors; Thrombophlebitis; Warfarin | 2002 |
Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Confidence Intervals; Emergency Medicine; Evidence-Based Medicine; Female; Fibrinolytic Agents; Humans; Male; Meta-Analysis as Topic; Middle Aged; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Stroke; Thromboembolism; Warfarin | 2003 |
Ever decreasing circles: advances in antiplatelet therapy and anticoagulation.
Topics: Animals; Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome; Warfarin | 2003 |
[Anticoagulation and antiaggregation during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abruptio Placentae; Administration, Oral; Adult; Anticoagulants; Aspirin; Blood Coagulation Tests; Coumarins; Female; Fetal Death; Fetal Growth Retardation; Fibrinolytic Agents; Heart Valve Prosthesis; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Pulmonary Embolism; Risk Factors; Thrombocytopenia; Thrombophilia; Thrombosis; Warfarin | 2003 |
Oral anticoagulants in patients with coronary artery disease.
Topics: Anticoagulants; Aspirin; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; International Normalized Ratio; Myocardial Infarction; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2003 |
Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
Topics: Aspirin; Atrial Appendage; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Prodrugs; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2003 |
[Anti thrombotic therapy after coronary thrombolysis].
Topics: Anticoagulants; Aspirin; Coronary Restenosis; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Warfarin | 2003 |
[Anticoagulant, antiplatelet agents].
Topics: Anticoagulants; Aspirin; Death, Sudden, Cardiac; Dipyridamole; Drug Therapy, Combination; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ticlopidine; Warfarin | 2003 |
Lessons from the Stroke Prevention in Atrial Fibrillation trials.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Warfarin | 2003 |
Anticoagulants for prevention of ischemic stroke: current concepts.
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2003 |
What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Brachytherapy; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Endothelium, Vascular; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombosis; Ticlopidine; Warfarin | 2003 |
[Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
Topics: Anticoagulants; Aspirin; Cardiovascular Diseases; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Warfarin | 2003 |
Managing chronic atrial fibrillation: strategies to control symptoms and prevent embolism.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Echocardiography, Transesophageal; Embolism; Humans; Middle Aged; Practice Guidelines as Topic; Warfarin | 2003 |
Prevention of vascular events in patients with atrial fibrillation: evidence, guidelines, and practice.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Controlled Clinical Trials as Topic; Evidence-Based Medicine; Hemorrhage; Humans; Placebo Effect; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Factors; Stroke; Treatment Outcome; Vascular Diseases; Warfarin | 2003 |
Angina (unstable).
Topics: Angina, Unstable; Aspirin; Clopidogrel; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Warfarin | 2003 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Warfarin | 2003 |
Evidence-based management of thrombosis in the antiphospholipid antibody syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Evidence-Based Medicine; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Recurrence; Thrombosis; Warfarin | 2003 |
[Choice of antithrombotic therapy in atrial fibrillation, a daily challenge. No convincing evidence that warfarin is better than acetylsalicylic acid].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Treatment Outcome; Warfarin | 2003 |
[Indications for anticoagulant use in secondary prevention of strokes].
Topics: Anticoagulants; Antiphospholipid Syndrome; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Intracranial Arterial Diseases; Platelet Aggregation Inhibitors; Primary Prevention; Retrospective Studies; Risk; Risk Factors; Stroke; Time Factors; Warfarin | 2003 |
Aspirin and warfarin versus aspirin monotherapy after myocardial infarction.
Topics: Aspirin; Drug Interactions; Drug Therapy, Combination; Humans; Myocardial Infarction; Warfarin | 2003 |
Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.
Topics: Anticoagulants; Aspirin; Female; Gynecologic Surgical Procedures; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; Venous Thrombosis; Warfarin | 2003 |
Continuation of medically necessary aspirin and warfarin during cutaneous surgery.
Topics: Anticoagulants; Aspirin; Dermatologic Surgical Procedures; Hemorrhage; Humans; Intraoperative Complications; Risk Factors; Warfarin | 2003 |
Duration of venous thromboembolism prophylaxis after surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Drug Administration Schedule; Fondaparinux; Hemorrhage; Heparin; Humans; Polysaccharides; Postoperative Complications; Prevalence; Radiography; Risk Factors; Time Factors; Venous Thrombosis; Warfarin | 2003 |
Indications for the closure of patent foramen ovale.
Topics: Anticoagulants; Aspirin; Balloon Occlusion; Decision Making; Decompression Sickness; Heart Septal Defects, Atrial; Humans; Migraine Disorders; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Warfarin | 2004 |
Trials of newer approaches to anticoagulation in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thrombin; Ticlopidine; Warfarin | 2004 |
The role of warfarin and aspirin in secondary prevention of stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Septal Defects, Atrial; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2004 |
Anticoagulation for atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2004 |
The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Brain Diseases; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Postoperative Complications; Venous Thrombosis; Warfarin | 2004 |
Atrial fibrillation: should we target platelets or the coagulation pathway?
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin | 2003 |
Warfarin for atrial fibrillation: the end of an era?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2004 |
Potential interactions between exercise and drug therapy.
Topics: Absorption; Acetaminophen; Adrenergic beta-Antagonists; Aspirin; Digoxin; Doxycycline; Exercise; Humans; Insulin; Pharmacokinetics; Theophylline; Tissue Distribution; Verapamil; Warfarin | 2004 |
[Acute coronary syndrome in patients using acetylsalicylic acid or warfarin].
Topics: Acute Disease; Anticoagulants; Aspirin; Contraindications; Coronary Disease; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Syndrome; Warfarin | 2004 |
Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Primary Prevention; Randomized Controlled Trials as Topic; Stroke; Thrombolytic Therapy; Warfarin | 2004 |
[EBM of cerebral infarction: message from mega-studies].
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Ticlopidine; Warfarin | 2003 |
First-generation agents: aspirin, heparin and coumarins.
Topics: Aspirin; Cardiovascular Diseases; Coumarins; Fibrinolytic Agents; Heparin; Humans; Practice Guidelines as Topic; Treatment Outcome | 2004 |
Atrial fibrillation and cardioembolic stroke.
Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Comorbidity; Diagnostic Imaging; Fibrinolytic Agents; Humans; Hypertension; Intracranial Embolism; Middle Aged; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Ultrasonography; Warfarin | 2004 |
Antithrombotic therapies for stroke prevention in atrial fibrillation.
Topics: Aged; Ambulatory Care Facilities; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Cerebral Hemorrhage; Drug Design; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Self Care; Stroke; Thrombin; Warfarin | 2004 |
Should aspirin be continued in patients started on warfarin?
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Risk Assessment; Thromboembolism; Warfarin | 2004 |
Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Drug Therapy, Combination; Evidence-Based Medicine; Hemorrhage; Humans; International Normalized Ratio; Middle Aged; Risk Factors; Stroke; Warfarin | 2004 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2004 |
Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue?
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Humans; Intraoperative Care; Intraoperative Complications; Mohs Surgery; Practice Guidelines as Topic; Risk Assessment; Skin Neoplasms; Warfarin | 2004 |
ALS lessons learned from other neurological diseases. Stroke.
Topics: Amyotrophic Lateral Sclerosis; Anticoagulants; Aspirin; Humans; Intracranial Arteriovenous Malformations; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2004 |
Angina (unstable).
Topics: Angina, Unstable; Aspirin; Cardiac Catheterization; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Warfarin | 2003 |
Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Thrombosis; Treatment Outcome; Warfarin | 2005 |
Guidelines and alternatives for neuraxial anesthesia and venous thromboembolism prophylaxis in major orthopedic surgery.
Topics: Anesthesia, Conduction; Anesthesia, General; Aspirin; Factor Xa Inhibitors; Heparin; Humans; Orthopedic Procedures; Venous Thrombosis; Vitamin K; Warfarin | 2004 |
New possibilities in anticoagulant management of atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; Oligosaccharides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2004 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials.
Topics: Anticoagulants; Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Warfarin | 2004 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin | 2004 |
Antithrombotic therapy in hypertension: a Cochrane Systematic review.
Topics: Aspirin; Blood Pressure; Fibrinolytic Agents; Humans; Hypertension; Middle Aged; Thrombosis; Warfarin | 2005 |
[Antithrombotic therapy after myocardial infarction: arguments for the use of acetylsalicylic acid and coumarin derivatives].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coumarins; Death, Sudden, Cardiac; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Stroke; Ticlopidine | 2005 |
[Stroke and other thromboembolic complications of atrial fibrillation. Part VI. Choice of optimal approach and drugs for prevention of stroke].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Agents; Electric Countershock; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Warfarin | 2005 |
[Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke | 2005 |
Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Salicylates; Stroke; Ticlopidine; Warfarin | 2005 |
Heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiotonic Agents; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin | 2004 |
Management problems of spontaneous ICH.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Hospitalization; Humans; Magnetic Resonance Angiography; Medical Records; Myocardial Infarction; Neurosurgical Procedures; Patient Education as Topic; Patient Selection; Platelet Aggregation Inhibitors; Pulmonary Embolism; Referral and Consultation; Terminology as Topic; Venous Thrombosis; Warfarin | 2005 |
Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase III as Topic; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombin; Thromboembolism; Warfarin | 2005 |
Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Clopidogrel; Female; Fibrinolytic Agents; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2005 |
Atrial fibrillation and anticoagulation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Warfarin | 2004 |
Anticoagulation therapy in the antiphospholipid syndrome: recent advances.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Kidney Transplantation; Pregnancy; Pregnancy Complications; Recurrence; Thrombosis; Warfarin | 2005 |
Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.
Topics: Acute Disease; Anticoagulants; Aspirin; Coronary Disease; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Secondary Prevention; Syndrome; Warfarin | 2005 |
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome; Warfarin | 2006 |
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Comorbidity; Drug Combinations; Humans; Stroke; Treatment Outcome; Warfarin | 2006 |
Antiplatelet therapy in anticoagulated patients requiring coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stents; Thromboembolism; Ticlopidine; Warfarin | 2005 |
Antiphospholipid antibodies in young adults with stroke.
Topics: Adolescent; Adult; Age Factors; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Humans; Ischemic Attack, Transient; Lupus Coagulation Inhibitor; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stroke; Thrombosis; Warfarin | 2005 |
[Triplex antithrombotic therapy after coronary-stent implantation (that is absent from recommendation)].
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Coumarins; Drug Therapy, Combination; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Secondary Prevention; Stents; Ticlopidine | 2005 |
Pharmacological prevention of venous thromboembolism in medical patients at risk.
Topics: Anticoagulants; Aspirin; Bandages; Clinical Trials as Topic; Heparin; Humans; Intermittent Pneumatic Compression Devices; Risk Factors; Thromboembolism; Venous Thrombosis; Warfarin | 2005 |
[Preventing cerebrovascular accidents during atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Drug Therapy, Combination; Electric Countershock; Humans; Hypolipidemic Agents; Incidence; Injections, Subcutaneous; Middle Aged; Oligosaccharides; Placebos; Platelet Aggregation Inhibitors; Prevalence; Prodrugs; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Ticlopidine; Warfarin | 2005 |
Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Risk Factors; Warfarin | 2006 |
[Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Recurrence; Stroke; Ticlopidine; Warfarin | 2005 |
[Evidence-based medicine in antithrombotic therapy].
Topics: Aspirin; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Thrombolytic Therapy; Thrombosis; Ticlopidine; Warfarin | 2005 |
Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heparin; Humans; Male; Phlebography; Platelet Aggregation Inhibitors; Postoperative Complications; Pulmonary Embolism; Reoperation; Risk Assessment; Venous Thrombosis; Warfarin | 2006 |
Angina (unstable).
Topics: Angina, Unstable; Aspirin; Cardiac Catheterization; Clopidogrel; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Warfarin | 2005 |
Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Embolism; Factor V; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Multiple Myeloma; Mutation; Prothrombin; Risk Reduction Behavior; Treatment Outcome; Venous Thrombosis; Warfarin | 2006 |
Drug therapy for atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Calcium Channel Blockers; Electrocardiography; Humans; Long QT Syndrome; Middle Aged; Platelet Aggregation Inhibitors; Potassium Channel Blockers; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Tachycardia, Ventricular; Warfarin | 2006 |
[Atheromatosis of the thoracic aorta and risk of stroke].
Topics: Anticoagulants; Aorta, Thoracic; Aortic Diseases; Aspirin; Atherosclerosis; Clopidogrel; Controlled Clinical Trials as Topic; Echocardiography, Transesophageal; Fibrinolytic Agents; Follow-Up Studies; Humans; Hypolipidemic Agents; Meta-Analysis as Topic; Odds Ratio; Platelet Aggregation Inhibitors; Prognosis; Recurrence; Risk Factors; Stroke; Ticlopidine; Time Factors; Warfarin | 2006 |
Prevention of thrombosis with warfarin, aspirin, and mechanical methods.
Topics: Anticoagulants; Aspirin; Bandages; Combined Modality Therapy; Heparin, Low-Molecular-Weight; Intermittent Pneumatic Compression Devices; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Thromboembolism; Vena Cava Filters; Venous Thrombosis; Warfarin | 2005 |
Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Humans; Incidence; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke; Treatment Outcome; Warfarin | 2006 |
Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
Topics: Adrenal Cortex Hormones; Aging; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Drug Administration Schedule; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Randomized Controlled Trials as Topic; Risk Factors; Ulcer; Warfarin | 2006 |
When should prophylactic anticoagulation begin after a hip fracture?
Topics: Anticoagulants; Aspirin; Chemoprevention; Heparin; Hip Fractures; Humans; Risk Assessment; Risk Factors; Thromboembolism; Time Factors; Venous Thrombosis; Warfarin | 2006 |
The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Damage, Chronic; Case Management; Contraindications; Craniotomy; Decompression, Surgical; Diabetes Complications; Evidence-Based Medicine; Facial Neoplasms; Fibrin Tissue Adhesive; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Hypercholesterolemia; Hypertension; Infarction, Middle Cerebral Artery; International Normalized Ratio; Intracranial Embolism; Male; Melanoma; Middle Aged; Mohs Surgery; Paresis; Postoperative Complications; Preoperative Care; Prospective Studies; Retrospective Studies; Skin Neoplasms; Skin Transplantation; Thrombolytic Therapy; Warfarin | 2006 |
Optimising stroke prevention in non-valvular atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Electric Countershock; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Warfarin | 2006 |
Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications.
Topics: Anticoagulants; Aspirin; Heart Failure; Humans; Thromboembolism; Warfarin | 2007 |
Atrial fibrillation and stroke prevention.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Risk Factors; Stroke; Warfarin | 2006 |
[Primary and secondary prevention of cardiogenic cerebral embolism].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Heart Valve Diseases; Humans; Intracranial Embolism; Male; Platelet Aggregation Inhibitors; Risk; Warfarin | 2006 |
Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Heart Valve Prosthesis Implantation; Heparin; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Practice Guidelines as Topic; Risk Factors; Stents; Thrombosis; Ticlopidine; Venous Thrombosis; Warfarin | 2006 |
[Paradoxical brain embolism].
Topics: Arteriovenous Fistula; Aspirin; Blood Circulation; Embolism, Paradoxical; Heart Aneurysm; Heart Septal Defects; Heart Septal Defects, Atrial; Humans; Intracranial Embolism; Primary Prevention; Pulmonary Artery; Pulmonary Veins; Randomized Controlled Trials as Topic; Secondary Prevention; Ultrasonography, Doppler, Transcranial; Warfarin | 2006 |
[Antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation Disorders; Humans; Practice Guidelines as Topic; Reference Standards; Risk Factors; Stroke; Warfarin | 2006 |
[Application of anticoagulating medicine after surgery of cavity of pelvis and abdomen].
Topics: Abdomen; Anticoagulants; Aspirin; Heparin; Humans; Pelvis; Postoperative Complications; Venous Thrombosis; Warfarin | 2006 |
Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Risk Factors; Thromboembolism; Warfarin | 2007 |
[Thromboembolic diseases in pregnancy].
Topics: Algorithms; Anticoagulants; Aspirin; Contraindications; Coumarins; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2007 |
Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinolytic Agents; Geriatrics; Humans; Hypertension; Male; Risk Assessment; Stroke; Warfarin | 2007 |
Management of dental patients taking common hemostasis-altering medications.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Dental Care for Chronically Ill; Humans; International Normalized Ratio; Mouthwashes; Prothrombin Time; Tranexamic Acid; Warfarin | 2007 |
Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome; Ticlopidine; Warfarin | 2007 |
WITHDRAWN: Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.
Topics: Anticoagulants; Aspirin; Female; Gynecologic Surgical Procedures; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; Venous Thrombosis; Warfarin | 2007 |
Anticoagulation for pregnant patients with mechanical heart valves.
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Drug Administration Schedule; Female; Fetal Diseases; Heart Valve Prosthesis; Heparin; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Assessment; Thromboembolism; Warfarin | 2007 |
Assessing stroke risk in patients with AF.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Humans; Risk Assessment; Stroke; Warfarin | 2007 |
[The antiphospholipid syndrome, an update].
Topics: Abortion, Spontaneous; Acenocoumarol; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enzyme-Linked Immunosorbent Assay; Female; Fibrinolytic Agents; Heparin; Humans; Lupus Coagulation Inhibitor; Male; Platelet Aggregation Inhibitors; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombophilia; Thrombosis; Warfarin | 2007 |
Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Pyridines; Stents; Vitamin K; Warfarin | 2007 |
Atrial fibrillation and stroke prevention.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2007 |
[Brief report: stroke in multiple myeloma patient treated with thalidomide].
Topics: Aged; Anticoagulants; Aspirin; Embolism, Paradoxical; Foramen Ovale, Patent; Humans; Male; Multiple Myeloma; Neuroprotective Agents; Risk; Stockings, Compression; Stroke; Thalidomide; Venous Thrombosis; Warfarin | 2007 |
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2007 |
A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Humans; Postoperative Hemorrhage; Skin Diseases; Thrombosis; Warfarin | 2008 |
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Topics: Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Premedication; Risk Assessment; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin | 2008 |
Adverse drug interactions involving common prescription and over-the-counter analgesic agents.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Interactions; Ethanol; Health Status; Humans; Lithium Compounds; Methotrexate; Nonprescription Drugs; Selective Serotonin Reuptake Inhibitors; Warfarin | 2007 |
Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Embolism; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Warfarin; Young Adult | 2008 |
[Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation. Results of the BAFTA trial].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Middle Aged; Myocardial Ischemia; Randomized Controlled Trials as Topic; Warfarin | 2008 |
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Topics: Anesthesia, Conduction; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Azetidines; Benzylamines; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin | 2008 |
[Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Thrombosis; Humans; Infant; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Warfarin | 2008 |
Practical aspects of treatment with drotrecogin alfa (activated).
Topics: Adult; Aged; Anti-Infective Agents; APACHE; Aspirin; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Disseminated Intravascular Coagulation; Drug Administration Schedule; Drug Interactions; European Union; Heparin; Humans; IgA Vasculitis; Meningitis; Meningococcal Infections; Multiple Organ Failure; Pancreatitis; Practice Guidelines as Topic; Protein C; Recombinant Proteins; Renal Replacement Therapy; Risk Assessment; Sepsis; Survival Rate; Thrombocytopenia; United States; Warfarin | 2007 |
[Antithrombotic therapy after percutanous coronary intervention with stenting].
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine; Time Factors; Warfarin | 2008 |
Anticoagulants, antiplatelets, and statins in heart failure.
Topics: Anticoagulants; Aspirin; Drug Administration Schedule; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Warfarin | 2008 |
Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Intracranial Hemorrhages; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Stroke; Warfarin | 2008 |
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Topics: Anticoagulants; Aprotinin; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Evidence-Based Medicine; Heart Valve Prosthesis Implantation; Hemostasis, Surgical; Hemostatics; Humans; Monitoring, Intraoperative; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Ticlopidine; Tranexamic Acid; Warfarin | 2008 |
What do we know about anticoagulation in patients with heart failure?
Topics: Anticoagulants; Aspirin; Heart Failure; Humans; Platelet Aggregation Inhibitors; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin | 2008 |
Should patients on long-term warfarin take aspirin for heart disease?
Topics: Anticoagulants; Aspirin; Drug Synergism; Heart Diseases; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Time Factors; Warfarin | 2008 |
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Drug Design; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Safety; Thrombin; Thrombosis; Warfarin | 2008 |
Antiplatelet agents and arterial thrombosis.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Primary Prevention; Randomized Controlled Trials as Topic; Thrombosis; Ticlopidine; Warfarin | 2008 |
Chronic antithrombotic therapy in post-myocardial infarction patients.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombolytic Therapy; Thrombosis; Ticlopidine; Vitamin K; Warfarin | 2008 |
The effect of anticoagulant pharmacotherapy on fracture healing.
Topics: Animals; Anticoagulants; Aspirin; Bone and Bones; Bone Remodeling; Disease Models, Animal; Fondaparinux; Fracture Healing; Heparin; Humans; Polysaccharides; Warfarin | 2008 |
Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine; Vascular Diseases; Warfarin | 2008 |
Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Coagulation; Drugs, Generic; Drugs, Investigational; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Prothrombin; Thrombin; Thrombosis; Treatment Outcome; Warfarin | 2008 |
Antithrombotic treatment in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Stroke; Vitamin K; Warfarin | 2008 |
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Revascularization; Postoperative Care; Stents; Thrombosis; Ticlopidine; Warfarin | 2008 |
Transient ischemic attack: risk stratification and treatment.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prognosis; Risk Assessment; Stroke; Warfarin | 2008 |
Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice.
Topics: Aspirin; Atrial Fibrillation; Family Practice; Humans; Premedication; Thrombosis; Warfarin | 2008 |
Approach to and management of the acute stroke patient with atrial fibrillation: a literature review.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Atrial Fibrillation; Factor VIIa; Heparin; Humans; Intracranial Hemorrhages; Plasma; Recombinant Proteins; Stroke; Thrombolytic Therapy; Vitamin K; Warfarin | 2008 |
Update on antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation; Complement System Proteins; Humans; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2008 |
[Ischemic stroke with antiphospholipid antibody].
Topics: Age of Onset; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Clinical Trials as Topic; Female; Heparin; Humans; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Stroke; Warfarin | 2008 |
Management of surgical patients receiving anticoagulation and antiplatelet agents.
Topics: Anticoagulants; Aspirin; Emergency Treatment; Heparin; Humans; Intraoperative Care; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Risk Assessment; Risk Factors; Thrombosis; Warfarin | 2008 |
Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Flutter; Female; Fibrinolytic Agents; Humans; Male; Warfarin | 2009 |
Pharmacogenetics in hemostasis: friend or foe?
Topics: Anticoagulants; Aspirin; Blood Coagulation Disorders; Drug Therapy; Environmental Monitoring; Hemostasis; Humans; Pharmacogenetics; Platelet Aggregation; Platelet Aggregation Inhibitors; Warfarin | 2009 |
Management of antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications, Hematologic; Venous Thrombosis; Warfarin | 2009 |
Systolic heart failure: a prothrombotic state.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Fibrinolytic Agents; Heart Failure, Systolic; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Pulmonary Embolism; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Thromboembolism; Warfarin | 2009 |
Deep vein thrombosis: risk factors and prevention in surgical patients.
Topics: Anticoagulants; Aspirin; Awareness; Clinical Competence; Cyclooxygenase Inhibitors; Dextrans; Dihydroergotamine; Fibrinolytic Agents; Heparin; Humans; Nigeria; Postoperative Complications; Risk Factors; Vasoconstrictor Agents; Venous Thrombosis; Warfarin | 2009 |
Management of nonvalvular atrial fibrillation: a comprehensive approach.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thromboembolism; Warfarin | 2009 |
[Management of antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Heparin; Humans; Lupus Coagulation Inhibitor; Male; Pregnancy; Pregnancy Complications; Warfarin | 2009 |
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Thromboembolism; Treatment Outcome; Warfarin | 2010 |
Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Cost-Benefit Analysis; Dabigatran; Humans; Platelet Aggregation Inhibitors; Pyridines; Stroke; Ticlopidine; Warfarin | 2010 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Blood Transfusion; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Lupus Erythematosus, Systemic; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Thrombocytopenia; Thrombophilia; Venous Thromboembolism; Warfarin | 2009 |
Periprocedural antithrombotic management: a review of the literature and practical approach for the hospitalist physician.
Topics: Aspirin; Blood Loss, Surgical; Drug-Eluting Stents; Fibrinolytic Agents; Heparin; Hospitalists; Humans; Preoperative Period; Risk Factors; Thromboembolism; Warfarin | 2009 |
A guide to anticoagulation and endocarditis prophylaxis during cutaneous surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Aspirin; Calcium Channel Blockers; Clopidogrel; Dipyridamole; Endocarditis, Bacterial; Humans; International Normalized Ratio; Perioperative Care; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Skin Diseases; Ticlopidine; Warfarin | 2010 |
Management of atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Electrocardiography; Fibrinolytic Agents; Hospitalization; Humans; Pacemaker, Artificial; Randomized Controlled Trials as Topic; Warfarin | 2009 |
Antithrombotic treatment for the primary prevention of stroke in patients with non valvular atrial fibrillation: a reappraisal of the evidence and network meta analysis.
Topics: Aspirin; Atrial Fibrillation; Bayes Theorem; Fibrinolytic Agents; Humans; Risk Factors; Stroke; Warfarin | 2010 |
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.
Topics: Aspirin; Drug Evaluation; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Randomized Controlled Trials as Topic; Retinal Vein Occlusion; Ticlopidine; Treatment Outcome; Visual Acuity; Warfarin | 2010 |
Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Anticoagulants; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Fondaparinux; Guidelines as Topic; Hematoma, Epidural, Spinal; Heparin; Hirudins; Humans; Polysaccharides; Pregnancy; Ticlopidine; Warfarin | 2010 |
DVT prophylaxis in total joint reconstruction.
Topics: Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Drug Interactions; Humans; International Normalized Ratio; Postoperative Complications; Practice Guidelines as Topic; Venous Thrombosis; Warfarin | 2010 |
VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Topics: Anticoagulants; Aspirin; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Neoplasms; Polysaccharides; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin | 2010 |
Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
Topics: Animals; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase II as Topic; Factor Xa Inhibitors; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Thrombin; Warfarin | 2011 |
Issues in assessing and reducing the risk for venous thromboembolism.
Topics: Anticoagulants; Aspirin; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Polysaccharides; Risk Assessment; Risk Factors; Risk Reduction Behavior; Thrombocytopenia; Ultrasonography; United States; Venous Thromboembolism; Warfarin | 2010 |
New antithrombotic agents--insights from clinical trials.
Topics: Adenosine; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine | 2010 |
Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Immunologic Factors; Lenalidomide; Multiple Myeloma; Thalidomide; Thromboembolism; Warfarin | 2011 |
[Antithrombotic therapy in patients with prosthetic heart valves].
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Drug Monitoring; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Prognosis; Thromboembolism; Ticlopidine; Warfarin | 2010 |
Multimodal prophylaxis for venous thromboembolic disease after total hip and knee arthroplasty: current perspectives.
Topics: Anesthesia, Epidural; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Venous Thromboembolism; Warfarin | 2010 |
Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Patient Selection; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2011 |
Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.
Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Triple therapy in hospitalized patients: facts and controversies.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hospitalization; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine; Warfarin | 2011 |
The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk; Ticlopidine; Warfarin | 2012 |
Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why?
Topics: Anticoagulants; Aspirin; Combined Modality Therapy; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Treatment Outcome; Warfarin | 2011 |
Post-traumatic interemispheric subdural hematoma: report of two cases and review of the literature.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Aspirin; Female; Hematoma, Subdural, Intracranial; Humans; Platelet Aggregation Inhibitors; Radiography; Warfarin | 2011 |
Triple therapy: boon or bane for high-risk CV patients?
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Patient Selection; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine; Warfarin | 2011 |
Incidental atrial fibrillation and its management.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Heart Rate; Humans; Risk Assessment; Stroke; Warfarin | 2011 |
Rare case of Takayasu's arteritis associated with Crohn's disease.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Aspirin; Coronary Artery Bypass; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Humans; Magnetic Resonance Angiography; Prednisolone; Takayasu Arteritis; Tomography, X-Ray Computed; Warfarin; Young Adult | 2011 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Atrial fibrillation.
Topics: Administration, Oral; Algorithms; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiovascular Agents; Catheter Ablation; Decision Trees; Electric Countershock; Humans; Patient-Centered Care; Risk Factors; Stroke; Warfarin | 2012 |
Endovascular treatment of intracranial stenosis.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Brain Ischemia; Cerebral Arteries; Constriction, Pathologic; Endovascular Procedures; Fibrinolytic Agents; Humans; Intracranial Arteriosclerosis; Platelet Aggregation Inhibitors; Prognosis; Secondary Prevention; Stents; Treatment Outcome; Warfarin | 2011 |
Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention.
Topics: Acute Disease; Anticoagulants; Aspirin; Fibrinolytic Agents; Graft Rejection; Heparin; Humans; Incidence; Inflammation; Pancreas Transplantation; Postoperative Hemorrhage; Risk Factors; Thrombectomy; Thrombosis; Warfarin | 2012 |
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Confidence Intervals; Evidence-Based Medicine; Female; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Thrombosis; Treatment Outcome; Warfarin | 2012 |
Apixaban for the prevention of stroke in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Stroke; Warfarin | 2012 |
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Brain Ischemia; Clopidogrel; Female; Humans; Incidence; Male; Oligosaccharides; Primary Prevention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
Optimal thromboprophylaxis following bioprosthetic aortic valve replacement: still a matter of debate?
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prosthesis Design; Risk Assessment; Risk Factors; Thrombosis; Treatment Outcome; Warfarin | 2012 |
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
Topics: Aspirin; Confidence Intervals; Europe; Fibrinolytic Agents; Heart Failure; Humans; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Thromboembolism; Warfarin | 2012 |
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options.
Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombolytic Therapy; Ticlopidine; Warfarin | 2012 |
Anticoagulation versus placebo for heart failure in sinus rhythm.
Topics: Administration, Oral; Anticoagulants; Aspirin; Chronic Disease; Heart Failure; Heart Rate; Humans; Placebo Effect; Randomized Controlled Trials as Topic; Thromboembolism; Warfarin | 2012 |
Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Warfarin | 2012 |
The management of antithrombotic medication in skin surgery.
Topics: Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Dermatologic Surgical Procedures; Fibrinolytic Agents; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Risk Assessment; Rivaroxaban; Thienopyridines; Thiophenes; Vitamin K; Warfarin | 2012 |
Thalidomide thromboprophylaxis in multiple myeloma: a review of current evidence.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Multiple Myeloma; Thalidomide; Venous Thromboembolism; Warfarin | 2012 |
Antithrombotic therapy.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation Disorders; Cat Diseases; Cats; Clopidogrel; Dog Diseases; Dogs; Heparin; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 2012 |
Antiphospholipid antibody syndrome.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Humans; Hydroxychloroquine; Retinal Artery Occlusion; Retinal Vein Occlusion; Warfarin | 2012 |
[Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive].
Topics: Anticoagulants; Aspirin; Hemorrhage; Humans; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Venous Thromboembolism; Warfarin | 2013 |
Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
Topics: Anticoagulants; Aspirin; Female; Heart Failure; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2013 |
[Novel agents for antithrombotic therapy in cardiology].
Topics: Adenosine; Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thrombolytic Therapy; Ticagrelor; Ticlopidine | 2012 |
Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.
Topics: Anticoagulants; Aspirin; Chi-Square Distribution; Female; Fibrinolytic Agents; Heart Failure; Humans; Intracranial Hemorrhages; Male; Middle Aged; Patient Selection; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2013 |
Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.
Topics: Administration, Oral; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Fibrinolytic Agents; Heart Failure; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism; Warfarin | 2013 |
[Secondary prevention of ischemic stroke in children].
Topics: Anticoagulants; Aspirin; Child; Heparin; Heparin, Low-Molecular-Weight; Humans; Secondary Prevention; Stroke; Warfarin | 2012 |
Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Meta-Analysis as Topic; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Warfarin | 2013 |
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
Topics: Adenosine; Aspirin; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2013 |
Thrombosis and embolism in pediatric cardiomyopathy.
Topics: Anticoagulants; Aspirin; Cardiomyopathy, Dilated; Cardiomyopathy, Restrictive; Child; Disease Management; Embolism; Humans; Risk Factors; Thrombosis; Ventricular Dysfunction, Left; Ventricular Function, Left; Warfarin | 2013 |
Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?
Topics: Anticoagulants; Aspirin; Humans; Occult Blood; Reproducibility of Results; Warfarin | 2013 |
Apixaban: a review of its use for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Embolism; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Stroke; Warfarin | 2013 |
Thromboprophylaxis in patients with pelvic and acetabular fractures: A short review and recommendations.
Topics: Acetabulum; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Fondaparinux; Fractures, Bone; Heparin; Humans; Mass Screening; Morpholines; Multiple Trauma; Pelvis; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Vena Cava Filters; Venous Thromboembolism | 2013 |
Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
Topics: Anticoagulants; Aspirin; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pulmonary Embolism; Randomized Controlled Trials as Topic; Secondary Prevention; Venous Thrombosis; Vitamin K; Warfarin | 2013 |
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Data Interpretation, Statistical; Databases, Bibliographic; Double-Blind Method; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2013 |
Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Drug Administration Schedule; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Warfarin | 2013 |
Antithrombotic therapy for pregnant women.
Topics: Aspirin; Contraindications; Cooperative Behavior; Dose-Response Relationship, Drug; Drug Labeling; Female; Fibrinolytic Agents; Guideline Adherence; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Interdisciplinary Communication; Japan; Pregnancy; Pregnancy Complications, Hematologic; Stroke; Teratogenesis; Thromboembolism; Warfarin | 2013 |
Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?
Topics: Administration, Oral; Aged; Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Meta-Analysis as Topic; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Failure; Reoperation; Thrombosis; Time Factors; Treatment Outcome; Warfarin | 2013 |
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies.
Topics: Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Dabigatran; Emergencies; Enoxaparin; Fondaparinux; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Platelet Transfusion; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Ticlopidine; Warfarin | 2013 |
The challenge of stroke prevention with intracranial arterial stenosis.
Topics: Aspirin; Carotid Artery, Common; Carotid Stenosis; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Intracranial Arteriosclerosis; Male; Platelet Aggregation Inhibitors; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin | 2013 |
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2014 |
Update on pharmacologic therapy for pulmonary embolism.
Topics: Animals; Anticoagulants; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pulmonary Embolism; Warfarin | 2014 |
Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
Topics: Anticoagulants; Aspirin; Heart Failure; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Ventricular Dysfunction, Left; Warfarin | 2014 |
Anticoagulation and antiplatelet therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2014 |
Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Warfarin | 2014 |
Anticoagulation versus placebo for heart failure in sinus rhythm.
Topics: Administration, Oral; Anticoagulants; Aspirin; Cardiomyopathy, Dilated; Chronic Disease; Heart Failure; Heart Rate; Humans; Placebo Effect; Randomized Controlled Trials as Topic; Thromboembolism; Warfarin | 2014 |
Anticoagulant therapy in pregnant patients with metabolic syndrome: a review.
Topics: Animals; Anticoagulants; Aspirin; Female; Fondaparinux; Heparin; Humans; Metabolic Syndrome; Polysaccharides; Pregnancy; Venous Thromboembolism; Warfarin | 2014 |
[Basic pathogenesis of, heterogeneity of , and its therapeutic strategy for West syndrome and tuberous sclerosis complex].
Topics: Anticoagulants; Anticonvulsants; Aspirin; Cosyntropin; Female; Gangliosides; Humans; Infant; Infant, Newborn; Male; Myelin Sheath; Spasms, Infantile; Thrombosis; Thyroid Hormones; Tuberous Sclerosis; Vitamin B 6; Warfarin | 2014 |
Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis.
Topics: Anticoagulants; Aspirin; Child; Coronary Aneurysm; Drug Therapy, Combination; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Warfarin | 2014 |
[Historical and future perspective of antithrombotic agents].
Topics: Anticoagulants; Aspirin; Humans; Platelet Aggregation Inhibitors; Thrombosis; Treatment Outcome; Warfarin | 2014 |
Vitamin E-drug interactions: molecular basis and clinical relevance.
Topics: Animals; Aspirin; Cyclosporine; Dietary Supplements; Dose-Response Relationship, Drug; Drug Interactions; Humans; Tamoxifen; Vitamin E; Warfarin | 2014 |
Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Ticlopidine; Vitamin K; Warfarin | 2014 |
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin | 2014 |
[More with atrial fibrillation, anticoagulants since the coming of NOAK ].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Drug Prescriptions; Drug Utilization; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Warfarin | 2015 |
Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Pulmonary Embolism; Stroke; Warfarin | 2015 |
[Anticoagulant therapy in secondary prevention of coronary events].
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Ticlopidine; Warfarin | 2014 |
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Combinations; Factor Xa Inhibitors; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stents; Thrombosis; Ticlopidine; Warfarin | 2015 |
Systematic review with meta-analysis: the risk of gastrointestinal haemorrhage post-polypectomy in patients receiving anti-platelet, anti-coagulant and/or thienopyridine medications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Coagulation Disorders; Colonic Polyps; Colonoscopy; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Pyridines; Risk Factors; Warfarin | 2015 |
Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis.
Topics: Anticoagulants; Aspirin; Chemoprevention; Comparative Effectiveness Research; Fontan Procedure; Humans; Incidence; Postoperative Complications; Thromboembolism; Warfarin | 2015 |
Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Embolism; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2015 |
Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Aspirin; Data Collection; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Sex Factors; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2015 |
Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Dabigatran; Equipment and Supplies; Hemorrhage; Humans; Ligation; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Warfarin | 2015 |
Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Creatinine; Diabetes Complications; Drugs, Investigational; Europe; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Myocardial Infarction; North America; Observational Studies as Topic; Pyrazoles; Pyridones; Registries; Renal Insufficiency, Chronic; Severity of Illness Index; Stroke; Tachycardia; Thrombophilia; Treatment Outcome; Warfarin | 2016 |
Update of thrombosis in multiple myeloma.
Topics: Anticoagulants; Antineoplastic Agents; Aspirin; Heparin, Low-Molecular-Weight; Humans; Lenalidomide; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin | 2016 |
Atrial fibrillation.
Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Countershock; Flecainide; Heart Failure; Heart Rate; Humans; Hypertension; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Propafenone; Quality of Life; Risk Factors; Sodium Channel Blockers; Stroke; Thromboembolism; Warfarin | 2016 |
Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Drug Administration Schedule; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Ischemic Attack, Transient; Odds Ratio; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Venous Thromboembolism; Warfarin | 2016 |
[ESUS (embolic stroke of undetermined sources)].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation Disorders; Clinical Trials as Topic; Embolism; Foramen Ovale, Patent; Humans; Intracranial Embolism; Neoplastic Cells, Circulating; Platelet Aggregation Inhibitors; Stroke; Thrombolytic Therapy; Warfarin | 2016 |
Patent foramen ovale and cryptogenic stroke: from studies to clinical practice: Position paper of the Italian Chapter, International Society Cardiovascular Ultrasound.
Topics: Anticoagulants; Aspirin; Cardiac Catheterization; Echocardiography; Embolism, Paradoxical; Foramen Ovale, Patent; Humans; Recurrence; Risk Assessment; Stroke; Warfarin | 2016 |
Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clinical Protocols; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Intraoperative Care; Randomized Controlled Trials as Topic; Registries; Venous Thromboembolism; Warfarin | 2016 |
A systematic review of anti-thrombotic therapy in epistaxis.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Clopidogrel; Dabigatran; Disease Management; Epistaxis; Humans; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Ticlopidine; Tranexamic Acid; Warfarin | 2016 |
[Direct oral anticoagulants in cardiology].
Topics: Administration, Oral; Anticoagulants; Aspirin; Cardiology; Cardiovascular Diseases; Clopidogrel; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2016 |
Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Genetic Predisposition to Disease; Genetic Variation; Genome, Human; Genomics; Humans; Pharmacogenetics; Precision Medicine; Ticlopidine; Warfarin | 2017 |
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Stents; Ticlopidine; Warfarin | 2016 |
Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis.
Topics: Acute Coronary Syndrome; Adult; Aged; Anticoagulants; Aspirin; Causality; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Incidence; Male; Middle Aged; Risk Factors; Stroke; Survival Rate; Thromboembolism; Warfarin; Young Adult | 2017 |
Pulmonary Embolism Rates Following Total Hip Arthroplasty With Prophylactic Anticoagulation: Some Pulmonary Emboli Cannot Be Avoided.
Topics: Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Aspirin; Factor Xa Inhibitors; Health Services; Heparin, Low-Molecular-Weight; Humans; Multicenter Studies as Topic; Prevalence; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thromboembolism; Warfarin | 2017 |
Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Hemorrhage; Humans; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Warfarin | 2016 |
Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin | 2017 |
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cause of Death; Female; Fibrinolytic Agents; Humans; Male; Placebo Effect; Prospective Studies; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Warfarin | 2017 |
Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
Topics: Anticoagulants; Arthroplasty; Arthroplasty, Replacement, Knee; Aspirin; Dabigatran; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Warfarin | 2017 |
Updates in venous thromboembolism management: evidence published in 2016.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Practice Guidelines as Topic; Pulmonary Embolism; Risk Factors; Venous Thromboembolism; Warfarin; Watchful Waiting | 2017 |
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
Topics: Anticoagulants; Aspirin; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Dabigatran; Dipyridamole; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Thiazoles; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
[Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Warfarin | 2017 |
Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Cardiac Resynchronization Therapy Devices; Cause of Death; Clopidogrel; Defibrillators, Implantable; Evidence-Based Medicine; Female; Humans; Injections, Subcutaneous; Male; Network Meta-Analysis; Observational Studies as Topic; Pacemaker, Artificial; Perioperative Care; Prognosis; Risk Assessment; Survival Analysis; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Optimal Intensity of Warfarin Therapy in Patients With Mechanical Aortic Valves.
Topics: Anticoagulants; Aortic Valve; Aspirin; Heart Valve Prosthesis; Humans; International Normalized Ratio; Practice Guidelines as Topic; Risk Factors; Thromboembolism; Warfarin | 2019 |
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Topics: Administration, Oral; Anticoagulants; Aspirin; Hemorrhage; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Secondary Prevention; Stroke; Venous Thromboembolism; Warfarin | 2017 |
A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Embolism; Glomerular Filtration Rate; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2019 |
Venous Thromboembolism Prophylaxis after Total Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Early Ambulation; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Venous Thromboembolism; Warfarin; Wound Healing | 2018 |
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hematologic Agents; Humans; Intracranial Hemorrhages; Tetrazoles; Ticlopidine; Warfarin | 2018 |
Pathophysiology of thrombosis and anticoagulation post Fontan surgery.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Fontan Procedure; Heart Defects, Congenital; Humans; Thromboembolism; Thrombolytic Therapy; Thrombosis; Warfarin | 2018 |
Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; DNA; Drug Therapy, Combination; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Histones; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Thrombosis; Warfarin | 2018 |
Dual and triple antithrombotic therapies: current patterns of practice and controversies.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Patient Safety; Percutaneous Coronary Intervention; Ticlopidine; Treatment Outcome; Warfarin | 2018 |
Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Stroke; Thrombosis; Warfarin | 2018 |
Antithrombotic strategies after interventional left atrial appendage closure: an update.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Atrial Appendage; Atrial Fibrillation; Embolism; Hemorrhage; Humans; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2018 |
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Observational Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Warfarin | 2018 |
The prevention of venous thromboembolism recurrence in the elderly: a still open issue.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clinical Trials as Topic; Humans; Incidence; Prognosis; Recurrence; Risk Assessment; Treatment Outcome; Venous Thromboembolism; Warfarin | 2018 |
Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Network Meta-Analysis; Platelet Aggregation Inhibitors; Secondary Prevention; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin | 2019 |
Antithrombotic dose: Some observations from published clinical trials.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2019 |
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
Topics: Anticoagulants; Aspirin; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Risk Factors; Treatment Outcome; Venous Thromboembolism; Warfarin | 2019 |
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
Topics: Anticoagulants; Area Under Curve; Aspirin; Blood Platelets; Cardiovascular Diseases; Catheter Ablation; Coronary Artery Disease; Fibrinolytic Agents; Hemorrhage; Hemostasis; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Warfarin | 2019 |
Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Ticagrelor; Warfarin | 2020 |
Controversial Topics in Total Knee Arthroplasty: A Five-Year Update (Part 2).
Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Tourniquets; Tranexamic Acid; Venous Thromboembolism; Warfarin; Wound Closure Techniques | 2020 |
Looking into the next decade of antithrombotic therapy for patients with atrial fibrillation and percutaneous coronary intervention.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiology; Coronary Thrombosis; Drug Therapy, Combination; Humans; Intracranial Thrombosis; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Warfarin | 2020 |
Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Heparin, Low-Molecular-Weight; Humans; Surgical Wound Infection; Venous Thrombosis; Warfarin | 2020 |
Aspirin monotherapy is a suitable standard thromboprophylactic agent following total hip arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Venous Thromboembolism; Warfarin | 2022 |
Interventions for preventing thrombosis in solid organ transplant recipients.
Topics: Anticoagulants; Aspirin; Bias; Dipyridamole; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Kidney Transplantation; Liver Transplantation; Placebos; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Thrombosis; Transplant Recipients; Warfarin | 2021 |
Anticoagulation versus placebo for heart failure in sinus rhythm.
Topics: Administration, Oral; Anticoagulants; Aspirin; Cardiomyopathy, Dilated; Chronic Disease; Heart Failure; Heart Rate; Hemorrhage; Humans; Placebo Effect; Placebos; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thromboembolism; Warfarin | 2021 |
Triple Antithrombotic Therapy in Patients With Left Ventricular Assist Devices.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Heart-Assist Devices; Humans; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Warfarin | 2022 |
Narrative Review of Antiplatelet and Anticoagulant Medications for Venous Thromboembolism Prevention in Spine Surgery.
Topics: Anticoagulants; Aspirin; Humans; Risk Factors; Spine; Venous Thromboembolism; Warfarin | 2022 |
Perioperative anticoagulation recommendations for cutaneous oncologic surgery: a review of the literature.
Topics: Anticoagulants; Aspirin; Clopidogrel; Humans; Skin Neoplasms; Warfarin | 2022 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin | 2022 |
Apixaban for Anticoagulation After Robotic Mitral Valve Repair.
Topics: Aftercare; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Hemorrhage; Humans; Male; Middle Aged; Mitral Valve; Patient Discharge; Pyridones; Robotic Surgical Procedures; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2023 |
Anticoagulation alone as an effective and safe antithrombotic therapy in LVAD: When less is more.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Hemorrhage; Humans; Warfarin | 2023 |
Thromboprophylaxis in Patients With Fontan Circulation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Fontan Procedure; Hemorrhage; Humans; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2023 |
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2023 |
Pharmacological interventions for asymptomatic carotid stenosis.
Topics: Aspirin; Atherosclerosis; Atorvastatin; Carotid Stenosis; Chlorthalidone; Fluvastatin; Hemorrhage; Humans; Ischemic Stroke; Metoprolol; Pravastatin; Probucol; Rosuvastatin Calcium; Stroke; Warfarin | 2023 |
Comprehensive systematic review and meta-analysis on anticoagulants and aspirin for stroke prevention in non-valvular atrial fibrillation patients.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Stroke; Warfarin | 2023 |
317 trial(s) available for aspirin and warfarin
| Article | Year |
|---|---|
Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Female; Humans; Male; Middle Aged; Random Allocation; Warfarin | 1979 |
Prophylaxis of thromboembolic disease.
Topics: Abdomen; Aspirin; Clinical Trials as Topic; Dextrans; Double-Blind Method; Early Ambulation; Hemorrhage; Heparin; Humans; Injections, Subcutaneous; Lidocaine; Male; Orthopedics; Postoperative Complications; Posture; Prostate; Thoracic Surgery; Thromboembolism; Warfarin | 1979 |
The hazards of aspirin plus heparin.
Topics: Aspirin; Drug Therapy, Combination; Hemorrhage; Heparin; Hip Fractures; Humans; Thrombophlebitis; Warfarin | 1978 |
Anticoagulants in cerebrovascular disease. A critical review of studies.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coumarins; Evaluation Studies as Topic; Humans; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Methods | 1975 |
[Clinical-pharmacological and pharmacokinetic studies with naproxen].
Topics: Administration, Oral; Animals; Antacids; Aspirin; Biological Availability; Clinical Trials as Topic; Coumarins; Drug Interactions; Gastric Mucosa; Half-Life; Humans; Injections, Intravenous; Kinetics; Models, Biological; Naphthaleneacetic Acids; Naproxen; Protein Binding; Rats; Sulfonylurea Compounds; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Proceedings: Arterial thromboembolism and prosthetic heart valves. Effects of acetylsalicylic acid.
Topics: Aspirin; Clinical Trials as Topic; Heart Valve Prosthesis; Humans; Thromboembolism; Warfarin | 1975 |
Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty.
Topics: Adult; Aspirin; Combined Modality Therapy; Dextrans; Female; Gravity Suits; Hemorrhage; Hip Prosthesis; Humans; Incidence; Male; Postoperative Complications; Thrombophlebitis; Warfarin | 1992 |
Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
Topics: Aspirin; Cardiac Catheterization; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Premedication; Reoperation; Warfarin | 1992 |
The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Risk Factors; Treatment Outcome; Warfarin | 1992 |
Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
Topics: Aged; Aspirin; Blood Coagulation; Coronary Thrombosis; Dietary Fats; Drug Therapy, Combination; Factor VII; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Risk Factors; Smoking; Warfarin | 1992 |
Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.
Topics: Administration, Oral; Aged; Aspirin; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Hemorrhage; Humans; Male; Middle Aged; Thrombosis; Warfarin | 1992 |
How should results from completed studies influence ongoing clinical trials? The CAFA Study experience.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Therapy, Combination; Embolism; Humans; Meta-Analysis as Topic; Research Design; Warfarin | 1991 |
Stroke Prevention in Atrial Fibrillation Study. Final results.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Warfarin | 1991 |
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Dipyridamole; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Stents; Time Factors; Warfarin | 1991 |
Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin.
Topics: Adult; Age Factors; Aged; Aspirin; Bandages; Combined Modality Therapy; Female; Heparin; Hip Prosthesis; Humans; Intraoperative Complications; Male; Middle Aged; Prospective Studies; Regression Analysis; Reoperation; Thrombophlebitis; Warfarin | 1991 |
Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Warfarin | 1990 |
Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.
Topics: Aged; Aspirin; Atrial Fibrillation; Denmark; Female; Humans; Male; Proportional Hazards Models; Randomized Controlled Trials as Topic; Regression Analysis; Risk Factors; Survival Rate; Thromboembolism; Warfarin | 1990 |
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Hemorrhage; Humans; Male; Middle Aged; Prothrombin Time; Risk; Warfarin | 1990 |
Progress report of the Stroke Prevention in Atrial Fibrillation Study.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Humans; Placebos; Warfarin | 1990 |
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Artery Bypass; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Prospective Studies; Recurrence; Reoperation; Thrombolytic Therapy; Warfarin | 1990 |
Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease.
Topics: Aspirin; Coronary Disease; Drug Therapy, Combination; Humans; Incidence; Randomized Controlled Trials as Topic; Warfarin | 1990 |
Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Thromboembolism; Warfarin | 1990 |
Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.
Topics: Adult; Aspirin; Cohort Studies; Drug Synergism; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Male; Random Allocation; Warfarin | 1989 |
Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Chronic Disease; Clinical Trials as Topic; Denmark; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Random Allocation; Thromboembolism; Warfarin | 1989 |
Warfarin to prevent thromboembolism in chronic atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Chronic Disease; Clinical Trials as Topic; Humans; Thromboembolism; Warfarin | 1989 |
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Female; Follow-Up Studies; Hemorrhage; Hip Fractures; Humans; Male; Middle Aged; Phlebography; Postoperative Care; Postoperative Complications; Pulmonary Embolism; Random Allocation; Thrombophlebitis; Warfarin | 1989 |
Antithrombotic therapy in the primary prevention of acute myocardial infarction.
Topics: Aged; Aspirin; Drug Administration Schedule; Drug Therapy, Combination; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Warfarin | 1989 |
Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Pentoxifylline; Postoperative Complications; Prospective Studies; Random Allocation; Theobromine; Thromboembolism; Warfarin | 1985 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Cold Temperature; Dextrans; Dipyridamole; Disease Models, Animal; Dogs; Heparin; Humans; Placebos; Platelet Adhesiveness; Postoperative Care; Rabbits; Rats; Thromboembolism; Thrombosis; Warfarin | 1974 |
[Thromboembolic complications following total hip prosthesis. Study of 478 cases of relative efficacy of 3 preventive methods].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Drug Evaluation; Drug Therapy, Combination; Female; Hematocrit; Hip Joint; Humans; Joint Prosthesis; Male; Osteoarthritis; Postoperative Complications; Pulmonary Embolism; Rh-Hr Blood-Group System; Thromboembolism; Thrombophlebitis; Warfarin | 1974 |
[The use of acetylsalicylic acid in anticoagulation therapy].
Topics: Adult; Aged; Analysis of Variance; Aspirin; Blood Coagulation; Blood Coagulation Factors; Clinical Trials as Topic; Coumarins; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Adhesiveness | 1972 |
Platelet survival in patients with prosthetic heart valves.
Topics: Aspirin; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Cell Survival; Chromium Radioisotopes; Clinical Trials as Topic; Heart Valve Prosthesis; Humans; Placebos; Platelet Adhesiveness; Prothrombin Time; Thrombosis; Warfarin | 1974 |
[Function of thrombocytes during myocardial infarct and the possible effects of acetylsalicylic acid].
Topics: Aspirin; Coumarins; Humans; Myocardial Infarction; Platelet Adhesiveness | 1972 |
Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Biphenyl Compounds; Blood Coagulation; Blood Urea Nitrogen; Chlorides; Clinical Trials as Topic; Constipation; Diarrhea; Digestive System; Drug Tolerance; Exanthema; Flatulence; Flufenamic Acid; Fluorine; Headache; Heartburn; Humans; Kidney Function Tests; Male; Mefenamic Acid; Methods; Muscle Cramp; Occult Blood; ortho-Aminobenzoates; Placebos; Potassium; Prothrombin; Sleep Initiation and Maintenance Disorders; Sodium; Uric Acid; Vertigo; Vision Disorders; Vomiting; Warfarin | 1966 |
Prevention of postoperative venous thrombosis.
Topics: Aspirin; Clinical Trials as Topic; Heparin; Hip; Humans; Postoperative Complications; Thromboembolism; Thrombophlebitis; Warfarin | 1971 |
Reduction in venous thromboembolism by agents affecting platelet function.
Topics: Adult; Aged; Arthroplasty; Aspirin; Blood Platelets; Chromium Alloys; Dextrans; Dipyridamole; Female; Hemorrhage; Hip; Humans; Joint Prosthesis; Male; Middle Aged; Platelet Adhesiveness; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Veins; Warfarin | 1971 |
Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coumarins; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Recurrence | 1984 |
Safety profile: fifteen years of clinical experience with ibuprofen.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Proteins; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Eruptions; Drug Interactions; Drug Tolerance; Gastrointestinal Diseases; Humans; Ibuprofen; Kidney Diseases; Liver Function Tests; Warfarin | 1984 |
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Thromboembolism; Warfarin | 1983 |
Prevention of stroke.
Topics: Aged; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Female; Heparin; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Placebos; Platelet Aggregation; Random Allocation; Risk; Sex Factors; Sulfinpyrazone; United States; Warfarin | 1984 |
Prophylaxis of venous thromboembolism by aspirin, warfarin and heparin in patients with hip fracture. A prospective clinical study with cost-benefit analysis.
Topics: Adult; Aspirin; Cost-Benefit Analysis; Female; Heparin; Hip Fractures; Humans; Male; Prospective Studies; Pulmonary Embolism; Pulmonary Veins; Thrombophlebitis; Warfarin | 1984 |
Drug prophylaxis for arterial thromboembolism--1981.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coumarins; Decision Making; Female; Hemorrhage; Heparin; Humans; Male; Myocardial Infarction; Pregnancy; Sex Factors; Thromboembolism; Warfarin | 1981 |
The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts.
Topics: Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Double-Blind Method; Female; Graft Survival; Humans; Male; Middle Aged; Prospective Studies; Saphenous Vein; Warfarin | 1982 |
Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
Topics: Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Care; Random Allocation; Risk; Sulfinpyrazone; Thrombosis; Veins; Warfarin | 1982 |
Topical aprotinin in cardiac operations.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Algorithms; Aortic Valve; Aprotinin; Aspirin; Blood Loss, Surgical; Cardiopulmonary Bypass; Coronary Artery Bypass; Double-Blind Method; Female; Heart Valve Prosthesis; Hemostasis, Surgical; Humans; Male; Middle Aged; Mitral Valve; Premedication; Prospective Studies; Warfarin | 1994 |
[Embolic complications in atrial fibrillation. Data of the Studio Italiano Fibrillation Atriale (SIFA)].
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Embolism; Female; Follow-Up Studies; Humans; Isoindoles; Italy; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Warfarin | 1995 |
[Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
Topics: Adult; Aged; Anticoagulants; Aspirin; Blood Coagulation; Depression, Chemical; Drug Therapy, Combination; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Warfarin | 1995 |
The Warfarin-Aspirin Symptomatic Intracranial Disease Study.
Topics: Animals; Aspirin; Cerebral Angiography; Cerebral Hemorrhage; Cerebrovascular Disorders; Cohort Studies; Constriction, Pathologic; Female; Guinea Pigs; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Vascular Diseases; Warfarin | 1995 |
[Bleeding complications in oral anticoagulant treatment].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Heart Valve Prosthesis; Hemorrhage; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; Thromboembolism; Warfarin | 1995 |
Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
Topics: Aged; Aspirin; Coronary Disease; Drug Therapy, Combination; Factor VIIa; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Prothrombin Time; Risk Factors; Treatment Outcome; Warfarin | 1995 |
A comparative evaluation of externally supported polytetrafluoroethylene axillobifemoral and axillounifemoral bypass grafts.
Topics: Aged; Aged, 80 and over; Anastomosis, Surgical; Aorta; Arteriosclerosis; Aspirin; Axillary Artery; Blood Vessel Prosthesis; Combined Modality Therapy; Female; Femoral Artery; Follow-Up Studies; Graft Occlusion, Vascular; Graft Survival; Humans; Male; Middle Aged; Polytetrafluoroethylene; Prosthesis Design; Reoperation; Thrombectomy; Thrombosis; Time Factors; Vascular Patency; Warfarin | 1995 |
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease.
Topics: Aged; Antithrombin III; Arteriosclerosis; Aspirin; Bleeding Time; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Fatty Acids; Female; Fibrin Fibrinogen Degradation Products; Fish Oils; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Peptide Hydrolases; Phospholipids; Platelet Count; Risk Factors; Treatment Outcome; Triglycerides; Warfarin | 1995 |
A comparative study of coumadin and aspirin for primary cardioembolic stroke and thromboembolic preventions of chronic rheumatic mitral stenosis with atrial fibrillation.
Topics: Adolescent; Adult; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chi-Square Distribution; Chronic Disease; Female; Humans; Male; Middle Aged; Mitral Valve Stenosis; Rheumatic Heart Disease; Survival Rate; Thromboembolism; Warfarin | 1994 |
Evaluation of myocardial infarction therapy at a Canadian tertiary referral hospital.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Drug Therapy, Combination; Electrocardiography; Fibrinolytic Agents; Hospitals, Teaching; Humans; Myocardial Infarction; Retrospective Studies; Time Factors; Treatment Outcome; Warfarin | 1995 |
Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high risk.
Topics: Aged; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Warfarin | 1995 |
[Adverse effects of combined use of acenocoumarol and acetylsalicylic acid after myocardial infarct and unstable angina].
Topics: Acenocoumarol; Angina, Unstable; Aspirin; Drug Synergism; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Warfarin | 1995 |
Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Unstable; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Partial Thromboplastin Time; Prospective Studies; Prothrombin Time; Recurrence; Risk Factors; Thrombolytic Therapy; Time Factors; Treatment Failure; Warfarin | 1993 |
Aspirin and prevention of stroke.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Warfarin | 1994 |
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Follow-Up Studies; Humans; Risk Factors; Thromboembolism; Warfarin | 1994 |
Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments.
Topics: Adolescent; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prospective Studies; Thrombosis; Warfarin | 1994 |
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hematuria; Humans; Male; Middle Aged; Pilot Projects; Proportional Hazards Models; Warfarin | 1994 |
Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Topics: Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Female; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Incidence; Male; Mitral Valve; Postoperative Complications; Proportional Hazards Models; Retrospective Studies; Risk Factors; Thromboembolism; Time Factors; Warfarin | 1994 |
Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Topics: Adult; Angina, Unstable; Aspirin; Delayed-Action Preparations; Drug Therapy, Combination; Epoprostenol; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Rest; Thrombolytic Therapy; Warfarin | 1994 |
Effects of low intensity antithrombotic regimes on the haemoglobin level.
Topics: Aged; Aspirin; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Hemoglobins; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Warfarin | 1994 |
[SPIRIT: new life spirit for anticoagulant treatment in the secondary prevention of brain infarcts? A new study. Stroke Prevention in Reversible Ischaemia Trial].
Topics: Aspirin; Cerebral Infarction; Coumarins; Humans; Ischemic Attack, Transient | 1994 |
Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.
Topics: Aspirin; Coronary Angiography; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Thrombolytic Therapy; Warfarin | 1993 |
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Topics: Angina, Unstable; Aspirin; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Time Factors; Warfarin | 1994 |
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Embolism; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Likelihood Functions; Male; Middle Aged; Prosthesis Design; Warfarin | 1993 |
Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. BAATAF Investigators.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Peptide Fragments; Prothrombin; Warfarin | 1993 |
Platelet aggregation in patients with atrial fibrillation taking aspirin or warfarin.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Collagen; Epinephrine; Humans; In Vitro Techniques; Kinetics; Platelet Aggregation; Warfarin | 1993 |
Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
Topics: Aged; Aspirin; Coronary Angiography; Coronary Thrombosis; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Warfarin | 1993 |
Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Dextrans; Dipyridamole; Female; Hemorrhage; Heparin; Humans; Length of Stay; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Stents; Warfarin | 1996 |
Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Warfarin | 1996 |
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Disease-Free Survival; Equipment Design; Exercise Test; Female; Follow-Up Studies; Heparin; Humans; Length of Stay; Male; Middle Aged; Pilot Projects; Safety; Stents; Ticlopidine; Treatment Outcome; Warfarin | 1996 |
Aspirin and warfarin for thromboembolic disease after total joint arthroplasty.
Topics: Aged; Anticoagulants; Aspirin; Female; Humans; Joint Prosthesis; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Thromboembolism; Treatment Outcome; Warfarin | 1996 |
Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Hemorrhage; Humans; Male; Middle Aged; Risk Factors; Warfarin | 1996 |
Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dermatologic Surgical Procedures; Female; Hematoma; Humans; Male; Middle Aged; Mohs Surgery; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Warfarin | 1996 |
Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Feces; Female; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 1996 |
Warfarin encouraged for stroke prevention in atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Peer Review; Treatment Outcome; Warfarin | 1996 |
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; beta-Thromboglobulin; Dose-Response Relationship, Drug; Female; Fibrin Fibrinogen Degradation Products; Humans; Longitudinal Studies; Male; Middle Aged; Platelet Activation; Prospective Studies; Thrombosis; Warfarin | 1996 |
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Risk Factors; United States; Warfarin | 1996 |
The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Female; Health Status; Humans; Male; Platelet Aggregation Inhibitors; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Warfarin | 1996 |
Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
Topics: Aged; Anticoagulants; Antithrombin III; Aspirin; Atrial Fibrillation; Biomarkers; Blood Coagulation; Blood Proteins; Echocardiography, Transesophageal; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Male; Mitral Valve; Partial Thromboplastin Time; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prospective Studies; Prothrombin; Risk; Thromboembolism; Tissue Plasminogen Activator; Warfarin | 1996 |
[Comparison of thrombolytic therapy and direct percutaneous transluminal coronary angioplasty for acute myocardial infarction: prospective multicenter trial at 16 clinical centers in Ibaraki prefecture TUGMI. Tsukuba University Group for Myocardial Infarc
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Thrombolytic Therapy; Ventricular Function, Left; Warfarin | 1996 |
A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trial.
Topics: Anistreplase; Anticoagulants; Aspirin; Death, Sudden, Cardiac; Female; Heparin; Humans; Male; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Warfarin | 1996 |
Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings.
Topics: Aged; Anticoagulants; Aspirin; Cardiovascular Diseases; Cognition; Cognition Disorders; Double-Blind Method; Humans; Male; Middle Aged; Multivariate Analysis; Neuropsychological Tests; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1997 |
Coronary stenting (Cordis) without anticoagulation.
Topics: Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Evaluation Studies as Topic; Fibrinolytic Agents; Humans; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors; Warfarin | 1997 |
Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.
Topics: Anticoagulants; Aspirin; Coumarins; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Time Factors | 1997 |
[Coumarin combined with low-dose acetylsalicylic acid in the prevention of thromboembolic complications in patients with mitral and aortic valve prostheses].
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Coumarins; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Thromboembolism | 1997 |
Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation; Cerebrovascular Disorders; Drug Therapy, Combination; Female; Humans; Male; Peptide Fragments; Prothrombin; Prothrombin Time; Warfarin | 1997 |
Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Peptide Fragments; Protein Precursors; Prothrombin; Warfarin | 1997 |
Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results.
Topics: Aged; Aspirin; Atherectomy, Coronary; Calcinosis; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Stents; Ticlopidine; Ultrasonography; Warfarin | 1997 |
Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Coronary Angiography; Coronary Vessels; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 1997 |
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Diabetes Complications; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Myocardial Infarction; Risk; Treatment Outcome; Warfarin | 1997 |
[Immediate and long-term clinical and angiographic results of the Wiktor stent in the treatment of chronic coronary occlusions].
Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Chronic Disease; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine; Time Factors; Warfarin | 1997 |
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Thrombosis; Warfarin | 1998 |
Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience.
Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Catheterization, Peripheral; Confidence Intervals; Coronary Angiography; Coronary Disease; Equipment Design; Female; Follow-Up Studies; Hemorrhage; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Platelet Aggregation Inhibitors; Recurrence; Stents; Survival Rate; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 1998 |
Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.
Topics: Aged; Anticoagulants; Aortic Diseases; Arteriosclerosis; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Atria; Heart Diseases; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Thromboembolism; Warfarin | 1998 |
Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Female; Follow-Up Studies; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Retrospective Studies; Thromboembolism; Treatment Outcome; Warfarin | 1998 |
Interpretation of Thrombosis Prevention Trial.
Topics: Anticoagulants; Aspirin; Coronary Thrombosis; Humans; Male; Myocardial Ischemia; Smoking; Smoking Cessation; Warfarin | 1998 |
Interpretation of Thrombosis Prevention Trial.
Topics: Anticoagulants; Aspirin; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Myocardial Ischemia; Risk Factors; Treatment Outcome; Warfarin | 1998 |
Interpretation of Thrombosis Prevention Trial.
Topics: Administration, Oral; Anticoagulants; Aspirin; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Italy; Male; Myocardial Ischemia; Risk Factors; Treatment Outcome; Warfarin | 1998 |
Interpretation of Thrombosis Prevention Trial.
Topics: Administration, Oral; Aspirin; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Myocardial Ischemia; Risk Factors; Treatment Outcome; Warfarin | 1998 |
Interpretation of Thrombosis Prevention Trial.
Topics: Anticoagulants; Aspirin; Coronary Thrombosis; Humans; Life Style; Male; Myocardial Ischemia; Risk Factors; Smoking Cessation; Treatment Outcome; Warfarin | 1998 |
Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group.
Topics: Aged; Anticoagulants; Aspirin; Basilar Artery; Brain Ischemia; Cerebellum; Cerebral Arteries; Cerebrovascular Disorders; Constriction, Pathologic; Female; Humans; Male; Pilot Projects; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Vertebral Artery; Warfarin | 1998 |
Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Denmark; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Treatment Outcome; Warfarin | 1998 |
Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
Topics: Administration, Oral; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Aspirin; Coronary Artery Bypass; Electrocardiography; Hemorrhage; Hirudins; Humans; Infusions, Intravenous; Myocardial Infarction; Myocardial Ischemia; Patient Compliance; Pilot Projects; Platelet Aggregation Inhibitors; Warfarin | 1998 |
Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure.
Topics: Aged; Anticoagulants; Arteries; Aspirin; Female; Hematoma; Heparin; Humans; Inguinal Canal; Leg; Male; Postoperative Complications; Prospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures; Veins; Warfarin | 1998 |
The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction.
Topics: Adult; Aged; Analysis of Variance; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Regression Analysis; Treatment Outcome; Warfarin | 1998 |
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S)
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Aspirin; Calcium Channel Blockers; Cause of Death; Coronary Disease; Female; Finland; Follow-Up Studies; Humans; Iceland; Male; Middle Aged; Myocardial Revascularization; Prognosis; Scandinavian and Nordic Countries; Simvastatin; Survival Rate; Warfarin | 1998 |
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Single-Blind Method; Stents; Thrombosis; Ticlopidine; Warfarin | 1998 |
Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography.
Topics: Aged; Anticoagulants; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Safety; Thromboembolism; Treatment Outcome; Warfarin | 1999 |
Strategy for balancing anticoagulation and hemostasis in aortocoronary bypass surgery: blood conservation and graft patency.
Topics: Adult; Anticoagulants; Aprotinin; Aspirin; Coronary Artery Bypass; Drug Administration Schedule; Hemostasis; Hemostatics; Heparin; Humans; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Thromboembolism; Vascular Patency; Warfarin | 1999 |
Transesophageal echocardiography and unexplained cerebral ischemia: a multicenter follow-up study. The STEPS Investigators. Significance of Transesophageal Echocardiography in the Prevention of Recurrent Stroke.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cerebrovascular Disorders; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Recurrence; United States; Warfarin | 1999 |
Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
Topics: Aged; Alcohol Drinking; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Estrogen Replacement Therapy; Female; Humans; Male; Multivariate Analysis; Regression Analysis; Risk Factors; Warfarin | 1999 |
Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Double-Blind Method; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Placebos; Warfarin | 1999 |
Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Fibrinolytic Agents; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Risk; Risk Factors; Severity of Illness Index; Warfarin | 1999 |
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Decision Making; Decision Support Techniques; Female; Fibrinolytic Agents; Humans; Logistic Models; Male; Patient Education as Topic; Patient Participation; Risk; Warfarin | 1999 |
Compliance to multiple interventions in a high risk population.
Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Aspirin; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Male; Niacin; Patient Compliance; Peripheral Vascular Diseases; Placebos; Platelet Aggregation Inhibitors; Pravastatin; Time Factors; Warfarin | 1999 |
Comparison of the efficacy and safety of aspirin alone with coumadin plus aspirin after provisional coronary stenting: final and follow-up results of a randomized study.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Safety; Stents; Ultrasonography, Interventional; Warfarin | 1999 |
The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation.
Topics: Acute Disease; Aged; Angina, Unstable; Anticoagulants; Aspirin; Canada; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Feasibility Studies; Female; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pilot Projects; Recombinant Proteins; Recurrence; Registries; Treatment Outcome; Warfarin | 1999 |
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Survival Analysis; Thromboembolism; Treatment Outcome | 1999 |
Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Canada; Coronary Angiography; Drug Therapy, Combination; Humans; Myocardial Infarction; Myocardial Revascularization; Survival Rate; United States; Warfarin | 1999 |
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antigens; Aspirin; Brain Ischemia; Death, Sudden, Cardiac; Drug Therapy, Combination; Factor VII; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Prognosis; Proportional Hazards Models; Prospective Studies; Protein C; Protein S; Prothrombin; Recurrence; Risk; Single-Blind Method; Thrombolytic Therapy; Thrombophilia; Ticlopidine; Treatment Outcome; Warfarin | 1999 |
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Blood Flow Velocity; Drug Therapy, Combination; Echocardiography, Doppler, Pulsed; Echocardiography, Transesophageal; Female; Heart Rate; Humans; Intracranial Embolism and Thrombosis; Male; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Stroke; Stroke Volume; Warfarin | 1999 |
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Flow Velocity; Contrast Media; Drug Therapy, Combination; Echocardiography, Doppler; Echocardiography, Transesophageal; Female; Humans; Injections, Intravenous; Intracranial Embolism and Thrombosis; Male; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Warfarin | 1999 |
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Fibrillation; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Recurrence; Risk Factors; Stroke; Warfarin | 2000 |
Five-year follow-up of valve replacement with the Jyros bileaflet mechanical valve.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Cause of Death; Cineradiography; Female; Fluoroscopy; Follow-Up Studies; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Male; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Prosthesis Design; Rotation; Survival Rate; Ventricular Premature Complexes; Warfarin | 2000 |
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Prospective Studies; Reference Values; Thrombosis; von Willebrand Factor; Warfarin | 2000 |
Cardiac surgery and catheterization in patients with haemophilia.
Topics: Adolescent; Adult; Aged; Aortic Valve; Aspirin; Cardiac Catheterization; Coronary Angiography; Coronary Artery Bypass; Factor IX; Factor VIII; Heart Valve Prosthesis Implantation; Hemophilia A; Hemophilia B; Hemorrhage; Hemostasis; Hepatitis B Surface Antigens; Hepatitis C Antibodies; HIV Antibodies; Humans; Isoantibodies; Middle Aged; Myocardial Ischemia; Thoracic Surgical Procedures; Warfarin | 2000 |
Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design.
Topics: Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Middle Aged; Myocardial Infarction; Thromboembolism; Warfarin | 2000 |
Effect of coumarins started before coronary angioplasty on acute complications and long-term follow-up: a randomized trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Coumarins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Complications; Treatment Outcome | 2000 |
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Coumarins; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Stents; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional | 2000 |
Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.
Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Drug Therapy, Combination; Follow-Up Studies; Heart Valves; Humans; Incidence; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Warfarin | 2000 |
Antithrombotic therapy in heart failure: a randomized comparison of warfarin vs. aspirin (HELAS).
Topics: Anticoagulants; Aspirin; Double-Blind Method; Fibrinolytic Agents; Heart Failure; Humans; Longitudinal Studies; Middle Aged; Thromboembolism; Warfarin | 1999 |
The WASH study (Warfarin/Aspirin Study in Heart failure) rationale, design and end-points.
Topics: Anticoagulants; Aspirin; Feasibility Studies; Fibrinolytic Agents; Heart Failure; Humans; Multicenter Studies as Topic; Patient Selection; Pilot Projects; Randomized Controlled Trials as Topic; Research Design; Warfarin | 1999 |
Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Recurrence; Risk Assessment; Stroke; Survival Analysis; Survival Rate; Treatment Failure; Treatment Outcome; Warfarin | 2000 |
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin.
Topics: Aged; Aspirin; Blood Coagulation Factors; Exercise; Female; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Warfarin | 2000 |
Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease.
Topics: Aged; Anticoagulants; Aspirin; Coronary Disease; Humans; International Normalized Ratio; Male; Middle Aged; Multivariate Analysis; Treatment Outcome; Warfarin | 2000 |
Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Arteriosclerosis; Aspirin; Cholesterol, LDL; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Niacin; Platelet Aggregation Inhibitors; Pravastatin; Risk Factors; Self Medication; Time Factors; Treatment Outcome; Triglycerides; Vitamins; Warfarin | 2000 |
Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Eye Hemorrhage; Eyelid Diseases; Female; Humans; Male; Middle Aged; Ophthalmologic Surgical Procedures; Prospective Studies; Retrobulbar Hemorrhage; Risk Factors; Warfarin | 2000 |
Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Factors; Survival Rate; Ventricular Function, Left; Warfarin | 2001 |
Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
Topics: Administration, Oral; Aneurysm, False; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cerebral Hemorrhage; Coronary Artery Disease; Coronary Restenosis; Coumarins; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk; Stents; Thrombosis; Ticlopidine; Treatment Outcome; Vascular Patency | 2001 |
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor VII; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Recurrence; Saphenous Vein; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; von Willebrand Factor; Warfarin | 2001 |
Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery.
Topics: Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Survival Analysis; Treatment Outcome; Warfarin | 2001 |
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
Topics: Aged; Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Secondary Prevention; Severity of Illness Index; Stroke; Survival Rate; Treatment Outcome; Warfarin | 2001 |
Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Secondary Prevention; Stroke; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Duplex; Warfarin | 2001 |
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Enoxaparin; Female; Hemorrhage; Humans; Infant, Newborn; Lupus Erythematosus, Systemic; Nervous System Diseases; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy, Multiple; Safety; Thrombosis; Warfarin | 2001 |
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Double-Blind Method; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Stroke; Warfarin | 2001 |
Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Hospitals, Veterans; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk Assessment; Survival Rate; Treatment Outcome; United States; Warfarin | 2002 |
The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial.
Topics: Aged; Amputation, Surgical; Anticoagulants; Aspirin; Boston; Femoral Vein; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Intermittent Claudication; International Normalized Ratio; Ischemia; Leg; Maryland; Middle Aged; Polytetrafluoroethylene; Popliteal Vein; Prospective Studies; Severity of Illness Index; Texas; Treatment Outcome; Warfarin | 2002 |
Heparin and coumadin versus acetylsalicylic acid for prevention of restenosis after coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Restenosis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Radiography; Thrombolytic Therapy; Warfarin | 2002 |
Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Boston; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extremities; Femoral Artery; Follow-Up Studies; Hemorrhage; Humans; International Normalized Ratio; Maryland; Middle Aged; Morbidity; Peripheral Vascular Diseases; Popliteal Artery; Postoperative Complications; Prospective Studies; Time; Treatment Outcome; Vascular Patency; Vascular Surgical Procedures; Warfarin | 2002 |
Antithrombotic treatment and the incidence of angina pectoris.
Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Cohort Studies; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Fibrinolytic Agents; Humans; Male; Middle Aged; Warfarin | 2002 |
Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; beta-Thromboglobulin; Blood Platelets; Cell Count; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Octoxynol; P-Selectin; Predictive Value of Tests; Reference Values; Warfarin | 2002 |
Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Topics: Ambulatory Care; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Cost-Benefit Analysis; Dalteparin; Decision Support Techniques; Drug Costs; Elective Surgical Procedures; Enoxaparin; Fibrinolytic Agents; Hemorrhage; Humans; Markov Chains; Models, Theoretical; Postoperative Complications; Postoperative Period; Recurrence; Thrombosis; Warfarin | 2002 |
Thrombosis prevention trial: follow-up study of practical implications.
Topics: Anticoagulants; Aspirin; Double-Blind Method; Family Practice; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2002 |
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Demography; Double-Blind Method; Echocardiography, Transesophageal; Follow-Up Studies; Heart Septal Defects, Atrial; Humans; Middle Aged; Risk Factors; Secondary Prevention; Stroke; Treatment Outcome; Warfarin | 2002 |
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial.
Topics: Aged; Anticoagulants; Aspirin; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Netherlands; Risk Factors; Stroke; Warfarin | 2002 |
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Follow-Up Studies; Humans; International Normalized Ratio; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Ticlopidine; Treatment Outcome; Warfarin | 2002 |
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
Topics: Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Disease-Free Survival; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Treatment Outcome | 2002 |
Warfarin, aspirin, or both after myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Disease-Free Survival; Drug Therapy, Combination; Female; Hemorrhage; Humans; Intracranial Thrombosis; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Secondary Prevention; Warfarin | 2002 |
A randomized trial assessing the effect of coumarins started before coronary angioplasty on restenosis: results of the 6-month angiographic substudy of the Balloon Angioplasty and Anticoagulation Study (BAAS).
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Thrombosis; Coumarins; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Premedication; Secondary Prevention; Treatment Outcome | 2003 |
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Coronary Artery Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Warfarin | 2002 |
Warfarin and aspirin give more benefit than aspirin alone but also more bleeding after myocardial infarction.
Topics: Aged; Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; International Normalized Ratio; Myocardial Infarction; Norway; Randomized Controlled Trials as Topic; Treatment Outcome; Warfarin | 2003 |
Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Double-Blind Method; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Stroke; Warfarin; Withholding Treatment | 2003 |
Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect.
Topics: Anticoagulants; Aspirin; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Warfarin | 2003 |
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Incidence; International Normalized Ratio; Multicenter Studies as Topic; Patient Selection; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sample Size; Stroke; Warfarin | 2003 |
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Topics: Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Angiography; Coronary Stenosis; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Factor Xa; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Lipoproteins; Male; Middle Aged; Statistics as Topic; Stents; Thromboplastin; Thrombosis; Ticlopidine; Time Factors; Warfarin | 2003 |
Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.
Topics: Aged; Anticoagulants; Aspirin; Canada; Cataract Extraction; Eye Hemorrhage; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Thromboembolism; United States; Warfarin | 2003 |
Influence of aspirin on inflammatory markers in patients after acute myocardial infarction.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Inflammation; Interleukin-10; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Time; Tumor Necrosis Factor-alpha; Warfarin | 2003 |
Soluble tissue factor as predictor of future events in patients with acute myocardial infarction.
Topics: Adult; Aged; Aspirin; Biomarkers; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Regression Analysis; Thromboplastin; Warfarin | 2003 |
Stroke prevention in hospitalized patients with atrial fibrillation: a population-based study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Utilization; Female; Fibrinolytic Agents; Humans; Inpatients; Male; Prospective Studies; Stroke; Warfarin | 2003 |
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
Topics: Aged; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Cohort Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Survival Analysis; Thrombosis; Warfarin | 2004 |
Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
Topics: Aged; Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemorrhage; Humans; International Normalized Ratio; Long-Term Care; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Stroke; Treatment Outcome; Warfarin | 2004 |
An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475].
Topics: Accidental Falls; Aged; Aged, 80 and over; Aspirin; Blood Pressure Determination; Chemoprevention; Community-Institutional Relations; Drug Utilization; Evidence-Based Medicine; Female; Geriatric Nursing; Homes for the Aged; Humans; Male; Nursing Homes; Pharmacists; Psychotropic Drugs; South Australia; Stroke; Warfarin | 2004 |
Effect of aspirin and warfarin therapy in stroke patients with valvular strands.
Topics: Adult; Aged; Aortic Valve; Aspirin; Echocardiography, Transesophageal; Endpoint Determination; Fibrinolytic Agents; Humans; Male; Middle Aged; Mitral Valve; Recurrence; Stroke; Warfarin | 2004 |
Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction.
Topics: Adult; Aged; Aspirin; Biomarkers; Blood Coagulation Factors; Drug Therapy, Combination; Female; Hemostasis; Humans; International Normalized Ratio; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Solubility; Thromboplastin; Time Factors; Warfarin | 2004 |
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.
Topics: Adult; Aged; Anticoagulants; Aspirin; Clopidogrel; Embolism; Female; Heart Failure; Humans; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Research Design; Ticlopidine; Warfarin | 2004 |
Watching the WATCH trial: the role of sponsors and data monitoring committees.
Topics: Anticoagulants; Aspirin; Clinical Trials Data Monitoring Committees; Clopidogrel; Heart Failure; Humans; Platelet Aggregation Inhibitors; Research Design; Research Support as Topic; Ticlopidine; Warfarin | 2004 |
Predictors of stroke in patients paced for sick sinus syndrome.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiac Pacing, Artificial; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Risk Factors; Sick Sinus Syndrome; Statistics as Topic; Stroke; Treatment Outcome; Warfarin | 2004 |
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.
Topics: Aged; Anticoagulants; Aspirin; Cardiomyopathy, Dilated; Feasibility Studies; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2004 |
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Bleeding Time; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Electric Countershock; Female; Humans; International Normalized Ratio; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Thromboembolism; Thromboxane B2; Ticlopidine; Warfarin | 2004 |
Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Double-Blind Method; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Septal Defects, Atrial; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk; Survival Analysis; Treatment Outcome; Warfarin | 2004 |
Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass.
Topics: Aged; Aged, 80 and over; Anastomosis, Surgical; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Iliac Artery; Ischemia; Limb Salvage; Lower Extremity; Male; Middle Aged; Platelet Aggregation Inhibitors; Polytetrafluoroethylene; Popliteal Artery; Prospective Studies; Prosthesis Design; Reoperation; Tibial Arteries; Time Factors; Treatment Outcome; Vascular Patency; Warfarin | 2004 |
Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Disease-Free Survival; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Incidence; Life Tables; Male; Middle Aged; Postoperative Complications; Prospective Studies; Survival Analysis; Thromboembolism; Warfarin | 2004 |
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Atrial Fibrillation; Blood Loss, Surgical; Cohort Studies; Dalteparin; Elective Surgical Procedures; Feasibility Studies; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Intraoperative Complications; Postoperative Complications; Postoperative Hemorrhage; Premedication; Preoperative Care; Prospective Studies; Risk; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2004 |
High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prognosis; Recurrence; Risk Factors; Thrombolytic Therapy; Warfarin | 2004 |
Factors associated with development of stroke long-term after myocardial infarction: experiences from the LoWASA trial.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Female; Follow-Up Studies; Humans; Hypertension; Male; Myocardial Infarction; Proportional Hazards Models; Regression Analysis; Risk Factors; Smoking; Stroke; Time Factors; Warfarin | 2005 |
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cardiovascular Diseases; Double-Blind Method; Female; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Secondary Prevention; Stroke; Warfarin | 2005 |
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Topics: Administration, Oral; Adult; Algorithms; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Fibrinolytic Agents; Humans; International Normalized Ratio; Male; Middle Aged; Odds Ratio; Recurrence; Risk; Statistics as Topic; Thromboembolism; Thrombosis; Time Factors; Treatment Outcome; Warfarin | 2005 |
Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Humans; Male; P-Selectin; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ventricular Dysfunction, Left; von Willebrand Factor; Warfarin | 2005 |
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Life Tables; Male; Middle Aged; Risk; Stroke; Thromboembolism; Warfarin | 2005 |
Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Finasteride; Hemoglobins; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Renal Insufficiency; Risk; Time Factors; Transurethral Resection of Prostate; Urethra; Warfarin | 2005 |
Antithrombotic therapy practices in US hospitals in an era of practice guidelines.
Topics: Aged; Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Humans; Incidence; Inpatients; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Thromboembolism; Treatment Outcome; United States; Warfarin | 2005 |
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Hematuria; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Occult Blood; Prospective Studies; Risk Factors; Treatment Outcome; Warfarin | 2006 |
Aspirin, warfarin and a thienopyridine for acute coronary syndromes.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Male; Pyridines; Risk Factors; Syndrome; Ticlopidine; Ventricular Function; Warfarin | 2006 |
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Circulation; Constriction, Pathologic; Female; Humans; Intracranial Arterial Diseases; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Stroke; Warfarin | 2006 |
Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
Topics: Anticoagulants; Aspirin; Cardiac Output, Low; Double-Blind Method; Female; Goals; Humans; Platelet Aggregation Inhibitors; Research Design; Stroke Volume; Warfarin | 2006 |
Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Cohort Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Treatment Outcome; Warfarin | 2006 |
Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Arterial Diseases; Cerebrovascular Disorders; Constriction, Pathologic; Coumarins; Female; Humans; Male; Middle Cerebral Artery; Platelet Aggregation Inhibitors; Treatment Outcome | 2006 |
Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Cardiac Output, Low; Cardiomyopathy, Dilated; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Placebos; Thromboembolism; Warfarin | 2006 |
[The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Follow-Up Studies; Humans; Male; Middle Aged; Warfarin | 2006 |
A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Blood Pressure; Cross-Sectional Studies; Female; Humans; Hypertension; Male; Prevalence; Stroke; Warfarin | 2007 |
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Arterial Diseases; Constriction, Pathologic; Female; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; United States; Warfarin | 2006 |
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2007 |
[Prevention of ischemic stroke in middle aged patients with atrial fibrillation. Effect of sinus rhythm maintenance, aspirin, warfarin, and simvastatin].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Contraction; Platelet Aggregation Inhibitors; Simvastatin; Sinoatrial Node; Treatment Outcome; Warfarin | 2007 |
Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis.
Topics: Aged; Anticoagulants; Aspirin; Constriction, Pathologic; Female; Humans; Intracranial Arterial Diseases; Kaplan-Meier Estimate; Life Style; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Sex Factors; Stroke; Treatment Outcome; Warfarin | 2007 |
A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial.
Topics: Aged; Anticoagulants; Anxiety; Aspirin; Atrial Fibrillation; Conflict, Psychological; Decision Making, Computer-Assisted; Decision Support Systems, Clinical; England; Female; Fibrinolytic Agents; Gambling; Humans; Logistic Models; Male; Patient Education as Topic; Patient Participation; Risk Assessment; Risk Factors; Warfarin | 2007 |
Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease.
Topics: Angiogenesis Inhibitors; Anticoagulants; Aspirin; Cell Proliferation; Cells, Cultured; Child; Child, Preschool; Coronary Aneurysm; Dexamethasone; Endothelium, Vascular; Glucocorticoids; Heparin; Humans; Immunoglobulins, Intravenous; Infant; Mucocutaneous Lymph Node Syndrome; Neovascularization, Physiologic; Prednisolone; Serum; Severity of Illness Index; Umbilical Veins; Warfarin | 2007 |
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Aspirin; Atherosclerosis; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2007 |
Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LI
Topics: Aged; Anticoagulants; Aortic Valve; Aspirin; Female; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Mitral Valve; Pilot Projects; Postoperative Hemorrhage; Postoperative Period; Prospective Studies; Warfarin | 2007 |
Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
Topics: Adult; Aged; Anticoagulants; Aspirin; Constriction, Pathologic; Female; Humans; Intracranial Arteriosclerosis; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke; Time Factors; Warfarin | 2007 |
[Warfarin in the treatment of antiphospholipid syndrome].
Topics: Anticoagulants; Antiphospholipid Syndrome; Aryl Hydrocarbon Hydroxylases; Aspirin; Blood Coagulation; Cerebrovascular Circulation; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genetic Variation; Humans; Male; Polymerase Chain Reaction; Thrombosis; Treatment Outcome; Warfarin | 2007 |
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Fibrillation; Female; Follow-Up Studies; Humans; International Normalized Ratio; Male; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke; Warfarin | 2007 |
Impact of valvular thickness on stroke recurrence in medically treated patients with stroke.
Topics: Adult; Aged; Aortic Valve; Aspirin; Brain Ischemia; Double-Blind Method; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Mitral Valve; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Warfarin | 2007 |
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Dabigatran; Female; Fibrin Fibrinogen Degradation Products; Humans; International Normalized Ratio; Liver Function Tests; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Pyridines; Thromboembolism; Warfarin | 2007 |
Stroke prevention: age alone does not rule out warfarin.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Drug Monitoring; Female; Humans; International Normalized Ratio; Myocardial Infarction; Warfarin | 2007 |
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Treatment Outcome; Warfarin | 2007 |
Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Topics: Aged; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Female; Heart Valve Prosthesis; Humans; Male; Pilot Projects; Postoperative Care; Thrombosis; Warfarin | 2007 |
Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cause of Death; Cerebral Hemorrhage; Cerebral Infarction; Cohort Studies; Death, Sudden, Cardiac; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Netherlands; Proportional Hazards Models; Risk Factors; Warfarin | 2008 |
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clinical Protocols; Clopidogrel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Irbesartan; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin | 2008 |
Less benefit from warfarin in diabetics after myocardial infarction?
Topics: Aged; Anticoagulants; Aspirin; Confounding Factors, Epidemiologic; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Risk Factors; Stroke; Survival Analysis; Thromboembolism; Treatment Outcome; Warfarin | 2008 |
Lack of complications in minor skin lesion excisions in patients taking aspirin or warfarin products.
Topics: Aged; Anticoagulants; Aspirin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Skin Diseases; Surgical Wound Dehiscence; Warfarin | 2008 |
Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Drug Therapy, Combination; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombin; Warfarin | 2009 |
Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS).
Topics: Anticoagulants; Aortic Dissection; Aspirin; Clinical Protocols; Clopidogrel; Diagnostic Imaging; Dipyridamole; Drug Therapy, Combination; Endpoint Determination; Feasibility Studies; Heparin; Humans; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Quality Assurance, Health Care; Research Design; Sample Size; Single-Blind Method; Stroke; Ticlopidine; United Kingdom; Warfarin | 2007 |
Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis.
Topics: Aged; Anticoagulants; Aspirin; Black People; Canada; Cerebral Angiography; Constriction, Pathologic; Double-Blind Method; Endpoint Determination; Female; Hemodynamics; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Racial Groups; Risk Factors; Socioeconomic Factors; United States; Warfarin; White People | 2009 |
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis.
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Constriction, Pathologic; Double-Blind Method; Endpoint Determination; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Treatment Outcome; Warfarin | 2009 |
Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
Topics: Aged; Anticoagulants; Aspirin; Coronary Occlusion; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Treatment Outcome | 2009 |
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Chronic Disease; Clopidogrel; Death; Double-Blind Method; Female; Fibrinolytic Agents; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Stroke; Stroke Volume; Ticlopidine; Warfarin | 2009 |
Aortic arch plaques and risk of recurrent stroke and death.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Aortic Diseases; Aspirin; Atherosclerosis; Death; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Risk; Secondary Prevention; Stroke; Treatment Outcome; Warfarin | 2009 |
Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Brain Ischemia; Cerebral Arteries; Cerebrovascular Disorders; Constriction, Pathologic; Double-Blind Method; Embolism; Endpoint Determination; Humans; Platelet Aggregation Inhibitors; Recurrence; Stents; Stroke; Warfarin | 2009 |
Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation Factors; Blood Coagulation Tests; Calibration; Drug Monitoring; Factor IX; Factor VII; Factor X; Female; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Middle Aged; Prothrombin; Sensitivity and Specificity; Thrombin; Thrombophilia; Warfarin | 2009 |
Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2009 |
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Embolism; Feasibility Studies; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Ontario; Platelet Aggregation Inhibitors; Recurrence; Stroke; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left; Warfarin | 2010 |
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Administration Schedule; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Research Design; Retreatment; Stroke; Treatment Failure; Vitamin K; Warfarin | 2010 |
Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiology; Decision Making; Follow-Up Studies; Heart Rate; Humans; Incidence; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome; Warfarin; Workforce | 2010 |
[Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aryl Hydrocarbon Hydroxylases; Aspirin; Blood Coagulation; Cytochrome P-450 CYP2C9; Drug Therapy, Combination; Female; Genetic Variation; Hemorrhage; Humans; Male; Mixed Function Oxygenases; Secondary Prevention; Thrombosis; Vitamin K Epoxide Reductases; Warfarin | 2010 |
Warfarin or aspirin in embolism prevention in patients with mitral valvulopathy and atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Bioprosthesis; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Medication Adherence; Mitral Valve Insufficiency; Prospective Studies; Risk Factors; Thromboembolism; Warfarin | 2010 |
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cardiovascular Diseases; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Italy; Male; Middle Aged; Multiple Myeloma; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thalidomide; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2011 |
Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Humans; International Normalized Ratio; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Stroke; Treatment Outcome; Warfarin | 2011 |
A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Venous Thromboembolism; Warfarin | 2012 |
Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Blood Pressure; Case-Control Studies; Databases, Factual; Female; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Male; Models, Cardiovascular; Platelet Aggregation Inhibitors; Pyridines; Risk; Sex Factors; Warfarin | 2011 |
A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
Topics: Anticoagulants; Aspirin; Child; Child, Preschool; Echocardiography; Female; Fontan Procedure; Heparin; Humans; International Cooperation; Male; Thromboembolism; Thrombosis; Treatment Outcome; Warfarin | 2011 |
Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement.
Topics: Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; International Normalized Ratio; Male; Prothrombin Time; Thromboembolism; Treatment Outcome; Warfarin; Young Adult | 2011 |
Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation; Canada; Chi-Square Distribution; Chronic Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Time Factors; Treatment Outcome; United States; Warfarin | 2011 |
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prostheses and Implants; Secondary Prevention; Stroke; Ticlopidine; Warfarin; Young Adult | 2012 |
Warfarin and aspirin in patients with heart failure and sinus rhythm.
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Stroke; Stroke Volume; Treatment Outcome; Warfarin | 2012 |
Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.
Topics: Administration, Oral; Aged; Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Comorbidity; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Logistic Models; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Popliteal Artery; Proportional Hazards Models; Prospective Studies; Ticlopidine; Treatment Outcome; Vascular Patency; Warfarin | 2012 |
Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Collagen; Coronary Artery Bypass; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Infarction, Middle Cerebral Artery; Male; Middle Aged; P-Selectin; Platelet Activation; Postoperative Complications; Prospective Studies; Ultrasonography, Doppler, Transcranial; Warfarin | 2012 |
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Contraindications; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Factors; Stroke; Vitamin K; Warfarin | 2012 |
Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
Topics: Anticoagulants; Aspirin; Child; Child, Preschool; Female; Fontan Procedure; Humans; Male; Postoperative Complications; Thrombosis; Tricuspid Atresia; Warfarin | 2013 |
Anticoagulation therapy in Chinese patients with non-valvular atrial fibrillation: a prospective, multi-center, randomized, controlled study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Warfarin | 2012 |
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Embolism; Female; Follow-Up Studies; Humans; Male; Prostheses and Implants; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2013 |
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.
Topics: Aged; Anticoagulants; Aspirin; Biomarkers; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Treatment Outcome; Warfarin | 2013 |
Anterior chamber bleeding after laser peripheral iridotomy.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anticoagulants; Aspirin; Clopidogrel; Eye Color; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Hyphema; Incidence; Intraocular Pressure; Iridectomy; Iris; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Risk Factors; Ticlopidine; Tonometry, Ocular; Warfarin | 2013 |
[Prevention of non-acute stent thrombosis after drug-eluting stent implantation].
Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Warfarin | 2013 |
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Data Interpretation, Statistical; Databases, Bibliographic; Double-Blind Method; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2013 |
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.
Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Stroke; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left; Warfarin | 2013 |
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications; Prospective Studies; Thrombosis; Treatment Outcome; Warfarin | 2014 |
Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES Trial.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Costs and Cost Analysis; Female; Humans; Male; Pyrazoles; Pyridones; Warfarin | 2015 |
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Embolism; Female; Humans; Kaplan-Meier Estimate; Male; Morpholines; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Therapy, Combination; Embolism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Stroke; Treatment Outcome; Warfarin | 2014 |
Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
Topics: Anticoagulants; Aortic Valve; Aspirin; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Prospective Studies; Thromboembolism; United States; United States Food and Drug Administration; Warfarin | 2014 |
Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
Topics: Aged; Aged, 80 and over; Aging; Anticoagulants; Aspirin; Atrial Fibrillation; Cognition Disorders; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Time Factors; Treatment Outcome; Warfarin | 2014 |
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aorta, Thoracic; Aortic Diseases; Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Embolism; Female; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Prospective Studies; Single-Blind Method; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complications.
Topics: Age Factors; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation; China; Coronary Disease; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Prospective Studies; Stroke; Time Factors; Treatment Outcome; Warfarin | 2014 |
Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Sex Factors; Treatment Outcome; Venous Thromboembolism; Warfarin | 2014 |
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
Topics: Aged; Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Heart Failure; Humans; Male; Middle Aged; Recurrence; Stroke; Stroke Volume; Warfarin | 2014 |
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.
Topics: Age Factors; Aged; Aspirin; Body Mass Index; Cognition; Cross-Sectional Studies; Educational Status; Exercise Tolerance; Female; Fibrinolytic Agents; Heart Failure, Systolic; Humans; Male; Middle Aged; Multivariate Analysis; Outpatients; Retrospective Studies; Severity of Illness Index; Smoking; Stroke Volume; Ventricular Function, Left; Walking; Warfarin | 2014 |
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial.
Topics: Aged; Anticoagulants; Aspirin; Cohort Studies; Female; Heart Failure; Humans; Male; Middle Aged; Quality of Life; Stroke Volume; Surveys and Questionnaires; Warfarin | 2014 |
Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Male; Postoperative Complications; Prothrombin Time; Warfarin | 2014 |
Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
Topics: Adenosine; Adolescent; Adult; Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Research Design; Ticagrelor; Ticlopidine; Warfarin; Young Adult | 2015 |
Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin.
Topics: Adolescent; Adult; Anticoagulants; Antidepressive Agents; Area Under Curve; Aspirin; Blood Coagulation; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Female; Healthy Volunteers; Humans; International Normalized Ratio; Male; Middle Aged; Piperazines; Platelet Aggregation; Sulfides; Vortioxetine; Warfarin; Young Adult | 2015 |
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Chi-Square Distribution; Double-Blind Method; Drug Monitoring; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Stroke; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left; Warfarin | 2015 |
Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention.
Topics: Adenosine; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Percutaneous Coronary Intervention; Research Design; Rivaroxaban; Ticagrelor; Ticlopidine; Warfarin | 2015 |
The effects of JAK inhibitor therapy upon novel markers of thrombosis In myeloproliferative neoplasms.
Topics: Aspirin; Biomarkers; Female; Hematologic Neoplasms; Humans; Janus Kinase 2; Male; Middle Aged; Nitriles; Polycythemia Vera; Pyrazoles; Pyrimidines; Pyrrolidines; Sulfonamides; Thrombocythemia, Essential; Thrombosis; Warfarin | 2015 |
Thromboembolism Prophylaxis in Hip Arthroplasty: Routine and High Risk Patients.
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Female; Hemorrhage; Humans; Incidence; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Missouri; Postoperative Period; Prospective Studies; Risk Assessment; Venous Thromboembolism; Warfarin | 2015 |
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
Topics: Aged; Anticoagulants; Aspirin; Female; Heart Failure; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Assessment; Stroke; Stroke Volume; Ventricular Dysfunction, Left; Warfarin | 2015 |
Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Bevacizumab; Cardiovascular Diseases; Clopidogrel; Female; Fluorescein Angiography; Humans; Hypertension; Intravitreal Injections; Male; Odds Ratio; Platelet Aggregation Inhibitors; Ranibizumab; Retinal Hemorrhage; Risk Factors; Ticlopidine; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Warfarin; Wet Macular Degeneration | 2016 |
The first prognostic model for stroke and death in patients with systolic heart failure.
Topics: Aged; Algorithms; Anticoagulants; Area Under Curve; Aspirin; Cause of Death; Double-Blind Method; Female; Heart Failure, Systolic; Humans; Male; Middle Aged; Models, Statistical; Prognosis; Risk Assessment; Risk Factors; Stroke; Warfarin | 2016 |
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial.
Topics: Age Factors; Aged; Aspirin; Atrial Fibrillation; Echocardiography; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Stroke Volume; Warfarin | 2016 |
Comparison of Aspirin and Naoxintong Capsule () with Adjusted-Dose Warfarin in Elderly Patients with High-Risk of Non-Valvular Atrial Fibrillation and Genetic Variants of Vitamin K Epoxide Reductase.
Topics: Aged; Aspirin; Atrial Fibrillation; Base Sequence; Capsules; Drugs, Chinese Herbal; Endpoint Determination; Female; Genetic Variation; Humans; Male; Risk Factors; Treatment Outcome; Vitamin K Epoxide Reductases; Warfarin | 2018 |
Economic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve Prostheses.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Cost-Benefit Analysis; Drug Therapy, Combination; Egypt; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Thromboembolism; Warfarin; Young Adult | 2016 |
Anticoagulation Therapy with Warfarin Versus Low-Dose Aspirin Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Azygos Vein; Female; Heparin, Low-Molecular-Weight; Humans; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Postoperative Complications; Retrospective Studies; Splenectomy; Treatment Outcome; Venous Thrombosis; Warfarin; Young Adult | 2016 |
Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Postoperative Complications; Prospective Studies; Thromboembolism; Thrombosis; Warfarin | 2017 |
Mobile pump deep vein thrombosis prophylaxis: just say no to drugs.
Topics: Adult; Aged; Ambulatory Care; Anticoagulants; Arthroplasty, Replacement; Aspirin; Combined Modality Therapy; Humans; Intermittent Pneumatic Compression Devices; Middle Aged; Postoperative Care; Postoperative Hemorrhage; Risk Assessment; Venous Thromboembolism; Venous Thrombosis; Warfarin; Young Adult | 2017 |
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers.
Topics: Adult; Anticoagulants; Aspirin; Blood Platelets; Carboxylic Acids; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Middle Aged; Platelet Function Tests; Simvastatin; Warfarin; Young Adult | 2017 |
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazoles; Pyridones; Warfarin | 2017 |
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Stroke Volume; Warfarin | 2017 |
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Topics: Adenosine; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk; Ticagrelor; Ticlopidine; Warfarin | 2017 |
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Quality of Health Care; Risk Factors; Treatment Outcome; Warfarin | 2018 |
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Drug Monitoring; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Proportional Hazards Models; Pyrazoles; Pyridones; Stroke; Warfarin | 2018 |
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rat
Topics: Acute Coronary Syndrome; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Selection; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2018 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Thromboembolism; Warfarin | 2018 |
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment.
Topics: Anticoagulants; Argentina; Aspirin; Canada; Cardiac Volume; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Atria; Heart Failure, Systolic; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke Volume; Survival Rate; Thromboembolism; Treatment Outcome; United States; Warfarin | 2018 |
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Quality of Life; Severity of Illness Index; Stroke Volume; Thromboembolism; Treatment Outcome; Warfarin | 2018 |
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Norway; Pharmacoepidemiology; Risk Factors; Rivaroxaban; Thrombosis; Warfarin | 2018 |
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Elective Surgical Procedures; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Ticagrelor; Warfarin | 2019 |
Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carotid Artery, Internal, Dissection; Clopidogrel; Dipyridamole; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke; Treatment Outcome; Vertebral Artery Dissection; Warfarin; Young Adult | 2019 |
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.
Topics: Aged; Anticoagulants; Aspirin; Cardiomyopathies; Cause of Death; Defibrillators, Implantable; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Propensity Score; Radionuclide Ventriculography; Retrospective Studies; Risk Factors; Stroke Volume; Survival Rate; United States; Ventricular Function, Left; Warfarin | 2019 |
Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aspirin; Female; Humans; Incidence; Laparoscopy; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Postoperative Complications; Splenectomy; Venous Thrombosis; Warfarin | 2019 |
Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Viscosity; Female; Humans; Male; Middle Aged; Prospective Studies; Stroke; Warfarin | 2019 |
Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.
Topics: Administration, Oral; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Canada; Defibrillators, Implantable; Drug Therapy, Combination; Follow-Up Studies; Hematoma; Incidence; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Single-Blind Method; Thromboembolism; Warfarin | 2019 |
Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Female; Florida; Humans; Male; Puerto Rico; Registries; Stroke; Warfarin | 2019 |
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Substitution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Warfarin | 2019 |
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Diabetes Mellitus; Drug Substitution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Warfarin | 2019 |
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Dual Anti-Platelet Therapy; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Stents; Thromboembolism; Ticagrelor; Time Factors; Treatment Outcome; Warfarin | 2020 |
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
Topics: Administration, Oral; Aspirin; Atrial Fibrillation; Atrial Flutter; Bioprosthesis; Brazil; Cause of Death; Creatinine; Embolism; Factor Xa Inhibitors; Heart Valve Prosthesis; Hemorrhage; Hospitalization; Humans; Ischemic Attack, Transient; Mitral Valve; Rivaroxaban; Sample Size; Stroke; Surgical Procedures, Operative; Thrombosis; Treatment Outcome; Warfarin | 2021 |
New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry.
Topics: Aged; Aspirin; Atrial Fibrillation; Coronary Artery Bypass; Coronary Artery Disease; Factor Xa Inhibitors; Female; Humans; Long Term Adverse Effects; Male; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Postoperative Complications; Sweden; Thromboembolism; Time-to-Treatment; Warfarin | 2021 |
Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients.
Topics: Aortic Valve; Aortic Valve Stenosis; Aspirin; Heart Valve Prosthesis; Humans; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome; United States; Warfarin | 2021 |
Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
Topics: Acenocoumarol; Adult; Anticoagulants; Aspirin; Carotid Artery, Internal, Dissection; Denmark; Female; Germany; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Stroke; Switzerland; Vertebral Artery Dissection; Warfarin | 2021 |
Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.
Topics: Aspirin; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Treatment Outcome; Warfarin | 2021 |
Assessment of the Potential for Veverimer Drug-Drug Interactions.
Topics: Absorption, Physicochemical; Acidosis; Administration, Oral; Adolescent; Adult; Aspirin; Cross-Over Studies; Dabigatran; Drug Interactions; Ethacrynic Acid; Female; Furosemide; Gastrointestinal Absorption; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Polymers; Polypharmacy; Renal Insufficiency, Chronic; Solubility; Warfarin; Young Adult | 2021 |
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Percutaneous Coronary Intervention; Prospective Studies; Pyrazoles; Pyridones; Stroke; Thromboembolism; Warfarin | 2022 |
Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-Up.
Topics: Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Aspirin; Follow-Up Studies; Heart Valve Prosthesis; Humans; Transcatheter Aortic Valve Replacement; Treatment Outcome; Warfarin | 2023 |
1274 other study(ies) available for aspirin and warfarin
| Article | Year |
|---|---|
Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.
Topics: Absorption; Adsorption; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Permeability; Pharmacokinetics; Spectrophotometry, Ultraviolet | 1998 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Synthesis of novel 3-carboxamide-benzocoumarin derivatives as orally active antithrombotic agents.
Topics: Administration, Oral; Animals; Aspirin; Blood Coagulation; Coumarins; Fibrinolytic Agents; Mice; Molecular Structure; Warfarin | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids: discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype.
Topics: Acetates; Benzene; Humans; Imidazoles; Molecular Structure; Receptors, Immunologic; Receptors, Prostaglandin; Structure-Activity Relationship; Sulfhydryl Compounds | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagon
Topics: Administration, Oral; Animals; Biological Availability; Dogs; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Indoles; Male; Naphthalenes; Rats; Rats, Wistar; Receptors, Immunologic; Receptors, Prostaglandin; Structure-Activity Relationship; Substrate Specificity | 2013 |
Novel 2-aminobenzamides as potential orally active antithrombotic agents.
Topics: | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Discovery of novel (6S/12aS)-heptachpyridone capable of inhibiting thrombosis in vivo.
Topics: Animals; Blood; Carbazoles; Diketopiperazines; Fibrinolytic Agents; Hydrolysis; Male; Rats, Sprague-Dawley; Vena Cava, Inferior; Venous Thrombosis | 2020 |
Effects of antacids on gastrointestinal absorption of drugs.
Topics: Animals; Antacids; Aspirin; Chlordiazepoxide; Chlorpromazine; Dicumarol; Digitoxin; Digoxin; Ephedrine; Guinea Pigs; Humans; Intestinal Absorption; Iron; Isoniazid; Levodopa; Naproxen; Pentobarbital; Pharmaceutical Preparations; Quinidine; Quinine; Rats; Sulfadiazine; Tetracyclines; Warfarin | 1976 |
Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.
Topics: Anticoagulants; Aspirin; Chlordiazepoxide; Drug Therapy, Combination; Ethacrynic Acid; Gastrointestinal Hemorrhage; Glucocorticoids; Heparin; Humans; Nitrofurantoin; Warfarin | 1978 |
Pulmonary embolism prophylaxis in the orthopaedic and trauma patient.
Topics: Arthroplasty; Aspirin; Dextrans; Femoral Neck Fractures; Heparin; Hip Joint; Humans; Postoperative Complications; Pulmonary Embolism; Warfarin | 1976 |
The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice.
Topics: Age Factors; Animals; Antineoplastic Agents; Aspirin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Female; Immunosuppression Therapy; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Metastasis; Neoplasm Transplantation; Plicamycin; Radiation Effects; Sarcoma, Experimental; Warfarin | 1977 |
[Studies on the influence of anticoagulants on metastase formation of autochthonic hepatomas in the rat (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Carcinoma, Hepatocellular; Coumarins; Diethylnitrosamine; Female; Hemangioendothelioma; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Phenprocoumon; Rats | 1975 |
The application of basic principles of drug interaction to clinical practice.
Topics: Aged; Aspirin; Binding Sites; Binding, Competitive; Depression, Chemical; Drug Interactions; Drug Synergism; Drug Therapy; Gastrointestinal Hemorrhage; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Kidney; Kinetics; Liver; Male; Pharmaceutical Preparations; Phenylbutazone; Protein Binding; Receptors, Drug; Stimulation, Chemical; Warfarin | 1975 |
Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery.
Topics: Aged; Aspirin; Coronary Artery Bypass; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Care; Warfarin | 1978 |
[Conservative therapy of peripheral arterial occlusive diseases. Possibilities and basic principles].
Topics: Arterial Occlusive Diseases; Aspirin; Coumarins; Dextrans; Digoxin; Exercise Therapy; Humans; Vasodilator Agents | 1978 |
Our experience with the Carpentier-Edwards bioprosthesis.
Topics: Adolescent; Adult; Aged; Aortic Valve; Aspirin; Bioprosthesis; Child; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Postoperative Complications; Pulmonary Valve; Rehabilitation, Vocational; Tricuspid Valve; Warfarin | 1979 |
Kawasaki disease: effect of treatment on coronary artery involvement.
Topics: Aspirin; Cephalexin; Child, Preschool; Coronary Angiography; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Heart Aneurysm; Humans; Infant; Lymphatic Diseases; Mucocutaneous Lymph Node Syndrome; Prednisolone; Warfarin | 1979 |
[Prevention and therapy with anticoagulants. Indications, experiences, results].
Topics: Anticoagulants; Aspirin; Blood Coagulation; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis | 1979 |
Thromboembolic complications after mitral valve replacement with Hancock xenograft.
Topics: Adolescent; Adult; Aged; Animals; Aortic Valve; Aspirin; Atrial Fibrillation; Blood Vessel Prosthesis; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Mitral Valve; Postoperative Complications; Swine; Thromboembolism; Transplantation, Heterologous; Warfarin | 1978 |
TIA, stroke, and mitral valve prolapse.
Topics: Adult; Aged; Aspirin; Carotid Artery Thrombosis; Cerebrovascular Disorders; Dipyridamole; Echocardiography; Electrocardiography; Female; Heparin; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mitral Valve Prolapse; Recurrence; Warfarin | 1979 |
Vasotropic drugs--a survey based on a unifying concept of their mechanism of action.
Topics: Animals; Aspirin; Blood Vessels; Calcium Dobesilate; Clofibrate; Coumarins; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavonoids; Glycosides; Pyrithioxin; Rats; Rutin; Vasomotor System | 1977 |
Initial tumor cell arrest in animals of defined coagulative status.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Carcinoma; Heparin; Lymphoma, Non-Hodgkin; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Thromboplastin; Warfarin | 1978 |
Incidence of emboli with cloth-covered Starr-Edwards valve without anticoagulation and with varying forms of anticoagulation. Analysis of 183 patients followed for 3 1/2 years.
Topics: Anticoagulants; Aortic Valve; Aspirin; Connecticut; Dipyridamole; Embolism; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Complications; Warfarin | 1978 |
Trial of aspirin during weaning patients with transient ischaemic attacks from anticoagulants.
Topics: Aspirin; Humans; Ischemic Attack, Transient; Substance Withdrawal Syndrome; Warfarin | 1978 |
[Influence of Anturane on platelets aggregation. Comparative study with acetylsalicylic acid in patients with and without oral anticoagulant therapy].
Topics: Administration, Oral; Anticoagulants; Aspirin; Coumarins; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1978 |
Antithrombotic therapy. Rationale and application.
Topics: Anticoagulants; Arteries; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Coagulation Factors; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator; Veins; Warfarin | 1979 |
[Letter: Do antirheumatic and anti gout drugs modify the effect of Marcumar?].
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Aspirin; Blood Coagulation; Coumarins; Drug Interactions; Humans; Myocardial Infarction; Pyrazoles; Uricosuric Agents | 1975 |
Dynamics of thrombus formation on an artificial surface in vivo. Effects of antithrombotic agents.
Topics: Animals; Aspirin; Dextrans; Fibrinolytic Agents; Haplorhini; Silicone Elastomers; Thrombosis; Time Factors; Venae Cavae; Warfarin | 1976 |
A multifaceted approach to prevention of thromboembolism: a report of 529 cases.
Topics: Aspirin; Bandages; Dextrans; Exercise Therapy; Heparin; Hip Joint; Humans; Joint Prosthesis; Phenylbutazone; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Warfarin | 1977 |
[Transient ischemic attack].
Topics: Aspirin; Coumarins; Humans; Ischemic Attack, Transient | 1977 |
Selecting and preparing patients for total hip replacement.
Topics: Aged; Anticoagulants; Arthritis, Rheumatoid; Arthroplasty; Aspirin; Blood Coagulation; Blood Platelets; Dextrans; Follow-Up Studies; Heparin; Hip Joint; Humans; Joint Prosthesis; Osteoarthritis; Postoperative Complications; Spondylitis, Ankylosing; Vitamin K; Warfarin | 1977 |
Patency of venous grafts in small veins: influence of aspirin and warfarin sodium.
Topics: Animals; Aspirin; Drug Therapy, Combination; Female; Jugular Veins; Male; Platelet Aggregation; Postoperative Complications; Prothrombin Time; Rabbits; Radiography; Thrombosis; Transplantation, Autologous; Warfarin | 1977 |
[The value of acetylsalicylic acid for the prevention of postoperative thromboembolic complications].
Topics: Aspirin; Coumarins; Dextrans; Heparin; Humans; Postoperative Complications; Thromboembolism | 1977 |
Using antithrombotic therapy in ischemic cerebrovascular disease.
Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intracranial Embolism and Thrombosis; Ischemia; Sulfinpyrazone; Warfarin | 1977 |
Competition between diftalone and other drugs for the binding site(s) on human serum albumin.
Topics: Acetaminophen; Aspirin; Binding Sites; Dexamethasone; Drug Interactions; Humans; Indomethacin; Phenobarbital; Phenylbutazone; Phthalazines; Protein Binding; Pyridazines; Serum Albumin; Temperature; Tolbutamide; Warfarin | 1976 |
[Studies on inhibition of platelet aggregation by carbocromen (author's transl)].
Topics: Adenosine Diphosphate; Agglutination Tests; Aspirin; Chromonar; Collagen; Coumarins; Depression, Chemical; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Nephelometry and Turbidimetry; Pentosan Sulfuric Polyester; Platelet Adhesiveness; Platelet Aggregation; Time Factors | 1976 |
Haemostasis in the microvasculature of the rabbit mesentery, effects of some pharmacological agents of current interest in haemostasis and thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Dextrans; Female; Hemostasis; Heparin; Male; Mesenteric Arteries; Mesenteric Veins; Microcirculation; Rabbits; Thrombosis; Warfarin | 1976 |
[Postoperative prophylaxis of thromboembolism. Present position.(author's transl)].
Topics: Aged; Aspirin; Coumarins; Dextrans; Heparin; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Care; Thromboembolism | 1976 |
[Platelet aggregation inhibitors and anticoagulant therapy].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Drug Antagonism; Humans; Platelet Aggregation | 1976 |
[Drug prophylaxis of thromboembolism in surgical medicine].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Humans; Postoperative Complications; Thromboembolism | 1976 |
Thromboembolism following total hip-replacement arthroplasty. The efficicy of dextran-aspirin and dextran-warfarin in prophylaxis.
Topics: Arthroplasty; Aspirin; Dextrans; Drug Therapy, Combination; Female; Hip Joint; Humans; Joint Prosthesis; Male; Middle Aged; Postoperative Complications; Pulmonary Embolism; Risk; Thromboembolism; Thrombophlebitis; Warfarin | 1976 |
Detection and management of hypercoagulability.
Topics: Adult; Aged; Aspirin; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Heparin; Humans; Male; Middle Aged; Warfarin | 1976 |
Platelet survival time following aortic valve replacement.
Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Cell Survival; Chromium Radioisotopes; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Sulfinpyrazone; Thromboembolism; Time Factors; Transplantation, Autologous; Warfarin | 1975 |
Increased platelet aggregability in young patients with stroke. Diagnosis and therapy.
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cell Survival; Cerebrovascular Disorders; Contraceptives, Oral; Drug Therapy, Combination; Female; Humans; Male; Platelet Adhesiveness; Platelet Aggregation; Pregnancy; Pyridinolcarbamate; Recurrence; Sulfinpyrazone; Warfarin | 1975 |
Civilian vascular injuries.
Topics: Adolescent; Adult; Age Factors; Aged; Aneurysm; Arteries; Arteriovenous Fistula; Aspirin; Blood Vessels; Child; Child, Preschool; Colorado; Female; Heparin; Humans; Infant; Male; Methods; Middle Aged; Postoperative Complications; Radiography; Sex Factors; Thrombosis; Veins; Warfarin; Wounds and Injuries | 1975 |
Some interactions of blood with tubular biomaterials.
Topics: Animals; Aspirin; Biocompatible Materials; Blood; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Proteins; Dogs; Female; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Polyethylenes; Polyvinyl Chloride; Polyvinyls; Prothrombin Time; Silicone Elastomers; Surface Properties; Thrombin; Thromboplastin; Warfarin | 1975 |
[A case of consumption coagulopathy due to atrial giant thrombus. Detection of thrombus by scintillation camera using fibrinogen labelled with 125I, 131I and warfarin-aspirin combination therapy (author's transl)].
Topics: Aspirin; Coronary Disease; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fibrinogen; Heart Atria; Humans; Iodine Radioisotopes; Middle Aged; Radionuclide Imaging; Thrombosis; Warfarin | 1975 |
[Letter: Influence of dipyridamole and carbochromene on bleeding time in man].
Topics: Aspirin; Chromonar; Coumarins; Dipyridamole; Hemostasis; Humans; In Vitro Techniques; Platelet Adhesiveness; Platelet Aggregation | 1975 |
Proceedings: The anti-thrombotic effect of warfarin, dipyridamole and aspirin in the rat.
Topics: Animals; Aspirin; Dipyridamole; Disease Models, Animal; Rats; Thrombosis; Warfarin | 1975 |
Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Coagulation; Blood Platelets; Collagen; Dogs; Fibrinolysis; Guinea Pigs; Hemostasis; Male; Phenylbutazone; Phenylpropionates; Platelet Adhesiveness; Platelet Aggregation; Prostaglandin Antagonists; Pyrimidines; Rats; Thiophenes; Time Factors; Warfarin | 1975 |
[The thrombosis of superficial venous system].
Topics: Aged; Aspirin; Coumarins; Female; Humans; Male; Microcirculation; Middle Aged; Necrosis; Phlebography; Thrombophlebitis; Varicose Veins | 1975 |
Proceedings: The antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon in experimental thrombosis.
Topics: Animals; Aspirin; Coumarins; Heparin; Phenprocoumon; Rabbits; Thrombosis | 1975 |
[Bleeding time and cardioactive drugs. Effects of dipyridamole and carbochromen].
Topics: Aspirin; Blood Coagulation; Chromonar; Coumarins; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Time Factors | 1975 |
Adverse drug reactions. A critical review.
Topics: Anti-Bacterial Agents; Antihypertensive Agents; Aspirin; Costs and Cost Analysis; Digitalis Glycosides; Diuretics; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Hospitalization; Pharmaceutical Preparations; Prospective Studies; Steroids; Tranquilizing Agents; United States; Warfarin | 1975 |
[Proceedings: Anticoagulant prevention following gynecologist and obstetrical surgery at the University Gynecological Hospital Freiburg from 1953 to 1973].
Topics: Aspirin; Coumarins; Dextrans; Female; Germany, West; Heparin; Humans; Postoperative Complications; Retrospective Studies; Thromboembolism | 1975 |
Interference on the haemostasis in dogs with induced coagulopathies by drugs affecting the platelet function.
Topics: Afibrinogenemia; Animals; Aspirin; Batroxobin; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Dogs; Hemostasis; Peptide Hydrolases; Phenylbutazone; Warfarin | 1976 |
Does lone atrial fibrillation constitute a risk of embolization, and how should we manage it?
Topics: Age Factors; Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Embolism; Humans; Risk Factors; Warfarin | 1992 |
Secondary prevention of coronary heart disease in patients after acute myocardial infarction at the Soroka Medical Center.
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Aspirin; Calcium Channel Blockers; Clinical Protocols; Comorbidity; Contraindications; Drug Utilization; Evaluation Studies as Topic; Female; Hospitals, University; Humans; Israel; Male; Medical Audit; Middle Aged; Myocardial Infarction; Practice Patterns, Physicians'; Quality of Health Care; Recurrence; Thrombolytic Therapy; Warfarin | 1992 |
Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Topics: Aged; Antithrombin III; Aspirin; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Prothrombin; Reference Values; Thrombosis; Warfarin | 1992 |
Venous thromboembolism associated with hip and knee arthroplasty: current prophylactic practices and outcomes.
Topics: Aspirin; Bandages; Hip Prosthesis; Humans; Knee Prosthesis; Postoperative Complications; Pulmonary Embolism; Risk Factors; Thrombophlebitis; Warfarin | 1992 |
[Prevention of thrombosis after surgical interventions on the venous system].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Heparin; Humans; Postoperative Complications; Thrombectomy; Thrombophlebitis; Varicose Veins; Veins | 1992 |
Antithrombotic therapy for lower extremity bypass.
Topics: Aspirin; Humans; Ischemia; Leg; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Vascular Patency; Warfarin | 1992 |
[Prevention of thrombosis with warfarin or acetylsalicylic acid related to the risk of hemorrhage].
Topics: Aspirin; Fibrinolytic Agents; Hemorrhage; Humans; Risk Factors; Warfarin | 1992 |
Complications after intracoronary stent implantation: three cases.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Dipyridamole; Drug Administration Schedule; Electrocardiography; Exercise Test; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Premedication; Recurrence; Stents | 1992 |
Anticoagulants for atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Middle Aged; Randomized Controlled Trials as Topic; Warfarin | 1992 |
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Topics: Aged; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Retrospective Studies; Thrombosis; Warfarin | 1992 |
Cerebral ischemia associated with anticardiolipin antibodies.
Topics: Adult; Aged; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Brain Ischemia; Cardiolipins; Cerebral Infarction; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Neurologic Examination; Prednisolone; Warfarin | 1992 |
From the National Institutes of Health.
Topics: Acute Disease; Acyclovir; Administration, Oral; Antibodies, Viral; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Embolism; Humans; Immunoassay; Infectious Mononucleosis; National Institutes of Health (U.S.); Simplexvirus; United States; Warfarin | 1991 |
Aspirin, warfarin, and recurrent stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Female; Humans; Male; Middle Aged; Recurrence; Warfarin | 1991 |
Aspirin, warfarin, and recurrent stroke.
Topics: Aspirin; Cerebrovascular Disorders; Humans; Recurrence; Warfarin | 1991 |
Dysarthria and a numb hand in an elderly woman.
Topics: Aged; Aspirin; Cerebral Infarction; Dysarthria; Female; Hand; Hematoma, Subdural; Humans; Paresthesia; Thrombocytopenia; Tomography, X-Ray Computed; Warfarin | 1992 |
[Valvular heart disease].
Topics: Aortic Valve; Arrhythmias, Cardiac; Aspirin; Digitalis; Echocardiography; Electrocardiography, Ambulatory; Heart Valve Diseases; Hemodynamics; Mitral Valve; Plants, Medicinal; Plants, Toxic; Warfarin | 1991 |
Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Aspirin; Bleeding Time; Blood Platelets; Calcium; Collagen; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Thromboembolism; Ticlopidine; Warfarin | 1991 |
[Rate of recurrence following PTA of pelvic-leg arteries in relation to selected risk factors and antithrombotic after care].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Combined Modality Therapy; Coumarins; Follow-Up Studies; Humans; Ischemia; Leg; Recurrence | 1991 |
Stroke prevention in atrial fibrillation trial.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Research Design; Warfarin | 1991 |
Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Coagulation Factors; Butylated Hydroxytoluene; Collagen; Epinephrine; Male; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains; Ristocetin; Warfarin | 1991 |
A monoclonal antibody reacting with platelets for monitoring thrombolysis.
Topics: Antibodies, Monoclonal; Aspirin; Blood Coagulation; Blood Platelets; Fibrinolytic Agents; Heparin; Humans; Streptokinase; Technetium; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Warfarin | 1991 |
Atrial fibrillation and embolic stroke.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dipyridamole; Embolism; Humans; Warfarin | 1991 |
Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Cerebrovascular Disorders; Dipyridamole; Drug Administration Schedule; Follow-Up Studies; Hemorrhage; Humans; Physicians; Platelet Aggregation Inhibitors; Surveys and Questionnaires; Warfarin | 1991 |
[Thrombin as a common target of action for antithrombotic drugs in vivo].
Topics: Aspirin; Drugs, Chinese Herbal; Female; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Hirudins; Humans; Male; Thrombin; Warfarin | 1990 |
Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
Topics: Animals; Aspirin; Bleeding Time; Blood Coagulation Tests; Blood Platelets; Dogs; Hemostasis; Microspheres; Mouth Mucosa; Platelet Aggregation; von Willebrand Factor; Warfarin | 1991 |
Systemic toxicity in mice induced by localized porphyrin photodynamic therapy.
Topics: Animals; Aspirin; Blood Cell Count; Dihematoporphyrin Ether; Dose-Response Relationship, Radiation; Female; Hematoporphyrins; Indomethacin; Melanoma, Experimental; Mice; Mice, Inbred Strains; Photochemotherapy; Skin Pigmentation; Warfarin | 1990 |
Atrial fibrillation--risk marker for stroke.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Middle Aged; Warfarin | 1990 |
Superiority of warfarin over aspirin long term after thrombolytic therapy for acute myocardial infarction.
Topics: Aspirin; Drug Evaluation; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Myocardial Infarction; Regression Analysis; Time Factors; Warfarin | 1990 |
Studies on the nature of iodothyronine binding in familial dysalbuminemic hyperthyroxinemia.
Topics: Aspirin; Binding Sites; Chlorides; Female; Hot Temperature; Humans; Hydrogen-Ion Concentration; Hyperthyroxinemia; Pregnancy; Serum Albumin; Thyroxine; Triiodothyronine; Warfarin | 1990 |
Prevention of stroke in atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Warfarin | 1990 |
Perioperative stroke risk in 173 consecutive patients with a past history of stroke.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anesthesia, General; Aspirin; Cerebrovascular Disorders; Female; Heparin; Humans; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Surgical Procedures, Operative; Warfarin | 1990 |
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
[Reevaluation of postoperative thrombosis prevention].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Dihydroergotamine; Heparin; Humans; Postoperative Complications; Pressure; Risk; Thrombosis | 1985 |
Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.
Topics: Adult; Aspirin; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Humans; Life Tables; Meta-Analysis as Topic; Prednisone; Survival Rate; Time Factors; United States; Warfarin | 1989 |
Risk associated with heparin withdrawal in ischaemic cerebrovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Drug Therapy, Combination; Female; Heparin; Humans; Ischemic Attack, Transient; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Warfarin | 1989 |
[A case of mitral stenosis with left atrial thrombus arose and reduced in a short-term].
Topics: Aspirin; Female; Heart Atria; Heart Diseases; Humans; Middle Aged; Mitral Valve Stenosis; Thrombosis; Ultrasonography; Warfarin | 1989 |
[Atrial fibrillation: an indication to prevent stroke].
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Warfarin | 1989 |
Aspirin, warfarin, and stroke prevention.
Topics: Aspirin; Cerebrovascular Disorders; Humans; Warfarin | 1988 |
Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents.
Topics: Acute Disease; Adult; Aspirin; Blood Platelets; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Platelet Function Tests; Warfarin | 1989 |
The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Aspirin; beta-Thromboglobulin; Blood Platelets; Chromonar; Coumarins; Drug Interactions; Epinephrine; Humans; In Vitro Techniques; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles | 1986 |
[Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis].
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Combined Modality Therapy; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Coumarins; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Recurrence | 1986 |
Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs.
Topics: Angiography; Angioplasty, Balloon; Animals; Aspirin; Coronary Angiography; Coronary Vessels; Dipyridamole; Dogs; Equipment Failure; Microscopy, Electron, Scanning; Time Factors; Warfarin | 1987 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinpyrazone | 1987 |
AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Chromonar; Coumarins; Diglycerides; Dose-Response Relationship, Drug; Humans; Phospholipids; Platelet Aggregation; Radioisotopes; Thrombin; Thromboxane B2 | 1987 |
Observations on the effects of some antiaggregating drugs on platelet specific protein discharge after a very weak stimulus.
Topics: Aminophylline; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survival; Chromonar; Coumarins; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Factor 4; Platelet-Derived Growth Factor | 1985 |
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Bioprosthesis; Blood Platelets; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Graft Occlusion, Vascular; Heart Valve Prosthesis; Heparin; Humans; Prothrombin Time; Random Allocation; Sulfinpyrazone; Thromboembolism; Time Factors; Warfarin | 1985 |
[Current topics of anticoagulant therapy and antiplatelet therapy after cardiac valve replacement].
Topics: Adolescent; Adult; Aspirin; Drug Evaluation; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Protein C; Thromboembolism; Ticlopidine; Warfarin | 1988 |
Endothelial cell seeding of expanded polytetrafluoroethylene vena cava conduits: effects on luminal production of prostacyclin, platelet adherence, and fibrinogen accumulation.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dogs; Endothelium, Vascular; Epoprostenol; Female; Fibrinogen; Platelet Adhesiveness; Polytetrafluoroethylene; Vena Cava, Inferior; Warfarin | 1988 |
Hemostatic effects of microfibrillar collagen hemostat (MCH) in experimental coagulopathy model and its mechanism of hemostasis.
Topics: Animals; Aspirin; Blood Coagulation Disorders; Cattle; Collagen; Dogs; Hemorrhage; Hemostatic Techniques; Hemostatics; Heparin; Spleen; Thiophenes; Thrombocytopenia; Ticlopidine; Warfarin | 1986 |
The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Arteriovenous Shunt, Surgical; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Evaluation; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Popliteal Artery; Retrospective Studies; Saphenous Vein; Thrombosis; Umbilical Veins; Warfarin | 1987 |
Pharmacologic approach to ischemic stroke management.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Dipyridamole; Drug Interactions; Heparin; Humans; Ischemic Attack, Transient; Monitoring, Physiologic; Risk; Warfarin | 1986 |
Use of antithrombotic agents in valvular heart disease.
Topics: Aspirin; Dipyridamole; Heart Valve Diseases; Humans; Patient Education as Topic; Warfarin | 1987 |
Intraluminal thrombus of the internal carotid arteries: angiographic demonstration of resolution with anticoagulant therapy alone.
Topics: Adult; Aged; Angiography; Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Female; Heparin; Humans; Male; Middle Aged; Thrombosis; Warfarin | 1986 |
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Hemorrhage; Humans; Mitral Valve; Platelet Aggregation; Postoperative Complications; Thromboembolism; Warfarin | 1986 |
Etiology and prevention of thromboembolic disease. Taming a complex circulatory malfunction.
Topics: Antithrombin III Deficiency; Aspirin; Blood Coagulation Disorders; Catheters, Indwelling; Contraceptives, Oral; Dihydroergotamine; Female; Glycoproteins; Heparin; Humans; Parity; Postoperative Complications; Pregnancy; Pregnancy Complications; Protein C; Sulfinpyrazone; Thrombophlebitis; Warfarin | 1986 |
Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Cineradiography; Dipyridamole; Echocardiography; Embolism; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Reoperation; Risk; Warfarin | 1986 |
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Fever; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Myocardium; Risk; Warfarin | 1986 |
Ulcerogenic and antiulcerogenic effects of a new antiinflammatory drug, the gamma-lactone-N-ethyl derivative of 6-[1S-(3S,4-dihydro-8-hydroxy-1H-2-benzo- pyran-1-one-3-yl)-3-methylbutylamino]-4S,5S-dihydroxy-6-oxo-3S- ammoniohexanoate, on gastrointestinal
Topics: Animals; Anti-Ulcer Agents; Aspirin; Coumarins; Gastrointestinal Motility; Indomethacin; Isocoumarins; Male; Pylorus; Rats; Rats, Inbred Strains; Stomach Ulcer | 1986 |
The use of antithrombotic therapy in the elderly.
Topics: Aged; Anticoagulants; Aspirin; Fibrinolytic Agents; Hemostasis; Heparin; Humans; Thromboembolism; Warfarin | 1985 |
Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Topics: Adolescent; Adult; Aortic Valve; Aspirin; Blood Platelets; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Complications; Prosthesis Design; Rheumatic Heart Disease; Risk; Thromboembolism; Time Factors; Warfarin | 1986 |
Intraocular lenses and anticoagulation and antiplatelet therapy.
Topics: Anticoagulants; Aspirin; Hemorrhage; Humans; Lenses, Intraocular; Surveys and Questionnaires; Warfarin | 1985 |
Anticoagulation therapy in children with mechanical prosthetic cardiac valves.
Topics: Aspirin; Child; Child, Preschool; Dipyridamole; Heart Valve Prosthesis; Hemorrhage; Humans; Thromboembolism; Warfarin | 1985 |
Thromboembolism in patients with aortic porcine bioprostheses.
Topics: Adolescent; Adult; Aged; Aorta; Aortic Valve; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Polytetrafluoroethylene; Postoperative Complications; Prospective Studies; Risk; Thromboembolism; Time Factors; Warfarin | 1985 |
Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Dipyridamole; Endarterectomy; Female; Femoral Artery; Humans; Male; Middle Aged; Popliteal Artery; Recurrence; Warfarin | 1985 |
Impact of aspirin and chlorthalidone on the pharmacodynamics of oral anticoagulant drugs in man.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Anticoagulants; Aspirin; Blood Coagulation Tests; Blood Platelets; Chlorthalidone; Collagen; Dicumarol; Epinephrine; Hematocrit; Hemorrhage; Humans; Male; Metabolism; Platelet Adhesiveness; Prothrombin Time; Sodium; Warfarin | 1971 |
Spontaneous aggregation of blood platelets as a cause of idiopothic thrombosis and recurrent painful toes and fingers.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Blood Platelet Disorders; Coumarins; Fingers; Humans; Male; Middle Aged; Pain; Serotonin; Thrombophlebitis; Toes | 1971 |
Haematological effects of aspirin.
Topics: Adenocarcinoma; Animals; Aspirin; Heparin; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Neoplastic Cells, Circulating; Sodium Chloride; Warfarin | 1972 |
Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.
Topics: Acetamides; Animals; Anticholesteremic Agents; Antipyrine; Aspirin; Blood Proteins; Carbon Isotopes; Chlorothiazide; Clofibrate; Dicumarol; Digitoxin; Drug Interactions; Fluorine; Glycolates; Half-Life; Haplorhini; Humans; Hypolipidemic Agents; Indomethacin; Macaca; Phenothiazines; Phenylbutazone; Salicylates; Warfarin | 1972 |
Effect of non-narcotic analgesics on anticoagulant-induced hypoprothrombinemia in rats.
Topics: Acetaminophen; Acetanilides; Administration, Oral; Animals; Antipyrine; Aspirin; Blood Coagulation; Dicumarol; Female; Hypoprothrombinemias; Injections, Intraperitoneal; Male; Phenacetin; Phenindione; Phenylbutazone; Rats; Salicylamides; Sodium Salicylate; Species Specificity; Time Factors; Warfarin | 1972 |
[Myocardial infarct and the shoulder-hand syndrome].
Topics: Adult; Age Factors; Aged; Aspirin; Benzyl Compounds; Coumarins; Exercise Therapy; Humans; Middle Aged; Myocardial Infarction; Phenindione; Reflex Sympathetic Dystrophy; Retrospective Studies | 1972 |
Anticoagulants: a guide for practitioners.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Dicumarol; Disseminated Intravascular Coagulation; Electric Countershock; Heart Valve Diseases; Humans; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis; Thrombosis; Warfarin | 1973 |
Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Cell Membrane; Chloroquine; Coumarins; Depression, Chemical; Dicumarol; Erythrocytes; Fibrinolysis; Flufenamic Acid; Hemolysis; Humans; Hypotonic Solutions; In Vitro Techniques; Indomethacin; Inflammation; Mefenamic Acid; Oxyphenbutazone; Phenylbutazone; Phenylpropionates; Platelet Adhesiveness; Pyrazoles; Receptors, Drug; Structure-Activity Relationship | 1972 |
[Comparative anti-inflammatory action of anticoagulant substances. Mode of action of phenylindanedione].
Topics: Adrenal Glands; Animals; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Carrageenan; Coumarins; Dicumarol; Edema; ortho-Aminobenzoates; Phenindione; Phenylbutazone; Radiation Injuries, Experimental; Rats; Warfarin | 1965 |
Study of the reactions of blood with artificial surfaces. Use of the thrombogenerator.
Topics: Albumins; Animals; Aspirin; Biocompatible Materials; Blood; Blood Coagulation; Blood Platelets; Dextrans; Dogs; Female; Hematology; Heparin; Humans; In Vitro Techniques; Leukocytes; Lipoproteins, HDL; Male; Microscopy, Electron, Scanning; Platelet Adhesiveness; Polysaccharides; Polyvinyls; Silicone Elastomers; Surface Properties; Time Factors; Warfarin | 1974 |
Salicylate-induced foetal damage late in pregnancy. An experimental study in mice.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Aspirin; Carbon Isotopes; Coumarins; Female; Fetal Death; Fetus; Gestational Age; Glycogen; Hemorrhage; Injections, Intramuscular; Liver; Maternal-Fetal Exchange; NADP; Obstetric Labor, Premature; Pentobarbital; Pregnancy; Prothrombin; Rats; Time Factors | 1971 |
Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
Topics: Aspirin; Dextrans; Female; Hemorrhage; Heparin; Hip Joint; Humans; Injections, Subcutaneous; Joint Prosthesis; Male; Middle Aged; Molecular Weight; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Radiography; Thromboembolism; Thrombophlebitis; Warfarin | 1974 |
[Antithrombotic effect of acetylsalicylic acid, heparin and phenprocoumon on the formation of experimental coagulation thrombi].
Topics: Animals; Aspirin; Blood Coagulation; Coumarins; Female; Fibrinolytic Agents; Heparin; Male; Rabbits; Thromboembolism | 1974 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin; Fibrinogen; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Iodine Radioisotopes; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Plasminogen; Proteinuria; Thrombosis; Transplantation, Homologous; Uremia; Warfarin | 1974 |
Induced optical activity following the binding of warfarin, indomethacin, 4-hydroxycoumarin and salicylic acid to human serum albumin.
Topics: Aspirin; Binding Sites; Circular Dichroism; Coumarins; Humans; Hydrogen-Ion Concentration; Indomethacin; Kinetics; Protein Binding; Salicylates; Serum Albumin; Warfarin | 1972 |
Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man.
Topics: Adult; Aspirin; Cholestyramine Resin; Coumarins; Humans; In Vitro Techniques; Intestinal Absorption; Male; Middle Aged; Prothrombin Time; Time Factors | 1972 |
Effects of drugs on platelet aggregation: attempt at quantitative comparison of inhibitory effects.
Topics: Adenine; Adenosine Diphosphate; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Cardiac Glycosides; Collagen; Coumarins; Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Epinephrine; Humans; In Vitro Techniques; Methods; Papaverine; Platelet Adhesiveness; Pyrazoles; Xanthines | 1972 |
Studies on gastrointestinal absorption of drugs.
Topics: Aspirin; Gastric Mucosa; Gastrointestinal Motility; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Warfarin | 1972 |
[Interactions of oral antidiabetics].
Topics: Acetazolamide; Acetohexamide; Aspirin; Coumarins; Diuretics; Drug Incompatibility; Drug Interactions; Ethacrynic Acid; Humans; Hypoglycemic Agents; Sulfonamides | 1972 |
Clinical application of platelet aggregation.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Dipyridamole; Epinephrine; Humans; Intracranial Embolism and Thrombosis; Platelet Adhesiveness; Thrombin; Thrombosis; Warfarin | 1973 |
The treatment of pulmonary embolism.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cholelithiasis; Diabetes Complications; Female; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; Radiography; Radionuclide Imaging; Thrombophlebitis; Thrombosis; Warfarin | 1973 |
[Prevention of thromboembolism using acetylsalicyclic acid].
Topics: Aspirin; Coumarins; Humans; Thromboembolism | 1973 |
Evaluation of anticoagulant therapy in cloth-covered prosthetic valves.
Topics: Anticoagulants; Aortic Valve; Aspirin; Cerebral Hemorrhage; Heart Valve Diseases; Heart Valve Prosthesis; Hemorrhage; Humans; Mitral Valve; Prosthesis Design; Thromboembolism; Tricuspid Valve; Warfarin | 1973 |
Impedance phlebography: a correlation with lower limb venography in the diagnosis of deep vein thrombosis.
Topics: Aspirin; Dextrans; False Negative Reactions; False Positive Reactions; Heparin; Hip; Humans; Joint Prosthesis; Leg; Phlebography; Thromboembolism; Thrombophlebitis; Warfarin | 1973 |
[Combination of coumarol derivatives].
Topics: Aspirin; Coumarins; Drug Combinations; Humans; Thromboembolism | 1973 |
[Peptic ulcer hemorrhage due to anticoagulants].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Blood Transfusion; Coumarins; Digitalis Glycosides; Dose-Response Relationship, Drug; Duodenal Ulcer; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Rheumatic Heart Disease; Vitamin K 1 | 1973 |
[Prevention of postoperative thromboembolism in patients with fractures in the region of the hip joint by the use of acetylsalicylic acid micropellets (author's transl)].
Topics: Aspirin; Coumarins; Drug Synergism; Female; Femoral Fractures; Fractures, Bone; Hip; Hip Joint; Humans; Male; Postoperative Complications; Thromboembolism; Wound Healing | 1973 |
[Inhibition of experimental thrombosis by combined administration of acetylsalicylic acid and cumarins].
Topics: Animals; Anticoagulants; Aspirin; Benzyl Compounds; Coumarins; Drug Combinations; Female; Jugular Veins; Male; Rabbits; Thrombophlebitis | 1973 |
Postoperative deep vein thrombosis and pulmonary embolism: a selective review and personal viewpoint.
Topics: Adult; Age Factors; Aged; Aspirin; Clothing; Dextrans; Dipyridamole; Exercise Therapy; Heparin; Humans; Iodine Radioisotopes; Middle Aged; Phlebography; Plethysmography, Impedance; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thrombophlebitis; Ultrasonography; Warfarin | 1974 |
Relations between price and quality in community pharmacy.
Topics: Aspirin; Community Pharmacy Services; Contraceptives, Oral; Drug Interactions; Drug Prescriptions; Erythromycin; Fees, Pharmaceutical; Health Education; Mississippi; Pharmacists; Quality of Health Care; Thermometers; Warfarin | 1974 |
Experimental interactions of components of hemodialysis units with human blood.
Topics: Albumins; Aspirin; Biocompatible Materials; Blood Coagulation; Blood Coagulation Tests; Dextrans; Humans; Kidneys, Artificial; Lipoproteins; Membranes, Artificial; Microscopy, Electron; Microscopy, Electron, Scanning; Models, Biological; Polyethylenes; Polysaccharides; Polytetrafluoroethylene; Polyvinyls; Silicones; Thrombosis; Warfarin | 1974 |
Drug-induced bleeding.
Topics: Acetaminophen; Anemia, Aplastic; Anticoagulants; Aspirin; Blood Platelets; Bone Marrow; Capillary Fragility; Drug Hypersensitivity; Drug Synergism; Hemorrhagic Disorders; Hemostasis; Heparin; Heparin Antagonists; Humans; Indenes; Platelet Adhesiveness; Purpura; Thrombocytopenia; Vascular Diseases; Warfarin | 1974 |
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Dipyridamole; Drug Synergism; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Plasminogen; Thromboembolism; Thrombophlebitis; Warfarin | 1974 |
[Problems in the treatment of myocardial infarct using anticoagulants or aggregation inhibitors].
Topics: Anticoagulants; Aspirin; Coumarins; Electrocardiography; Humans; Myocardial Infarction; Platelet Adhesiveness; Thrombelastography | 1972 |
Thrombosis prevention.
Topics: Animals; Arteries; Arthroplasty; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Hemorrhage; Hip; Humans; Joint Prosthesis; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Veins; Warfarin | 1971 |
Inhibition by dipyridamole of arterial thrombosis in rats.
Topics: Animals; Aspirin; Dipyridamole; Heparin; Mesenteric Arteries; Rats; Thrombosis; Warfarin | 1968 |
The interaction between cholestyramine and drugs.
Topics: Adsorption; Animals; Aspirin; Bile Acids and Salts; Blood; Chlorothiazide; Cholestyramine Resin; Dogs; Intestinal Absorption; Nicotinic Acids; Phenobarbital; Phenylbutazone; Quinidine; Rats; Spectrophotometry; Tetracycline; Urine; Warfarin | 1965 |
Drug interactions in alcoholic patients.
Topics: Alcoholism; Anesthetics; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Aspirin; Disulfiram; Drug Interactions; Ethanol; Ethylene Dibromide; Hemorrhage; Humans; Hypoglycemia; Hypotension; Methotrexate; Narcotics; Procarbazine; Sulfonylurea Compounds; Warfarin | 1981 |
[Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism].
Topics: Adult; Aspirin; Bandages; Blood Flow Velocity; Coumarins; Dextrans; Dihydroergotamine; Dipyridamole; Hemodilution; Humans; Middle Aged; Myocardial Infarction; Streptokinase; Sulfinpyrazone; Thromboembolism | 1981 |
Treatment of cerebral ischemia.
Topics: Aspirin; Brain Ischemia; Carotid Arteries; Dicumarol; Dipyridamole; Endarterectomy; Heart Murmurs; Heparin; Humans; Hypertension; Ischemic Attack, Transient; Risk; Sulfinpyrazone; Warfarin | 1981 |
Experience with deep venous thrombosis and IPG - 200 as a diagnostic aid.
Topics: Adult; Aged; Aspirin; Dextrans; Diagnosis, Differential; Female; Heparin; Humans; Male; Middle Aged; Phlebography; Plethysmography, Impedance; Thrombophlebitis; Tourniquets; Warfarin | 1980 |
[Modern aspects relating to prophylaxis against thrombo-embolism in gynaecology and obstetrics (author's transl)].
Topics: Age Factors; Aspirin; Coumarins; Dextrans; Dihydroergotamine; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Heparin; Humans; Hysterectomy; Risk; Sex Factors; Thromboembolism | 1981 |
Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Child; Child, Preschool; Dicumarol; Dipyridamole; Drug Therapy, Combination; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Infant; Mitral Valve; Postoperative Complications; Retrospective Studies; Thromboembolism; Warfarin | 1982 |
Pharmacology of angioplasty and intravascular thrombolysis.
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Heparin; Humans; Middle Aged; Prostaglandins; Streptokinase; Sulfinpyrazone; Thromboembolism; Urokinase-Type Plasminogen Activator; Warfarin | 1982 |
[Comparative characteristics of the effect of drugs on the microcirculation in reconstructive operations on the hand].
Topics: Aspirin; Coumarins; Dextrans; Hand; Humans; Microcirculation | 1983 |
[Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Aged; Anticoagulants; Aspirin; Coumarins; Dicumarol; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation; Streptokinase; Sulfinpyrazone | 1984 |
In vivo platelet activation in lower limbs thrombophlebitis. A longitudinal study.
Topics: Adult; Aspirin; beta-Thromboglobulin; Blood Platelets; Dipyridamole; Female; Heparin; Humans; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation; Thrombophlebitis; Warfarin | 1984 |
Role of percutaneous transluminal coronary angioplasty in patients with variant angina and coexistent coronary stenosis refractory to maximal medical therapy.
Topics: Adult; Angina Pectoris, Variant; Angiography; Angioplasty, Balloon; Aspirin; Constriction, Pathologic; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nifedipine; Nitrates; Recurrence; Warfarin | 1984 |
Use of ibuprofen in unusual circumstances.
Topics: Arthritis, Rheumatoid; Aspirin; Bartter Syndrome; Cyclooxygenase Inhibitors; Digoxin; Drug Hypersensitivity; Drug Interactions; Ductus Arteriosus, Patent; Humans; Ibuprofen; Indomethacin; Kidney; Kinetics; Lithium; Liver; Lupus Erythematosus, Systemic; Mixed Connective Tissue Disease; Phenytoin; Platelet Aggregation; Prostaglandins E; Warfarin | 1984 |
An unusual case of Bjork-Shiley mitral valve dysfunction corrected nonsurgically.
Topics: Aspirin; Cardiomegaly; Dipyridamole; Echocardiography; Female; Furosemide; Heart Murmurs; Heart Valve Prosthesis; Humans; Hypotension; Middle Aged; Mitral Valve Prolapse; Phenylephrine; Prothrombin Time; Warfarin | 1981 |
Transluminal angioplasty of the iliac and femoral arteries: follow-up results without anticoagulation.
Topics: Adult; Aged; Angioplasty, Balloon; Anticoagulants; Aspirin; Female; Femoral Artery; Follow-Up Studies; Humans; Iliac Artery; Intermittent Claudication; Male; Middle Aged; Vascular Resistance; Warfarin | 1981 |
[Problems of hemostatic therapy after myocardial infarct].
Topics: Aspirin; Coumarins; Humans; Middle Aged; Myocardial Infarction; Placebos; Platelet Aggregation; Thrombosis | 1984 |
Use of anticoagulants. Therapy and prophylaxis for thromboembolic phenomena.
Topics: Anticoagulants; Aspirin; Blood Platelets; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Thromboembolism; Warfarin | 1984 |
Effect of TEI-4120 (3-benzoyl-N-beta-ethoxyisopropyl-2-methlindole) on carrageenan induced disseminated intravascular coagulation (DIC) in rats.
Topics: Animals; Aspirin; Bleeding Time; Carrageenan; Disseminated Intravascular Coagulation; Fibrinolytic Agents; Hemodynamics; Heparin; Indoles; Male; Rats; Rats, Inbred Strains; Thromboxane B2; Warfarin | 1984 |
Use of common antiplatelet drugs for vascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Coumarins; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valves; Humans; Postoperative Care; Sulfinpyrazone | 1983 |
Coronary artery bypass and antiplatelet therapy.
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Bypass; Dipyridamole; Humans; Warfarin | 1984 |
Polytetrafluoroethylene grafts in the peripheral venous circulation of rabbits.
Topics: Animals; Aspirin; Dipyridamole; Female; Graft Survival; Jugular Veins; Male; Polytetrafluoroethylene; Rabbits; Warfarin | 1983 |
Effects of oxametacin on coumarin anticoagulation and on platelet function in humans.
Topics: Adult; Aged; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Blood Platelets; Drug Interactions; Female; Humans; Indomethacin; Male; Middle Aged; Platelet Aggregation; Serotonin; Time Factors; Warfarin | 1983 |
The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography.
Topics: Adult; Aged; Anticoagulants; Aspirin; Dipyridamole; Echocardiography; Heart Ventricles; Humans; Indium; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Radioisotopes; Radionuclide Imaging; Sulfinpyrazone; Thrombosis; Warfarin | 1984 |
Transient ischemic attacks. Strategies for minimizing stroke risk.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Ischemic Attack, Transient; Middle Aged; Neurologic Examination; Risk; Warfarin | 1984 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Assessment of the interaction of warfarin with aspirin and dipyridamole.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Interactions; Heart Valve Prosthesis; Humans; Postoperative Complications; Warfarin | 1982 |
Risk-benefit analysis of warfarin therapy in Hancock mitral valve replacement.
Topics: Adult; Aged; Aspirin; Bioprosthesis; Cerebral Hemorrhage; Female; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Postoperative Complications; Risk; Thromboembolism; Warfarin | 1982 |
Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis.
Topics: Adolescent; Adult; Aged; Aortic Valve; Aspirin; Bioprosthesis; Child; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Postoperative Complications; Thromboembolism; Tricuspid Valve; Warfarin | 1982 |
[Intraocular hemorrhage due to systemic drugs].
Topics: Adult; Aged; Aspirin; Dipyridamole; Eye Diseases; Female; Hemorrhage; Humans; Male; Middle Aged; Quinidine; Warfarin | 1982 |
The detection and prevention of pulmonary embolism in total hip replacement. A study comparing aspirin and low-dose warfarin.
Topics: Aspirin; Female; Hip Joint; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Warfarin | 1982 |
[Thrombotic thrombocytopenic purpura--successful treatment by warfarin and antiplatelet drugs (author's transl)].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Prednisolone; Purpura, Thrombotic Thrombocytopenic; Warfarin | 1981 |
Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prospective Studies; Thromboembolism; Warfarin | 1981 |
Case study: complications associated with anticoagulant therapy.
Topics: Adult; Anticoagulants; Aspirin; Drug Interactions; Hemorrhage; Heparin; Humans; Male; Thrombophlebitis; Warfarin | 1981 |
[Myocardial infarct: present status of anticoagulant therapy].
Topics: Anticoagulants; Aspirin; Humans; Myocardial Infarction; Streptokinase; Urokinase-Type Plasminogen Activator; Warfarin | 1980 |
Triple therapy for acute deep thrombophlebitis.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Chymotrypsin; Drug Therapy, Combination; Humans; Male; Middle Aged; Phlebography; Thrombophlebitis; Trypsin; Warfarin | 1980 |
Binding of erythromycin base to human plasma proteins.
Topics: Aspirin; Bilirubin; Blood Proteins; Erythromycin; Furosemide; Humans; Hydrogen-Ion Concentration; Orosomucoid; Phenylbutazone; Protein Binding; Serum Albumin; Temperature; Warfarin | 1980 |
Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; California; Cerebrovascular Disorders; Cost-Benefit Analysis; Decision Support Techniques; Hemorrhage; Humans; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Treatment Outcome; Warfarin | 1995 |
Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Platelet Aggregation Inhibitors; Warfarin | 1995 |
ACP guideline on drug therapy for stroke prevention.
Topics: Aspirin; Cerebrovascular Disorders; Humans; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Societies, Medical; Ticlopidine; United States; Warfarin | 1995 |
Low dose anticoagulation after St. Jude Medical prosthesis implantation in patients under 18 years of age.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Period; Retrospective Studies; Warfarin | 1995 |
US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices.
Topics: Aspirin; Attitude of Health Personnel; Brain Ischemia; Carotid Arteries; Cerebral Angiography; Cerebrovascular Disorders; Echocardiography; Echocardiography, Transesophageal; Education, Medical, Continuing; Electrocardiography, Ambulatory; Endarterectomy, Carotid; Health Care Rationing; Health Services Accessibility; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged; Physicians; Practice Patterns, Physicians'; Professional Practice; Risk Factors; Tomography, X-Ray Computed; United States; Warfarin | 1995 |
Angelol-type coumarins from Angelica pubescence F. biserrata and their inhibitory effect on platelet aggregation.
Topics: Aspirin; Coumarins; Humans; Plant Extracts; Plant Roots; Plants, Medicinal; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 1995 |
Stroke prevention.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dementia, Vascular; Humans; Hypertension; Ischemic Attack, Transient; Risk Factors; Warfarin | 1995 |
Systemic thromboembolism leading to myocardial infarction and stroke after fenestrated total cavopulmonary connection.
Topics: Aspirin; Cerebrovascular Disorders; Child, Preschool; Drug Administration Schedule; Female; Fontan Procedure; Humans; Myocardial Infarction; Postoperative Complications; Thromboembolism; Warfarin | 1995 |
CarboMedics valve in congenital heart disease. Midterm follow-up study of 14 patients.
Topics: Aortic Valve; Aspirin; Child; Dipyridamole; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Complications; Prosthesis Design; Thrombosis; Time Factors; Tricuspid Valve; Warfarin | 1994 |
Neurology quiz. Patent foramen ovale.
Topics: Adult; Angiography; Aspirin; Echocardiography, Transesophageal; Heart Septal Defects, Atrial; Humans; Male; Streptokinase; Tomography, X-Ray Computed; Warfarin | 1994 |
Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Topics: Administration, Oral; Adult; Antithrombin III; Aspirin; beta-Thromboglobulin; Biomarkers; Coumarins; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fibrinopeptide A; Heart Valve Prosthesis; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Peptide Hydrolases; Postoperative Complications; Thromboembolism; Ultrasonography, Doppler, Transcranial | 1995 |
Omission of aspirin in patients following coronary artery bypass graft surgery.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Drug Administration Schedule; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Vascular Patency; Warfarin | 1994 |
The management of thrombosis in the antiphospholipid-antibody syndrome.
Topics: Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Recurrence; Retrospective Studies; Thrombosis; Warfarin | 1995 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Incidence; Male; Middle Aged; Mitral Valve; Postoperative Complications; Proportional Hazards Models; Risk Factors; Survival Analysis; Thromboembolism; Time Factors; Warfarin | 1995 |
Atrial fibrillation: current understandings and research imperatives. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation.
Topics: Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Catheter Ablation; Cerebrovascular Disorders; Heart Conduction System; Humans; Incidence; Intracranial Embolism and Thrombosis; National Institutes of Health (U.S.); United States; Warfarin | 1993 |
Aspirin or warfarin for non-rheumatic atrial fibrillation?
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Warfarin | 1994 |
Stroke Prevention in Atrial Fibrillation II Study.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Warfarin | 1994 |
Antiphospholipid syndrome: clinical and therapeutic aspects.
Topics: Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Thrombosis; Warfarin | 1994 |
Pregnancy and prosthetic heart valves.
Topics: Abnormalities, Drug-Induced; Aspirin; Bioprosthesis; Embryo, Mammalian; Female; Heart Valve Prosthesis; Heparin; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Warfarin | 1994 |
Anticoagulation update.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Prothrombin Time; Risk Factors; Warfarin | 1994 |
Anticoagulation after intracoronary stent insertion.
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clinical Protocols; Coronary Disease; Drug Administration Schedule; Heparin; Humans; Postoperative Care; Postoperative Complications; Stents; Thrombosis; Warfarin | 1994 |
Resolution of thrombocytopenia in a patient with lupus anticoagulant who received warfarin therapy.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Humans; Lupus Coagulation Inhibitor; Male; Platelet Count; Thrombocytopenia; Warfarin | 1994 |
Is this the end of the aspirin and vein graft story?
Topics: Aspirin; Coronary Artery Bypass; Graft Occlusion, Vascular; Humans; Postoperative Complications; Time Factors; Warfarin | 1994 |
Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Aspirin; Chi-Square Distribution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Warfarin | 1994 |
[Diagnosis of iatrogenic vascular injuries with color-coded duplex ultrasound].
Topics: Aneurysm, False; Arteriovenous Fistula; Aspirin; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Coumarins; Female; Femoral Artery; Femoral Vein; Hematoma; Humans; Iatrogenic Disease; Male; Prothrombin Time; Ultrasonography | 1994 |
Warfarin in chronic atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chronic Disease; Humans; Thromboembolism; Warfarin | 1993 |
Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons.
Topics: Arthroplasty; Aspirin; Femoral Neck Fractures; Heparin; Heparin, Low-Molecular-Weight; Hip Joint; Humans; Knee Joint; New Zealand; Orthopedics; Premedication; Surveys and Questionnaires; Thromboembolism; Thrombophlebitis; Warfarin | 1994 |
Warfarin and aspirin after heart-valve replacement.
Topics: Administration, Cutaneous; Aspirin; Heart Valve Prosthesis; Humans; Warfarin | 1994 |
[Simultaneous administration of coumarin derivatives and acetylsalicylic acid?].
Topics: Aspirin; Coumarins; Drug Interactions; Drug Therapy, Combination; Humans; Thrombophlebitis | 1994 |
Renal coagulopathy, thrombocytopenia, and the anticardiolipin antibody: therapeutic response to corticosteroids and aspirin but not anticoagulation.
Topics: Adolescent; Antibodies, Anticardiolipin; Aspirin; Blood Coagulation Disorders; Humans; Male; Prednisone; Renal Circulation; Thrombocytopenia; Warfarin | 1994 |
Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention.
Topics: Adult; Aged; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Echocardiography, Transesophageal; Embolism; Female; Heart Aneurysm; Heart Diseases; Heart Septal Defects, Atrial; Heart Septum; Humans; Male; Middle Aged; Recurrence; Warfarin | 1994 |
A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin.
Topics: Anticoagulants; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Data Collection; Follow-Up Studies; Heparin; Humans; Ischemic Attack, Transient; Neurology; Practice Patterns, Physicians'; Surveys and Questionnaires; Warfarin | 1994 |
Survey of use of anticoagulation in patients with atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Contraindications; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Warfarin | 1993 |
Guidelines for medical treatment for stroke prevention. American College of Physicians.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Ischemic Attack, Transient; Myocardial Infarction; Recurrence; Risk Factors; Ticlopidine; Warfarin | 1994 |
Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Coagulation Disorders; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders; Cohort Studies; Female; Follow-Up Studies; Heparin; Humans; Ischemic Attack, Transient; Male; Middle Aged; Neoplasms; Recurrence; Retrospective Studies; Thrombosis; Warfarin | 1994 |
Patient counseling: there is a need.
Topics: Aged; Aspirin; Ecchymosis; Female; Hematoma; Humans; Medication Errors; Patient Education as Topic; Self Administration; Warfarin | 1993 |
Response to Dr. Arthur's Koffler's case report.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Intracranial Embolism and Thrombosis; Warfarin | 1993 |
[Isolated atrial fibrillation. Risk of embolism and its prevention].
Topics: Aged; Aspirin; Atrial Fibrillation; Humans; Intracranial Embolism and Thrombosis; Risk Factors; Warfarin | 1993 |
Oral anticoagulant therapy recommendations.
Topics: Administration, Oral; Aspirin; Clinical Protocols; Hemorrhage; Humans; Thromboembolism; Thrombophlebitis; Warfarin | 1994 |
Anticoagulation in patients with atrial fibrillation. No consensus among doctors.
Topics: Aspirin; Atrial Fibrillation; Family Practice; Humans; Retrospective Studies; Risk Factors; Thromboembolism; Warfarin | 1993 |
Anticoagulation in patients with atrial fibrillation. Use of warfarin dependent on local services.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Family Practice; Health Promotion; Humans; Randomized Controlled Trials as Topic; Warfarin | 1993 |
Anticoagulation in patients with atrial fibrillation. Atrial fibrillation associated with aging.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Warfarin | 1993 |
History of drugs for thrombotic disease. Discovery, development, and directions for the future.
Topics: Animals; Aspirin; Canada; Europe; Fibrinolytic Agents; Heparin; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, Ancient; Humans; Thrombosis; United States; Warfarin | 1994 |
Warfarin and aspirin after heart-valve replacement.
Topics: Aspirin; Drug Therapy, Combination; Embolism; Heart Valve Prosthesis; Hemorrhage; Humans; Warfarin | 1994 |
The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Guérin efficacy for superficial bladder cancer.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; BCG Vaccine; Blood Coagulation; Carcinoma in Situ; Female; Fibronectins; Humans; Male; Middle Aged; Urinary Bladder Neoplasms; Warfarin | 1993 |
Treatment of atrial fibrillation in a district general hospital.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Digoxin; Echocardiography; Electric Countershock; Emergencies; Female; Hospitalization; Humans; Length of Stay; Male; Medical Audit; Middle Aged; Scotland; Thyroid Function Tests; Warfarin | 1994 |
The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery.
Topics: Adult; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Cardiac Tamponade; Coronary Artery Bypass; Dipyridamole; Echocardiography; Female; Heart Defects, Congenital; Heart Valves; Heparin; Humans; Male; Pericardial Effusion; Postoperative Complications; Warfarin | 1993 |
Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Aspirin; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery Thrombosis; Dipyridamole; Fibrinolytic Agents; Heparin; Male; Oxazoles; Propionates; Rats; Rats, Sprague-Dawley; Thrombolytic Therapy; Ticlopidine; Triazoles; Warfarin | 1993 |
Stroke and atrial fibrillation: to anticoagulate or not.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Humans; Male; Randomized Controlled Trials as Topic; Warfarin | 1993 |
Low-dose anticoagulant management of patients with St. Jude Medical mechanical valve prostheses.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Hospital Mortality; Humans; Male; Middle Aged; Mitral Valve; Postoperative Care; Postoperative Complications; Prosthesis Design; Turkey; Warfarin | 1993 |
Aspirin versus coumadin.
Topics: Aspirin; Humans; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Warfarin | 1993 |
Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Female; Heart Diseases; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Thrombosis; Ventricular Function, Left; Warfarin | 1993 |
Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heparin; Humans; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Warfarin | 1993 |
Changing patterns of prophylaxis for deep venous thrombosis following elective hip replacement.
Topics: Aspirin; Heparin; Hip Prosthesis; Humans; Medical Audit; Retrospective Studies; Thrombolytic Therapy; Thrombophlebitis; Warfarin | 1993 |
Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators.
Topics: Aged; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Female; Humans; Male; Risk Factors; Warfarin | 1993 |
Ischemic stroke, Part 2: Optimal treatment and prevention.
Topics: Aged; Aspirin; Brain Edema; Brain Ischemia; Cerebral Infarction; Heparin; Humans; Recurrence; Risk Factors; Ticlopidine; Warfarin | 1993 |
Maintaining the patency of double-lumen silastic jugular catheters for haemodialysis.
Topics: Aspirin; Catheterization, Central Venous; Catheters, Indwelling; Female; Humans; Jugular Veins; Male; Renal Dialysis; Urokinase-Type Plasminogen Activator; Warfarin | 1993 |
Antiplatelet therapy in children with left-sided mechanical prostheses.
Topics: Adolescent; Aortic Valve; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Infant; Male; Mitral Valve; Patient Compliance; Postoperative Complications; Retrospective Studies; Thromboembolism; Time Factors; Warfarin | 1993 |
Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
Topics: Administration, Intravesical; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Coumarins; Dipyridamole; Fibrin; Humans; Male; Random Allocation; Urinary Bladder Neoplasms; Warfarin | 1993 |
Rose red and Prussian blue.
Topics: Antidotes; Aspirin; Ferrocyanides; Germany; History, 19th Century; History, 20th Century; Humans; Political Systems; United States; Warfarin | 1993 |
Liposome capillary electrophoresis for analysis of interactions between lipid bilayers and solutes.
Topics: Amino Acid Sequence; Aspirin; Electrophoresis, Capillary; Lipid Bilayers; Liposomes; Molecular Sequence Data; Molecular Structure; Peptides; Pharmaceutical Preparations; Salicylates; Salicylic Acid; Sulfasalazine; Thermodynamics; Warfarin | 1995 |
Miniature axial flow pump for ventricular assistance in children and small adults.
Topics: Adult; Animals; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Child; Coronary Circulation; Electric Power Supplies; Embolism; Equipment Design; Heart-Assist Devices; Heparin; Humans; Polyethylene Terephthalates; Sheep; Thrombosis; Warfarin | 1996 |
Cost-effectiveness of stroke prophylaxis for nonvalvular atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Cost-Benefit Analysis; Humans; Platelet Aggregation Inhibitors; Warfarin | 1996 |
Primary prevention of stroke.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1996 |
Prevention of cardioembolic stroke with anticoagulant therapy.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Intracranial Embolism and Thrombosis; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 1996 |
Management of intracranial hemorrhage associated with anticoagulant therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cerebral Hemorrhage; Child; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 1995 |
Altering anticoagulation therapy: a survey of physicians.
Topics: Anticoagulants; Aspirin; Cardiology; Data Collection; Dental Care for Chronically Ill; Family Practice; Health Knowledge, Attitudes, Practice; Hematology; Humans; Internal Medicine; Oral Hemorrhage; Postoperative Hemorrhage; Surveys and Questionnaires; Warfarin | 1996 |
[A study of spontaneous nosebleed. Pharmaceuticals contributed probably in every third case].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antihypertensive Agents; Aspirin; Electrocoagulation; Epistaxis; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Tampons, Surgical; Warfarin | 1996 |
Is aspirin safe for patients with heart failure?
Topics: Aspirin; Atrial Fibrillation; Humans; Thrombolytic Therapy; Warfarin | 1996 |
Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease.
Topics: Analysis of Variance; Anticoagulants; Aspirin; Cardiovascular Diseases; Chronic Disease; Cross-Over Studies; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Occult Blood; Platelet Aggregation Inhibitors; Prospective Studies; Specimen Handling; Warfarin | 1996 |
[Atrial fibrillation and apoplexy--risks and prevention].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Diabetes Complications; Female; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1996 |
Elective implantation of intracoronary stents without intravascular ultrasound guidance or subsequent warfarin.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Premedication; Recurrence; Stents; Treatment Outcome; Ultrasonography, Interventional; Warfarin | 1996 |
Primary stent implantation without coumadin in acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Case-Control Studies; Coronary Angiography; Coronary Disease; Disease-Free Survival; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 1996 |
Cerebrovascular events in adult patients with cyanotic congenital heart disease.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Heart Defects, Congenital; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Smoking; Warfarin | 1996 |
Atrial fibrillation and stroke prevention in the community.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Contraindications; Cross-Sectional Studies; England; Female; Geriatric Assessment; Humans; Incidence; Male; Platelet Aggregation Inhibitors; Primary Health Care; Risk Factors; Warfarin | 1996 |
Considerations in the prophylactic treatment of transient ischemic attack or ischemic stroke in the carotid artery territory.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carotid Stenosis; Cerebrovascular Disorders; Endarterectomy, Carotid; Female; Humans; Ischemic Attack, Transient; Long-Term Care; Male; Middle Aged; Patient Care Team; Platelet Aggregation Inhibitors; Primary Health Care; Prospective Studies; Warfarin | 1995 |
Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE members. American Society for Gastrointestinal Endoscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Colonoscopy; Dipyridamole; Endoscopy, Digestive System; Endoscopy, Gastrointestinal; Heparin; Humans; Platelet Aggregation Inhibitors; Societies, Medical; Sphincterotomy, Endoscopic; Surveys and Questionnaires; United States; Warfarin | 1996 |
Development and validation of a reversed-phase liquid chromatographic method for analysis of aspirin and warfarin in a combination tablet formulation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Chromatography, Liquid; Drug Combinations; Drug Stability; Reproducibility of Results; Structure-Activity Relationship; Warfarin | 1996 |
Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Topics: Academic Medical Centers; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Drug Utilization Review; Female; Fibrinolytic Agents; Humans; Male; Medical Audit; Middle Aged; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Risk Factors; United States; Warfarin | 1996 |
Aspirin and warfarin are comparable for prophylaxis.
Topics: Aspirin; Humans; Joint Prosthesis; Thromboembolism; Warfarin | 1997 |
Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Heparin; Humans; Middle Aged; Retrospective Studies; Risk Factors; Stents; Thrombosis; Warfarin | 1997 |
Foundation project promotes stroke prevention.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Female; Foundations; Humans; Male; Middle Aged; Mississippi; Patient Education as Topic; Risk Factors; Warfarin | 1997 |
The management of acute myocardial infarction in a patient with polycythemia rubra vera during the thrombolytic era--does it make a difference?
Topics: Adult; Anticoagulants; Aspirin; Cardiac Catheterization; Coronary Angiography; Electrocardiography; Fibrinolytic Agents; Heparin; Humans; Male; Myocardial Infarction; Phlebotomy; Platelet Aggregation Inhibitors; Polycythemia Vera; Warfarin | 1997 |
[Anticoagulation in transitory ischemic attack after bypass surgery].
Topics: Adult; Anticoagulants; Aspirin; Coronary Artery Bypass; Coumarins; Heparin; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation Inhibitors | 1997 |
[Cataract surgery and anticoagulation--current status].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Cataract Extraction; Coumarins; Heparin; Humans; Patient Care Team; Prothrombin Time; Risk Factors; Thromboembolism | 1996 |
Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Radiography; Reoperation; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome; Warfarin | 1997 |
Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bandages; Blood Loss, Surgical; Dermatologic Surgical Procedures; Evaluation Studies as Topic; Hematoma; Humans; Incidence; Medical History Taking; Mohs Surgery; Postoperative Hemorrhage; Practice Guidelines as Topic; Prospective Studies; Skin Transplantation; Surgical Flaps; Warfarin | 1997 |
Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals.
Topics: Acute Disease; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Echocardiography; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Hospitals, University; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; United States; Warfarin | 1997 |
An audit of discharge medication for secondary prophylaxis post-myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Contraindications; Drug Prescriptions; Female; Humans; Male; Medical Audit; Myocardial Infarction; Patient Discharge; Platelet Aggregation Inhibitors; Retrospective Studies; Warfarin | 1996 |
Anticoagulation in children with mechanical valve prostheses.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Infant; Male; Platelet Aggregation Inhibitors; Prospective Studies; Thromboembolism; Warfarin | 1997 |
Mobile thromboses of the aortic arch without aortic debris. A transesophageal echocardiographic finding associated with unexplained arterial embolism. The Filiale Echocardiographie de la Société Française de Cardiologie.
Topics: Adult; Aorta, Thoracic; Arteriosclerosis; Aspirin; Blood Coagulation Tests; Diabetes Complications; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Smoking; Thrombectomy; Thrombosis; Warfarin | 1997 |
Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes.
Topics: Animals; Aspirin; Biotransformation; Carbon Monoxide; Coumarins; Cytochrome P-450 Enzyme System; Erythrocebus patas; Female; Isothiocyanates; Lipoxygenase; Lung; Masoprocol; Microsomes; Microsomes, Liver; Nitrosamines; Oxygenases; Prostaglandin-Endoperoxide Synthases | 1997 |
Development and validation of a dissolution method for warfarin sodium and aspirin combination tablets.
Topics: Aspirin; Drug Combinations; Drug Stability; Filtration; Injections; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Solubility; Tablets; Warfarin | 1997 |
[Results of heart valve replacement: especially on the selection criteria for valve prostheses and on a new anticoagulation regimen].
Topics: Adult; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Thrombosis; Warfarin | 1989 |
CARS trial: warfarin and thrombin generation. Coumadin Aspirin Reinfarction Study.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Myocardial Infarction; Thrombin; Thrombosis; Warfarin | 1997 |
A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Thrombosis; Treatment Outcome; Warfarin | 1997 |
Chronic atrial fibrillation: optimizing anticoagulation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Drug Therapy, Combination; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Thromboembolism; Warfarin | 1997 |
Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.
Topics: Anticoagulants; Aspirin; Canada; Female; Heart Valve Prosthesis Implantation; Humans; Male; Medicine; Postoperative Care; Specialization; Thoracic Surgery; United States; Warfarin | 1997 |
Aspirin, the poor man's statin?
Topics: Anticoagulants; Aspirin; Female; Humans; Lovastatin; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Pravastatin; Risk Factors; Warfarin | 1998 |
Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebrovascular Disorders; Endarterectomy, Carotid; Europe; Fibrinolytic Agents; Humans; Middle Aged; North America; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1998 |
ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation. American Society of Health-System Pharmacists.
Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chronic Disease; Cost-Benefit Analysis; Humans; Middle Aged; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Thrombosis; Warfarin | 1998 |
Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Autoimmune Diseases; Blood Platelets; Child; Child, Preschool; Female; Heparin; Humans; Infant; Infant, Newborn; Male; Middle Aged; Morbidity; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Syndrome; Thrombocytopenia; Warfarin | 1998 |
Heart attack rehabilitation. Helping your heart heal.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Depression; Diet; Exercise; Humans; Myocardial Infarction; Sexual Behavior; Warfarin | 1998 |
Anticoagulation for nonvalvular atrial fibrillation: effects of type of practice on physicians' self-reported behavior.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Baltimore; Drug Utilization; Humans; Maryland; Practice Patterns, Physicians'; Warfarin | 1998 |
A late complication of internal carotid artery stenting.
Topics: Angioplasty; Anticoagulants; Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Carotid Stenosis; Endarterectomy, Carotid; Equipment Failure; Follow-Up Studies; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polyethylene Terephthalates; Prostheses and Implants; Recurrence; Stents; Ultrasonography, Doppler, Duplex; Warfarin | 1998 |
Influence of low-intensity anticoagulation and low-dose antiplatelet agent on coagulation-fibrinolysis system after mechanical prosthetic valve replacement.
Topics: Anticoagulants; Aortic Valve; Aspirin; Blood Coagulation; Blood Vessel Prosthesis; Female; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Postoperative Care; Ticlopidine; Time Factors; Warfarin | 1998 |
[Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Dipyridamole; Female; Heart Diseases; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Prevalence; Prognosis; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Warfarin | 1998 |
Warfarin and aspirin for prevention of IHD.
Topics: Aged; Anticoagulants; Aspirin; Double-Blind Method; Drug Combinations; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Factors; Treatment Outcome; Warfarin | 1998 |
[Atrial fibrillation and anticoagulant therapy].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Middle Aged; Warfarin | 1998 |
[Consensus on antithrombotic prophylaxis of vascular events in patients with manifested atherosclerotic vascular disease].
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Coumarins; Humans; Ischemic Attack, Transient | 1998 |
Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Embolism; Female; Health Care Costs; Humans; Male; Middle Aged; Patient Satisfaction; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Thrombolytic Therapy; Warfarin | 1998 |
Warfarin versus aspirin in paroxysmal atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Warfarin | 1998 |
Atrial fibrillation and anticoagulation in patients with permanent pacemakers: implications for stroke prevention.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Electrocardiography; Female; Humans; Male; Pacemaker, Artificial; Prevalence; Prospective Studies; Risk Factors; Warfarin | 1998 |
Interpretation of Thrombosis Prevention Trial.
Topics: Administration, Oral; Anticoagulants; Aspirin; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Myocardial Ischemia; Risk Factors; Survival Rate; Warfarin | 1998 |
Risk of stroke in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Cohort Studies; Dose-Response Relationship, Drug; Family Practice; Female; Humans; Hypertension; Male; Platelet Aggregation Inhibitors; Prospective Studies; Risk; Treatment Outcome; Warfarin | 1998 |
Warfarin, aspirin, and atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1998 |
Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Echocardiography; Female; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Prospective Studies; Risk Factors; Time Factors; Warfarin | 1998 |
Prothrombin fragment 1 + 2 measures treatment effect in patients with antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Biomarkers; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Protein Precursors; Prothrombin; Thrombosis; Warfarin | 1998 |
Coronary stenting in unstable angina: early and late clinical outcomes.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Postoperative Complications; Reoperation; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome; Warfarin | 1998 |
Phacoemulsification and lens implantation in patients treated with aspirin or warfarin.
Topics: Anticoagulants; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Conjunctival Diseases; Eye Hemorrhage; Humans; Lens Implantation, Intraocular; Phacoemulsification; Retrospective Studies; Warfarin | 1998 |
A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation Tests; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Fibrinolytic Agents; Health Policy; Hemorrhage; Humans; Italy; Myocardial Infarction; National Health Programs; Platelet Aggregation Inhibitors; Recurrence; Warfarin | 1998 |
Spontaneous arterial thrombosis in children.
Topics: Aspirin; Child; Diagnostic Errors; Female; Fibrinolytic Agents; Heparin; Humans; Popliteal Artery; Radiography; Thrombosis; Warfarin | 1999 |
Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Hemorrhage; Cerebrovascular Disorders; Cohort Studies; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Warfarin | 1999 |
Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Contraindications; Drug Utilization; Female; Fibrinolytic Agents; Humans; Logistic Models; Male; Medicare; Missouri; Practice Patterns, Physicians'; Risk Factors; Rural Population; Thrombolytic Therapy; United States; Warfarin | 1999 |
Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cardiotonic Agents; Cerebrovascular Disorders; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Creatinine; Diabetes Complications; Digoxin; Female; Fibrinolytic Agents; Forecasting; Hemoglobins; Hospital Mortality; Humans; Hypertension; Logistic Models; Lung Diseases; Male; Middle Aged; Myocardial Infarction; Nitrates; Reoperation; Risk Factors; Sex Factors; Survival Rate; Ventricular Function, Left; Warfarin | 1999 |
Thromboprophylaxis for atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1999 |
Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Female; Follow-Up Studies; Humans; Incidence; International Normalized Ratio; Intracranial Embolism and Thrombosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Warfarin | 1999 |
Treatment of acute ischemic stroke: where are we?
Topics: Animals; Aspirin; Brain Damage, Chronic; Brain Ischemia; Calcium Channel Blockers; Cerebral Hemorrhage; Cerebrovascular Circulation; Clinical Trials as Topic; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; N-Methylaspartate; Neuroprotective Agents; Platelet Aggregation Inhibitors; Reperfusion Injury; Rodentia; Thrombolytic Therapy; Warfarin | 1999 |
Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thrombosis; Ticlopidine; Time Factors; Warfarin | 1999 |
Atrial fibrillation: prevalence and management in an acute general medical unit.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Digoxin; Electric Countershock; Female; Humans; Male; Middle Aged; New Zealand; Patient Admission; Platelet Aggregation Inhibitors; Prospective Studies; Thromboembolism; Warfarin | 1999 |
Late deep venous thrombosis and delayed weightbearing after total hip arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Bandages; Cementation; Cohort Studies; Female; Heparin; Humans; Leg; Male; Middle Aged; Patient Discharge; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Thromboembolism; Ultrasonography, Doppler, Duplex; Venous Thrombosis; Warfarin; Weight-Bearing | 1999 |
Venous thromboembolic disease after hybrid hip arthroplasty with negative duplex screening.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Bandages; Female; Follow-Up Studies; Heparin; Humans; Leg; Male; Mass Screening; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Care; Prevalence; Prosthesis Design; Pulmonary Embolism; Ultrasonography, Doppler, Duplex; Venous Thrombosis; Warfarin | 1999 |
Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Combined Modality Therapy; Cost-Benefit Analysis; Decision Support Techniques; Electric Countershock; Female; Humans; Male; Markov Chains; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Recurrence; Risk Factors; Warfarin | 1999 |
Finding what you seek: analyzing therapies for nonvalvular atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 1999 |
Real risks of two common drugs.
Topics: Anticoagulants; Aspirin; Drug Interactions; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk; Warfarin | 1999 |
Warfarin vs aspirin and AFASAK 2.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Warfarin | 1999 |
Treatment for the secondary prevention of stroke in older patients: the influence of dementia status.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dementia; Drug Utilization; Female; Geriatric Assessment; Humans; Logistic Models; Male; Middle Aged; Neurologic Examination; Patient Discharge; Patient Selection; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Warfarin | 1999 |
Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Drug Therapy; Electrocardiography; Female; Humans; Incidence; Male; Prevalence; Treatment Outcome; Warfarin | 1999 |
Antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.
Topics: Accidental Falls; Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Decision Support Techniques; Fibrinolytic Agents; Hematoma, Subdural; Humans; Life Expectancy; Markov Chains; Risk Factors; Treatment Outcome; Warfarin | 1999 |
Underuse of anticoagulation in older patients with chronic atrial fibrillation: malpractice or accuracy?
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chronic Disease; Contraindications; Depression; Drug Utilization; Female; Humans; Male; Malpractice; Platelet Aggregation Inhibitors; Residence Characteristics; Retrospective Studies; Risk Factors; Serum Albumin; Sex Factors; Warfarin | 1999 |
Additional risk factors in atrial fibrillation patients not receiving warfarin.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Drug Therapy; Female; Humans; Male; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Warfarin | 1999 |
Heart failure: a diagnostic and therapeutic dilemma in elderly patients.
Topics: Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Myocardial Infarction; Warfarin | 1999 |
Oxidation of LDL and extent of peripheral atherosclerosis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cholesterol, Dietary; Coumarins; Diet, Fat-Restricted; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Odds Ratio; Risk Factors | 1999 |
Anticoagulation in atrial fibrillation in older people.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Contraindications; Humans; Ischemic Attack, Transient; Risk Factors; Warfarin | 1999 |
Vale, warfarin: a stentorian farewell.
Topics: Animals; Anticoagulants; Aspirin; Coronary Thrombosis; Dogs; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Ticlopidine; Warfarin | 1999 |
Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy: a survey of current practice amongst radiologists and urologists.
Topics: Anticoagulants; Aspirin; Biopsy; Health Care Surveys; Hemostasis; Humans; Male; Platelet Aggregation Inhibitors; Prostate; Radiology; Urology; Warfarin | 1999 |
Atrial fibrillation: the epidemic of the new millennium.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Fibrinolytic Agents; Humans; Risk Factors; Warfarin | 1999 |
[The thromboembolic risk of atrial fibrillation].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Echocardiography; Electric Countershock; Hemorrhage; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thromboembolism | 1999 |
Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Male; Risk Assessment; Stroke; Warfarin | 1999 |
Use of antithrombotic measures for stroke prevention in atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cross-Sectional Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Patient Selection; Risk Assessment; Stroke; Warfarin | 1999 |
Effects of aspirin and warfarin on fatal and non-fatal heart attacks.
Topics: Anticoagulants; Aspirin; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Warfarin | 1999 |
Stroke risk, cholesterol and statins.
Topics: Aged; Aspirin; Diabetes Complications; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Life Style; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Warfarin | 1999 |
Warfarin or aspirin: both or others?
Topics: Aged; Anticoagulants; Aspirin; Embolism; Female; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Factors; Thrombosis; Warfarin | 1999 |
Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; beta-Thromboglobulin; Biomarkers; Factor V; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Multivariate Analysis; Peptide Fragments; Phlebotomy; Prothrombin; Sex Factors; Stroke; Thromboembolism; Warfarin | 1999 |
An alternative model of carotid artery thrombosis in rats.
Topics: Animals; Aspirin; Blood Cell Count; Carotid Artery Thrombosis; Catheterization; Disease Models, Animal; Fibrinolytic Agents; Heparin; Male; Rats; Time Factors; Warfarin | 1999 |
Vitamin E and blood thinners. You advised readers not to take extra vitamin E if they were taking aspirin or Coumadin. Why?
Topics: Anticoagulants; Aspirin; Drug Synergism; Humans; Platelet Aggregation Inhibitors; Vitamin E; Warfarin | 1999 |
Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Postoperative Care; Prosthesis Design; Retrospective Studies; Survival Rate; Thromboembolism; Warfarin | 1999 |
Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment.
Topics: Aged; Anticoagulants; Aspirin; Female; Hematuria; Humans; Male; Retrospective Studies; Warfarin | 2000 |
Clinical assessment of vascular thrombosis using indium-111 platelet scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Epoprostenol; Female; Fibrinolytic Agents; Humans; Indium Radioisotopes; Male; Middle Aged; Organometallic Compounds; Oxyquinoline; Platelet Aggregation Inhibitors; Pulmonary Embolism; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Vasodilator Agents; Venous Thrombosis; Warfarin | 2000 |
Aspirin for atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Evidence-Based Medicine; Humans; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Primary Health Care; Research Design; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin | 2000 |
Preventing stroke in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Evidence-Based Medicine; Female; Humans; Male; Patient Selection; Platelet Aggregation Inhibitors; Primary Prevention; Research Design; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2000 |
Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Heart Diseases; Humans; Practice Patterns, Physicians'; Retrospective Studies; Thromboembolism; Thrombolytic Therapy; Thrombosis; Warfarin | 2000 |
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Hydroxyurea; Leukemia; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Outcome; Primary Myelofibrosis; Prospective Studies; Risk Factors; Splenectomy; Thrombocythemia, Essential; Venous Thrombosis; Warfarin | 2000 |
Risk stratification in the management of atrial fibrillation in the community.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Family Practice; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Stroke; Thrombolytic Therapy; Warfarin | 1999 |
Underutilization of antithrombotic therapy in atrial fibrillation.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Thrombolytic Therapy; Warfarin | 2000 |
Effect of warfarin versus aspirin on the incidence of new thromboembolic stroke in older persons with chronic atrial fibrillation and abnormal and normal left ventricular ejection fraction.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Incidence; Intracranial Embolism and Thrombosis; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left; Warfarin | 2000 |
Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience.
Topics: Abciximab; Adult; Aged; Angiography; Angioplasty; Antibodies, Monoclonal; Anticoagulants; Aspirin; Basilar Artery; Cerebrovascular Circulation; Clopidogrel; Female; Follow-Up Studies; Heparin; Humans; Immunoglobulin Fab Fragments; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Stents; Stroke; Subarachnoid Hemorrhage; Ticlopidine; Vertebral Artery; Vertebrobasilar Insufficiency; Warfarin | 2000 |
[Prevention of embolism in atrial septal defects?].
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Coumarins; Embolism; Female; Fibrinolytic Agents; Heart Septal Defects, Atrial; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Time Factors; Venous Thrombosis | 2000 |
Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Communication Barriers; Comorbidity; Drug Prescriptions; Drug Utilization; Echocardiography; Female; Heart Diseases; Hospital Departments; Hospitalization; Humans; Israel; Lung Diseases, Obstructive; Male; Middle Aged; Physician-Patient Relations; Physicians; Practice Patterns, Physicians'; Recurrence; Refusal to Treat; Retrospective Studies; Risk Factors; Stroke; Thyrotoxicosis; Warfarin | 2000 |
Anticoagulation for chronic atrial fibrillation.
Topics: Aged; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Echocardiography, Transesophageal; Female; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Stroke; Warfarin | 2000 |
Non-rheumatic atrial fibrillation and stroke.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Risk Assessment; Risk Factors; Stroke; Warfarin | 1999 |
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Fibrinolytic Agents; Heart Valves; Humans; Risk Factors; Stroke; Warfarin | 2000 |
Antithrombotic therapy in atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Protocols; Fibrinolytic Agents; Humans; Warfarin | 2000 |
Prescribing patterns for the use of antithrombotics in the management of atrial fibrillation in Zimbabwe.
Topics: Adult; Aspirin; Atrial Fibrillation; Cross-Sectional Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Risk Factors; Stroke; Warfarin; Zimbabwe | 1999 |
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome.
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Cluster Analysis; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Humans; Immunoglobulin G; Immunoglobulin M; Male; Prognosis; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Severity of Illness Index; Time Factors; Warfarin | 2000 |
Sex differences and similarities in the management and outcome of stroke patients.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Humans; Hypertension; Male; Myocardial Ischemia; Ontario; Platelet Aggregation Inhibitors; Retrospective Studies; Sex Characteristics; Stroke; Stroke Rehabilitation; Survival Rate; Ticlopidine; Treatment Outcome; Warfarin | 2000 |
Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Drug Prescriptions; Eye Hemorrhage; Female; Humans; Macular Degeneration; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ultrasonography; Visual Acuity; Vitreous Hemorrhage; Warfarin | 2000 |
Which acute stroke patients with atrial fibrillation are prescribed warfarin therapy? Results from one-year's experience in Dundee.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Contraindications; Female; Hospitalization; Humans; Intracranial Hemorrhages; Male; Middle Aged; Risk Factors; Scotland; Stroke; Warfarin | 2000 |
Implementation of antithrombotic management in atrial fibrillation.
Topics: Aged; Aged, 80 and over; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Medical Audit; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Warfarin | 2000 |
Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Decision Support Techniques; Humans; Multimedia; Platelet Aggregation Inhibitors; Program Development; Stroke; Thrombolytic Therapy; Warfarin | 2000 |
Aspirin and warfarin therapy in oculoplastic surgery.
Topics: Anticoagulants; Aspirin; Contraindications; Humans; Ophthalmologic Surgical Procedures; Platelet Aggregation Inhibitors; Preoperative Care; Professional Practice; Risk Management; Surveys and Questionnaires; Warfarin | 2000 |
The impact of aspirin therapy and anticoagulation on the prevalence of spontaneous subdural haematoma.
Topics: Adult; Aged; Anticoagulants; Aspirin; Female; Hematoma, Subdural; Humans; Male; Prevalence; Reoperation; Retrospective Studies; Warfarin | 2000 |
Is optimal antithrombotic therapy after myocardial infarction well defined?
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2001 |
Atrial fibrillation and anticoagulation.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Warfarin | 2001 |
Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin.
Topics: Adult; Anticoagulants; Aspirin; Brain Infarction; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Heparin, Low-Molecular-Weight; Humans; Injections; Mitral Valve; Pregnancy; Pregnancy Complications, Cardiovascular; Thromboembolism; Warfarin | 2001 |
Prevention of cerebral thromboembolism by low-dose anticoagulant therapy in atrial fibrillation with mitral regurgitation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Circulation; Echocardiography; Female; Humans; Intracranial Embolism; Intracranial Thrombosis; Male; Middle Aged; Mitral Valve Insufficiency; Risk Factors; Warfarin | 2001 |
Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Hemarthrosis; Hematoma; Hematoma, Subdural; Hemorrhage; Humans; Hypertension; Kidney Diseases; Male; Menorrhagia; Middle Aged; Ovarian Diseases; Recurrence; Risk Factors; Thrombosis; Warfarin | 2001 |
Better stroke prevention.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2001 |
Short-term outcome of stent implantation in saphenous vein grafts: predictors of distal embolization and restenosis.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Combined Modality Therapy; Comorbidity; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Embolism; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular; Heparin; Humans; Japan; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Saphenous Vein; Stents; Ticlopidine; Treatment Outcome; Warfarin | 2001 |
By the way, doctor... Drugs for atrial fibrillation. I had atrial fibrillation and was zapped back into sinus rhythm several weeks ago. It seems like I'm going to have to take either aspirin or Coumadin. Which is better, and why?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Platelet Aggregation Inhibitors; Warfarin | 2001 |
Balancing risk in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Risk Factors; Thromboembolism; Warfarin | 2001 |
Clinical correlates and drug treatment of residents with stroke in long-term care.
Topics: Aged; Aged, 80 and over; Aspirin; Cognition Disorders; Comorbidity; Cross-Sectional Studies; Databases, Factual; Dipyridamole; Drug Therapy, Combination; Female; Humans; Inpatients; Logistic Models; Long-Term Care; Male; Nursing Homes; Odds Ratio; Prevalence; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Ticlopidine; United States; Warfarin | 2001 |
The real cost of aspirin.
Topics: Anticoagulants; Aspirin; Humans; International Normalized Ratio; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 2001 |
Long term anticoagulation or antiplatelet treatment. Inclusion criteria determine results of review.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Warfarin | 2001 |
Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2001 |
Long term anticoagulation or antiplatelet treatment. Giving warfarin always depends on balancing risks.
Topics: Anticoagulants; Aspirin; Drug Administration Schedule; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Warfarin | 2001 |
Long term anticoagulation or antiplatelet treatment. How do we decide between warfarin and aspirin?
Topics: Anticoagulants; Aspirin; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Warfarin | 2001 |
Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database.
Topics: Administration, Oral; Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Child; Child, Preschool; England; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Sex Distribution; Wales; Warfarin | 2001 |
Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Databases, Factual; Female; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin | 2001 |
Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper.
Topics: Aged; Anticoagulants; Aortic Valve Stenosis; Aspirin; Atrial Fibrillation; Communication; Decision Making; Humans; Informed Consent; Patient Participation; Physician-Patient Relations; Risk Assessment; Warfarin | 2001 |
Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Bandages; Cause of Death; Data Collection; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Pulmonary Embolism; Societies, Medical; United States; Venous Thrombosis; Warfarin | 2001 |
Spontaneous intracerebral hemorrhage.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Hemorrhage; Humans; Risk Factors; Vitamin E; Warfarin | 2001 |
Warfarin therapy does not increase bleeding in patients undergoing heart transplantation.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Transfusion; Chest Tubes; Heart Transplantation; Humans; International Normalized Ratio; Logistic Models; Middle Aged; Multivariate Analysis; Platelet Count; Postoperative Care; Postoperative Hemorrhage; Preoperative Care; Risk Factors; ROC Curve; Warfarin | 2001 |
Reduction in the intensity of abortive migraine drug use during coumarin therapy.
Topics: Anticoagulants; Aspirin; Coumarins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergotamine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Severity of Illness Index; Sumatriptan; Vasoconstrictor Agents | 2001 |
Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors.
Topics: Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Black People; Case-Control Studies; Databases, Factual; Drug Therapy, Combination; Drug Utilization; Female; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Nursing Homes; Odds Ratio; Platelet Aggregation Inhibitors; Risk Assessment; Sex Distribution; Stroke; Warfarin; White People | 2001 |
Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Defibrillators, Implantable; Echocardiography; Electrocardiography; Fees, Pharmaceutical; Guidelines as Topic; Humans; Middle Aged; Patient Compliance; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Time; Time Factors; Treatment Outcome; United Kingdom; United States; Warfarin | 2001 |
Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis.
Topics: Adult; Aged; Annexin A5; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Aspirin; Blood Platelets; Cell Aggregation; Cell Degranulation; Dual Specificity Phosphatase 2; Female; Humans; Leukocytes; Lupus Erythematosus, Systemic; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Count; Protein Phosphatase 2; Protein Tyrosine Phosphatases; Thrombosis; Warfarin | 2001 |
Aspirin and warfarin equally good for stroke patients.
Topics: Anticoagulants; Aspirin; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke; Warfarin | 2001 |
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Attitude to Health; Hemorrhage; Humans; Middle Aged; Patient Participation; Patient Selection; Physicians; Prospective Studies; Risk Assessment; Stroke; Warfarin | 2001 |
Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME.
Topics: Anticoagulants; Aspirin; Cardiovascular Diseases; Clinical Trials, Phase II as Topic; Electric Countershock; Europe; Guanidines; Humans; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Tetrazoles; Vasodilator Agents; Warfarin | 2001 |
Oral anticoagulation therapy during and after coronary angioplasty.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Stenosis; Coumarins; Drug Therapy, Combination; International Normalized Ratio; Thrombosis; Time Factors | 2001 |
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Diabetes Complications; Double-Blind Method; Fibrinolytic Agents; Heart Valve Diseases; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Warfarin | 2001 |
Low daily aspirin doses reduce risk of blood clots as effectively as higher doses.
Topics: Anticoagulants; Antithrombins; Aspirin; Glycoproteins; Heparin, Low-Molecular-Weight; Humans; Organizations; Practice Guidelines as Topic; Thromboembolism; United States; Warfarin | 2001 |
Oral anticoagulant therapy for the prevention of stroke.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2001 |
Atrial fibrillation and anticoagulation.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Risk Factors; Warfarin | 2001 |
Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease.
Topics: Administration, Oral; Aged; Arteriosclerosis; Aspirin; Comorbidity; Coronary Artery Disease; Drug Utilization; Female; Fibrinolytic Agents; Health Maintenance Organizations; Humans; Male; Middle Aged; Socioeconomic Factors; Surveys and Questionnaires; United States; Warfarin | 2002 |
Fontan's operation: is aspirin enough? Is coumadin too much?
Topics: Adolescent; Anticoagulants; Aspirin; Child, Preschool; Female; Fontan Procedure; Humans; Infant; Male; Retrospective Studies; Thromboembolism; Treatment Outcome; Warfarin | 2002 |
Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Catheters, Indwelling; Embolism, Paradoxical; Female; Follow-Up Studies; Heart Septal Defects, Atrial; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2002 |
Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Cohort Studies; Contraindications; Coumarins; Drug Interactions; Drug Prescriptions; Female; Glucocorticoids; Humans; Male; Osteoarthritis; Peptic Ulcer Hemorrhage; Retrospective Studies | 2002 |
Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Decision Support Techniques; Gastrointestinal Hemorrhage; Humans; Middle Aged; Quality-Adjusted Life Years; Risk Assessment; Stroke; Warfarin | 2002 |
Oral anticoagulation for acute coronary syndromes.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Clopidogrel; Controlled Clinical Trials as Topic; Diabetes Complications; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Patient Care Planning; Risk Factors; Stroke; Thrombosis; Ticlopidine; Warfarin | 2002 |
Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Decision Trees; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Venous Thrombosis; Warfarin | 2002 |
Evaluation of the blood coagulation mechanism and platelet aggregation in individuals with mechanical or biological heart prostheses.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Blood Coagulation Tests; Case-Control Studies; Drug Evaluation; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation; Warfarin | 2002 |
Warfarin or aspirin for recurrent ischemic stroke.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Data Interpretation, Statistical; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2002 |
Warfarin or aspirin for recurrent ischemic stroke.
Topics: Anticoagulants; Aorta; Aspirin; Brain Ischemia; Echocardiography, Transesophageal; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2002 |
Warfarin or aspirin for recurrent ischemic stroke.
Topics: Anticoagulants; Aspirin; Heart Septal Defects, Atrial; Humans; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2002 |
Warfarin or aspirin for recurrent ischemic stroke.
Topics: Administration, Oral; Anticoagulants; Aspirin; Brain Ischemia; Hemorrhage; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Warfarin | 2002 |
[Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin].
Topics: Administration, Oral; Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aspirin; Chronic Disease; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Esters; Gabexate; Guanidines; Humans; Male; Warfarin | 2002 |
Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Drug Utilization; Elective Surgical Procedures; Heparin; Heparin, Low-Molecular-Weight; Humans; New Zealand; Orthopedics; Postoperative Complications; Practice Patterns, Physicians'; Venous Thrombosis; Warfarin | 2002 |
Patent foramen ovale and recurrent stroke: another paradoxical twist.
Topics: Anticoagulants; Aspirin; Embolism, Paradoxical; Heart Septal Defects, Atrial; Humans; Intracranial Embolism; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stroke; Treatment Outcome; Warfarin | 2002 |
Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?
Topics: Anticoagulants; Aspirin; Brain Ischemia; Data Interpretation, Statistical; Embolism; Endpoint Determination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Secondary Prevention; Sensitivity and Specificity; Stroke; Treatment Outcome; Warfarin | 2002 |
Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Dermatologic Surgical Procedures; Humans; Interprofessional Relations; Perioperative Care; Platelet Aggregation Inhibitors; Surveys and Questionnaires; Warfarin | 2002 |
[Secondary prophylaxis after cerebral infarction without cardiac source of embolism. Anticoagulants are not better than ASA according to a new extensive trial (WARSS)].
Topics: Anticoagulants; Aspirin; Cerebral Infarction; Fibrinolytic Agents; Humans; International Normalized Ratio; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Warfarin | 2002 |
Cutaneous surgeons cannot predict blood-thinner status by intraoperative visual inspection.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Dermatologic Surgical Procedures; Female; Hemostasis, Surgical; Humans; Male; Middle Aged; Mohs Surgery; Observation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Vitamin E; Warfarin | 2002 |
The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Australia; Embolism; Hemorrhage; Hospitalization; Humans; Incidence; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Warfarin | 2002 |
Low molecular weight heparin: a bridge over troubled water.
Topics: Anticoagulants; Aspirin; Coronary Artery Disease; Dalteparin; Heparin, Low-Molecular-Weight; Humans; Randomized Controlled Trials as Topic; Warfarin | 2002 |
Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Electric Countershock; Heparin; Humans; Thromboembolism; Warfarin | 2002 |
Stroke prevention in elderly patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Male; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Stroke; Warfarin | 2002 |
Acute peripheral arterial ischemia and suspected aortic dissection: usefulness of transesophageal echocardiography in differential diagnosis with aortic thrombosis.
Topics: Acute Disease; Adult; Aged; Amputation, Surgical; Anticoagulants; Aortic Diseases; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Diagnosis, Differential; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Ischemia; Leg; Male; Middle Aged; Spain; Thrombectomy; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2002 |
Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Australia; Clinical Audit; Cross-Sectional Studies; Evidence-Based Medicine; Fibrinolytic Agents; Hospitals, Teaching; Humans; Interdisciplinary Communication; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2002 |
Anticoagulation therapy in cerebral sinovenous thrombosis and ulcerative colitis in children.
Topics: Adolescent; Adult; Antibodies, Anticardiolipin; Anticoagulants; Aspirin; Child; Colitis, Ulcerative; Female; Heparin; Homocysteine; Humans; Mutation; Platelet Aggregation Inhibitors; Prothrombin; Recurrence; Sinus Thrombosis, Intracranial; Treatment Outcome; Warfarin | 2002 |
Antithrombotic therapy after myocardial infarction.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2002 |
Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity.
Topics: Amino Acid Sequence; Amino Acid Substitution; Anticoagulants; Aspirin; Base Sequence; Drug Hypersensitivity; Factor IX; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Mutation; Partial Thromboplastin Time; Polymorphism, Single Nucleotide; Protein Precursors; Warfarin | 2002 |
Management of thrombophilia in renal transplant patients.
Topics: Anticoagulants; Aspirin; Graft Rejection; Humans; Kidney Transplantation; Platelet Aggregation Inhibitors; Thrombophilia; Warfarin | 2002 |
Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model.
Topics: Animals; Aspirin; Clopidogrel; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart Valve Prosthesis; In Vitro Techniques; Male; Microscopy, Electron; Rabbits; Thrombosis; Ticlopidine; Warfarin | 2002 |
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; beta-Thromboglobulin; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Glycoproteins; Humans; Male; Multivariate Analysis; Platelet Activation; Platelet Aggregation Inhibitors; Warfarin | 2002 |
[Anticoagulation in permanent atrial fibrillation after 75 years of age].
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Warfarin | 2002 |
Evaluation of the marker of hypercoagulability prothrombin fragment F 1+2 in patients with mechanical or biological heart valve prostheses.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticoagulants; Aspirin; Biomarkers; Bioprosthesis; Female; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Platelet Aggregation Inhibitors; Prothrombin; Prothrombin Time; Thrombophilia; Warfarin | 2002 |
Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Drug Evaluation; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Longitudinal Studies; Prospective Studies; Regression Analysis; Renal Dialysis; Risk Factors; Treatment Failure; Treatment Outcome; Vascular Patency; Vasodilator Agents; Warfarin | 2002 |
Stroke prevention in patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Prescriptions; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2003 |
Consecutive central retinal artery and vein occlusions in primary antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Platelet Aggregation Inhibitors; Retinal Artery Occlusion; Retinal Vein Occlusion; Visual Acuity; Warfarin | 2002 |
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cross-Sectional Studies; Evidence-Based Medicine; Female; Humans; Logistic Models; Male; Middle Aged; Practice Patterns, Physicians'; Primary Health Care; Risk Assessment; Thromboembolism | 2003 |
Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
Topics: Anticoagulants; Aspirin; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stroke; Warfarin | 2002 |
Warfarin, aspirin, or both after myocardial infarction.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Stroke; Warfarin | 2003 |
Warfarin, aspirin, or both after myocardial infarction.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2003 |
Warfarin, aspirin, or both after myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Disease; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 2003 |
The underutilization of cardiac medications of proven benefit, 1990 to 2002.
Topics: Adrenergic beta-Antagonists; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atrial Fibrillation; Cardiovascular Agents; Coronary Artery Disease; Drug Therapy; Drug Utilization; Health Care Surveys; Heart Failure; Hematologic Agents; Humans; Longitudinal Studies; Office Visits; United States; Warfarin | 2003 |
Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mohs Surgery; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Stroke; Vascular Diseases; Warfarin | 2003 |
Embolic attack in patients with atrial fibrillation and atrial thrombus depends on the character of the thrombus.
Topics: Aged; Aspirin; Atrial Fibrillation; Disease-Free Survival; Drug Therapy, Combination; Echocardiography, Transesophageal; Embolism; Female; Heart Atria; Humans; Male; Middle Aged; Practice Guidelines as Topic; Predictive Value of Tests; Survival Analysis; Thrombosis; Ticlopidine; Warfarin | 2003 |
Going with the flow of anticoagulant therapy.
Topics: Anticoagulants; Aspirin; Dipyridamole; Heparin; Humans; Patient Education as Topic; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Pulmonary Embolism; Pyridines; Thoracic Surgery; Thrombophilia; Warfarin | 2003 |
The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Choroid Hemorrhage; Contraindications; Female; Fibrinolytic Agents; Humans; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Risk Factors; Scleral Buckling; United Kingdom; Vitrectomy; Vitreous Hemorrhage; Warfarin | 2003 |
Bedside calculation of stroke risk in patients with atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Computers, Handheld; Hemorrhage; Humans; Point-of-Care Systems; Predictive Value of Tests; Risk Factors; Software; Stroke; Warfarin | 2003 |
[Anticoagulation and antiaggregation in neurological patients].
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Meta-Analysis as Topic; Middle Aged; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Ticlopidine; Warfarin | 2003 |
Synthesis of vanillin ethers from 4-(bromomethyl) coumarins as anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzaldehydes; Carrageenan; Coumarins; Edema; Ethers; Female; Granuloma; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Pain Measurement; Rats; Rats, Wistar; Reaction Time; Spectrophotometry, Infrared; Stomach Ulcer | 2003 |
Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Atria; Heart Diseases; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Regression Analysis; Risk Factors; Thrombosis; Warfarin | 2003 |
Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortality.
Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Benzothiadiazines; Calcium Channel Blockers; Diuretics; Drug Utilization; Hospital Mortality; Humans; Male; Models, Statistical; Multivariate Analysis; Myocardial Infarction; Nitro Compounds; Patient Admission; Receptors, Angiotensin; Retrospective Studies; Sodium Chloride Symporter Inhibitors; Survival Rate; Time Factors; Warfarin | 2003 |
Maintaining patency of tunneled hemodialysis catheters--efficacy of aspirin compared to warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Catheters, Indwelling; Equipment Failure; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Renal Dialysis; Thrombosis; Treatment Outcome; Warfarin | 2003 |
Editorial comment: Low-dose or moderate-dose anticoagulation: dream or hope for stroke prevention?
Topics: Administration, Oral; Anticoagulants; Aspirin; Brain Ischemia; Clinical Trials as Topic; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; International Normalized Ratio; Risk Assessment; Stroke; Treatment Outcome; Warfarin | 2003 |
Efficacy of antithrombotic therapy for atrial fibrillation in the oldest old.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Treatment Outcome; Warfarin | 2003 |
Towards better management of chronic atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Chronic Disease; Humans; Warfarin | 2003 |
Antithrombotic treatment of atrial fibrillation in a regional hospital in Hong Kong.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Chronic Disease; Contraindications; Female; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Stroke; Warfarin | 2003 |
Bone marrow biopsy morbidity and mortality.
Topics: Anticoagulants; Aspirin; Biopsy, Needle; Bone Marrow Examination; Hemorrhage; Humans; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Risk Factors; Warfarin | 2003 |
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Cohort Studies; Decision Support Techniques; Fibrinolytic Agents; Humans; Intracranial Thrombosis; Male; Markov Chains; Quality-Adjusted Life Years; Risk; Risk Assessment; Sensitivity and Specificity; Warfarin | 2003 |
[Secondary prevention of stroke].
Topics: Anticoagulants; Aspirin; Endarterectomy, Carotid; Humans; Secondary Prevention; Stroke; Warfarin | 2003 |
[Current approaches to prevention and treatment of antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Contraceptives, Oral; Enzyme Inhibitors; Female; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Male; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Risk Factors; Smoking; Time Factors; Warfarin | 2003 |
Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Transfusion; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Minnesota; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Pyridines; Retrospective Studies; Stents; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Warfarin | 2003 |
Regression of intracardiac heparin-induced thrombosis after aortic root surgery.
Topics: Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Follow-Up Studies; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2003 |
Subintimal angioplasty of long superficial femoral artery occlusions.
Topics: Angioplasty; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Female; Femoral Artery; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Postoperative Care; Proportional Hazards Models; Stents; Ticlopidine; Time Factors; Treatment Outcome; Vascular Patency; Warfarin | 2003 |
Massive chronic atrial thrombosis.
Topics: Anticoagulants; Aspirin; Chronic Disease; Coronary Thrombosis; Drug Therapy, Combination; Echocardiography, Transesophageal; Heart Atria; Humans; Male; Middle Aged; Warfarin | 2003 |
Atrial fibrillation and stroke prevention.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Stroke; Thromboembolism; Warfarin | 2003 |
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cohort Studies; Female; Fibrinolytic Agents; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Severity of Illness Index; Stroke; Warfarin | 2003 |
Veterans Affairs (VA) Cooperative Study #362.
Topics: Aspirin; Cohort Studies; Female; Graft Rejection; Graft Survival; Hospitals, Veterans; Humans; Male; Netherlands; Peripheral Vascular Diseases; Postoperative Complications; Postoperative Period; Risk Assessment; Thrombolytic Therapy; Treatment Outcome; United States; Vascular Patency; Vascular Surgical Procedures; Warfarin | 2003 |
Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.
Topics: Anticoagulants; Aspirin; Double-Blind Method; Female; Heart Aneurysm; Heart Atria; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Warfarin | 2003 |
Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents.
Topics: Aged; Anticoagulants; Aspirin; Databases, Factual; Dipyridamole; Drug Therapy, Combination; Drug Utilization Review; Health Services Accessibility; Humans; Nursing Homes; Prejudice; Preventive Medicine; Racial Groups; Risk Reduction Behavior; Secondary Prevention; Stroke; Ticlopidine; United States; Warfarin | 2003 |
Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angelica; Animals; Arachidonic Acid; Aspirin; Benzopyrans; Blood Platelets; Butyrates; Collagen; Coumarins; Furocoumarins; Glucosides; Herbal Medicine; Heterocyclic Compounds, 3-Ring; Korea; Male; Medicine, East Asian Traditional; Methanol; Nephelometry and Turbidimetry; Plant Extracts; Plant Roots; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley | 2003 |
Methods for mid-course corrections in clinical trials with survival outcomes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Computer Simulation; Humans; Markov Chains; Models, Statistical; Myocardial Infarction; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Survival Analysis; Treatment Outcome; Warfarin | 2003 |
["Economy class syndrome" associated with diabetes and Graves disease].
Topics: Aged; Aircraft; Anticoagulants; Aspirin; Diabetes Complications; Female; Graves Disease; Humans; Pulmonary Embolism; Risk Factors; Syndrome; Travel; Venous Thrombosis; Warfarin | 2003 |
Discontinuing aspirin or warfarin optional before cataract surgery.
Topics: Anticoagulants; Aspirin; Cataract Extraction; Eye Hemorrhage; Humans; Middle Aged; Prospective Studies; Risk Factors; Warfarin | 2003 |
Assessment of bleeding propensity in non-human primates by combination of selective tissue factor/VIIa inhibition and aspirin compared to warfarin and aspirin treatment.
Topics: Aminobenzoates; Animals; Anticoagulants; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Drug Combinations; Factor VIIa; Hemorrhage; Macaca fascicularis; Male; Platelet Aggregation Inhibitors; Prothrombin Time; Pyrazines; Thromboplastin; Warfarin; Whole Blood Coagulation Time | 2004 |
Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients.
Topics: Aged; Aspirin; Drug Prescriptions; Humans; Intracranial Thrombosis; Medical Records; Warfarin | 2004 |
Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Humans; Long-Term Care; Male; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2004 |
When guidelines collide...
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Ticlopidine; Warfarin | 2004 |
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Warfarin | 2004 |
Ximelagatran or warfarin in atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Humans; Prodrugs; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2004 |
Ximelagatran or warfarin in atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Humans; Randomized Controlled Trials as Topic; Research Design; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2004 |
Regarding "regarding 'Veterans Affairs (VA) Cooperative Study #362'".
Topics: Anticoagulants; Aspirin; Blood Vessel Prosthesis Implantation; Chemoprevention; Clinical Trials as Topic; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Netherlands; United States; United States Department of Veterans Affairs; Warfarin | 2004 |
Community-based study of atrial fibrillation and stroke prevention.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Clinical Competence; Cohort Studies; Community Health Services; Family Practice; Female; Health Care Surveys; Humans; Ireland; Male; Middle Aged; Outcome Assessment, Health Care; Practice Patterns, Physicians'; Risk Assessment; Stroke; Warfarin | 2004 |
Upper gastrointestinal haemorrhage following cardiac surgery: a comparative study with vascular surgery patients from a single centre.
Topics: Aged; Aspirin; Cardiac Surgical Procedures; Coronary Artery Bypass; Duodenal Ulcer; Female; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Postoperative Hemorrhage; Smoking; Stomach Ulcer; Time Factors; Vascular Surgical Procedures; Warfarin | 2004 |
Secondary prevention of stroke: more than just aspirin or warfarin.
Topics: Aged; Anticoagulants; Aspirin; Fibrinolytic Agents; Humans; Hypertension; Secondary Prevention; Stroke; Warfarin | 2004 |
Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Stroke; Ticlopidine; Warfarin | 2004 |
[Aspirin versus oral anticoagulants following lower limb arterial reconstructions: what to choose?].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Administration Schedule; Humans; Lower Extremity; Plastic Surgery Procedures; Postoperative Care; Venous Thrombosis; Warfarin | 2004 |
Anticoagulation in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Electric Countershock; Fibrinolytic Agents; Humans; Prodrugs; Stroke; Warfarin | 2004 |
The beginning of the end of warfarin?
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Glycine; Humans; Platelet Aggregation Inhibitors; Prodrugs; Thrombin; Warfarin | 2004 |
Retinal vein occlusions in patients taking warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Humans; Male; Middle Aged; Retinal Vein; Retinal Vein Occlusion; Retrospective Studies; Warfarin | 2004 |
Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Female; Follow-Up Studies; Hemorrhage; Humans; Israel; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Warfarin | 2004 |
Aspirin bias in SPORTIF III trial.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Humans; Platelet Aggregation Inhibitors; Prodrugs; Randomized Controlled Trials as Topic; Selection Bias; Stroke; Thrombin; Warfarin | 2004 |
[Stroke and Other Thromboembolic Complications of Atrial Fibrillation. Part III. Prevention With Aspirin].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Stroke; Warfarin | 2004 |
Late incidence and determinants of stroke after aortic and mitral valve replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Comorbidity; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Incidence; International Normalized Ratio; Intracranial Embolism; Life Tables; Male; Middle Aged; Mitral Valve; Postoperative Complications; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; Stroke; Ventricular Dysfunction, Left; Warfarin | 2004 |
Incidence of anticoagulation in patients with bioprostheses.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Intracranial Embolism; Platelet Aggregation Inhibitors; Prospective Studies; Survival Analysis; Warfarin | 2004 |
[A 78-year-old man with anterior chest pain].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Biomarkers; Cardiomyopathies; Chest Pain; Echocardiography; Electrocardiography; Heart Diseases; Heart Ventricles; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Syndrome; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome; Troponin; Warfarin | 2004 |
Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atrial Fibrillation; Community Health Services; Comorbidity; Cross-Sectional Studies; Drug Utilization; Dyspnea; Echocardiography; Electrocardiography; Family Practice; Female; Humans; Male; Mass Screening; Ventricular Dysfunction, Left; Wales; Warfarin | 2004 |
Antiphospholipid syndrome in a child: an insight into the pathology, identification, and means of cure.
Topics: Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Arterial Occlusive Diseases; Aspirin; Child, Preschool; Collateral Circulation; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin G; Immunosuppressive Agents; Intermittent Claudication; Leg Ulcer; Male; Prednisolone; Skin Diseases, Vascular; Thrombophilia; Warfarin | 2004 |
Adverse drug reactions as cause of admission to hospital: admissions to ear, nose, and throat departments were not mentioned.
Topics: Anticoagulants; Aspirin; Epistaxis; Hospitalization; Humans; Middle Aged; Warfarin | 2004 |
Physicians' attitudes toward anticoagulant therapy in patients with chronic atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Chronic Disease; Drug Utilization; Electrocardiography; Female; Health Care Surveys; Humans; Japan; Male; Middle Aged; Practice Patterns, Physicians'; Probability; Severity of Illness Index; Stroke; Surveys and Questionnaires; Warfarin | 2004 |
Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biomarkers; Brain Infarction; Brain Ischemia; Cohort Studies; Comorbidity; Female; Fibrinopeptide A; Follow-Up Studies; Humans; International Normalized Ratio; Intracranial Thrombosis; Male; Middle Aged; Multicenter Studies as Topic; Peptide Fragments; Prothrombin; Randomized Controlled Trials as Topic; Recurrence; Stroke; Thrombin; Warfarin | 2004 |
Ask the doctor. Does low-dose Coumadin plus aspirin prevent blood clots?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Humans; International Normalized Ratio; Pacemaker, Artificial; Thrombosis; Warfarin | 2004 |
Anticoagulation interruptus: not without risk.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Blood Loss, Surgical; Carotid Arteries; Dalteparin; Drug Administration Schedule; Elective Surgical Procedures; Filtration; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Intraoperative Care; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Premedication; Stents; Thromboembolism; Thrombosis; Vitamin K; Warfarin | 2004 |
A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Attitude to Health; Case-Control Studies; Female; Health Education; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Tasmania; Warfarin | 2004 |
The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
Topics: Angioplasty; Animals; Arteries; Aspirin; Blood Coagulation Factors; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; International Normalized Ratio; Platelet Adhesiveness; Swine; Thrombosis; Vitamin K; Warfarin | 2004 |
Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Gastrointestinal Hemorrhage; Heart Failure; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Warfarin | 2004 |
Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Middle Aged; Mitral Valve Stenosis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Salicylates; Warfarin | 2004 |
Anticoagulation to prevent strokes in older people with atrial fibrillation: assembling individualized risk and benefit information.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Long-Term Care; Risk Factors; Stroke; Warfarin | 2004 |
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Case-Control Studies; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Multivariate Analysis; Odds Ratio; Risk Factors; Warfarin | 2004 |
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Monitoring; Humans; International Normalized Ratio; Middle Aged; Patient Satisfaction; Quality of Life; Stroke; Warfarin | 2005 |
Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cause of Death; Female; Humans; International Normalized Ratio; Male; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Recurrence; Risk Factors; Stroke; Warfarin | 2005 |
Arterial thrombosis in four patients treated with thalidomide.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Female; Humans; Intracranial Thrombosis; Lymphoma; Male; Middle Aged; Multiple Myeloma; Thalidomide; Thrombosis; Warfarin | 2005 |
[Primary prevention of thrombosis for patients with atrial fibrillation].
Topics: Aged; Aspirin; Atrial Fibrillation; Humans; Intracranial Thrombosis; Japan; Practice Guidelines as Topic; Warfarin | 2004 |
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clopidogrel; Drug Therapy, Combination; Feasibility Studies; Humans; Pilot Projects; Platelet Aggregation Inhibitors; Research Design; Thromboembolism; Ticlopidine; Warfarin | 2005 |
Coronary endarterectomy and stent removal in patients with in-stent restenosis.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coronary Restenosis; Device Removal; Endarterectomy; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Postoperative Care; Retrospective Studies; Stents; Warfarin | 2005 |
Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Chronic Disease; Cost-Benefit Analysis; Decision Support Techniques; Humans; Prodrugs; Quality-Adjusted Life Years; Stroke; United States; Warfarin | 2005 |
Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens.
Topics: Acute Disease; Aspirin; Coronary Aneurysm; Coronary Stenosis; gamma-Globulins; Humans; Longitudinal Studies; Mucocutaneous Lymph Node Syndrome; Prednisolone; Retrospective Studies; Warfarin | 2005 |
Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biopsy; Blood; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Hematuria; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prostate; Prostatic Neoplasms; Rectum; Semen; Severity of Illness Index; Ultrasonography, Interventional; Warfarin | 2005 |
Atrial fibrillation: when the heart loses its rhythm. You may not even feel it happening, but if the atria of the heart don't beat correctly you could be in danger of a stroke.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Function, Left; Atrial Function, Right; Humans; Myocardial Contraction; Thrombosis; Warfarin | 2005 |
Warfarin, aspirin, and intracranial vascular disease.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Mortality; Stroke; Thromboembolism; Treatment Failure; Warfarin | 2005 |
Pregnancy after heart valve replacement--case report.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Female; Heart Valve Prosthesis; Heparin; Humans; Mitral Valve; Oxygen Inhalation Therapy; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Warfarin | 2004 |
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Warfarin | 2005 |
Strategies for stroke prevention in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Balloon Occlusion; Electric Countershock; Heart Atria; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Warfarin | 2005 |
Atrial septal abnormalities and cryptogenic stroke: a paradoxical science.
Topics: Anticoagulants; Aspirin; Heart Atria; Heart Septal Defects, Atrial; Heart Septum; Humans; Stroke; United States; Warfarin | 2005 |
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Hemorrhage; Humans; International Normalized Ratio; Mass Screening; Warfarin | 2005 |
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Hemorrhage; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Pregnancy; Recurrence; Retrospective Studies; Risk; Vitamin K; Warfarin | 2005 |
Oral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more?
Topics: Administration, Oral; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Humans; International Normalized Ratio; Lupus Coagulation Inhibitor; Male; Retrospective Studies; Risk; Thromboembolism; Venous Thrombosis; Warfarin | 2005 |
Anticoagulation influences long-term outcome in patients with nonvalvular atrial fibrillation and severe ischemic stroke.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Female; Follow-Up Studies; Humans; Male; Prognosis; Prospective Studies; Secondary Prevention; Severity of Illness Index; Stroke; Thromboembolism; Warfarin | 2004 |
Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Heart Valve Prosthesis; Humans; Mitral Valve; Risk Factors; Thromboembolism; Warfarin | 2005 |
Oral anticoagulation and mechanical heart valves: the case of the elderly and pregnancy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Contraindications; Female; Heart Valve Prosthesis; Heparin; Humans; International Normalized Ratio; Practice Guidelines as Topic; Pregnancy; Risk Factors; Thromboembolism; Warfarin | 2005 |
Prophylactic anticoagulation following the Fontan operation.
Topics: Adult; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Fontan Procedure; Heart Diseases; Humans; Postoperative Care; Risk Factors; Thromboembolism; Warfarin | 2005 |
Images in cardiovascular medicine. Giant coronary artery aneurysms in Kawasaki disease.
Topics: Angiography; Aspirin; Coronary Aneurysm; Electrocardiography; Fever; Heart Murmurs; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocutaneous Lymph Node Syndrome; Pericardial Effusion; Tachycardia, Sinus; Warfarin | 2005 |
Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of Cataract and Refractive Surgery members: survey.
Topics: Anesthesia, Local; Anticoagulants; Aspirin; Canada; Cataract Extraction; Drug Utilization; Female; Health Surveys; Humans; Male; Ophthalmology; Perioperative Care; Practice Patterns, Physicians'; Societies, Medical; Surveys and Questionnaires; Warfarin | 2005 |
Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Evidence-Based Medicine; Female; Humans; Male; Middle Aged; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Stroke; Warfarin | 2005 |
Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Treatment Outcome; Warfarin | 2005 |
Two-stage adaptive design for clinical trials with survival data.
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Data Interpretation, Statistical; Follow-Up Studies; Humans; Long-Term Care; Myocardial Infarction; Patient Compliance; Platelet Aggregation Inhibitors; Secondary Prevention; Survival Analysis; Warfarin | 2005 |
Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
Topics: Anticoagulants; Aspirin; Heart Failure; Humans; Platelet Aggregation Inhibitors; Treatment Outcome; Warfarin | 2005 |
Summaries for patients. Benefits and harms of warfarin plus aspirin after acute coronary events.
Topics: Acute Disease; Anticoagulants; Aspirin; Coronary Disease; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Secondary Prevention; Syndrome; Warfarin | 2005 |
Oral surgery procedures in patients on anticoagulants. Preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Coumarins; Female; Humans; International Normalized Ratio; Male; Middle Aged; Oral Surgical Procedures; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Treatment Outcome | 2005 |
Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels?
Topics: Adult; Aged; Amaurosis Fugax; Anticoagulants; Aspirin; Atrial Fibrillation; Catheters, Indwelling; Echocardiography; Embolism; Embolization, Therapeutic; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Predictive Value of Tests; Retinal Vessels; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vision, Low; Warfarin | 2005 |
[Should warfarin and acetylsalicylic acid be withdrawn prior to tooth extraction?].
Topics: Anticoagulants; Aspirin; Cyclooxygenase Inhibitors; Fibrinolytic Agents; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Tooth Extraction; Warfarin | 2005 |
Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
Topics: Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Utilization; Female; Humans; Illinois; Male; Middle Aged; Patient Compliance; Risk Factors; Sex Factors; Specialization; Stroke; United States; Urban Population; Warfarin | 2005 |
Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Gastrointestinal Neoplasms; Hemoglobins; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Distribution; Sex Factors; Warfarin | 2005 |
Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Blood Pressure; Female; Fibrinolytic Agents; Humans; Incidence; Ischemia; Male; Medical Records; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Regression Analysis; Risk; Sex Factors; Stroke; Time Factors; Treatment Outcome; Warfarin | 2005 |
An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.
Topics: Adult; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Consultants; Fibrinolytic Agents; Guideline Adherence; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Ireland; Mitral Valve; Practice Guidelines as Topic; Practice Patterns, Physicians'; Surveys and Questionnaires; Thoracic Surgery; Treatment Outcome; United Kingdom; Warfarin | 2005 |
Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention.
Topics: Aged; Aged, 80 and over; Algorithms; Aspirin; Atrial Fibrillation; Contraindications; Cooperative Behavior; Evidence-Based Medicine; Female; Fibrinolytic Agents; Follow-Up Studies; Hospitals, Teaching; Humans; Intracranial Embolism; Male; New South Wales; Patient Care Team; Patient Discharge; Pharmacists; Risk; Risk Assessment; Warfarin | 2005 |
[Anticoagulation therapy and oral surgery].
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Humans; Oral Hemorrhage; Risk Factors; Tooth Extraction; Tranexamic Acid; Warfarin | 2005 |
Bleeding complications in elderly patients following acute myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Warfarin | 2005 |
Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Hemorrhage; Cohort Studies; Female; Hematoma; Hemorrhage; Humans; Iatrogenic Disease; Male; Middle Aged; Models, Statistical; Platelet Aggregation Inhibitors; Platelet Transfusion; Risk; Risk Factors; Time Factors; Treatment Outcome; Warfarin | 2006 |
Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Warfarin | 2006 |
[Characteristics of colon cancer diagnosed in patients taking aspirin or warfarin].
Topics: Aged; Anticoagulants; Aspirin; Cardiovascular Diseases; Colonic Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Warfarin | 2005 |
Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Esophagitis; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hematemesis; Humans; Intestinal Mucosa; Male; Middle Aged; Platelet Aggregation Inhibitors; Stomach Ulcer; Ticlopidine; Warfarin | 2006 |
Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Thromboembolism; Warfarin | 2006 |
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Female; Humans; Infusion Pumps; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Failure; Treatment Outcome; Tyrosine; Warfarin | 2006 |
Oral anticoagulant therapy, endocapsular hematoma, and neodymium:YAG capsulotomy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Hematoma; Humans; Laser Therapy; Lens Capsule, Crystalline; Lens Diseases; Male; Mitral Valve; Pseudophakia; Stroke; Warfarin | 2006 |
The effect of aspirin and warfarin therapy in trabeculectomy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Aspirin; Blood Loss, Surgical; Child; Drug Administration Schedule; Epidemiologic Methods; Eye Hemorrhage; Glaucoma; Humans; Hyphema; Intraocular Pressure; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Trabeculectomy; Treatment Outcome; Warfarin | 2007 |
Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Black or African American; Blood Coagulation; Case-Control Studies; Clopidogrel; Drug Interactions; Enoxaparin; Female; Gastrointestinal Hemorrhage; Hispanic or Latino; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Warfarin; White People | 2006 |
[Postoperative antithrombotic treatment in diabetic patients].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Thrombosis; Ticlopidine; Warfarin | 2006 |
Capsule endoscopy in clinical routine in patients with suspected disease of the small intestine: a 2-year prospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Diarrhea; Endoscopy, Gastrointestinal; Female; Humans; Intestinal Diseases; Intestine, Small; Male; Middle Aged; Norway; Prospective Studies; Warfarin | 2006 |
Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
Topics: Aged; Aspirin; Brain Ischemia; Cohort Studies; Comorbidity; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Intracranial Arteriosclerosis; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Racial Groups; Randomized Controlled Trials as Topic; Risk; Risk Factors; Survival Analysis; Vascular Diseases; Warfarin | 2006 |
Medications with anticoagulant properties increase the likelihood of a negative colonoscopy in faecal occult blood test population screening.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Colonoscopy; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; False Positive Reactions; Female; Humans; Male; Mass Screening; Middle Aged; Occult Blood; Warfarin | 2006 |
Antithrombotic therapy in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Heart Failure; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2006 |
Aspirin for prevention of stroke in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Platelet Aggregation Inhibitors; Stroke; Thrombophilia; Treatment Failure; Warfarin | 2006 |
Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Severity of Illness Index; Stents; Ticlopidine; Warfarin | 2006 |
Preventing vascular complications after gastric bypass.
Topics: Adult; Aged; Anticoagulants; Aspirin; Bandages; Clinical Protocols; Drug Monitoring; Early Ambulation; Evidence-Based Medicine; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Male; Middle Aged; Obesity, Morbid; Postoperative Care; Program Evaluation; Risk Factors; South Carolina; Thromboembolism; Vena Cava Filters; Venous Thrombosis; Warfarin | 2006 |
Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Coagulation Tests; Coronary Angiography; Coronary Disease; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Doppler; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Pyridines; Research Design; Retrospective Studies; Survival Analysis; Warfarin | 2006 |
[Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; China; Female; Humans; Male; Retrospective Studies; Stroke; Treatment Outcome; Warfarin | 2006 |
Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anticoagulants; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Conjunctival Diseases; Connective Tissue; Eye Hemorrhage; Female; Humans; Lens Implantation, Intraocular; Male; Medical Audit; Middle Aged; Phacoemulsification; Prospective Studies; Risk Factors; Ticlopidine; Warfarin | 2006 |
A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
Topics: Adult; Aged; Aspirin; Databases, Factual; Foramen Ovale, Patent; Humans; Middle Aged; Recurrence; Risk Factors; Stress Disorders, Traumatic; Stroke; Warfarin | 2006 |
An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent.
Topics: Adolescent; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Equipment Failure; Fibrinolytic Agents; Heart Transplantation; Heart-Assist Devices; Humans; Male; Thrombosis; Ticlopidine; Warfarin | 2006 |
Patients' knowledge of adverse reactions to current medications.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug-Related Side Effects and Adverse Reactions; Emergency Service, Hospital; Female; Health Knowledge, Attitudes, Practice; Humans; Inpatients; Male; Middle Aged; Proton Pump Inhibitors; Risk Assessment; Warfarin | 2006 |
Utilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapy.
Topics: Acetaminophen; Adult; Ambulatory Care; Analgesics, Non-Narcotic; Anticoagulants; Antithyroid Agents; Aspirin; Diclofenac; Drug Interactions; Drug Monitoring; Drug Prescriptions; Drug Utilization Review; Female; Follow-Up Studies; Humans; International Normalized Ratio; Male; Middle Aged; Polypharmacy; Propylthiouracil; Retrospective Studies; Thailand; Warfarin | 2007 |
Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey.
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Canada; Data Collection; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Heart Valves; Heparin; Heparin, Low-Molecular-Weight; Mitral Valve; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Period; Practice Guidelines as Topic; Practice Patterns, Physicians'; Surveys and Questionnaires; Thoracic Surgery; Time Factors; Treatment Outcome; Warfarin | 2006 |
Leaflet movement of the ATS valve in the aortic position: unique behavior observed in 19-mm valves.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Cardiac Surgical Procedures; Cineradiography; Comorbidity; Echocardiography, Doppler; Equipment Design; Female; Heart Valve Prosthesis; Hemorheology; Humans; Male; Middle Aged; Motion; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Prosthesis Failure; Reoperation; Thromboembolism; Warfarin | 2006 |
Cardiology groups' antithrombotic guidelines challenge ACCP's.
Topics: Aspirin; Atrial Fibrillation; Cardiology; Fibrinolytic Agents; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke; Warfarin | 2006 |
Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Glasgow Coma Scale; Hematoma, Subdural, Chronic; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Warfarin | 2006 |
[Prevention of vascular events after transient ischemic attack or cerebral infarct].
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Warfarin | 2006 |
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin | 2006 |
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Embolism; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Treatment Outcome; Warfarin | 2006 |
Antithrombotic therapy and predilection for cerebellar hemorrhage.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriosclerosis; Aspirin; Blood Glucose; Cerebellar Diseases; Female; Fibrinolytic Agents; Heart Diseases; Humans; Intracranial Hemorrhages; Japan; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Registries; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Warfarin | 2007 |
Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thromboph
Topics: Aged; Anticoagulants; Aspirin; Drug Resistance; Erythromelalgia; Female; Humans; Ischemia; Male; Microcirculation; Middle Aged; Phlebotomy; Platelet Aggregation Inhibitors; Polycythemia Vera; Thrombocythemia, Essential; Thrombophilia; Thrombosis; Warfarin | 2006 |
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Combined Modality Therapy; Consensus Development Conferences as Topic; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stents; Stroke; Ticlopidine; Warfarin | 2006 |
Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: case report and review of the literature.
Topics: Accidental Falls; Aged; Anticoagulants; Aspirin; Drug Interactions; Fatty Acids, Omega-3; Hematoma, Subdural; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2007 |
Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Body Mass Index; Drainage; Female; Heparin, Low-Molecular-Weight; Humans; Kaplan-Meier Estimate; Length of Stay; Linear Models; Logistic Models; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Retrospective Studies; Risk Factors; Surgical Wound Infection; Venous Thrombosis; Warfarin; Wound Healing | 2007 |
Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions.
Topics: Adrenal Cortex Hormones; Aging; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Drug Administration Schedule; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Randomized Controlled Trials as Topic; Risk Factors; Ulcer; Warfarin | 2007 |
New guidelines for atrial fibrillation focus on stroke risk.
Topics: Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Practice Guidelines as Topic; Risk Factors; Stroke; Warfarin | 2006 |
Platelet adhesion in atrial fibrillation.
Topics: Age Factors; Aged; Aspirin; Atrial Fibrillation; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Platelet Adhesiveness; Risk Factors; Warfarin | 2007 |
Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Fibrinolytic Agents; Humans; Middle Aged; Platelet Aggregation Inhibitors; Warfarin | 2007 |
Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2007 |
Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Anticoagulants; Aspirin; Case-Control Studies; Cohort Studies; Cyclooxygenase 2 Inhibitors; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Duodenal Ulcer; Gastrointestinal Diseases; Half-Life; Humans; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Retrospective Studies; Risk Assessment; Risk Factors; Steroids; Stomach Ulcer; Time Factors; United Kingdom; Upper Gastrointestinal Tract; Warfarin | 2007 |
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prosthesis Failure; Retrospective Studies; Stents; Ticlopidine; Warfarin | 2007 |
Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Guideline Adherence; Humans; Male; Middle Aged; Practice Guidelines as Topic; Risk Factors; Stroke; Warfarin | 2007 |
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Topics: Aged; Aspirin; Atrial Fibrillation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Cell Membrane; Cerebral Infarction; Coronary Disease; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Fibrinolytic Agents; Flow Cytometry; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; P-Selectin; Particle Size; Platelet Activation; Reference Values; Risk Factors; Statistics as Topic; Warfarin | 2007 |
Cerebral venous sinus thrombosis associated with essential thrombocytosis in a pediatric patient.
Topics: Adolescent; Anticoagulants; Aspirin; Bone Marrow; Follow-Up Studies; Humans; Hydroxyurea; Magnetic Resonance Angiography; Male; Mucositis; Platelet Count; Sensitivity and Specificity; Sinus Thrombosis, Intracranial; Thrombocytosis; Treatment Outcome; Warfarin | 2007 |
Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation?
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome; Warfarin | 2007 |
Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Factors; Ticlopidine; Warfarin | 2007 |
Changes in the use of cardiovascular medicines in the elderly aged 75 years or older--a population-based Kuopio 75+ study.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Cohort Studies; Digoxin; Diuretics; Drug Utilization; Finland; Homebound Persons; Humans; Hypertension; Institutionalization; Nitrates; Survivors; Time Factors; Warfarin | 2007 |
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Topics: Aged; Anticoagulants; Antigens, CD; Aspirin; Atrial Fibrillation; Blood Platelets; Case-Control Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Count; Platelet Membrane Glycoproteins; Tetraspanin 30; Warfarin | 2007 |
Study suggests limiting use of aspirin plus warfarin.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Disease; Drug Therapy, Combination; Humans; Warfarin | 2007 |
Spontaneous dissection of the celiac artery: a case report.
Topics: Abdominal Pain; Analgesics, Opioid; Anticoagulants; Aortic Dissection; Aspirin; Celiac Artery; Diagnosis, Differential; Drug Therapy, Combination; Enoxaparin; Humans; Male; Meperidine; Middle Aged; Platelet Aggregation Inhibitors; Splenic Artery; Splenic Infarction; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2007 |
National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.
Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Cyclooxygenase Inhibitors; Digoxin; Female; Humans; Male; Middle Aged; Sex Factors; Thrombosis; Treatment Outcome; Warfarin | 2007 |
Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Regression Analysis; Risk Assessment; Risk Factors; Stents; Survival Analysis; Treatment Outcome; Warfarin | 2007 |
Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy.
Topics: Aged; Anticoagulants; Aspirin; Female; Hematoma; Humans; Male; Neoplasms; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Risk Factors; Warfarin | 2007 |
Comment on the WASPO study.
Topics: Aged; Aged, 80 and over; Aspirin; Humans; Risk Factors; Stroke; Thrombosis; Warfarin | 2007 |
I've had atrial fibrillation without associated heart disease for 40 years. I'm unable to take Coumadin, so for many years I've taken one 325 mg aspirin daily for its anticoagulation effect. How do you compare aspirin's benefits with Coumadin's?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Stroke; Treatment Outcome; Warfarin | 2007 |
Stroke prevention in elderly patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Warfarin | 2007 |
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2007 |
Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Renal Dialysis; Warfarin | 2007 |
Practical approach to treating essential thrombocythaemia: case studies.
Topics: Adult; Aspirin; Disease Management; Female; Humans; Hydroxyurea; Interferon-alpha; Leg Ulcer; Male; Middle Aged; Pipobroman; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Quinazolines; Thrombocythemia, Essential; Warfarin | 2007 |
Safety of intravitreal injections in patients receiving warfarin anticoagulation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aptamers, Nucleotide; Aspirin; Celecoxib; Choroidal Neovascularization; Drug Therapy, Combination; Eye Hemorrhage; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Pyrazoles; Retrospective Studies; Sulfonamides; Vascular Endothelial Growth Factor A; Vitreous Body; Warfarin | 2007 |
Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Thromboembolism; Warfarin | 2007 |
Is clopidogrel stopped prior to hip fracture surgery--A survey of current practice in the United Kingdom.
Topics: Anticoagulants; Aspirin; Clinical Protocols; Clopidogrel; Contraindications; Femoral Neck Fractures; Health Care Surveys; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Professional Practice; Surgery Department, Hospital; Ticlopidine; United Kingdom; Warfarin | 2007 |
Partial reversal of hemolysis-associated pulmonary arterial hypertension in response to oral administration of L-arginine in a patient with hereditary spherocytosis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arginine; Aspirin; Hemolysis; Humans; Hypertension, Pulmonary; Male; Middle Aged; Spherocytosis, Hereditary; Vasodilator Agents; Warfarin | 2007 |
Treatment of massive cardiac thrombi in a patient with protein C and protein S deficiency.
Topics: Anticoagulants; Aspirin; Cardiomyopathy, Dilated; Child, Preschool; Female; Fibrinolytic Agents; Heart Diseases; Heart Ventricles; Heparin; Humans; Protein C Deficiency; Protein S Deficiency; Thrombosis; Treatment Outcome; Ultrasonography; Warfarin | 2007 |
Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Dermatology; Drug Utilization Review; Humans; Mohs Surgery; Perioperative Care; Practice Patterns, Physicians'; Skin Diseases; Surveys and Questionnaires; Ticlopidine; United States; Vitamin E; Warfarin | 2007 |
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin--a persisting dilemma.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk Factors; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |
Central retinal vein occlusion case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Female; Glaucoma; Humans; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Warfarin | 2007 |
Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Quebec; Retrospective Studies; Risk Factors; Ticlopidine; Warfarin | 2007 |
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Stroke; Warfarin | 2007 |
Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Clinical Protocols; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Pulmonary Embolism; Retrospective Studies; Survival Rate; Thromboembolism; Venous Thrombosis; Warfarin | 2007 |
[A study on the recurrence of ischemic stroke in nonvalvular atrial fibrillation].
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cohort Studies; Female; Follow-Up Studies; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Multivariate Analysis; Recurrence; Regression Analysis; Retrospective Studies; Risk Factors; Warfarin | 2007 |
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Humans; Practice Guidelines as Topic; Risk Factors; Stents; Thrombosis; Ticlopidine; Warfarin | 2007 |
Warfarin versus aspirin for stroke prevention (BAFTA).
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Humans; Risk Factors; Stroke; Warfarin | 2007 |
Major bleeding in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Renal Dialysis; Risk Factors; Thrombosis; Warfarin | 2008 |
[Anticoagulation treatment in real-life practice of patient with nonvalvular atrial fibrillation in Beijing city].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; China; Female; Humans; International Normalized Ratio; Male; Middle Aged; Prevalence; Surveys and Questionnaires; Warfarin | 2007 |
Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Bias; Humans; Intracranial Hemorrhages; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Warfarin | 2008 |
Distribution of etiologies in patients above and below age 45 with first-ever ischemic stroke.
Topics: Adult; Age Distribution; Aging; Anticoagulants; Aspirin; Atrial Fibrillation; Embolism; Female; Foramen Ovale; Humans; Male; Middle Aged; Registries; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2008 |
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clopidogrel; Combined Modality Therapy; Dipyridamole; Early Ambulation; Enoxaparin; Female; Fibrinolytic Agents; Hematologic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Thromboembolism; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |
Outcomes associated with combined antiplatelet and anticoagulant therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2008 |
Warfarin trumps aspirin for stroke prevention in elderly.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Stroke; Warfarin | 2007 |
Incidence of ocular hemorrhages in anticoagulated patients receiving repeated intravitreal injections.
Topics: Angiogenesis Inhibitors; Anticoagulants; Aptamers, Nucleotide; Aspirin; Choroidal Neovascularization; Drug Therapy, Combination; Eye Hemorrhage; Humans; Incidence; Injections; Macular Degeneration; Risk Factors; Vascular Endothelial Growth Factor A; Vitreous Body; Warfarin | 2008 |
Combined antithrombotic therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2008 |
The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.
Topics: Aged; Anesthetics, Local; Anticoagulants; Aspirin; Blood Loss, Surgical; Cataract Extraction; Choroid Hemorrhage; Clopidogrel; Dipyridamole; Eye Hemorrhage; Humans; Intraoperative Complications; Lens Capsule, Crystalline; Platelet Aggregation Inhibitors; Risk Factors; Rupture; Ticlopidine; Warfarin | 2009 |
Which patients receiving warfarin can be treated safely with a drug-eluting stent?
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Stroke; Ticlopidine; Warfarin | 2008 |
Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study.
Topics: Anticoagulants; Aspirin; Data Interpretation, Statistical; Double-Blind Method; Drug Administration Schedule; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Stroke; Warfarin | 2008 |
"Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Pyridines; Risk Factors; Stents; Thromboembolism; Warfarin | 2008 |
Effect of aspirin and warfarin on early survival after intracerebral haemorrhage.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain; Cerebral Hemorrhage; Female; Humans; Logistic Models; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Prognosis; Survival; Time Factors; Warfarin | 2008 |
Vertebral artery dissection: not a rare cause of stroke in the young.
Topics: Adult; Amlodipine; Anticoagulants; Antihypertensive Agents; Aspirin; Craniocerebral Trauma; Female; Hemianopsia; Humans; Hypertension; Magnetic Resonance Angiography; Stroke; Tomography, X-Ray Computed; Vertebral Artery Dissection; Warfarin | 2008 |
Withholding warfarin therapy for atrial fibrillation patients in the perioperative period.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Enoxaparin; Humans; Perioperative Care; Stroke; Time Factors; Warfarin | 2008 |
Did we really need another comparison of warfarin with aspirin? An assessment of the BAFTA trial.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Humans; Platelet Aggregation Inhibitors; Treatment Outcome; Warfarin | 2007 |
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation Factors; Brain Ischemia; Cerebral Hemorrhage; Clinical Protocols; Clinical Trials as Topic; Comorbidity; Humans; Patient Selection; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Assessment; Risk Factors; Stroke; Warfarin | 2008 |
Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Factor V; Humans; Male; Middle Aged; Mutation; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Ticlopidine; Warfarin | 2008 |
Common blood thinners: what are the differences?
Topics: Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug Utilization; Emergency Nursing; Emergency Service, Hospital; Humans; Monitoring, Physiologic; Risk Assessment; Sensitivity and Specificity; Ticlopidine; Warfarin | 2008 |
Anticoagulation therapy in glaucoma surgery.
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Glaucoma; Humans; International Normalized Ratio; Ophthalmology; Practice Patterns, Physicians'; Surveys and Questionnaires; Time Factors; Trabeculectomy; Warfarin | 2008 |
Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Catheter Ablation; Digoxin; Drug Utilization; Electric Countershock; Female; Hospitalization; Humans; Male; Medicine; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Specialization; United States; Warfarin; Wolff-Parkinson-White Syndrome | 2008 |
Commentary on "Antiplatelet therapy for vascular interventions".
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Vascular Surgical Procedures; Warfarin | 2008 |
Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
Topics: Anticoagulants; Aspirin; Diabetes Complications; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome; Warfarin | 2008 |
Antiaggregant and anticoagulant therapy of free-floating thrombus in left atrium.
Topics: Adult; Anticoagulants; Aspirin; Clopidogrel; Diagnosis, Differential; Dyspnea; Echocardiography, Transesophageal; Female; Heart Atria; Heart Diseases; Heparin; Humans; Platelet Aggregation Inhibitors; Radiography; Thrombosis; Ticlopidine; Warfarin | 2008 |
Aspirin decreases the prevalence and severity of heterotopic ossification after 1-stage bilateral total hip arthroplasty for osteoarthrosis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ossification, Heterotopic; Osteoarthritis, Hip; Prevalence; Retrospective Studies; Severity of Illness Index; Thrombosis; Warfarin | 2009 |
Safety and efficacy of clopidogrel in children with heart disease.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Clopidogrel; Female; Heart Diseases; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Warfarin | 2008 |
Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Stroke; Warfarin | 2008 |
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Evidence-Based Medicine; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Injections, Subcutaneous; International Normalized Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Vitamin K; Warfarin | 2008 |
[The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2008 |
Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Case-Control Studies; Duodenal Ulcer; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Ulcer; Treatment Outcome; Warfarin | 2008 |
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Warfarin | 2008 |
VTE prevention in major orthopedic surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Orthopedic Procedures; Polysaccharides; Postoperative Complications; Risk Assessment; Risk Reduction Behavior; Venous Thromboembolism; Warfarin | 2008 |
Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
Topics: Adult; Anticoagulants; Aspirin; Female; Heart-Assist Devices; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine; Warfarin | 2008 |
Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Endocarditis, Bacterial; Epistaxis; Heart Failure; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Prosthesis Design; Self Medication; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2008 |
Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Female; Heparin; Humans; Infant, Newborn; Male; Mitral Valve Insufficiency; Pregnancy; Pregnancy Complications, Hematologic; Stroke; Warfarin | 2008 |
Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; China; Humans; Incidence; Platelet Aggregation Inhibitors; Risk; Risk Factors; Stroke; Thromboembolism; Warfarin | 2008 |
Comment: Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Warfarin | 2008 |
Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Prescriptions; Female; Fibrinolytic Agents; Guideline Adherence; Humans; Logistic Models; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Factors; Stroke; Taiwan; Warfarin | 2008 |
The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Brain Hemorrhage, Traumatic; Cardiovascular Diseases; Cause of Death; Clopidogrel; Cohort Studies; Comorbidity; Female; Follow-Up Studies; Geriatric Assessment; Hospital Mortality; Humans; Injury Severity Score; Male; Middle Aged; Platelet Aggregation Inhibitors; Preoperative Care; Retrospective Studies; Risk Assessment; Sex Factors; Survival Analysis; Ticlopidine; Trauma Centers; Treatment Outcome; Warfarin; Wounds, Nonpenetrating | 2008 |
Patient with hypofibrinolysis-mediated thromboembolism converted to a hypercoagulable/hyperfibrinolytic state via ventricular assist device placement.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Fibrinolysis; Heart Ventricles; Heart-Assist Devices; Hemostasis; Heparin; Humans; Middle Aged; Thromboembolism; Thrombophilia; Warfarin | 2008 |
Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Focus Groups; Humans; Male; Middle Aged; Patient Participation; Patient Satisfaction; Practice Patterns, Physicians'; Spain; Stroke; Warfarin | 2008 |
Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Thrombosis; Ticlopidine; Warfarin | 2008 |
Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Thrombosis; Ticlopidine; Warfarin | 2008 |
Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
Topics: Adult; Aged; Anticoagulants; Aspirin; Female; Heart-Assist Devices; Hemorrhage; Humans; Male; Middle Aged; Prosthesis Design; Stroke; Thromboembolism; Thrombosis; Time Factors; Warfarin | 2008 |
eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Endocarditis, Bacterial; Epistaxis; Heart Failure; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Mitral Valve; Platelet Aggregation Inhibitors; Prosthesis Design; Self Medication; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2008 |
[The BAFTA study].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2008 |
The effects of clopidogrel on elderly traumatic brain injured patients.
Topics: Aged; Aspirin; Brain Damage, Chronic; Brain Injuries; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Disability Evaluation; Female; Glasgow Coma Scale; Humans; Length of Stay; Male; Platelet Aggregation Inhibitors; Prognosis; Registries; Retrospective Studies; Ticlopidine; Warfarin | 2008 |
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Risk Factors; Ticlopidine; Warfarin | 2008 |
Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K | 2008 |
Prevention strategies of cardioembolic ischemic stroke in Chagas' disease.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Chagas Cardiomyopathy; Epidemiologic Methods; Female; Hemorrhage; Humans; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Reference Values; Stroke; Warfarin | 2008 |
Indirect comparison: relative risk fallacies and odds solution.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Interferon beta-1b; Interferon-beta; Multiple Sclerosis; Natalizumab; Odds Ratio; Randomized Controlled Trials as Topic; Research Design; Risk; Stroke; Treatment Outcome; Warfarin | 2009 |
Off-pump replacement of the INCOR implantable axial-flow pump.
Topics: Anticoagulants; Aspirin; Clopidogrel; Equipment Design; Heart-Assist Devices; Humans; Infusion Pumps, Implantable; International Normalized Ratio; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left; Warfarin | 2009 |
Atrial fibrillation: Ways to refine your care.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Echocardiography, Transesophageal; Electric Countershock; Electrocardiography; Humans; Lung; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Radiography; Warfarin | 2009 |
Paget-Schroetter syndrome forerunning the diagnoses of thoracic outlet syndrome and thrombophilia.
Topics: Activated Protein C Resistance; Anticoagulants; Aspirin; Enoxaparin; Factor V; Heterozygote; Humans; Magnetic Resonance Angiography; Male; Methylenetetrahydrofolate Reductase (NADPH2); Occupational Diseases; Subclavian Vein; Thoracic Outlet Syndrome; Thrombophilia; Upper Extremity Deep Vein Thrombosis; Warfarin; Wrestling; Young Adult | 2010 |
Athero-embolic isolated splenic infarction following left cardiac catheterization.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Aneurysm, Abdominal; Aspirin; Atherosclerosis; Cardiac Catheterization; Clopidogrel; Coronary Stenosis; Embolism, Cholesterol; Heparin; Humans; Infarction; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Spleen; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2009 |
Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Evidence-Based Medicine; Heparin, Low-Molecular-Weight; Humans; Inpatients; Intraoperative Care; Patient Discharge; Platelet Aggregation Inhibitors; Polysaccharides; Postoperative Care; Practice Guidelines as Topic; Preoperative Care; Prothrombin Time; Pulmonary Embolism; Review Literature as Topic; Risk Assessment; Warfarin | 2009 |
Atrial fibrillation and mild cognitive impairment: what correlation?
Topics: Activities of Daily Living; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Case-Control Studies; Cognition Disorders; Disability Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Prevalence; Psychiatric Status Rating Scales; Research Design; Risk Factors; Sicily; Treatment Outcome; Warfarin | 2009 |
Atrial fibrillation and stroke risk prevention in real-life clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Clinical Trials as Topic; Female; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Stroke; Time Factors; Warfarin | 2009 |
How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; International Normalized Ratio; Male; Middle Aged; Risk Factors; Stroke; Time Factors; United Kingdom; Warfarin | 2009 |
[Guidelines for the general management of patients with acute ischemic stroke].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Fibrinolytic Agents; Humans; Inpatients; Stroke; Taiwan; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Warfarin | 2008 |
Combined aspirin plus warfarin: recent evidence and residual questions.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Warfarin | 2009 |
Does the combination of warfarin and aspirin have a place in secondary stroke prevention? No.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Warfarin | 2009 |
Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
Topics: Anticoagulants; Aspirin; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Warfarin | 2009 |
[Atrial fibrillation].
Topics: Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Electric Countershock; Electrocardiography; Heart Rate; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Time Factors; Warfarin | 2009 |
Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.
Topics: Aged; Aspirin; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Factors; Ticlopidine; Warfarin | 2009 |
The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pulmonary Embolism; Thromboembolism; Warfarin; Young Adult | 2009 |
Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.
Topics: Administration, Oral; Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Coronary Aneurysm; Coronary Thrombosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Warfarin | 2009 |
Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Heart Diseases; Humans; Models, Cardiovascular; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Warfarin | 2009 |
Prevention of stroke in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin | 2009 |
Does anticoagulation benefit patients with congestive heart failure (CHF) who have reduced left ventricular ejection fraction (LVEF) and are in normal sinus rhythm?
Topics: Anticoagulants; Aspirin; Evidence-Based Medicine; Female; Heart Failure; Humans; Male; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Stroke Volume; Thrombophilia; Ventricular Function, Left; Warfarin | 2009 |
Coronary embolism causing acute myocardial infarction in a patient with mitral valve prosthesis: successful management with angioplasty.
Topics: Adrenergic beta-Antagonists; Adult; Angioplasty, Balloon; Anticoagulants; Antihypertensive Agents; Aspirin; Coronary Angiography; Coronary Artery Disease; Echocardiography, Transesophageal; Embolism; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Myocardial Infarction; Platelet Aggregation Inhibitors; Treatment Outcome; Warfarin | 2009 |
[Oral anticoagulant use in patients with atrial fibrillation].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Hypertension; International Normalized Ratio; Male; Middle Aged; Practice Guidelines as Topic; Risk Factors; Stroke; Warfarin | 2009 |
Prevalence and characteristics of traumatic intracranial hemorrhage in elderly fallers presenting to the emergency department without focal findings.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chi-Square Distribution; Clopidogrel; Emergency Service, Hospital; Female; Humans; Intracranial Hemorrhage, Traumatic; Logistic Models; Male; Prevalence; Retrospective Studies; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2009 |
How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
Topics: Algorithms; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Male; Pregnancy; Pregnancy Complications; Warfarin | 2009 |
Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Dementia; Female; Fibrinolytic Agents; Hemorrhage; Humans; International Normalized Ratio; Male; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2009 |
Venous thromboembolism debate in joint arthroplasty.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Heparin, Low-Molecular-Weight; Humans; Practice Guidelines as Topic; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2009 |
Perioperative anticoagulant management.
Topics: Adult; Aged; Anticoagulants; Aspirin; Drug Administration Schedule; Drug Synergism; Female; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Perioperative Care; Polysaccharides; Risk Factors; Vena Cava Filters; Venous Thromboembolism; Warfarin | 2009 |
Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Female; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polysaccharides; Postoperative Complications; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome; Venous Thromboembolism; Warfarin | 2010 |
Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer.
Topics: Adjuvants, Immunologic; Aged; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma, Transitional Cell; Clopidogrel; Drug Interactions; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Urinary Bladder Neoplasms; Warfarin | 2009 |
Editorial comment.
Topics: Adjuvants, Immunologic; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma, Transitional Cell; Clopidogrel; Drug Interactions; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine; Urinary Bladder Neoplasms; Warfarin | 2009 |
Who is ineligible for warfarin in atrial fibrillation?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Patient Selection; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2009 |
Testing a no-warfarin heart valve.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2006 |
Peri-operative management of anti-platelet agents.
Topics: Aged; Aged, 80 and over; Aspirin; Chi-Square Distribution; Clopidogrel; Female; Humans; Interviews as Topic; Male; Middle Aged; Platelet Aggregation Inhibitors; Preoperative Care; Surgical Procedures, Operative; Ticlopidine; Warfarin | 2009 |
Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Blood Transfusion; Equipment Design; Female; Heart Transplantation; Heart-Assist Devices; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Outpatients; Retrospective Studies; Stroke; Thromboembolism; Warfarin; Young Adult | 2009 |
Bilateral facial nerve palsy in Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Child; Facial Nerve Diseases; Facial Paralysis; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Prednisolone; Ultrasonography; Warfarin | 2009 |
Acute myocardial infarction as the first manifestation of the incomplete Kawasaki disease in a young male.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Biomarkers; Captopril; Child; Coronary Angiography; Diagnosis, Differential; Drug Therapy, Combination; Echocardiography; Electrocardiography; Humans; Male; Mucocutaneous Lymph Node Syndrome; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 2009 |
Retrospective analysis on the management of anticoagulants and antiplatelet agents for scheduled endoscopy.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Appointments and Schedules; Aspirin; Drug Monitoring; Drug Therapy, Combination; Drug Utilization; Endoscopy, Digestive System; Female; Guidelines as Topic; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Warfarin | 2009 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Contraindications; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K; Warfarin | 2009 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vitamin K; Warfarin | 2009 |
Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Anemia; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Drug Utilization; Female; Humans; Logistic Models; Male; Middle Aged; Patient Discharge; Platelet Aggregation Inhibitors; Registries; Smoking; Stents; Stroke; Stroke Volume; Ticlopidine; United States; Warfarin | 2009 |
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Warfarin | 2009 |
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Vitamin K; Warfarin | 2009 |
Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial".
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Chronic Disease; Clopidogrel; Death; Double-Blind Method; Female; Fibrinolytic Agents; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Stroke; Stroke Volume; Ticlopidine; Warfarin | 2009 |
By the way, doctor. I am currently on Coumadin because I had atrial fibrillation after my bypass, Plavix because of my stent, and a baby aspirin. Why do I need to take three blood thinners?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiopulmonary Bypass; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2009 |
A retrospective review of patients with head injury with coexistent anticoagulant and antiplatelet use admitted from a UK emergency department.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Craniocerebral Trauma; Emergency Service, Hospital; Female; Hospitalization; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Retrospective Studies; Tomography, X-Ray Computed; Warfarin | 2009 |
Primary antiphospholipid syndrome with and without Sneddon's syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Chloroquine; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prevalence; Sneddon Syndrome; Treatment Outcome; Venous Thrombosis; Warfarin | 2011 |
The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Assessment; Stroke; Warfarin | 2010 |
Impact of chronic antithrombotic therapy on hospital course of patients with acute myocardial infarction.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Bundle-Branch Block; Coumarins; Diabetes Mellitus; Female; Germany; Hemorrhage; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sex Factors; Shock, Cardiogenic; Stroke | 2009 |
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk; Stents; Stroke; Thromboembolism; Thrombosis; Ticlopidine; Warfarin | 2009 |
[Influence of anticoagulants on the appearance of chronic subdural hematoma].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Chronic Disease; Coumarins; Female; Hematoma, Subdural; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Poland; Surveys and Questionnaires | 2009 |
Dabigatran versus warfarin in patients with atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Warfarin | 2009 |
Dabigatran versus warfarin in patients with atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Pyridines; Warfarin | 2009 |
The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Defibrillators, Implantable; Female; Hematoma; Humans; International Normalized Ratio; Male; Pacemaker, Artificial; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prosthesis Implantation; Retrospective Studies; Ticlopidine; Warfarin | 2010 |
Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; International Normalized Ratio; Stroke; Warfarin | 2010 |
Letter by Bhindi and Ormerod regarding article, "Aortic arch plaques and risk of recurrent stroke and death".
Topics: Anticoagulants; Aortic Diseases; Aspirin; Atherosclerosis; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Risk; Secondary Prevention; Stroke; Warfarin | 2010 |
Interactions of human serum albumin with meloxicam: characterization of binding site.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bilirubin; Binding Sites; Circular Dichroism; Humans; Hydrogen-Ion Concentration; Ligands; Meloxicam; Molecular Structure; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence; Thiazines; Thiazoles; Warfarin; Water | 2010 |
Warfarin versus aspirin: using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Monitoring; Female; Fibrinolytic Agents; Humans; Male; Risk Assessment; Risk Factors; Stroke; Warfarin | 2009 |
Stroke in heart failure: atrial fibrillation revisited?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Heart Failure; Hemorrhage; Humans; Patient Selection; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2010 |
Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome; Warfarin | 2010 |
Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Dermatologic Surgical Procedures; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythema; Female; Follow-Up Studies; Hematoma; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Surgical Wound Dehiscence; Surgical Wound Infection; Ticlopidine; Warfarin | 2010 |
Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin therapy.
Topics: Adolescent; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Enoxaparin; Female; Gelatin Sponge, Absorbable; Hemostatic Techniques; Hemostatics; Humans; Male; Middle Aged; Oral Hemorrhage; Oral Surgical Procedures; Plasma; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Sutures; Thrombin; Tooth Extraction; Venous Thrombosis; Vitamin K; Warfarin; Young Adult | 2010 |
Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study.
Topics: Aspirin; Brain; Female; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Magnetic Resonance Imaging; Male; Risk Factors; Sinus Thrombosis, Intracranial; Stroke; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2010 |
The dental implant patient on anticoagulant therapy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Dental Care for Chronically Ill; Dental Implantation, Endosseous; Heparin; Ticlopidine; Warfarin | 2010 |
Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Female; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drugs; Registries; Risk Factors; Sex Characteristics; Thromboembolism; Warfarin | 2010 |
[Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Embolism; Exercise Test; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2010 |
Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Colonic Neoplasms; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Logistic Models; Male; Mass Screening; Middle Aged; Occult Blood; Odds Ratio; Platelet Aggregation Inhibitors; Predictive Value of Tests; Retrospective Studies; Ticlopidine; Unnecessary Procedures; Warfarin | 2010 |
Management of anticoagulation before and after gastrointestinal endoscopy.
Topics: Anticoagulants; Asian People; Aspirin; Cerebral Infarction; Endoscopy, Gastrointestinal; Humans; Risk Factors; Warfarin; White People | 2010 |
Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Prospective Studies; Risk Factors; Stroke; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2010 |
Strategy to prevent recurrent portal vein stenosis following interventional radiology in pediatric liver transplantation.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Catheterization; Child; Child, Preschool; Constriction, Pathologic; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Infant; Liver Transplantation; Living Donors; Male; Portal Vein; Postoperative Complications; Radiology, Interventional; Regional Blood Flow; Retrospective Studies; Secondary Prevention; Treatment Outcome; Ultrasonography; Vascular Diseases; Warfarin; Young Adult | 2010 |
Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Bioprosthesis; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Selection; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Thromboembolism; Time Factors; Treatment Outcome; Vitamin K; Warfarin | 2010 |
Brain microbleeds.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Brain; Cerebral Amyloid Angiopathy; Humans; Intracranial Hemorrhages; Magnetic Resonance Imaging; Warfarin | 2010 |
Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
Topics: Anticoagulants; Aspirin; Dipyridamole; Female; Gastrointestinal Hemorrhage; Heart Ventricles; Heart-Assist Devices; Heparin; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Warfarin | 2010 |
Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cardiovascular Diseases; Coronary Disease; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Prognosis; Pyridines; Retrospective Studies; Ventricular Dysfunction; Warfarin | 2010 |
I've read where people on coumadin shouldn't take acetaminophen (Tylenol), but I've also been told that it's a safe alternative to aspirin, which warfarin (Coumadin) takers are not supposed to take. Can you clear up the confusion?
Topics: Acetaminophen; Anticoagulants; Aspirin; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Health Knowledge, Attitudes, Practice; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Warfarin | 2009 |
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Topics: Anticoagulants; Aspirin; Drug Administration Schedule; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hemorrhage; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Postoperative Care; Postoperative Complications; Postoperative Period; Retrospective Studies; Stroke; Thromboembolism; Thrombosis; Time Factors; Unnecessary Procedures; Warfarin | 2010 |
Probing the occult: testing for blood in the stools.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Colonic Neoplasms; Colonoscopy; Gastrointestinal Hemorrhage; Humans; Mass Screening; Occult Blood; Platelet Aggregation Inhibitors; Predictive Value of Tests; Ticlopidine; Unnecessary Procedures; Warfarin | 2010 |
Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
Topics: Algorithms; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Vessels; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Management; Stents; Ticlopidine; Warfarin | 2010 |
Spontaneous coronary dissection as cause of recurring myocardial infarction.
Topics: Anticoagulants; Aortic Dissection; Aspirin; Coronary Aneurysm; Coronary Angiography; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Warfarin | 2011 |
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Clopidogrel; Confidence Intervals; Defibrillators, Implantable; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Hemorrhage; Prevalence; Reference Values; Retrospective Studies; Risk Assessment; Ticlopidine; Warfarin | 2010 |
Spontaneous intramural hematoma of the small intestine.
Topics: Adult; Aged; Anticoagulants; Aspirin; Hematoma; Hemophilia A; Humans; Intestinal Diseases; Intestine, Small; Male; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2010 |
Extracardiac Fontan operation after late bidirectional Glenn shunt.
Topics: Adolescent; Anticoagulants; Aspirin; Blood Pressure; Chest Tubes; Child; Child, Preschool; Drainage; Drug Therapy, Combination; Exercise Tolerance; Female; Fontan Procedure; Heart Bypass, Right; Heart Defects, Congenital; Humans; India; Male; Oxygen; Platelet Aggregation Inhibitors; Pleural Effusion; Pulmonary Artery; Retrospective Studies; Time Factors; Treatment Outcome; Warfarin; Young Adult | 2010 |
Antithrombotic therapies in patients with heart failure: hypothesis formulation from a research database.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Databases, Factual; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Sex Factors; Ticlopidine; United Kingdom; Warfarin; Young Adult | 2010 |
Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Eye Hemorrhage; Female; Humans; Incidence; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Visual Acuity; Warfarin | 2010 |
6 steps to safer use of triple therapy. Take care when combining aspirin, Plavix, and warfarin.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Health Knowledge, Attitudes, Practice; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin | 2009 |
How can stretching maneuvers involving the neck cause vertebral artery dissection and transient ischemic attack?
Topics: Adult; Aged; Aspirin; Confusion; Headache; Heparin; Humans; Ischemic Attack, Transient; Muscle Stretching Exercises; Neck; Simvastatin; Treatment Outcome; Vertebral Artery Dissection; Warfarin | 2010 |
Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Calcium Channel Blockers; Digoxin; Diuretics; Female; Heart Failure, Diastolic; Heart Rate; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Warfarin | 2010 |
Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Comorbidity; Hospital Mortality; Hospitalization; Humans; Incidence; Peptic Ulcer Hemorrhage; Regression Analysis; Retrospective Studies; Risk Factors; Sweden; Warfarin | 2010 |
Hand surgery on anticoagulated patients: a prospective study of 121 operations.
Topics: Anticoagulants; Aspirin; Clopidogrel; Hand; Hemostasis, Surgical; Humans; International Normalized Ratio; Perioperative Care; Postoperative Hemorrhage; Thrombosis; Ticlopidine; Tourniquets; Warfarin | 2010 |
Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Warfarin | 2010 |
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Cohort Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Secondary Prevention; Warfarin | 2010 |
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Cohort Studies; Comorbidity; Denmark; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Proportional Hazards Models; Registries; Risk; Stroke; Ticlopidine; Warfarin | 2010 |
DVT prophylaxis: better living through chemistry: affirms.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Patient Readmission; Platelet Aggregation Inhibitors; Polysaccharides; Postoperative Hemorrhage; Practice Guidelines as Topic; Pulmonary Embolism; Venous Thrombosis; Warfarin | 2010 |
Epistaxis in patients taking oral anticoagulant and antiplatelet medication: prospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Epistaxis; Hemostatic Techniques; Humans; International Normalized Ratio; Length of Stay; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Ticlopidine; Warfarin; Young Adult | 2011 |
Association of warfarin use with CHADS(2) score in 441 patients with nonvalvular atrial fibrillation and no contraindications to warfarin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Female; Fibrinolytic Agents; Health Status Indicators; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Warfarin | 2010 |
Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Retrospective Studies; Stroke; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Treatment Outcome; Warfarin | 2010 |
Effect of anticoagulation on endothermal ablation of the great saphenous vein.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; Saphenous Vein; Varicose Veins; Venous Thromboembolism; Warfarin | 2011 |
Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chi-Square Distribution; Clopidogrel; Endarterectomy, Carotid; Female; Hematoma; Humans; Male; Middle Aged; Minnesota; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2011 |
Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Aspirin; Bevacizumab; Choroidal Neovascularization; Clopidogrel; Eye Hemorrhage; Female; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Platelet Aggregation Inhibitors; Ranibizumab; Retrospective Studies; Risk Factors; Ticlopidine; Vascular Endothelial Growth Factor A; Warfarin | 2010 |
Calcified ball-like left ventricular thrombus embolized during echocardiography follow-up.
Topics: Aspirin; Atrial Fibrillation; Cardiomegaly; Dyspnea; Echocardiography; Embolization, Therapeutic; Heart Failure; Heparin; Humans; Male; Middle Aged; Stroke Volume; Warfarin | 2010 |
Transcatheter closure of congenital coronary arteriovenous fistula using detachable balloon technique.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arteriovenous Fistula; Aspirin; Child, Preschool; Coronary Vessel Anomalies; Equipment Design; Fibrinolytic Agents; Heart Murmurs; Humans; Male; Treatment Outcome; Warfarin | 2010 |
National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin.
Topics: Acute Disease; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Emergency Service, Hospital; Female; Health Care Surveys; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Sex Distribution; Ticlopidine; United States; Warfarin; Young Adult | 2010 |
On the use of prothrombin complex concentrate in patients with coagulopathy requiring tooth extraction.
Topics: Adult; Aspirin; Blood Coagulation Factors; Blood Loss, Surgical; Cellulose, Oxidized; Contraindications; Electrocoagulation; Female; Fibrinolytic Agents; Gingival Hemorrhage; Heart Failure; Heart-Assist Devices; Hematoma; Hemostatics; Heparin; Humans; International Normalized Ratio; Male; Molar, Third; Periapical Periodontitis; Pericoronitis; Plasma; Postoperative Hemorrhage; Prothrombin Time; Thrombosis; Tooth Extraction; Tooth, Impacted; Warfarin | 2010 |
Feverfew. Bachelor's buttons, Featherfew (Tanacetum parthenium L. aka Chrysanthemum parthenium L. aka Pyrethrum parthenium L.).
Topics: Arthritis, Rheumatoid; Aspirin; Drug Interactions; Gastrointestinal Diseases; Humans; Hypersensitivity; Migraine Disorders; Oral Ulcer; Phytotherapy; Plant Preparations; Randomized Controlled Trials as Topic; Tanacetum parthenium; Warfarin | 2010 |
Long term treatment of atrial fibrillation in elderly patients: a decision analysis.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cohort Studies; Decision Support Techniques; Female; Follow-Up Studies; Humans; Male; Markov Chains; Middle Aged; Time Factors; Treatment Outcome; Warfarin | 2012 |
Hughes syndrome (the antiphospholipid syndrome): a disease of our time.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Arterial Occlusive Diseases; Aspirin; Brain Diseases; Cardiovascular Diseases; Constriction, Pathologic; Female; Heparin, Low-Molecular-Weight; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infarction; Pregnancy; Thrombosis; Warfarin | 2011 |
Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.
Topics: Aged; Aged, 80 and over; Aspirin; Capsule Endoscopy; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Pyridines; Retrospective Studies; Ticlopidine; Ulcer; Warfarin | 2011 |
Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Administration Schedule; Fibrinolytic Agents; Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Safety; Secondary Prevention; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin | 2010 |
Ask the doctor. I am a 79-year-old man with atrial fibrillation that is well controlled by Pacerone. I also take warfarin and aspirin to prevent stroke. I plan to have a tooth pulled next month and wonder if is is safe to go off the blood thinners. Ho
Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Prescriptions; Health Knowledge, Attitudes, Practice; Humans; Male; Medication Therapy Management; Oral Hemorrhage; Patient Education as Topic; Platelet Aggregation Inhibitors; Stroke; Tooth Extraction; Warfarin | 2010 |
Heterotopic ossification is less after THA in patients who receive aspirin compared to coumadin.
Topics: Aged; Arthroplasty, Replacement, Hip; Aspirin; Chi-Square Distribution; Elective Surgical Procedures; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Ossification, Heterotopic; Osteoarthritis, Hip; Radiography; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2010 |
Variation in anticoagulation prophylaxis practice after Fontan: a call for a national Fontan registry.
Topics: Anticoagulants; Aspirin; Fontan Procedure; Health Care Surveys; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Patterns, Physicians'; Registries; United Kingdom; Warfarin | 2011 |
Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Chest Pain; Dyspnea; Female; Heparin; Humans; Hyperventilation; Lung Diseases; Oxygen; Prednisolone; Pregnancy; Pregnancy Complications; Radiography; Respiratory Paralysis; Respiratory Sounds; Syndrome; Treatment Outcome; Warfarin | 2011 |
Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option.
Topics: Anticoagulants; Aspirin; Female; Heart Valve Prosthesis; Heparin; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Thromboembolism; Warfarin | 2011 |
Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".
Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2011 |
TIAs - management in general practice.
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Dipyridamole; Dopamine Antagonists; General Practitioners; Heptanoic Acids; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Perindopril; Platelet Aggregation Inhibitors; Primary Health Care; Prochlorperazine; Pyrroles; Ticlopidine; Vasodilator Agents; Warfarin | 2010 |
[Warfarin combined with blood platelet inhibition].
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Hemorrhage; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Risk Factors; Stents; Thrombosis; Warfarin | 2011 |
Some considerations about the hypercoagulable states and their treatments.
Topics: Anticoagulants; Aspirin; Heparin; Humans; Platelet Aggregation Inhibitors; Thrombophilia; Warfarin | 2011 |
Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data.
Topics: Aged; Aspirin; Atrial Fibrillation; Cohort Studies; Community Pharmacy Services; Databases, Factual; Drug Utilization Review; Female; Humans; Male; Medical Records; Medical Records Systems, Computerized; Reproducibility of Results; Sensitivity and Specificity; Warfarin; Washington | 2011 |
What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
Topics: Anticoagulants; Aspirin; Cilostazol; Evidence-Based Medicine; Humans; Intracranial Arteriosclerosis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Tetrazoles; Treatment Outcome; Warfarin | 2011 |
Antiplatelet and anticoagulation therapy in vitreoretinal surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Child; Clopidogrel; Contraindications; Eye Hemorrhage; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Vitreoretinal Surgery; Warfarin | 2011 |
Optimal timing of anticoagulation pre- and post-colonoscopy with polypectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Period; Retrospective Studies; Ticlopidine; Warfarin | 2011 |
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
Topics: Activated Protein C Resistance; Aged; Anticoagulants; Aspirin; Boronic Acids; Bortezomib; Dexamethasone; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin | 2011 |
Atrial fibrillation, is warfarin the only option for stroke prevention?
Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clopidogrel; Evidence-Based Medicine; Follow-Up Studies; Humans; Hypertension; Irbesartan; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin | 2011 |
Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry.
Topics: Aged; Aged, 80 and over; Anticoagulants; Asian People; Aspirin; Atrial Fibrillation; Blood Coagulation; Chi-Square Distribution; Drug Monitoring; Female; Fibrinolytic Agents; Guideline Adherence; Humans; International Normalized Ratio; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prospective Studies; Registries; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2011 |
Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis.
Topics: Anticoagulants; Aspirin; Cerebral Angiography; Fibrinolytic Agents; Humans; Intracranial Arteriosclerosis; Randomized Controlled Trials as Topic; Risk Factors; Warfarin | 2011 |
Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Dermatologic Surgical Procedures; Female; Humans; Male; Middle Aged; Mohs Surgery; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Ticlopidine; Warfarin | 2011 |
A postal survey of UK practice on discontinuation of anticoagulant/antithrombotics therapy before minor cutaneous surgery of the head and neck.
Topics: Ambulatory Surgical Procedures; Anticoagulants; Aspirin; Cervicoplasty; Clopidogrel; Drug Administration Schedule; Fibrinolytic Agents; Humans; Practice Patterns, Physicians'; Preoperative Care; Surveys and Questionnaires; Ticlopidine; United Kingdom; Warfarin | 2011 |
Finding a balance in long-term anticoagulation therapy.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Practice Guidelines as Topic; Stroke; Time Factors; Warfarin | 2010 |
A pharmacoeconomic perspective on stroke prevention in atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Drug Monitoring; Fibrinolytic Agents; Humans; Practice Guidelines as Topic; Stroke; Warfarin | 2010 |
How do we manage patients treated with antithrombotic therapy in the perioperative interval.
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coagulants; Factor Xa Inhibitors; Fibrinolytic Agents; Hemostasis, Surgical; Heparin; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Assessment; Ticlopidine; Vitamin K; Warfarin | 2011 |
Dual antiplatelet therapy and the risk of bleeding.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Warfarin | 2011 |
Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Catheterization; Cryosurgery; Echocardiography; Embolism, Paradoxical; Female; Follow-Up Studies; Heart Septal Defects, Atrial; Heart Septum; Humans; Iatrogenic Disease; Male; Middle Aged; Prevalence; Prospective Studies; Pulmonary Veins; Punctures; Treatment Outcome; Warfarin | 2011 |
Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Dose-Response Relationship, Drug; Gene Frequency; Genotype; Humans; Linear Models; Male; Middle Aged; Mixed Function Oxygenases; Multiplex Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Precision Medicine; Vitamin K Epoxide Reductases; Warfarin | 2011 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin | 2011 |
Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; California; Cohort Studies; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Motion Therapy, Continuous Passive; Multivariate Analysis; Prevalence; Prospective Studies; Pulmonary Embolism; Registries; Retrospective Studies; Treatment Outcome; Warfarin; Young Adult | 2012 |
Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Budd-Chiari Syndrome; Child; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Survival; Hepatic Artery; Humans; Hydroxyurea; Liver Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Portal Vein; Postoperative Complications; Thrombosis; Warfarin; Young Adult | 2011 |
Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Ankle Brachial Index; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Chi-Square Distribution; Clopidogrel; Endovascular Procedures; Female; Femoral Artery; Humans; Illinois; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Design; Reoperation; Severity of Illness Index; Stents; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency; Warfarin | 2011 |
Apixaban in patients with atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Stroke; Warfarin | 2011 |
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Therapy, Combination; Eye Hemorrhage; Female; Humans; Intraoperative Complications; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Prothrombin Time; Risk Assessment; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cohort Studies; Dipyridamole; Female; Humans; Macular Edema; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Retinal Hemorrhage; Retinal Vein Occlusion; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields; Warfarin; Young Adult | 2011 |
Wireless pulmonary artery haemodynamic monitoring.
Topics: Anticoagulants; Aspirin; Clopidogrel; Electrodes, Implanted; Equipment Design; Female; Heart Failure; Hemodynamics; Humans; Male; Microchip Analytical Procedures; Monitoring, Physiologic; Pulmonary Artery; Pulmonary Wedge Pressure; Sensitivity and Specificity; Survival Analysis; Ticlopidine; Warfarin | 2011 |
Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device.
Topics: Aged; Anticoagulants; Aspirin; Biomarkers; CD40 Ligand; Creatinine; Cross-Sectional Studies; Female; Heart Failure; Heart-Assist Devices; Hematocrit; Hemolysis; Humans; Illinois; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prosthesis Design; Time Factors; Treatment Outcome; Warfarin | 2011 |
The Australian arthroplasty thromboprophylaxis survey.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Attitude of Health Personnel; Australia; Data Collection; Heparin, Low-Molecular-Weight; Humans; Motion Therapy, Continuous Passive; Practice Guidelines as Topic; Practice Patterns, Physicians'; Risk Factors; Surveys and Questionnaires; Venous Thromboembolism; Warfarin | 2012 |
Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Diabetic Retinopathy; Female; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Hemorrhage; Warfarin | 2011 |
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Bleeding Time; Heparin; Male; Peptide Fragments; Proteins; Rats; Rats, Wistar; Thrombocytopenia; Warfarin; Wound Healing | 2012 |
Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic/anticoagulant medications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biopsy, Fine-Needle; Chi-Square Distribution; Clopidogrel; Female; Head and Neck Neoplasms; Hematoma; Hemorrhage; Heparin; Humans; Male; Middle Aged; Retrospective Studies; Ticlopidine; Ultrasonography, Interventional; Warfarin | 2011 |
Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications.
Topics: Aged; Angina Pectoris; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Blood Transfusion; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Prostatectomy; Retrospective Studies; Stroke; Venous Thrombosis; Warfarin | 2011 |
Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Registries; Risk Factors; Stroke; Ticlopidine; Warfarin | 2011 |
Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Chi-Square Distribution; Chronic Disease; Clopidogrel; Drug Interactions; Drug Utilization; Female; Health Care Surveys; Heart Failure; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke Volume; Ticlopidine; Time Factors; Turkey; Ventricular Function, Left; Warfarin | 2012 |
Hemostasis effects of direct intraparenchymal injection of platelets and fresh frozen plasma before cutting needle biopsy in an animal model.
Topics: Animals; Anticoagulants; Aspirin; Biopsy, Needle; Blood Platelets; Hemorrhage; Hemostasis; Hemostatic Techniques; Injections; Models, Animal; Plasma; Platelet Aggregation Inhibitors; Swine; Warfarin | 2011 |
The use of dabigatran immediately after atrial fibrillation ablation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Drug Tolerance; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombin; Thromboembolism; Treatment Outcome; Warfarin | 2012 |
The effect of admission blood pressure on the prognosis of patients with intracerebral hemorrhage that occurred during treatment with aspirin, warfarin, or no drugs.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Aspirin; Blood Pressure; Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Hypertension; International Normalized Ratio; Male; Middle Aged; Prognosis; Risk Factors; Warfarin | 2012 |
Development of a tool to improve the quality of decision making in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Decision Support Techniques; Hemorrhage; Humans; Patient Participation; Physician-Patient Relations; Risk Assessment; Stroke; Warfarin | 2011 |
Impact of WASID and Wingspan on the frequency of intracranial angioplasty and stenting at a high volume tertiary care hospital.
Topics: Angioplasty; Anticoagulants; Aspirin; Combined Modality Therapy; Drug Therapy, Combination; Evidence-Based Medicine; Hospitals, Special; Humans; Intracranial Arteriosclerosis; Neurology; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Factors; Stents; Warfarin | 2009 |
Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopidogrel; Cohort Studies; Female; Humans; Infant; Intracranial Hemorrhages; Length of Stay; Male; Middle Aged; Multivariate Analysis; New York; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Young Adult | 2011 |
Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Drug Monitoring; Humans; Orthopedics; Population Surveillance; Practice Guidelines as Topic; Practice Patterns, Physicians'; Societies, Medical; Stockings, Compression; United States; Venous Thromboembolism; Warfarin | 2012 |
Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Warfarin | 2011 |
Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approach.
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Evidence-Based Medicine; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Risk Assessment; Surgical Procedures, Operative; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Warfarin | 2011 |
A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Humans; Male; Perioperative Care; Platelet Aggregation Inhibitors; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Transurethral Resection of Prostate; Warfarin | 2011 |
We should cease offering turp in favour of alternative surgery options for anticoagulated patients.
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Humans; Male; Platelet Aggregation Inhibitors; Transurethral Resection of Prostate; Warfarin | 2011 |
First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study.
Topics: Age Factors; Aged; Antidepressive Agents; Antihypertensive Agents; Aspirin; Chronic Disease; Depression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Male; Medication Adherence; Middle Aged; Retrospective Studies; Saskatchewan; Warfarin | 2012 |
Aspirin versus warfarin in atrial fibrillation: decision analysis may help patients' choice.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Decision Support Techniques; Decision Trees; Hemorrhage; Humans; Patient Selection; Primary Prevention; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2012 |
Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now.
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hospitals, Teaching; Humans; Male; New South Wales; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Stroke; Warfarin | 2012 |
Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Computer Simulation; Cost-Benefit Analysis; Drug Therapy, Combination; Follow-Up Studies; Humans; Markov Chains; Medicare; Monte Carlo Method; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Research Design; Risk Factors; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cross-Sectional Studies; Health Care Surveys; Humans; Middle Aged; Nursing Homes; Platelet Aggregation Inhibitors; Ticlopidine; United States; Warfarin | 2012 |
Transient ischemic attacks in a 22-year-old.
Topics: Anticoagulants; Aspirin; Carotid Stenosis; Diagnosis, Differential; Female; Glucocorticoids; Heparin; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Methylprednisolone; Prednisone; Takayasu Arteritis; Treatment Outcome; Ultrasonography; Warfarin; Young Adult | 2012 |
Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Anticoagulants; Aspirin; Bupivacaine; Clopidogrel; Conjunctiva; Female; Humans; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Suture Techniques; Ticlopidine; Treatment Outcome; Visual Acuity; Vitrectomy; Warfarin | 2012 |
Influence of warfarin and low-dose aspirin on the outcomes of geriatric patients with traumatic intracranial hemorrhage resulting from ground-level fall.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chi-Square Distribution; Female; Glasgow Coma Scale; Humans; Intracranial Hemorrhage, Traumatic; Logistic Models; Male; Retrospective Studies; Treatment Outcome; Warfarin | 2012 |
Thromboprophylaxis in multiple myeloma: is the evidence there?
Topics: Antineoplastic Agents; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Immunomodulation; Multiple Myeloma; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Adjustment; Secondary Prevention; Thalidomide; Venous Thromboembolism; Warfarin | 2012 |
High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study.
Topics: Aged; Antibodies, Antiphospholipid; Aspirin; Biomarkers; Chronic Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lupus Coagulation Inhibitor; Male; Middle Aged; Pulmonary Embolism; Risk Factors; Stroke; Venous Thrombosis; Warfarin | 2012 |
Cardiology patient page: Aspirin.
Topics: Aspirin; Blood Coagulation; Cardiovascular Diseases; Coronary Artery Disease; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Period; Stroke; Thrombosis; Warfarin | 2012 |
Role for the left atrial appendage occlusion device in managing thromboembolic risk in atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Female; Humans; Hypertension; Ischemic Attack, Transient; Patient Preference; Risk; Risk Assessment; Septal Occluder Device; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography; Warfarin | 2012 |
Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Comorbidity; Contraindications; Craniotomy; Female; Heart Valve Prosthesis; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Thailand; Thromboembolism; Time Factors; Vitamin K; Warfarin | 2011 |
The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Female; Hip Fractures; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prospective Studies; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2012 |
Gastrointestinal bleeding associated with antithrombotic therapy in the elderly in Japan.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Asian People; Aspirin; Chi-Square Distribution; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Hemostatic Techniques; Humans; Japan; Male; Middle Aged; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome; Warfarin; Young Adult | 2012 |
Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anticoagulants; Aspirin; Clopidogrel; Conscious Sedation; Electrocardiography; Eye Hemorrhage; Female; Humans; Male; Middle Aged; Orbit; Oximetry; Phenindione; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Ticlopidine; Vitreoretinal Surgery; Warfarin; Young Adult | 2012 |
What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Hemorrhage; Humans; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Warfarin | 2012 |
Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: necessary or too hazardous?
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Warfarin | 2012 |
Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Medicare; Myocardial Infarction; Patient Readmission; Proportional Hazards Models; Registries; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
Postoperative anticoagulation in patients with mechanical heart valves following surgical treatment of subdural hematomas.
Topics: Aged; Anticoagulants; Aspirin; Enoxaparin; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Hematoma, Subdural; Humans; Male; Middle Aged; Morbidity; Patient Discharge; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Thromboembolism; Warfarin | 2013 |
Interaction between ticlopidine or warfarin or cardioaspirin with a highly standardized deterpened Ginkgo biloba extract (VR456) in rat and human.
Topics: Animals; Aspirin; Blood Pressure; Drug Interactions; Ginkgo biloba; Ginkgolides; Heart Rate; Hemorrhage; International Normalized Ratio; Male; Partial Thromboplastin Time; Plant Extracts; Plant Leaves; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Ticlopidine; Warfarin | 2010 |
Warfarin in heart failure.
Topics: Anticoagulants; Aspirin; Female; Heart Failure; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2012 |
Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Child; Child, Preschool; Chronic Disease; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Heart Defects, Congenital; Heparin, Low-Molecular-Weight; Humans; Infant; Male; Postthrombotic Syndrome; Recurrence; Retrospective Studies; Risk Factors; Thrombectomy; Thrombophilia; Thrombosis; Tissue Plasminogen Activator; Warfarin | 2012 |
Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clinical Protocols; Combined Modality Therapy; Elective Surgical Procedures; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; New York City; Patient Readmission; Platelet Aggregation Inhibitors; Postoperative Complications; Pulmonary Embolism; Retrospective Studies; Survival Rate; Thromboembolism; Treatment Outcome; Venous Thrombosis; Warfarin; Young Adult | 2012 |
Management of acute upper gastrointestinal bleeding: summary of NICE guidance.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Component Transfusion; Clopidogrel; Contraindications; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lypressin; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Resuscitation; Risk Assessment; Secondary Prevention; Terlipressin; Ticlopidine; United Kingdom; Vasoconstrictor Agents; Warfarin | 2012 |
Impact of age and anticoagulation: need for neurosurgical intervention in trauma patients with mild traumatic brain injury.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Craniotomy; Decompressive Craniectomy; Glasgow Coma Scale; Humans; Intracranial Hemorrhages; Middle Aged; Retrospective Studies; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Warfarin | 2012 |
A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Databases, Factual; Female; General Practice; Humans; Intracranial Hemorrhages; Logistic Models; Male; Odds Ratio; Platelet Aggregation Inhibitors; Preventive Health Services; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; United Kingdom; Warfarin | 2012 |
Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Cost-Benefit Analysis; Drug Costs; Hemorrhage; Humans; Markov Chains; Medicare; Models, Economic; Primary Prevention; Probability; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; United States; Warfarin | 2012 |
Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Research Design; Risk Assessment; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Dalteparin; Female; Humans; Male; Retrospective Studies; Risk; Thromboembolism; Tranexamic Acid; Warfarin | 2013 |
[Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.
Topics: Adverse Drug Reaction Reporting Systems; Aspirin; Clopidogrel; Data Mining; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine; United States; United States Food and Drug Administration; Warfarin | 2012 |
Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
Topics: Animals; Anticoagulants; Area Under Curve; Aspirin; Drugs, Chinese Herbal; Herb-Drug Interactions; Lactates; Male; Prothrombin Time; Rats; Rats, Sprague-Dawley; Salicylic Acid; Warfarin | 2012 |
Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
Topics: Anticoagulants; Aspirin; Bone Density; Breast Feeding; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infant, Newborn; Polysaccharides; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism; Thrombophilia; Warfarin | 2012 |
Stroke and bleeding in atrial fibrillation with chronic kidney disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Kidney Failure, Chronic; Male; Myocardial Infarction; Proportional Hazards Models; Renal Insufficiency, Chronic; Renal Replacement Therapy; Risk; Stroke; Thromboembolism; Warfarin | 2012 |
Warfarin versus aspirin in heart failure and sinus rhythm.
Topics: Anticoagulants; Aspirin; Female; Heart Failure; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2012 |
Warfarin versus aspirin in heart failure and sinus rhythm.
Topics: Anticoagulants; Aspirin; Female; Heart Failure; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2012 |
Thromboprophylaxis in heart failure patients with sinus rhythm: aspirin and warfarin lead to similar cardiovascular outcomes.
Topics: Anticoagulants; Aspirin; Female; Heart Failure; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2013 |
Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Cohort Studies; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Incidence; Male; Risk Factors; Survival Analysis; Thoracic Surgery; Thromboembolism; Treatment Outcome; Warfarin | 2012 |
Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Female; Heart Valve Prosthesis; Humans; Male; Thromboembolism; Warfarin | 2012 |
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoprevention; Clopidogrel; Enoxaparin; Humans; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Risk; Ticlopidine; Warfarin | 2012 |
Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes.
Topics: Aged; Anticoagulants; Aspirin; Biopsy; Hemorrhage; Humans; Male; Prospective Studies; Prostatic Neoplasms; Regression Analysis; Risk Factors; Surveys and Questionnaires; Ultrasonography, Interventional; Ultrasound, High-Intensity Focused, Transrectal; Warfarin | 2012 |
Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug Utilization Review; Endovascular Procedures; Guideline Adherence; Health Care Surveys; Humans; Lower Extremity; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Stents; Surveys and Questionnaires; Ticlopidine; Time Factors; Warfarin | 2013 |
In vitro platelet antiaggregatory properties of 4-methylcoumarins.
Topics: Adenosine Diphosphate; Anticoagulants; Arachidonic Acid; Aspirin; Collagen; Coumarins; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Humans; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane-A Synthase; Umbelliferones | 2012 |
Use of antithrombotic agents in patients with intracerebral cavernous malformations.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Dipyridamole; Female; Fibrinolytic Agents; Follow-Up Studies; Hemangioma, Cavernous, Central Nervous System; Humans; Male; Middle Aged; Risk Factors; Warfarin | 2013 |
Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Cancer Care Facilities; Enoxaparin; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Practice Patterns, Physicians'; Prognosis; Retrospective Studies; Specialization; Thalidomide; Thrombosis; Warfarin | 2013 |
[Journal club].
Topics: Adenoma; Adenomatous Polyps; Anticoagulants; Aspirin; Coffee; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Heart Failure; Humans; Male; Mortality; Platelet Aggregation Inhibitors; Warfarin | 2012 |
Evaluation of platelet aggregability during left ventricular bypass using a MedTech MagLev VAD in a series of chronic calf experiments.
Topics: Animals; Anticoagulants; Aspirin; Cattle; Heart Bypass, Left; Heart-Assist Devices; Heparin; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Warfarin | 2013 |
Symptomatic patients with intraluminal carotid artery thrombus: outcome with a strategy of initial anticoagulation.
Topics: Adult; Aged; Anticoagulants; Aspirin; Brain Ischemia; Carotid Arteries; Carotid Artery Thrombosis; Carotid Stenosis; Cerebral Angiography; Endarterectomy, Carotid; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Treatment Outcome; Warfarin | 2013 |
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Fibrinolytic Agents; Heart Failure; Humans; Hypertension; Male; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Comparison of outcomes in patients with head trauma, taking preinjury antithrombotic agents.
Topics: Aged; Aged, 80 and over; Aspirin; Australia; Clopidogrel; Craniocerebral Trauma; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fibrinolytic Agents; Glasgow Coma Scale; Hospital Mortality; Humans; Intensive Care Units; Male; Outcome Assessment, Health Care; Prospective Studies; Ticlopidine; Warfarin | 2013 |
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Chi-Square Distribution; Clopidogrel; Comorbidity; Decision Support Techniques; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Sweden; Ticlopidine; Treatment Outcome; Warfarin | 2012 |
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
Topics: Anticoagulants; Aspirin; Case-Control Studies; Coronary Thrombosis; Europe; Fibrinolytic Agents; Heart Failure; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Risk Factors; Societies, Medical; Stroke; Thromboembolism; Ventricular Dysfunction, Left; Warfarin | 2012 |
Oral anticoagulation and the risk of vitreous hemorrhage and retinal tears in eyes with acute posterior vitreous detachment.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Retinal Detachment; Retinal Perforations; Retrospective Studies; Risk Assessment; Ticlopidine; Vitreous Detachment; Vitreous Hemorrhage; Warfarin | 2013 |
[Risks in atrial fibrillation and simultaneous renal failure].
Topics: Aspirin; Atrial Fibrillation; Cerebral Infarction; Comorbidity; Fibrinolytic Agents; Humans; Kidney Failure, Chronic; Proportional Hazards Models; Risk Factors; Thromboembolism; Warfarin | 2012 |
Safety and efficacy of multimodal thromboprophylaxis following total knee arthroplasty: a comparative study of preferential aspirin vs. routine coumadin chemoprophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Retrospective Studies; Thromboembolism; Warfarin | 2013 |
Double consecutive retrobulbar hemorrhage in a high-risk patient in treatment with aspirin and warfarin.
Topics: Aged; Anticoagulants; Aspirin; Eye Injuries; Humans; Male; Retrobulbar Hemorrhage; Tomography, X-Ray Computed; Warfarin | 2012 |
[Expert answer. Coronary artery patients with atrial fibrillation on anticoagulation treatment may need antithrombotic treatment. What kind is there?].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ticlopidine; Warfarin | 2012 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin | 2012 |
Atrial fibrillation and chronic kidney disease.
Topics: Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Male; Renal Insufficiency, Chronic; Stroke; Warfarin | 2012 |
Atrial fibrillation and chronic kidney disease.
Topics: Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Male; Renal Insufficiency, Chronic; Stroke; Warfarin | 2012 |
Atrial fibrillation and chronic kidney disease.
Topics: Aspirin; Atrial Fibrillation; Female; Hematologic Agents; Hemorrhage; Humans; Male; Renal Insufficiency, Chronic; Stroke; Warfarin | 2012 |
The assessment of risk for gastrointestinal injury with anticoagulant and antiplatelet drugs: the possible beneficial effect of eicosapentaenoic Acid for the risk of gastrointestinal injury.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Eicosapentaenoic Acid; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Agents; Retrospective Studies; Risk Assessment; Ticlopidine; Warfarin | 2013 |
A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of throm
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Humans; Incidence; Japan; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Risk Factors; Thalidomide; Venous Thromboembolism; Warfarin | 2013 |
Incidence of symptomatic thromboembolic disease after patellofemoral arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Female; Humans; Incidence; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Patellofemoral Joint; Reoperation; Venous Thromboembolism; Warfarin | 2012 |
Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Female; Humans; Japan; Male; Middle Aged; Prevalence; Registries; Stroke; Urban Population; Warfarin | 2013 |
Cardiac magnetic resonance detection of left ventricular thrombus in acute myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Echocardiography; Female; Humans; Incidence; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Stroke Volume; Thrombosis; Ticlopidine; Ventricular Dysfunction, Left; Warfarin | 2013 |
Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia.
Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Platelet Aggregation Inhibitors; Telangiectasia, Hereditary Hemorrhagic; Warfarin | 2013 |
Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; China; Clopidogrel; Cross-Sectional Studies; Defibrillators, Implantable; Drug Therapy, Combination; Female; Hematoma; Heparin; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Thrombocytopenia; Ticlopidine; Warfarin | 2013 |
The effect of fibrin clot inhibitors on the immunomodulatory efficacy of Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Anticoagulants; Aspirin; BCG Vaccine; Clopidogrel; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunomodulation; Induction Chemotherapy; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Ticlopidine; Urinary Bladder Neoplasms; Warfarin | 2013 |
Intracranial hemorrhages related with warfarin use and comparison of warfarin and acetylsalicylic acid.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Comorbidity; Diabetes Mellitus; Female; Fibrinolytic Agents; Glasgow Coma Scale; Humans; Hypertension; Intracranial Hemorrhages; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Turkey; Warfarin; Young Adult | 2014 |
[The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
Topics: Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Fibrinolytic Agents; Heart Valve Prosthesis Implantation; Humans; Postoperative Care; Postoperative Complications; Thrombosis; Warfarin | 2013 |
The use, misuse and abuse of dabigatran.
Topics: Advertising; Anticoagulants; Antithrombins; Aspirin; Australia; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Insufficiency; Research Design; Selection Bias; Stroke; Warfarin | 2013 |
[Atrial fibrillation. Apixaban reduces stroke risk].
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Drug Approval; Embolism; Germany; Humans; Middle Aged; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2013 |
Successful treatment of mechanical mitral valve thrombosis without thrombolytic therapy or surgery.
Topics: Anticoagulants; Aspirin; Echocardiography; Female; Heart Valve Prosthesis; Humans; Middle Aged; Mitral Valve; Mitral Valve Stenosis; Platelet Aggregation Inhibitors; Rheumatic Heart Disease; Thrombosis; Warfarin | 2013 |
Saccular aneurysm of the left main trunk.
Topics: Aged; Anticoagulants; Aspirin; Computed Tomography Angiography; Coronary Aneurysm; Coronary Angiography; Humans; Male; Warfarin | 2017 |
Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) Study.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Electrocardiography; Female; Humans; International Normalized Ratio; Logistic Models; Male; Prospective Studies; Turkey; Warfarin | 2013 |
Epidemiology of atrial fibrillation in Turkey: preliminary results of the multicenter AFTER study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Electrocardiography; Female; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Stroke; Thromboembolism; Turkey; Warfarin; Young Adult | 2013 |
Management of antithrombotic agents for colonoscopic polypectomies in Israeli gastroenterologists relative to published guidelines.
Topics: Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Fibrinolytic Agents; Gastroenterology; Guideline Adherence; Health Maintenance Organizations; Heparin, Low-Molecular-Weight; Hospitals; Humans; Israel; Logistic Models; Practice Guidelines as Topic; Practice Patterns, Physicians'; Surveys and Questionnaires; Ticlopidine; Warfarin | 2013 |
Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted?
Topics: Aged; Anticoagulants; Aspirin; Cohort Studies; Confidence Intervals; Databases, Factual; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Length of Stay; Male; Middle Aged; Mitral Valve; Multivariate Analysis; Needs Assessment; Odds Ratio; Patient Discharge; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Thromboembolism; Treatment Outcome; Warfarin | 2013 |
Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Thromboembolism; Warfarin | 2013 |
Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Middle Aged; Morpholines; Patient Safety; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin | 2013 |
Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Complications; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin | 2013 |
Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement; Aspirin; Female; Fibrinolytic Agents; Humans; Incidence; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Philadelphia; Propensity Score; Pulmonary Embolism; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Venous Thrombosis; Warfarin; Wound Healing | 2014 |
Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Cohort Studies; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Population Surveillance; Risk Factors; Stroke; Warfarin; Young Adult | 2013 |
Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Cohort Studies; Female; Follow-Up Studies; Fontan Procedure; Heart Defects, Congenital; Heart Ventricles; Humans; Male; Registries; Thromboembolism; Treatment Outcome; Warfarin | 2013 |
Anti-inflammatory effect of auraptene extracted from trifoliate orange (Poncirus trifoliate) on LPS-stimulated RAW 264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Cell Line; Coumarins; Cyclooxygenase 2; Dinoprostone; Inflammation; Lipopolysaccharides; Medicine, Chinese Traditional; Mice; Plant Extracts; Poncirus; RNA, Messenger | 2013 |
The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Lithotripsy, Laser; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome; Ureteroscopy; Urolithiasis; Warfarin | 2013 |
[A case of atraumatic hematomyelia extending from the C1 to T11 segments of the spinal cord].
Topics: Anticoagulants; Aspirin; Cervical Vertebrae; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Spinal Cord Vascular Diseases; Thoracic Vertebrae; Warfarin | 2013 |
Improving cardiovascular disease management in Australia: NPS MedicineWise.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Australia; Cardiovascular Diseases; Databases, Factual; Disease Management; Drug Utilization; Female; Humans; Male; Middle Aged; National Health Programs; Primary Health Care; Program Evaluation; Quality Improvement; Retrospective Studies; Survival Analysis; Treatment Outcome; Warfarin | 2013 |
Thrombotic occlusion of extracardiac conduit 4 months after Fontan surgery.
Topics: Aspirin; Child, Preschool; Drug Substitution; Drug Therapy, Combination; Fibrinolytic Agents; Fontan Procedure; Graft Occlusion, Vascular; Heart Defects, Congenital; Heart Ventricles; Hemodynamics; Humans; Male; Pleural Effusion; Thrombosis; Time Factors; Treatment Outcome; Vascular Patency; Warfarin | 2013 |
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
Topics: Anticoagulants; Aspirin; Brain Damage, Chronic; Brain Ischemia; Cerebral Hemorrhage; Heart Failure; Humans; Intracranial Embolism; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index; Stroke; Stroke Volume; Warfarin | 2013 |
Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Asian People; Aspirin; Atrial Fibrillation; Blood Coagulation; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2014 |
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection.
Topics: Adenoma; Aged; Anti-Ulcer Agents; Anticoagulants; Aspirin; Carcinoma; Case-Control Studies; Clopidogrel; Dissection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Stomach Diseases; Stomach Neoplasms; Stomach Ulcer; Thienopyridines; Ticlopidine; Warfarin | 2013 |
Imaging diagnosis and surgical treatment of popliteal artery entrapment syndrome: a single-center experience.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Child; Constriction, Pathologic; Decompression, Surgical; Diagnostic Imaging; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation Inhibitors; Popliteal Artery; Predictive Value of Tests; Syndrome; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler; Vascular Patency; Vascular Surgical Procedures; Warfarin; Young Adult | 2014 |
Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Humans; Kidney Failure, Chronic; Polysaccharides; Renal Dialysis; Thromboembolism; Vascular Calcification; Vitamin K; Warfarin | 2013 |
Cervical rib resulting in amaurosis fugax and stroke.
Topics: Adolescent; Amaurosis Fugax; Aspirin; Cerebral Angiography; Cervical Rib; Humans; Male; Shoulder Joint; Stroke; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2013 |
Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; China; Clopidogrel; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Models, Economic; Morpholines; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Warfarin | 2014 |
Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aspirin; Child; Child, Preschool; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Middle Aged; Practice Patterns, Physicians'; Risk; Sex Factors; Sweden; Ticlopidine; Warfarin; Young Adult | 2014 |
Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Anticoagulants; Aspirin; Colorectal Neoplasms; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Iceland; Male; Middle Aged; Occult Blood; Retrospective Studies; Warfarin | 2014 |
Use of ASA after warfarin for unprovoked VTE.
Topics: Anticoagulants; Aspirin; Drug Administration Schedule; Fibrinolytic Agents; Humans; Venous Thromboembolism; Warfarin | 2013 |
Efficacy of contemporary medical management for asymptomatic carotid artery stenosis.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogrel; Databases, Factual; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2013 |
Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Cross-Sectional Studies; Female; Health Services Accessibility; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Registries; Risk Assessment; Risk Factors; Sweden; Thrombosis; Warfarin; Young Adult | 2013 |
Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement; Aspirin; Chi-Square Distribution; Child; Comorbidity; Decision Support Techniques; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multidetector Computed Tomography; Nomograms; Patient Selection; Perfusion Imaging; Philadelphia; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Warfarin; Young Adult | 2014 |
Anti-phospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Autoimmune Diseases; Female; Humans; Male; Pregnancy; Pregnancy Complications; Thrombosis; Warfarin | 2014 |
CORR Insights®: Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Female; Fibrinolytic Agents; Humans; Male; Pulmonary Embolism; Warfarin | 2014 |
Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biomarkers; Female; Fibrinolytic Agents; Glomerulonephritis; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; London; Male; Middle Aged; Nephrotic Syndrome; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Serum Albumin, Human; Severity of Illness Index; Time Factors; Treatment Outcome; Venous Thromboembolism; Warfarin; Young Adult | 2014 |
Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Postpartum Period; Pregnancy; Pregnancy Complications; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Thrombophilia; Warfarin | 2015 |
Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Thienopyridines; Ticlopidine; Warfarin | 2014 |
Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement.
Topics: Adolescent; Anticoagulants; Aspirin; Coronary Aneurysm; Drug Resistance; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymph Node Syndrome; Rare Diseases; Treatment Outcome; Warfarin | 2013 |
Repeat head computed tomography in anticoagulated traumatic brain injury patients: still warranted.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Cohort Studies; Disease Progression; Female; Head Injuries, Closed; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Tomography, X-Ray Computed; Warfarin | 2014 |
Incidence and related factors of upper gastrointestinal bleeding in a Chinese population of peripheral arterial disease during a six-year follow-up.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; China; Comorbidity; Female; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Peripheral Arterial Disease; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Warfarin | 2014 |
Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices.
Topics: Adult; Aged; Anticoagulants; Aspirin; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Failure; Heart-Assist Devices; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Warfarin; Withholding Treatment | 2014 |
Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Vitamin K; Warfarin | 2014 |
Chronic subdural hematoma in elderly patient with EDTA-dependent pseudothrombocytopenia recently treated with aspirin and warfarin: case report.
Topics: Aged; Anticoagulants; Aspirin; Calcium; Chelating Agents; Diagnosis, Differential; Diagnostic Errors; Edetic Acid; False Negative Reactions; Hematoma, Subdural, Chronic; Heparin; Humans; Male; Platelet Aggregation; Platelet Count; Preoperative Care; Thrombocytopenia; Tomography, X-Ray Computed; Warfarin | 2014 |
Warfarin: Impact on hemostasis after radial catheterization.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiac Catheterization; Catheterization, Peripheral; Clopidogrel; Databases, Factual; Drug Administration Schedule; Female; Hemorrhage; Hemostasis; Hemostatic Techniques; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Radial Artery; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2015 |
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Drug Costs; Factor Xa Inhibitors; Female; Hemorrhage; Hospitalization; Humans; Male; Markov Chains; Middle Aged; Multicenter Studies as Topic; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin K; Warfarin | 2014 |
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
Topics: Angioplasty; Aspirin; Cerebral Arteries; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Drug Utilization; Fibrinolytic Agents; Health Care Surveys; Humans; Intracranial Arteriosclerosis; Neurology; Practice Patterns, Physicians'; Radiology, Interventional; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Secondary Prevention; Stents; Stroke; Surveys and Questionnaires; Ticlopidine; United States; Warfarin | 2014 |
Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology.
Topics: Academies and Institutes; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Practice Guidelines as Topic; Stroke; Treatment Outcome; United States; Warfarin | 2014 |
Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carcinoma, Ovarian Epithelial; Cohort Studies; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Multivariate Analysis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pulmonary Embolism; Retrospective Studies; Risk Factors; Thromboembolism; Venous Thromboembolism; Warfarin; Young Adult | 2014 |
Management of acute limb ischemia in the pediatric population.
Topics: Acute Disease; Adolescent; Anticoagulants; Aspirin; Canada; Catheterization, Peripheral; Child; Child, Preschool; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hospitals, Pediatric; Humans; Infant; Intracranial Hemorrhages; Ischemia; Lower Extremity; Male; Organ Size; Retrospective Studies; Tertiary Care Centers; Upper Extremity; Warfarin | 2014 |
Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoradiotherapy; Clopidogrel; Drug Screening Assays, Antitumor; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Retrospective Studies; Risk; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Aortic arch atheroma: a plaque of a different color or more of the same?
Topics: Anticoagulants; Aortic Diseases; Aspirin; Clopidogrel; Female; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2014 |
Fatal bleedings with prasugrel as part of triple antithrombotic therapy.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arteriovenous Malformations; Aspirin; Drug Therapy, Combination; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stents; Thiophenes; Thrombosis; Warfarin | 2014 |
Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Mental Status Schedule; Middle Aged; Patient Preference; Physicians; Risk Assessment; Stroke; Warfarin | 2015 |
Multiple dual mode counter-current chromatography with variable duration of alternating phase elution steps.
Topics: Aspirin; Caffeine; Coumarins; Countercurrent Distribution; Models, Theoretical; Salicylic Acid | 2014 |
Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comparative Effectiveness Research; Cost-Benefit Analysis; Dabigatran; Factor Xa Inhibitors; Female; France; Humans; Male; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2014 |
Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Topics: Age Distribution; Aged; Alcohol Drinking; Anticoagulants; Aspirin; Atrial Fibrillation; Diabetes Complications; Europe; Female; Health Surveys; Heart Failure; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Risk Assessment; Sex Distribution; Stroke; Substance-Related Disorders; Thromboembolism; Warfarin | 2014 |
Letter to the editor: symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Female; Fibrinolytic Agents; Humans; Male; Pulmonary Embolism; Warfarin | 2014 |
Reply to the letter to the editor: symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.
Topics: Anticoagulants; Arthroplasty, Replacement; Aspirin; Female; Fibrinolytic Agents; Humans; Male; Pulmonary Embolism; Warfarin | 2014 |
[Urolithiasis - settle antiplatelets before ureteroscopy?].
Topics: Anticoagulants; Aspirin; Female; Humans; Lithotripsy, Laser; Male; Platelet Aggregation Inhibitors; Ticlopidine; Ureteroscopy; Urolithiasis; Warfarin | 2014 |
Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Stroke; Sweden; Warfarin | 2014 |
Recurrence and mortality among patients hospitalized for acute lower gastrointestinal bleeding.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Survival Analysis; Warfarin | 2015 |
Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Assessment; Thromboembolism; Treatment Outcome; Warfarin | 2014 |
Letter by Zito et Al regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham atrial fibrillation treatment of the aged study)".
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cognition Disorders; Female; Fibrinolytic Agents; Humans; Male; Warfarin | 2014 |
Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cognition Disorders; Female; Fibrinolytic Agents; Humans; Male; Warfarin | 2014 |
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Combined Modality Therapy; Dabigatran; Female; Heparin; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Radio Waves; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin | 2014 |
[The clinical analysis of atrial fibrillation of 1 310 in patients in Urumqi of China].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; China; Comorbidity; Diabetes Mellitus; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Hypertension; Incidence; Inpatients; Male; Morpholines; Retrospective Studies; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin | 2014 |
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Comorbidity; Coumarins; Diabetes Mellitus; Female; Humans; Hypertension; Kidney Calculi; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Prevalence; Prospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urolithiasis; Young Adult | 2015 |
An aspirin a day to keep the clots away: can aspirin prevent recurrent thrombosis in extended treatment for venous thromboembolism?
Topics: Anticoagulants; Aspirin; Female; Humans; Male; Platelet Aggregation Inhibitors; Venous Thromboembolism; Warfarin | 2014 |
Anticoagulation management of left ventricular assist devices.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Heart Failure; Heart Transplantation; Heart Ventricles; Heart-Assist Devices; Humans; Middle Aged; Thrombosis; Treatment Outcome; Warfarin | 2015 |
New ways to assess stroke risk and tame an abnormal heartbeat. Cardiology groups update guidelines to treat atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Middle Aged; Practice Guidelines as Topic; Primary Health Care; Risk Assessment; Stroke; United States; Warfarin | 2014 |
Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Female; Hemorrhage; Humans; Male; Risk; Stroke; Sweden; Thromboembolism; Warfarin | 2014 |
Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Disease Progression; Health Resources; Humans; Markov Chains; Portugal; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Sensitivity and Specificity; Stroke; Time Factors; Warfarin | 2014 |
Extremely elevated international normalized ratio of warfarin in a patient with CYP2C9*1/*3 and thyrotoxicosis.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Tandem Mass Spectrometry; Thromboembolism; Thyrotoxicosis; Vitamin K Epoxide Reductases; Warfarin | 2014 |
Incidence of intracranial hemorrhage and outcomes after ground-level falls in geriatric trauma patients taking preinjury anticoagulants and antiplatelet agents.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Logistic Models; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Warfarin | 2014 |
Transient homonymous hemianopia caused by cerebral venous sinus thrombosis: case report.
Topics: Anticoagulants; Aspirin; Cerebral Veins; Enoxaparin; Female; Hemianopsia; Humans; Magnetic Resonance Imaging; Sinus Thrombosis, Intracranial; Visual Field Tests; Visual Fields; Warfarin; Young Adult | 2014 |
Gastroprotective agent underuse in high-risk older daily nonsteroidal anti-inflammatory drug users over time.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Controlled Before-After Studies; Cyclooxygenase 2 Inhibitors; Female; Humans; Insurance, Pharmaceutical Services; Male; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Warfarin | 2014 |
Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?
Topics: Anticoagulants; Aspirin; Coronary Aneurysm; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Warfarin | 2014 |
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Databases, Bibliographic; Drug Therapy, Combination; Drug-Eluting Stents; Follow-Up Studies; Hemorrhage; Prospective Studies; Registries; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Coronary and mesenteric involvement in polyarteritis nodosa.
Topics: Aged; Aspirin; Celiac Artery; Coronary Vessels; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Mesenteric Arteries; Polyarteritis Nodosa; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2015 |
Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2015 |
Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; China; Cohort Studies; Dabigatran; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Time Factors; Warfarin | 2015 |
The mystery of recurrent idiopathic cerebrovascular and coronary arterial thrombosis.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Warfarin | 2014 |
Antiplatelet therapy as sole anticoagulant in patients with aortic mechanical prostheses.
Topics: Anticoagulants; Aortic Valve; Aspirin; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Thromboembolism; Warfarin | 2014 |
Routine aortic valve replacement for mild stenosis is not necessary during rheumatic mitral surgery.
Topics: Anticoagulants; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Rheumatic Heart Disease; Thromboembolism; Warfarin | 2014 |
Mobile compression devices and aspirin for VTE prophylaxis following simultaneous bilateral total knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Female; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Retrospective Studies; Venous Thromboembolism; Warfarin | 2015 |
Antiplatelet and anticoagulant drugs management before gastrointestinal endoscopy: do clinicians adhere to current guidelines?
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biopsy; Cohort Studies; Colonic Polyps; Colonoscopy; Endoscopy, Digestive System; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastroenterology; Guideline Adherence; Humans; Ligation; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Preoperative Care; Prospective Studies; Thienopyridines; Warfarin | 2015 |
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome; Warfarin | 2015 |
Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Topics: Administration, Oral; Anticoagulants; Aspirin; Female; Hemorrhage; Humans; Male; Middle Aged; Mortality; Recurrence; Secondary Prevention; Venous Thromboembolism; Warfarin | 2015 |
Serum albumin binding analysis and toxicological screening of novel chroman-2,4-diones as oral anticoagulants.
Topics: Administration, Oral; Animals; Anticoagulants; Antioxidants; Aspirin; Chromans; Coumarins; DNA Damage; Dose-Response Relationship, Drug; Ethylenediamines; Kidney; Liver; Male; Protein Binding; Rats; Rats, Wistar; Serum Albumin; Vitamin K Epoxide Reductases | 2015 |
Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Denmark; Female; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Male; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Renal Replacement Therapy; Risk Assessment; Stroke; Thromboembolism; Warfarin | 2014 |
Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; China; Cohort Studies; Databases, Factual; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Proportional Hazards Models; Sex Factors; Stroke; Time Factors; Warfarin | 2015 |
Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectum; Retrospective Studies; Risk; Telangiectasis; Ticlopidine; Warfarin | 2014 |
[Perioperative complications of transurethral resection of bladder tumor in patients receiving antithrombotic therapy].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Cystectomy; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Retrospective Studies; Urethra; Urinary Bladder Neoplasms; Warfarin | 2014 |
[Thromboprophylaxis in patients with coronary aneurysms caused by Kawasaki disease].
Topics: Aspirin; Coronary Aneurysm; Coronary Thrombosis; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Warfarin | 2014 |
Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Cohort Studies; Cost-Benefit Analysis; Female; Humans; Male; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Venous Thromboembolism; Warfarin | 2015 |
[Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation].
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; China; Female; Humans; Male; Middle Aged; Registries; Risk Assessment; Risk Factors; Stroke; Warfarin | 2014 |
Letter by Feng et al regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2015 |
Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2015 |
Comment on the paper by Su et al. entitled 'safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to kawasaki disease: a meta-analysis'.
Topics: Anticoagulants; Aspirin; Coronary Aneurysm; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Warfarin | 2015 |
Author's Reply.
Topics: Anticoagulants; Aspirin; Coronary Aneurysm; Humans; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Warfarin | 2015 |
ACP Journal Club: after initial anticoagulation for a first unprovoked venous thromboembolism, aspirin reduced recurrence.
Topics: Anticoagulants; Aspirin; Female; Humans; Male; Platelet Aggregation Inhibitors; Venous Thromboembolism; Warfarin | 2015 |
Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Ticlopidine; Warfarin; Young Adult | 2015 |
Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Length of Stay; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Survival Rate; Ticlopidine; Tomography, X-Ray Computed; Trauma Severity Indices; Warfarin | 2015 |
Heart failure in sinus rhythm: no routine antithrombotic therapy.
Topics: Aspirin; Fibrinolytic Agents; Heart Failure; Hemorrhage; Humans; Patient Safety; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Thrombosis; Treatment Outcome; Unnecessary Procedures; Warfarin | 2015 |
Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Pyridines; Republic of Korea; Retrospective Studies; Risk Factors; Stents; Time Factors; Treatment Outcome; Warfarin | 2015 |
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Smoking; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2015 |
[Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Case-Control Studies; Causality; Comorbidity; Female; Humans; Hypercholesterolemia; Incidence; Macular Degeneration; Male; Population Surveillance; Prevalence; Risk Factors; Smoking; Vitamin K; Warfarin | 2015 |
Rapid diagnosis of cardiac tamponade using pulsatility index variability in a patient with a HeartWare ventricular assist device.
Topics: Anticoagulants; Aspirin; Cardiac Tamponade; Diastole; Heart Failure; Heart-Assist Devices; Humans; Hypertension, Pulmonary; Male; Middle Aged; Postoperative Complications; Pulsatile Flow; Sternotomy; Systole; Thoracotomy; Warfarin | 2015 |
Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Primary Health Care; Residence Characteristics; Socioeconomic Factors; Stroke; Sweden; Warfarin | 2015 |
Is long-term warfarin therapy necessary in Chinese patients with atrial fibrillation after bioprosthetic mitral valve replacement and left atrial appendage obliteration?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Bioprosthesis; Causality; China; Comorbidity; Female; Heart Valve Prosthesis Implantation; Humans; Longitudinal Studies; Male; Middle Aged; Mitral Valve Insufficiency; Prevalence; Retrospective Studies; Risk Factors; Survival Rate; Thromboembolism; Treatment Outcome; Turkey; Unnecessary Procedures; Utilization Review; Warfarin | 2015 |
Effects of anticoagulants on outcome of femoral neck fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Femoral Neck Fractures; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Ticlopidine; Warfarin | 2015 |
Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Female; Fibrinolytic Agents; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Stents; Warfarin | 2015 |
Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Clopidogrel; Drug Therapy, Combination; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Ventricles; Heart-Assist Devices; Heparin; Humans; Male; Platelet Activation; Platelet Aggregation; Ticlopidine; Warfarin | 2015 |
Management and outcome of major bleeding in patients on triple therapy after coronary stenting. Clues from the WARfarin and coronary STENTing (WAR-STENT) registry.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Registries; Stents; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2015 |
Direct Costs of Aspirin versus Warfarin for Venous Thromboembolism Prophylaxis after Total Knee or Hip Arthroplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Health Care Costs; Humans; Length of Stay; Male; Middle Aged; Multivariate Analysis; Patient Admission; Patient Satisfaction; Postoperative Period; Retrospective Studies; Venous Thromboembolism; Warfarin; Young Adult | 2015 |
Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Female; Fibrinolytic Agents; Hong Kong; Humans; Incidence; Male; Risk Factors; Stroke; Warfarin | 2015 |
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Elective Surgical Procedures; Enoxaparin; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Prostate; Prostatic Hyperplasia; Retrospective Studies; Thromboembolism; Ticlopidine; Transurethral Resection of Prostate; Victoria; Warfarin; Withholding Treatment | 2015 |
Administration of Aspirin as a Prophylaxis Agent Against Venous Thromboembolism Results in Lower Incidence of Periprosthetic Joint Infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Female; Humans; Incidence; Joint Prosthesis; Logistic Models; Male; Middle Aged; Prosthesis-Related Infections; Retrospective Studies; Risk Factors; Venous Thromboembolism; Warfarin; Young Adult | 2015 |
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Blood Coagulation; California; Comorbidity; Drug Monitoring; Female; Fibrinolytic Agents; Health Maintenance Organizations; Hemorrhage; Humans; International Normalized Ratio; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Warfarin | 2015 |
Antithrombotic Therapy Practices in Older Adults Residing in the Long-Term Care Setting.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Body Mass Index; Drug Therapy, Combination; Hemorrhage; Humans; Long-Term Care; Male; New York; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Residential Facilities; Retrospective Studies; Risk Assessment; Venous Thrombosis; Warfarin | 2015 |
Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex).
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Denmark; Female; Humans; Male; Risk Factors; Stroke; Warfarin | 2015 |
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Decision Support Techniques; Denmark; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Registries; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Warfarin | 2015 |
Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Registries; Stroke; Treatment Outcome; Warfarin | 2015 |
Point-of-care Ultrasound to Identify Distal Ulnar Artery Thrombosis: Case of Hypothenar Hammer Syndrome.
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Emergency Medical Services; Humans; Male; Point-of-Care Testing; Thrombosis; Tomography, X-Ray Computed; Ulnar Artery; Ultrasonography; Warfarin | 2015 |
Isolated brachiocephalic artery dissection presenting as acute stroke.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Aortic Dissection; Aspirin; Ataxia; Brachiocephalic Trunk; Heparin; Humans; Male; Medical History Taking; Obesity; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2015 |
[Anticoagulants to more people can prevent many cases of stroke].
Topics: Age Factors; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Disease; Humans; Medication Adherence; Risk Factors; Stroke; Warfarin | 2015 |
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin | 2015 |
Prevention of deep vein thrombosis. First choice treatments.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Early Ambulation; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Stockings, Compression; Thrombocytopenia; Venous Thrombosis; Vitamin K; Warfarin | 2015 |
Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Genetic Predisposition to Disease; Humans; Markov Chains; Medication Adherence; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Warfarin | 2015 |
Another pharyngitis mimic: intraoral haematoma of the posterior wall of the pharynx in a patient on warfarin and drug-drug interaction.
Topics: Aspirin; Drug Interactions; Hematoma; Humans; Laryngoscopy; Male; Middle Aged; Mouth Diseases; Pharyngitis; Warfarin | 2015 |
Hemoptysis due to aspirin treatment alternative to warfarin therapy in a patient with atrial fibrillation.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Interactions; Female; Hemoptysis; Humans; International Normalized Ratio; Tooth Extraction; Vitamin K; Warfarin | 2015 |
Inappropriate combination of warfarin and aspirin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cross-Sectional Studies; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Humans; Male; Practice Patterns, Physicians'; Thromboembolism; Turkey; Warfarin | 2016 |
[INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Hemorrhage; Hospitalization; Humans; International Normalized Ratio; Male; Middle Aged; Prospective Studies; Warfarin | 2015 |
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Female; Glucuronosyltransferase; Hemorrhage; Humans; Hyaluronan Synthases; Male; Middle Aged; Multicenter Studies as Topic; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; ROC Curve; Warfarin | 2016 |
Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Hong Kong; Hospitalization; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Peritoneal Dialysis; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Stroke; Warfarin | 2016 |
Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.
Topics: Animals; Aspirin; Dogs; Dose-Response Relationship, Drug; Drug Interactions; International Normalized Ratio; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prothrombin Time; Reference Standards; Salicylic Acid; Warfarin | 2016 |
Predictors of hospital mortality and serious complications in patients admitted with excessive warfarin anticoagulation.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Incidence; Intracranial Hemorrhages; Iran; Male; Platelet Aggregation Inhibitors; Prescription Drug Overuse; Risk Factors; Survival Rate; Thromboembolism; Warfarin | 2016 |
Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Drug Substitution; Female; Humans; Male; Medication Adherence; Pyrazoles; Pyridones; Rivaroxaban; Warfarin | 2016 |
Cochlear Implantation in the Setting of Perioperative Anticoagulation and Antiplatelet Therapy.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cochlear Implantation; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Warfarin | 2016 |
Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Transcatheter Aortic Valve Replacement; Warfarin | 2016 |
Puerperal Extracranial Vertebral Artery Dissection and Nonaneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Female; Humans; Neck Pain; Puerperal Disorders; Subarachnoid Hemorrhage; Treatment Outcome; Vertebral Artery Dissection; Vertigo; Warfarin | 2016 |
Dual platelet inhibition in cases of severe retrobulbar hemorrhage following retrobulbar and peribulbar anesthesia.
Topics: Aged; Anesthesia, Local; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiac Surgical Procedures; Cardiovascular Diseases; Clopidogrel; Drug Combinations; Female; Humans; Lens Implantation, Intraocular; Male; Phacoemulsification; Platelet Aggregation Inhibitors; Retrobulbar Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Warfarin | 2015 |
Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Topics: Adult; Aged; Anticoagulants; Aspirin; Chi-Square Distribution; Dipyridamole; Disease-Free Survival; Drug Therapy, Combination; Female; Heart Failure; Heart-Assist Devices; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Multivariate Analysis; New York City; Platelet Aggregation Inhibitors; Prevalence; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; Ventricular Function, Left; Warfarin | 2016 |
[Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification].
Topics: Aspirin; Child; Child, Preschool; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Disease Management; Echocardiography; Electrocardiography; Female; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Treatment Outcome; Ventricular Function, Left; Warfarin | 2015 |
Triple Antithrombotic Therapy - Always One Too Many?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Warfarin | 2016 |
The Effectiveness of a Risk Stratification Protocol for Thromboembolism Prophylaxis After Hip and Knee Arthroplasty.
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Period; Prospective Studies; Pulmonary Embolism; Risk Assessment; Stockings, Compression; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2016 |
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hospitalization; Humans; Male; Markov Chains; Monte Carlo Method; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyridines; Registries; Stroke; Ticlopidine; Warfarin | 2016 |
Hemorrhagic esophageal mucosal injuries caused by transesophageal echocardiogram.
Topics: Aged; Aspirin; Echocardiography, Transesophageal; Esophageal Mucosa; Heart Failure; Hemorrhage; Humans; Male; Warfarin | 2016 |
Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessment.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Incidence; Male; Medication Adherence; Middle Aged; Recurrence; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome; Warfarin; Young Adult | 2016 |
A Newly Characterized Hemoglobin Variant with a High Oxygen Affinity, Hb Fuchu-II, Presenting with Acute Myocardial Infarction.
Topics: Aged; Anticoagulants; Aspirin; Chest Pain; Coronary Angiography; Hemoglobins, Abnormal; Humans; Male; Myocardial Infarction; Oxygen; Platelet Aggregation Inhibitors; Polycythemia; Treatment Outcome; Warfarin | 2016 |
Warfarin or aspirin after mitral valve repair: Why work harder?
Topics: Anticoagulants; Aspirin; Bioprosthesis; Follow-Up Studies; Heart Valve Prosthesis; Humans; Mitral Valve; Thromboembolism; Warfarin | 2016 |
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Cost-Benefit Analysis; Germany; Humans; Markov Chains; Models, Theoretical; Pyrazoles; Pyridones; Quality of Life; Quality-Adjusted Life Years; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2016 |
Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Canada; Female; Fibrinolytic Agents; Guideline Adherence; Humans; Male; Medical Audit; Middle Aged; Patient Selection; Practice Guidelines as Topic; Warfarin | 2016 |
Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Female; Humans; Male; Middle Aged; Risk Factors; Stroke; Sweden; Treatment Outcome; Warfarin | 2016 |
Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis.
Topics: Aspirin; Atrial Fibrillation; Clinical Laboratory Techniques; Coronary Artery Disease; Fibrinolysis; Fibrinolytic Agents; Heart Diseases; Heart Failure; Humans; Thrombelastography; Thrombosis; Tissue Array Analysis; Warfarin | 2016 |
Study shows aspirin as effective as warfarin for people with heart failure.
Topics: Anticoagulants; Aspirin; Heart Failure; Humans; Warfarin | 2012 |
Ask the doctors. I am a 78-year-old woman and have atrial fibrillation. My physician prescribed me Coumadin. Last month aspirin was added to my regimen. Is it okay to take both of these drugs together?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Female; Humans; Warfarin | 2013 |
Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Australia; Dabigatran; Drug Prescriptions; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Warfarin | 2016 |
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female; Fibrinolytic Agents; Heart Failure; Hemorrhage; Humans; Infections; Lung Diseases; Male; Middle Aged; Neoplasms; Pneumonia; Pulmonary Alveoli; Retrospective Studies; Survival Rate; Tetrazoles; Ticlopidine; Vasculitis; Warfarin | 2016 |
Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Topics: Adolescent; Anticoagulants; Aspirin; Calcium Channel Blockers; Child; Consensus; Contraceptives, Oral; Diuretics; Endothelin Receptor Antagonists; Endothelium-Dependent Relaxing Factors; Humans; Hypertension, Pulmonary; Mineralocorticoid Receptor Antagonists; Nitric Oxide; Oxygen Inhalation Therapy; Phosphodiesterase 5 Inhibitors; Platelet Aggregation Inhibitors; Prostaglandins; Vasodilator Agents; Warfarin | 2016 |
Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Prospective Studies; Risk Assessment; Stroke; Treatment Outcome; Warfarin | 2016 |
Aspirin Is as Effective as and Safer Than Warfarin for Patients at Higher Risk of Venous Thromboembolism Undergoing Total Joint Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Postoperative Period; Retrospective Studies; Risk Factors; Venous Thromboembolism; Warfarin | 2016 |
Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of Japan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Female; Humans; Japan; Male; Markov Chains; Middle Aged; Models, Econometric; Practice Guidelines as Topic; Rivaroxaban; Stroke; Warfarin | 2016 |
Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Hemorrhage; Humans; Incidence; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Odds Ratio; Philadelphia; Platelet Aggregation Inhibitors; Postoperative Complications; Pulmonary Embolism; Reoperation; Retrospective Studies; Surgical Wound Infection; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2016 |
The participations of the physicians on the diagnosis and treatments of antiphospholipid related pregnancy morbidities in Japan: from the result of nationwide survey.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female; Heparin; Humans; Japan; Morbidity; Prednisolone; Pregnancy; Pregnancy Complications; Surveys and Questionnaires; Warfarin | 2015 |
Fatal pulmonary embolism following elective total hip arthroplasty: a 12-year study.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Chemoprevention; Clinical Audit; Elective Surgical Procedures; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Respiratory Tract Infections; United Kingdom; Warfarin | 2016 |
Factors predicting adverse events associated with therapeutic colonoscopy for colorectal neoplasia: a retrospective nationwide study in Japan.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebrovascular Disorders; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Comorbidity; Endoscopic Mucosal Resection; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Incidence; Intestinal Perforation; Japan; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Sex Factors; Steroids; Tumor Burden; Warfarin | 2016 |
Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Ohio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2017 |
No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.
Topics: Anticoagulants; Aspirin; Australia; Female; Fontan Procedure; Heart Defects, Congenital; Hemorrhage; Humans; Long-Term Care; Male; New Zealand; Postoperative Care; Propensity Score; Registries; Thromboembolism; Treatment Outcome; Warfarin | 2016 |
Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Prescriptions; Female; Fibrinolytic Agents; Humans; Male; Risk Assessment; Risk Factors; Stroke; Warfarin | 2016 |
Aspirin in Atrial Fibrillation: The Clot Thickens.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Thrombosis; Warfarin | 2016 |
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.
Topics: Aged; Aspirin; Cardiovascular Diseases; Cerebral Hemorrhage; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Risk Factors; Stroke; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Warfarin | 2016 |
Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Aspirin; Brazil; Cross-Sectional Studies; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Hospitalization; Humans; Male; Middle Aged; Tertiary Care Centers; Warfarin | 2016 |
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Sweden; Thromboembolism; Treatment Outcome; Warfarin | 2016 |
CHA
Topics: Aged; Anticoagulants; Aspirin; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Stroke Volume; Systole; Warfarin | 2016 |
Differences in Esterase Activity to Aspirin and p-Nitrophenyl Acetate among Human Serum Albumin Preparations.
Topics: Aspirin; Esterases; Humans; Hydrolysis; Indomethacin; Naproxen; Nitrophenols; Serum Albumin; Sulfhydryl Compounds; Warfarin | 2016 |
Theoretical study of closed-loop recycling liquid-liquid chromatography and experimental verification of the theory.
Topics: Acetates; Aspirin; Caffeine; Coumarins; Countercurrent Distribution; Ethanol; Hexanes; Models, Theoretical; Recycling; Reproducibility of Results; Solutions; Solvents; Water | 2016 |
Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Clopidogrel; Coronary Artery Disease; Enoxaparin; Female; Fibrinolytic Agents; Humans; Inappropriate Prescribing; Intracranial Hemorrhages; Lebanon; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drug Misuse; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin; Young Adult | 2016 |
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dabigatran; Humans; Italy; Pyrazoles; Pyridones; Rivaroxaban; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin | 2016 |
Repeated Thrombosis After Synthetic Cannabinoid Use.
Topics: Adult; Anticoagulants; Aspirin; Cannabinoids; Enoxaparin; Female; Humans; Infarction; Platelet Aggregation Inhibitors; Pregnancy; Pulmonary Embolism; Risk Factors; Stroke; Substance-Related Disorders; Thromboembolism; Tomography, X-Ray Computed; Warfarin | 2016 |
Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Comorbidity; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Female; Heart Failure; Hemorrhage; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Warfarin | 2016 |
Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.
Topics: Academic Medical Centers; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Retrospective Studies; Warfarin | 2017 |
High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
Topics: Aged; Animals; Anticoagulants; Aspirin; Atrial Fibrillation; Black or African American; C-Reactive Protein; Case-Control Studies; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Risk Factors; Stroke; Warfarin; White People | 2016 |
Acute pulmonary embolism with precordial T-wave inversion and negative D-dimer.
Topics: Aged; Angiography; Anticoagulants; Aspirin; Chest Pain; Diagnosis, Differential; Dyspnea; Electrocardiography; Female; Heparin; Humans; Lower Extremity; Pulmonary Embolism; Tomography, X-Ray Computed; Ultrasonography; Venous Thrombosis; Warfarin | 2017 |
Left ventricular non-compaction cardiomyopathy: Incidental diagnosis after ST-elevation myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiomyopathy, Hypertrophic, Familial; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Echocardiography, Doppler, Color; Electrocardiography; Female; Hematologic Agents; Humans; Incidental Findings; ST Elevation Myocardial Infarction; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2016 |
Letter by Chen et al Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial".
Topics: Aspirin; Heart Failure; Humans; Stroke; Stroke Volume; Warfarin | 2016 |
Response by Di Tullio et al to Letter Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial".
Topics: Aspirin; Heart Failure; Humans; Stroke; Stroke Volume; Ventricular Function, Left; Warfarin | 2016 |
Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation-a cohort study in primary care.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Stroke; Sweden; Ticlopidine; Warfarin | 2017 |
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Computer Simulation; Cost-Benefit Analysis; Drug Costs; Female; Greece; Humans; Male; Models, Theoretical; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk; Stroke; Warfarin | 2017 |
[Current status of warfarin therapy in Chinese patients with nonvalvular atrial fibrillation: a single center analysis].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Asian People; Aspirin; Atrial Fibrillation; China; Hospitalization; Humans; Platelet Aggregation Inhibitors; Warfarin | 2016 |
Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
Topics: Aged; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Blood Coagulation; Brain Ischemia; Female; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Prosthesis Design; Retrospective Studies; Stroke; Thrombosis; Time Factors; Treatment Outcome; Warfarin | 2016 |
Atrial Fibrillation and PCI - Do We Still Need Aspirin?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2016 |
New evidence on old drugs; warfarin versus aspirin after bioprosthetic aortic valve placement.
Topics: Anticoagulants; Aortic Valve; Aspirin; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Thrombosis; Warfarin | 2017 |
Simultaneous Determination of Warfarin and Aspirin Contents in Biological Fluids Using Excitation-Emission Matrix Fluorescence Coupled with a Second-order Calibration Method.
Topics: Algorithms; Aspirin; Blood Chemical Analysis; Calibration; Humans; Spectrometry, Fluorescence; Time Factors; Urinalysis; Warfarin | 2017 |
Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Elective Surgical Procedures; Female; Fibrosis; Humans; Male; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin | 2018 |
Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Cardiac Catheterization; Clopidogrel; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Mitral Valve; Mitral Valve Stenosis; Postoperative Complications; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention: An Evaluation of Prasugrel or Ticagrelor Versus Clopidogrel.
Topics: Adenosine; Aged; Aspirin; Cohort Studies; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Ticagrelor; Warfarin | 2017 |
Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Chi-Square Distribution; Drug Administration Schedule; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Logistic Models; Male; Propensity Score; Prosthesis Design; Republic of Korea; Retrospective Studies; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2017 |
The Cost Differential Between Warfarin Versus Aspirin Treatment After a Fontan Procedure.
Topics: Aspirin; Australia; Costs and Cost Analysis; Female; Fontan Procedure; Humans; International Normalized Ratio; Male; New Zealand; Registries; Warfarin | 2017 |
Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dabigatran; Female; Humans; Injury Severity Score; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Wounds, Nonpenetrating | 2017 |
The risk of lower gastrointestinal bleeding in low-dose aspirin users.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Clopidogrel; Comorbidity; Cyclooxygenase 2 Inhibitors; Databases, Factual; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Taiwan; Ticlopidine; Warfarin; Young Adult | 2017 |
Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prevalence; Proportional Hazards Models; Republic of Korea; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2017 |
Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Databases, Factual; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Pulmonary Embolism; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2017 |
Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
Topics: Anticoagulants; Arrhythmias, Cardiac; Aspirin; Defibrillators, Implantable; Drug Therapy, Combination; Female; Hematoma; Humans; Male; Middle Aged; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Warfarin | 2017 |
Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Polysaccharides; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2017 |
CORR Insights
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Enoxaparin; Factor Xa Inhibitors; Humans; Thromboembolism; Venous Thromboembolism; Warfarin | 2017 |
Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Japan; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; Warfarin | 2017 |
A comparison between vitamin K antagonists and new oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Vitamin K; Warfarin | 2017 |
Internal Carotid Artery Agenesis with an Intercavernous Anastomosis: A Rare Case.
Topics: Angiography, Digital Subtraction; Anticoagulants; Arteriovenous Anastomosis; Aspirin; Carotid Artery, Internal; Cerebral Angiography; Diagnosis, Differential; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Male; Middle Aged; Warfarin | 2017 |
Isolated tricuspid valve Libman-Sacks endocarditis in a patient with antiphospholipid antibody syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Echocardiography; Endocarditis; Female; Heart Valve Diseases; Humans; Ischemic Attack, Transient; Lupus Erythematosus, Systemic; Tricuspid Valve; Warfarin | 2017 |
Superior safety of dual therapy with dabigatran and clopidogrel vs. triple therapy with warfarin, aspirin and clopidogrel in the RE-DUAL PCI trial: What is key, the strategy or the drug?
Topics: Aspirin; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Thromboembolism after WATCHMAN
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Resistance; Drug Substitution; Echocardiography, Transesophageal; Female; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2018 |
Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant).
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Prospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Venous Thrombosis; Warfarin | 2017 |
Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
Topics: Administration, Oral; Aged; Anticoagulants; Arteriovenous Malformations; Aspirin; Blood Transfusion; Case-Control Studies; Dabigatran; Diverticulum; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Hemorrhoids; Hospitalization; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Warfarin | 2018 |
The Effect of Ethanol on the Hydrolysis of Ester-Type Drugs by Human Serum Albumin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antihypertensive Agents; Aspirin; Binding Sites; Drug Stability; Ethanol; Excipients; Fatty Acids, Nonesterified; Humans; Hydrolysis; Indomethacin; Kinetics; Ligands; Naproxen; Nitrophenols; Olmesartan Medoxomil; Preservatives, Pharmaceutical; Serum Albumin, Human; Warfarin | 2018 |
Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Time Factors; Warfarin | 2018 |
Warfarin Prophylaxis for Anterior Infarction: Another Black Mark for Triple Therapy.
Topics: Anterior Wall Myocardial Infarction; Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Infarction; Myocardial Infarction; Warfarin | 2017 |
Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Pulmonary Embolism; Retrospective Studies; Risk Factors; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2018 |
Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Topics: Adolescent; Anticoagulants; Antipyretics; Aspirin; Child; Child, Preschool; China; Coronary Aneurysm; Female; Fever; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocutaneous Lymph Node Syndrome; Prospective Studies; Remission Induction; Risk Factors; Time Factors; Warfarin | 2018 |
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?
Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine; Warfarin | 2018 |
Population-based study examining the utilization of preventive medicines by older people in the last year of life.
Topics: Aged; Aspirin; Cohort Studies; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Terminal Care; Warfarin | 2018 |
Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; England; Female; Gastrointestinal Hemorrhage; Humans; Male; Renal Insufficiency, Chronic; Retrospective Studies; Stroke; Wales; Warfarin | 2018 |
Non-Vitamin K Antagonist Preferred in Patients With Nonvalvular Atrial Fibrillation and Indication for Aspirin Therapy.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Randomized Controlled Trials as Topic; Warfarin | 2018 |
CO poisoning as an associated risk factor for CVT.
Topics: Anticoagulants; Aspirin; Carbon Monoxide Poisoning; Female; Headache Disorders; Humans; Intracranial Thrombosis; Neuroimaging; Treatment Outcome; Venous Thrombosis; Warfarin; Young Adult | 2018 |
Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple-pathway strategy.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Atrial Fibrillation; Cardiovascular System; Comorbidity; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Interleukin-1beta; Models, Theoretical; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Warfarin | 2018 |
Cerebrovascular Accidents During Mechanical Circulatory Support: New Predictors of Ischemic and Hemorrhagic Strokes and Outcome.
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Female; Heart Failure; Heart-Assist Devices; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Quality of Life; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2018 |
Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies.
Topics: Anticoagulants; Aspirin; Clopidogrel; Defibrillators, Implantable; Female; Hematoma; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Implantation; Retrospective Studies; Risk Factors; Warfarin | 2018 |
Monotherapy of acetylsalicylic acid or warfarin for prevention of ischemic stroke in low-risk atrial fibrillation: A Easter Asian population-based study.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Comparative Effectiveness Research; Databases, Factual; Female; Humans; Hyperlipidemias; Hypertension; Incidence; Male; Middle Aged; Risk Assessment; Risk Factors; Stroke; Taiwan; Time Factors; Treatment Outcome; Warfarin; Young Adult | 2019 |
Impact of Aspirin on Warfarin Control as Measured by Time in Therapeutic Range.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Drug Interactions; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Treatment Outcome; Warfarin | 2018 |
Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Conflict of Interest; Dabigatran; Enoxaparin; Female; Fondaparinux; Health Care Sector; Hemorrhage; Humans; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Venous Thromboembolism; Warfarin | 2018 |
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®).
Topics: Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Curcumin; Drug Compounding; Drug Interactions; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Osteoarthritis; Platelet Aggregation Inhibitors; Thyroxine; Ticlopidine; Warfarin | 2018 |
The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cross-Sectional Studies; Drug Combinations; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Prevalence; Statistics, Nonparametric; Treatment Outcome; Turkey; Warfarin | 2019 |
Nonoperative Management of Brachiocephalic Artery Dissection.
Topics: Aged; Anticoagulants; Aorta, Thoracic; Aortic Dissection; Aspirin; Brachiocephalic Trunk; Brain; Clopidogrel; Computed Tomography Angiography; Humans; Male; Platelet Aggregation Inhibitors; Warfarin | 2019 |
Type of Anticoagulant Used After Total Knee Arthroplasty Affects the Rate of Knee Manipulation for Postoperative Stiffness.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Range of Motion, Articular; Retrospective Studies; Venous Thromboembolism; Warfarin | 2018 |
Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case-control study.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Case-Control Studies; Deprescriptions; Endoscopic Mucosal Resection; Factor Xa Inhibitors; Female; Gastroscopy; Heparin; Humans; Incidence; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Propensity Score; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Stomach Neoplasms; Thromboembolism; Time Factors; Warfarin | 2019 |
Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clinical Decision-Making; Dabigatran; Databases, Factual; Enoxaparin; Female; Fondaparinux; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin | 2018 |
Antithrombotic treatment and risk of complications after head and neck full thickness skin graft surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Fibrinolytic Agents; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Perioperative Care; Postoperative Complications; Retrospective Studies; Skin Neoplasms; Skin Transplantation; Warfarin; Young Adult | 2018 |
Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Clopidogrel; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Vitamin K; Warfarin | 2018 |
Management of dental extractions in patients on warfarin and antiplatelet therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Clopidogrel; Female; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Taiwan; Tooth Extraction; Tranexamic Acid; Warfarin; Young Adult | 2018 |
Coronary embolism following Bentall procedure and hemiarch resection for acute Type A aortic dissection.
Topics: Acute Disease; Anticoagulants; Aortic Aneurysm; Aortic Dissection; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Thrombosis; Heparin; Humans; Male; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Treatment Outcome; Warfarin | 2018 |
[Cerebral embolism in Duchenne muscular dystrophy after respiratory tract infection - Report of two cases].
Topics: Adult; Anticoagulants; Aspirin; Brain; Diffusion Magnetic Resonance Imaging; Echocardiography; Heart Diseases; Heart Ventricles; Heparin; Humans; Intracranial Embolism; Magnetic Resonance Angiography; Male; Muscular Dystrophy, Duchenne; Respiratory Tract Infections; Risk; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2018 |
Impact of oral anticoagulants on 30-day readmission: a study from a single academic centre.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Comorbidity; Confounding Factors, Epidemiologic; Emergency Service, Hospital; Facilities and Services Utilization; Female; Hemorrhage; Humans; Illinois; Length of Stay; Male; Middle Aged; Patient Readmission; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Rivaroxaban; Warfarin | 2019 |
Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Coronary Artery Disease; Denmark; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Stroke; Warfarin | 2018 |
[Side Effects of Anticoagulant and Antithrombotic Therapy and their Management].
Topics: Anticoagulants; Aspirin; Heparin; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Warfarin | 2016 |
The Effects of Direct Oral Anticoagulants, Warfarin, Aspirin and Thienopyridine on the Performance of Immunochemical, Faecal, Occult Blood Tests.
Topics: Adenoma; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; False Positive Reactions; Feces; Female; Humans; Japan; Male; Mass Screening; Middle Aged; Occult Blood; Predictive Value of Tests; Prospective Studies; Pyridines; Retrospective Studies; Warfarin | 2019 |
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Female; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Intracranial Hemorrhages; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan; Thrombosis; Treatment Failure; Warfarin; Young Adult | 2019 |
Triple therapy after PCI - Warfarin treatment quality and bleeding risk.
Topics: Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Hematologic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Warfarin | 2018 |
Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
Topics: Aged; Aortic Valve; Aspirin; Bioprosthesis; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Treatment Outcome; Veterans Health; Warfarin | 2019 |
Aspirin Alone Is Not Enough to Prevent Deep Venous Thrombosis After Total Joint Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Drug Therapy, Combination; Enoxaparin; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Venous Thrombosis; Warfarin | 2019 |
Anticoagulation in patients with Embolic Stroke of Unknown Source.
Topics: Anticoagulants; Aspirin; Embolism, Paradoxical; Foramen Ovale, Patent; Humans; Monitoring, Physiologic; Phenotype; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2019 |
Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Databases, Factual; Enoxaparin; Female; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Orthopedic Procedures; Orthopedics; Practice Patterns, Physicians'; Risk Factors; Rivaroxaban; United States; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2019 |
Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening.
Topics: Adenoma; Administration, Oral; Aged; Anticoagulants; Aspirin; Colonoscopy; Colorectal Neoplasms; Cross-Sectional Studies; Early Detection of Cancer; Female; Humans; Immunochemistry; Male; Middle Aged; Occult Blood; Platelet Aggregation Inhibitors; Predictive Value of Tests; Warfarin | 2019 |
Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Databases, Factual; Factor Xa Inhibitors; Female; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Venous Thromboembolism; Warfarin | 2019 |
Stroke prevention in atrial fibrillation: Closing the gap.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Health Services Misuse; Hemorrhage; Humans; International Normalized Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Septal Occluder Device; Stroke; Thiazoles; Warfarin | 2019 |
Nasogastric Tubes Can Cause Intramural Hematoma of the Esophagus.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Esophageal Diseases; Hematoma; Humans; Intubation, Gastrointestinal; Male; Platelet Aggregation Inhibitors; Warfarin | 2019 |
Assessment of Late Thromboembolic Complications Post-Fontan Procedure in Relation to Different Antithrombotic Regimens: 30-Years' Follow-up Experience.
Topics: Aspirin; Child, Preschool; Female; Fibrinolytic Agents; Follow-Up Studies; Fontan Procedure; Hemorrhage; Humans; Primary Prevention; Retrospective Studies; Thromboembolism; Warfarin | 2019 |
A Quality Improvement Educational Intervention to Increase Knowledge of Cardiogastroenterology Amongst Medical Trainees and Nursing Staff.
Topics: Anticoagulants; Aspirin; Clinical Competence; Clopidogrel; Endoscopy; Fibrinolytic Agents; Gastroenterology; Guideline Adherence; Guidelines as Topic; Humans; Nursing Staff; Platelet Aggregation Inhibitors; Quality Improvement; Students, Medical; Surveys and Questionnaires; Teaching; Warfarin | 2017 |
Uptake of Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in a Single Clinical Commissioning Group in England Without Restrictions to Their Use.
Topics: Administration, Oral; Advisory Committees; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Utilization; England; Female; Humans; Male; Middle Aged; Retrospective Studies; Stroke; Warfarin | 2019 |
Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Thromboembolism; United States; Warfarin | 2019 |
Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Logistic Models; Male; Middle Aged; Postoperative Complications; Prevalence; Propensity Score; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Venous Thromboembolism; Warfarin | 2019 |
Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2020 |
In Regard to Kılıç et al.
Topics: Aspirin; Prevalence; Warfarin | 2019 |
Development and Validation of the Warfarin-Aspirin Bleeding Assessment Tool (WA-BAT) in Children.
Topics: Adolescent; Anticoagulants; Aspirin; Blood Coagulation Disorders; Blood Coagulation Tests; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Predictive Value of Tests; Warfarin | 2020 |
Critical appraisal of the AUGUSTUS trial.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Factor Xa Inhibitors; Hemorrhage; Humans; Incidence; Percutaneous Coronary Intervention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome; Warfarin | 2019 |
In Reply to Keskin and Orhan
Topics: Anticoagulants; Aspirin; Drug Interactions; Prevalence; Warfarin | 2019 |
Petechial cimicosis in a patient on aspirin 81 mg, clopidogrel and warfarin.
Topics: Aged; Animals; Anticoagulants; Aspirin; Bedbugs; Clopidogrel; Humans; Insect Bites and Stings; Male; Platelet Aggregation Inhibitors; Purpura; Warfarin | 2019 |
Systolic anterior motion: an unusual cause of late mitral valve repair failure.
Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Cardiomyopathy, Hypertrophic; Dyspnea; Echocardiography, Transesophageal; Female; Humans; Middle Aged; Mitral Valve Insufficiency; Platelet Aggregation Inhibitors; Reoperation; Systole; Treatment Outcome; Ventricular Outflow Obstruction; Warfarin | 2019 |
Stroke and transient ischemic attacks related to antiplatelet or warfarin interruption.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brazil; Clopidogrel; Cross-Sectional Studies; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2019 |
Anticoagulation in Revision Total Joint Arthroplasty: A Retrospective Review of 1917 Cases.
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Humans; Male; Middle Aged; Postoperative Complications; Postoperative Period; Reoperation; Retrospective Studies; Risk Factors; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Warfarin | 2019 |
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation Tests; Cross-Sectional Studies; Factor Xa Inhibitors; Female; Fibrin Clot Lysis Time; Fibrinolysis; Humans; Ischemic Stroke; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Thrombelastography; Warfarin | 2019 |
The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
Topics: Aged; Anticoagulants; Aspirin; Deprescriptions; Female; Fibrinolytic Agents; Heart Failure; Heart-Assist Devices; Heparin; Humans; International Normalized Ratio; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Thromboembolism; Time Factors; Warfarin | 2020 |
Long-term discontinuation of warfarin in a patient with HeartMate 3 left ventricular assist device without complication.
Topics: Adult; Anticoagulants; Aspirin; Cardiomyopathies; Female; Heart Ventricles; Heart-Assist Devices; Humans; Thromboembolism; Time Factors; Treatment Refusal; Warfarin; Withholding Treatment | 2020 |
Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF.
Topics: Aged; Anticoagulants; Aspirin; Cognitive Dysfunction; Female; Fibrinolytic Agents; Heart Failure, Systolic; Humans; Male; Middle Aged; Retrospective Studies; Stroke Volume; Time Factors; Warfarin | 2019 |
Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Blood Coagulation Factors; Cerebral Hemorrhage; Female; Heart Valve Prosthesis; Hematoma, Subdural; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Middle Aged; Mitral Valve; Plasma; Platelet Aggregation Inhibitors; Pregnancy; Retrospective Studies; Subarachnoid Hemorrhage; Subarachnoid Hemorrhage, Traumatic; Thromboembolism; Vitamin K; Warfarin | 2020 |
Multi spectroscopy and molecular modeling aspects related to drug interaction of aspirin and warfarin with pepsin; structural change and protease activity.
Topics: Aspirin; Binding Sites; Circular Dichroism; Computer Simulation; Drug Interactions; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Molecular Dynamics Simulation; Pepsin A; Protein Binding; Protein Conformation; Spectrometry, Fluorescence; Spectrophotometry; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Thermodynamics; Warfarin | 2020 |
Coronary artery aneurysm in Kawasaki disease: from multimodality imaging.
Topics: Anticoagulants; Aspirin; Computed Tomography Angiography; Coronary Aneurysm; Coronary Angiography; Coronary Thrombosis; Echocardiography; Female; Humans; Imaging, Three-Dimensional; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Tomography, X-Ray Computed; Vascular Calcification; Warfarin; Young Adult | 2020 |
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percut
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Thromboembolism; Ticagrelor; Treatment Outcome; Warfarin | 2020 |
Prevalence of Intracranial Injury in Adult Patients With Blunt Head Trauma With and Without Anticoagulant or Antiplatelet Use.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Injuries; Clopidogrel; Female; Head Injuries, Closed; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Risk Factors; Warfarin | 2020 |
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine.
Topics: Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Aspirin; Clinical Decision-Making; Clopidogrel; Coronary Stenosis; Disease Progression; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Assessment; Thrombosis; Treatment Outcome; Warfarin | 2020 |
Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.
Topics: Adalimumab; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Aspirin; Crohn Disease; Female; Hand; Humans; Ischemia; Middle Aged; Peripheral Vascular Diseases; Radial Artery; Warfarin | 2020 |
Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Female; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Incidence; Male; Medical Audit; New Zealand; Orthopedic Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2020 |
Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk.
Topics: Aged; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Aspirin; Diet Therapy; Exercise; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Recurrence; Risk Reduction Behavior; Secondary Prevention; Smoking Cessation; Stroke; Warfarin | 2020 |
Risk Versus Benefit of Combined Aspirin and Warfarin Therapy in Patients With Atrial Fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2021 |
Is aspirin needed to prevent thrombotic events in patients treated with a HeartMate 3 left ventricular assist device?
Topics: Aspirin; Heart-Assist Devices; Humans; Thrombosis; Warfarin | 2020 |
A methodology for investigating the impact of medical countermeasures on the risk of exposure induced death.
Topics: Aerospace Medicine; Aspirin; Astronauts; Cosmic Radiation; Humans; Medical Countermeasures; Neoplasms, Radiation-Induced; Radiation Protection; Risk Assessment; Space Flight; Warfarin | 2020 |
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
Topics: Antigens, Human Platelet; Arginine; Aspirin; Autoantibodies; Combined Modality Therapy; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Eptifibatide; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Stents; Sulfonamides; Thrombectomy; Thrombolytic Therapy; Thrombosis; Ticagrelor; Warfarin | 2020 |
Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Conduction; Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Chemoprevention; Early Ambulation; Elective Surgical Procedures; Female; Follow-Up Studies; Heparin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Rivaroxaban; Venous Thromboembolism; Warfarin | 2020 |
Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Atrial Fibrillation; Bicuspid Aortic Valve Disease; Bioprosthesis; Coronary Artery Disease; Factor Xa Inhibitors; Female; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Postoperative Care; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Stroke; Thromboembolism; Warfarin; Young Adult | 2020 |
Prevalence and Outcome of Potential Candidates for Left Atrial Appendage Closure After Stroke With Atrial Fibrillation: WATCH-AF Registry.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Female; Follow-Up Studies; Humans; Male; Prevalence; Prospective Studies; Registries; Stroke; Treatment Outcome; Warfarin | 2020 |
Continued Aspirin Treatment May Be a Risk Factor of Delayed Bleeding after Gastric Endoscopic Submucosal Dissection under Heparin Replacement: A Retrospective Multicenter Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Endoscopic Mucosal Resection; Female; Heparin; Humans; Japan; Male; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Stomach Neoplasms; Warfarin | 2020 |
Anticoagulation and Antiplatelet Therapy in Atrial Fibrillation: A Teachable Moment.
Topics: Accidental Falls; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Humans; Male; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stroke; Warfarin | 2020 |
Cap-fitted identification and endoscopic haemostasis of a tiny vascular colonic lesion under maintained triple antithrombotic therapy.
Topics: Aspirin; Blood Transfusion; Clopidogrel; Colonic Diseases; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Digestive System; Equipment Design; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Ileocecal Valve; Male; Middle Aged; Reoperation; Thrombosis; Warfarin | 2021 |
Is it safe to take Radix Salvia Miltiorrhiza - Radix Pueraria Lobate product with warfarin and aspirin? A pilot study in healthy human subjects.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Healthy Volunteers; Herb-Drug Interactions; Humans; Male; Middle Aged; Pilot Projects; Pueraria; Salvia miltiorrhiza; Warfarin; Young Adult | 2020 |
Persistent Wound Drainage among Total Joint Arthroplasty Patients Receiving Aspirin vs Coumadin.
Topics: Arthroplasty, Replacement, Hip; Aspirin; Drainage; Humans; Postoperative Complications; Retrospective Studies; Risk Factors; Venous Thromboembolism; Warfarin | 2020 |
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biomarkers; Cohort Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Warfarin | 2020 |
Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Bioprosthesis; China; Comorbidity; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Middle Aged; Mortality; Prospective Studies; Risk Factors; Sex Factors; Stroke; Thromboembolism; Time Factors; Warfarin | 2021 |
Desmopressin with four-factor prothrombin complex concentrate for life-threatening bleeding: A case series.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Cerebral Hemorrhage, Traumatic; Cerebral Intraventricular Hemorrhage; Clopidogrel; Deamino Arginine Vasopressin; Female; Fractures, Bone; Hematoma; Hematoma, Subdural, Intracranial; Hemostatics; Humans; International Normalized Ratio; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Pelvic Bones; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Subarachnoid Hemorrhage, Traumatic; Thrombosis; Warfarin | 2020 |
Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Blood Transfusion; Clopidogrel; Continuity of Patient Care; Humans; Incidence; Male; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prasugrel Hydrochloride; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Robotic Surgical Procedures; Thrombosis; Warfarin | 2021 |
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutio
Topics: Academic Medical Centers; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Computer Security; Databases, Factual; Embolism; Female; Humans; Information Dissemination; Male; Multicenter Studies as Topic; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2021 |
Comparison of Warfarin to Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thrombosis; Transcatheter Aortic Valve Replacement; Warfarin | 2021 |
Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Coronary Aneurysm; Female; Guideline Adherence; Humans; Male; Mucocutaneous Lymph Node Syndrome; Registries; Retrospective Studies; Venous Thromboembolism; Warfarin | 2021 |
Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO).
Topics: Anticoagulants; Aspirin; C-Reactive Protein; Gangrene; Heparin, Low-Molecular-Weight; Humans; Inflammation; Pain; Prospective Studies; Thromboangiitis Obliterans; Treatment Outcome; Ulcer; Warfarin | 2021 |
The efficacy and safety of Hirudin plus Aspirin versus Warfarin in the secondary prevention of Cardioembolic Stroke due to Nonvalvular Atrial Fibrillation: A multicenter prospective cohort study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Embolic Stroke; Female; Follow-Up Studies; Hirudins; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Secondary Prevention; Treatment Outcome; Warfarin | 2021 |
Long-term outcomes of warfarin versus aspirin after Fontan surgery.
Topics: Anticoagulants; Aspirin; Australia; Bone Density; Chemoprevention; Child; Cohort Studies; Female; Fontan Procedure; Heart Defects, Congenital; Hemorrhage; Humans; Long Term Adverse Effects; Male; New Zealand; Outcome Assessment, Health Care; Postoperative Complications; Quality of Life; Thromboembolism; Warfarin | 2021 |
Commentary: Aspirin versus warfarin in patients with a Fontan circulation-the clot thickens.
Topics: Aspirin; Fontan Procedure; Humans; Thromboembolism; Thrombosis; Warfarin | 2021 |
Comparative risk for intracranial hemorrhage related to new oral anticoagulants: A network meta-analysis.
Topics: Administration, Oral; Antithrombins; Aspirin; Clinical Trials, Phase III as Topic; Humans; Intracranial Hemorrhages; Mortality; Network Meta-Analysis; Randomized Controlled Trials as Topic; Risk Assessment; Warfarin | 2021 |
Timing of bleeding and thromboembolism associated with endoscopic submucosal dissection for gastric cancer in Japan.
Topics: Anticoagulants; Aspirin; Endoscopic Mucosal Resection; Fibrinolytic Agents; Gastric Mucosa; Humans; Japan; Male; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Stomach Neoplasms; Thienopyridines; Thromboembolism; Warfarin | 2021 |
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Bortezomib; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Female; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Survival Rate; Thromboembolism; Warfarin | 2021 |
Spontaneous Spinal Epidural Hematoma in an Adult Patient with Complex Congenital Heart Disease.
Topics: Adult; Anticoagulants; Aortic Valve Stenosis; Aspirin; Heart Defects, Congenital; Heart Septal Defects, Ventricular; Heart Valve Prosthesis Implantation; Hematoma, Epidural, Spinal; Humans; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Warfarin | 2021 |
A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Cohort Studies; Humans; Postoperative Complications; Retrospective Studies; Venous Thromboembolism; Warfarin | 2021 |
[Anti-Platelet and Anti-Coagulant Drugs].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Pharmaceutical Preparations; Platelet Aggregation Inhibitors; Stroke; Warfarin | 2021 |
In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Japan; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Registries; Retrospective Studies; Warfarin | 2021 |
Letter to the Editor. Aspirin versus anticoagulation for stroke prophylaxis: a dispute not yet closed.
Topics: Anticoagulants; Aspirin; Dissent and Disputes; Humans; Stroke; Warfarin | 2021 |
Eastern Association for the Surgery of Trauma Multicenter Trial: Comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients.
Topics: Aged; Anticoagulant Reversal Agents; Aspirin; Brain Injuries, Traumatic; Cardiovascular Diseases; Comorbidity; Deamino Arginine Vasopressin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Hospital Mortality; Humans; Male; Platelet Transfusion; Risk Assessment; Trauma Severity Indices; Treatment Outcome; United States; Warfarin | 2022 |
Is Continuing Anticoagulation or Antiplatelet Therapy Safe Prior to Kidney Transplantation?
Topics: Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Warfarin | 2021 |
Bleeding in patients with continuous-flow left ventricular assist devices: acquired von Willebrand disease or antithrombotics?
Topics: Aspirin; Fibrinolytic Agents; Heart-Assist Devices; Hemorrhage; Humans; von Willebrand Diseases; von Willebrand Factor; Warfarin | 2022 |
Aspirin, NOACs, warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Cognitive Dysfunction; Dementia; Humans; Warfarin | 2022 |
Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anticoagulants; Aspirin; BCG Vaccine; Clopidogrel; Fibrin; Humans; Neoplasm Recurrence, Local; Thrombosis; Urinary Bladder Neoplasms; Warfarin | 2022 |
Endothelium-Mimicking Nanomatrix Coating to Enhance Endothelialization after Left Atrial Appendage Closure Device Implantation.
Topics: Animals; Anticoagulants; Aorta; Aspirin; Atrial Appendage; Cardiac Surgical Procedures; Cell Proliferation; Cells, Cultured; Dogs; Endothelial Cells; Endothelium; Humans; Membranes, Artificial; Nanostructures; Nitric Oxide; Peptides; Platelet Adhesiveness; Warfarin | 2021 |
Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Hemorrhage; Heparin; Humans; Retrospective Studies; Venous Thromboembolism; Warfarin | 2022 |
Therapeutic-Dose Warfarin (International Normalized Ratio >1.6) Plus Aspirin Improved Long-Term Patency of Saphenous Vein Graft without Bleeding Complication.
Topics: Aspirin; Coronary Angiography; Graft Occlusion, Vascular; Humans; International Normalized Ratio; Saphenous Vein; Treatment Outcome; Vascular Patency; Warfarin | 2022 |
Time to Venous Thromboembolism Events Following Total Hip Arthroplasty: A Comparison Between Aspirin and Warfarin.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; Pulmonary Embolism; Retrospective Studies; Venous Thromboembolism; Warfarin | 2022 |
Anticoagulation Therapy After the Fontan Procedure.
Topics: Anticoagulants; Aspirin; Child; Fontan Procedure; Hemorrhage; Humans; Retrospective Studies; Thromboembolism; Warfarin | 2022 |
Long-term anticoagulation is associated with type II endoleaks and failure of sac regression after endovascular aneurysm repair.
Topics: Anticoagulants; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Aspirin; Blood Vessel Prosthesis Implantation; Endoleak; Endovascular Procedures; Humans; Retrospective Studies; Risk Factors; Treatment Outcome; Warfarin | 2022 |
Antiplatelets and Anticoagulants in Ischemic Stroke,Transient Ischaemic Attack: A Practice Survey Among Singapore Neurologists.
Topics: Adult; Anticoagulants; Aspirin; Cerebrovascular Disorders; Female; Heparin; Humans; Ischemic Attack, Transient; Ischemic Stroke; Neurologists; Platelet Aggregation Inhibitors; Singapore; Stroke; Surveys and Questionnaires; Warfarin | 2022 |
Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Fibrinolytic Agents; Frailty; Humans; Stroke; Treatment Outcome; Warfarin | 2022 |
Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization.
Topics: Anticoagulants; Aspirin; Humans; Hypertension, Portal; Laparoscopy; Liver Cirrhosis; Portal Vein; Risk Factors; Splenectomy; Thrombosis; Venous Thrombosis; Warfarin | 2022 |
The effect of antithrombotic drug use on delayed bleeding with esophageal endoscopic resection.
Topics: Anticoagulants; Aspirin; Endoscopic Mucosal Resection; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Thienopyridines; Warfarin | 2022 |
Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty.
Topics: Ankle; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Chemoprevention; Cost-Benefit Analysis; Enoxaparin; Humans; Postoperative Complications; Rivaroxaban; Venous Thromboembolism; Warfarin | 2022 |
Some Points for the KDIGO 2021 Guideline for Prophylactic Anticoagulation in Membranous Nephropathy: Is It Clear Enough for Us to Follow?
Topics: Anticoagulants; Aspirin; Glomerulonephritis, Membranous; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Hypoalbuminemia; Kidney; Venous Thromboembolism; Warfarin | 2023 |
Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Hemorrhage; Humans; Male; Middle Aged; Venous Thromboembolism; Warfarin | 2022 |
A descriptive cross-sectional study of self-management in patients with nonvalvular atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cross-Sectional Studies; Humans; Self-Management; Stroke; Warfarin | 2022 |
A rare cause of abdominal pain managed unconventionally: acute renal infarction caused by atrial fibrillation: a case report.
Topics: Abdominal Pain; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Diltiazem; Humans; Infarction; Male; Nitroglycerin; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin | 2022 |
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; Humans; Male; Mucocutaneous Lymph Node Syndrome; Quality of Life; Tissue Plasminogen Activator; Warfarin | 2022 |
Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients.
Topics: Anticoagulants; Aspirin; Child; Fibrinolytic Agents; Fontan Procedure; Humans; Prospective Studies; Thrombosis; Venous Thromboembolism; Warfarin | 2023 |
Thromboprophylaxis in the Fontan Circulation: Long-Awaited Validation.
Topics: Anticoagulants; Aspirin; Fontan Procedure; Humans; Venous Thromboembolism; Warfarin | 2023 |
Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Aspirin; Cohort Studies; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Venous Thromboembolism; Warfarin | 2023 |
Aspirin for Venous Thromboembolic Prophylaxis Following Total Hip and Total Knee Arthroplasty: An Analysis of Safety and Efficacy Accounting for Surgeon Selection Bias.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Humans; Pulmonary Embolism; Selection Bias; Surgeons; Venous Thromboembolism; Warfarin | 2023 |
Full Reversal of Anticoagulants Before Cephalomedullary Fixation of Geriatric Hip Fractures May Not Be Necessary.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Cohort Studies; Hip Fractures; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Warfarin | 2023 |
Impact of continued clopidogrel use on outcomes of patients undergoing carotid endarterectomy.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Endarterectomy, Carotid; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2023 |
Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Eye; Hemorrhage; Humans; Japan; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Rivaroxaban; Warfarin | 2023 |
Not all traumatic brain injury patients on preinjury anticoagulation are the same.
Topics: Aged; Anticoagulants; Aspirin; Brain Injuries, Traumatic; Humans; Retrospective Studies; Warfarin | 2023 |
The Budget Impact Analysis of Adopting Direct Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation Patients in Malawi.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Malawi; Stroke; Warfarin | 2023 |
Genetics and the Quest to Define Sources of Cardiac Embolism.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Embolism; Humans; Risk Factors; Warfarin | 2023 |
Warfarin and Aspirin or Aspirin Alone After Transcatheter Aortic Valve Replacement? "No" to Warfarin.
Topics: Anticoagulants; Aortic Valve; Aspirin; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Transcatheter Aortic Valve Replacement; Warfarin | 2023 |
Long-Term Medical Treatment and Adherence in Patients With Left Ventricular Assist Devices: A Danish Nationwide Cohort Study.
Topics: Aspirin; Cohort Studies; Denmark; Heart Failure; Heart-Assist Devices; Humans; Retrospective Studies; Treatment Outcome; Warfarin | 2023 |
DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Registries; Stroke; Thrombosis; Treatment Outcome; Warfarin | 2023 |